| FHH-Chr 16BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
14 |
|
|
104.54 |
breaths/min |
4.82 |
18.05 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14979 |
381 |
| GH/OmrMcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
7 |
|
|
108.72 |
breaths/min |
8.81 |
23.32 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14980 |
381 |
| FHH-Chr 19BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
11 |
|
|
101.42 |
breaths/min |
5.09 |
16.87 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14993 |
381 |
| FHH-Chr 13BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
10 |
|
|
98.24 |
breaths/min |
2.05 |
6.49 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14996 |
381 |
| FHH-Chr 11BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
7 |
|
|
101.79 |
breaths/min |
8.32 |
22.01 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15009 |
381 |
| SS-Chr XBN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
10 |
|
|
91.48 |
breaths/min |
3.38 |
10.69 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15005 |
381 |
| FHH-Chr 11BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
4 |
|
|
103.4 |
breaths/min |
13.56 |
27.11 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15010 |
381 |
| FHH-Chr 12BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
17 |
|
|
127.74 |
mmHg |
4.23 |
17.45 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15064 |
381 |
| SS-Chr 10BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
9 |
|
|
119.36 |
mmHg |
5.26 |
15.77 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15077 |
381 |
| FHH-Chr 16BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
4 |
|
|
125.37 |
mmHg |
4.72 |
9.44 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15079 |
381 |
| SS-Chr 15BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
4 |
|
|
135.04 |
mmHg |
2.78 |
5.56 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15099 |
381 |
| SS-Chr 13BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
10 |
|
|
119.15 |
mmHg |
2.18 |
6.89 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15107 |
381 |
| FHH/EurMcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
18 |
|
|
129.83 |
mmHg |
3.33 |
14.14 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15113 |
381 |
| SS-Chr 2BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
10 |
|
|
124.3 |
mmHg |
7.17 |
22.68 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15133 |
381 |
| SS-Chr 19BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
1 |
|
|
134.49 |
mmHg |
|
|
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15131 |
381 |
| SS-Chr XBN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
7 |
|
|
140.41 |
mmHg |
7.53 |
19.92 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15138 |
381 |
| BN/NHsdMcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
14 |
|
|
122.79 |
mmHg |
5.11 |
19.13 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15136 |
381 |
| Hsd:SD |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
17 |
|
|
32.44 |
ml/min |
1.32 |
5.46 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
15161 |
381 |
| GH/OmrMcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
7 |
|
|
35.08 |
ml/min |
2.41 |
6.38 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
15178 |
381 |
| SS/JrHsdMcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
6 |
|
|
427.49 |
beats/min |
15.86 |
38.84 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
15191 |
381 |
| GH/OmrMcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
7 |
|
|
169.25 |
mmHg |
4.4 |
11.63 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
15206 |
381 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
7 |
|
|
126.83 |
mmHg |
3.13 |
8.27 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
15205 |
381 |
| FHH-Chr 7BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
8 |
|
|
0.21 |
ml |
0.04 |
0.11 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15480 |
381 |
| LEW/Crl |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
16 |
|
|
29.03 |
ml/min |
1.12 |
4.46 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
15494 |
381 |
| F344/DuCrl |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
11 |
|
|
26.17 |
ml/min |
2.81 |
9.32 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
15496 |
381 |
| LE/BluGill |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
12 |
|
|
41.14 |
ml/min |
2.95 |
10.21 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
15497 |
381 |
| Hsd:SD |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
male |
82.0 days-99.0 days |
8 |
|
|
36.59 |
mmHg |
1.24 |
3.5 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
15521 |
381 |
| SS-Chr 18BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
7 |
|
|
118.51 |
mmHg |
2.56 |
6.78 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
15551 |
381 |
| FHH/EurMcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
9 |
|
|
129.17 |
mmHg |
2.23 |
6.69 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
15553 |
381 |
| SS/JrHsdMcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
13 |
|
|
27.16 |
ml/min |
1.72 |
6.22 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
15612 |
381 |
| SHR/NCrl |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
9 |
|
|
25.84 |
ml/min |
1.96 |
5.89 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
15615 |
381 |
| FHH/EurMcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
8 |
|
|
32.2 |
ml/min |
2.64 |
7.48 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
15618 |
381 |
| FHH-Chr 12BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
15 |
|
|
421.37 |
beats/min |
8.75 |
33.89 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15902 |
381 |
| SS-Chr 6BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
11 |
|
|
441.34 |
beats/min |
6.17 |
20.47 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15906 |
381 |
| FHH-Chr 16BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
8 |
|
|
417.53 |
beats/min |
15.72 |
44.46 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15926 |
381 |
| SS-Chr 16BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
9 |
|
|
452.12 |
beats/min |
11.47 |
34.4 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15931 |
381 |
| SS-Chr 3BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
5 |
|
|
441.68 |
beats/min |
10.42 |
23.3 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15933 |
381 |
| FHH-Chr 8BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
7 |
|
|
378.8 |
beats/min |
6.76 |
17.88 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15937 |
381 |
| F344/NHsd |
mean pulmonary arterial blood pressure |
control condition |
Zhao L et al., 2001, Circulation, 103(3), 442-7 |
pulmonary arterial blood pressure trait |
male |
105.0 days
| 12 |
|
median |
16.0 |
mmHg |
|
|
vascular indwelling catheter method |
pulmonary artery |
0 |
|
|
|
|
|
|
|
66123 |
102 |
| FHH/EurMcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
0.36 |
ml |
0.01 |
0.05 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
15326 |
381 |
| SS/JrHsdMcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
13 |
|
|
0.32 |
ml |
0.02 |
0.08 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
15325 |
381 |
| GH/OmrMcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
6 |
|
|
0.33 |
ml |
0.01 |
0.03 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
15332 |
381 |
| FHH-Chr 10BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
10 |
|
|
0.2 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15396 |
381 |
| FHH-Chr 8BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
10 |
|
|
0.3 |
ml |
0.02 |
0.08 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15402 |
381 |
| FHH-Chr 4BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
13 |
|
|
0.28 |
ml |
0.02 |
0.07 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15413 |
381 |
| FHH-Chr 1BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
15 |
|
|
0.27 |
ml |
0.01 |
0.05 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15412 |
381 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
9 |
|
|
0.3 |
ml |
0.02 |
0.07 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15416 |
381 |
| SS-Chr 2BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
12 |
|
|
0.32 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15424 |
381 |
| SS-Chr 10BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
11 |
|
|
0.27 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15426 |
381 |
| SS-Chr 14BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
0.24 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15429 |
381 |
| FHH/EurMcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
12 |
|
|
0.32 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15450 |
381 |
| SS-Chr 3BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
0.29 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15459 |
381 |
| SS-Chr 11BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
9 |
|
|
0.26 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15460 |
381 |
| SS-Chr 11BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
10 |
|
|
0.26 |
ml |
0.02 |
0.05 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15463 |
381 |
| SS-Chr 1BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
10 |
|
|
0.25 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15466 |
381 |
| SS/JrHsdMcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
12 |
|
|
0.32 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15470 |
381 |
| SS-Chr 4BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
13 |
|
|
0.24 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15473 |
381 |
| FHH-Chr 9BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
0.2 |
ml |
0.02 |
0.05 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15474 |
381 |
| Hsd:SD |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
17 |
|
|
0.34 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
14388 |
381 |
| WKY/NCrl |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
11 |
|
|
0.27 |
ml |
0.02 |
0.07 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
14428 |
381 |
| F344/DuCrl |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
11 |
|
|
0.23 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
14437 |
381 |
| LE/BluGill |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
9 |
|
|
0.31 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
14434 |
381 |
| LE/BluGill |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
12 |
|
|
0.36 |
ml |
0.03 |
0.09 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
14438 |
381 |
| SS-Chr 18BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
9 |
|
|
98.79 |
breaths/min |
6.44 |
19.32 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
14439 |
381 |
| BN/NHsdMcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
9 |
|
|
96.96 |
breaths/min |
3.05 |
9.16 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
14447 |
381 |
| SS-Chr 18BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
7 |
|
|
83.95 |
breaths/min |
2.65 |
7.02 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
14444 |
381 |
| BN/NHsdMcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
8 |
|
|
83.34 |
breaths/min |
5.83 |
16.48 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
14448 |
381 |
| SHR/NCrl |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
10 |
|
|
99.31 |
breaths/min |
3.06 |
9.68 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
14450 |
381 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
4 |
|
|
122.43 |
mmHg |
4.51 |
9.02 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
14658 |
381 |
| SHR/Snk |
platelet intracellular calcium level |
control condition |
Ohno Y, et al., Am J Hypertens. 2007 Feb;20(2):172-6. |
platelet calcium amount |
not specified |
105.0 days
| 15 |
|
|
42.0 |
nmol/l |
2.07 |
8.0 |
Fura-2 intracellular calcium assay |
|
0 |
|
|
|
|
|
|
|
64974 |
301 |
| SHR.F344-(D12Mgh5-D12Mgh6)/Snk |
platelet intracellular calcium level |
control condition |
Ohno Y, et al., Am J Hypertens. 2007 Feb;20(2):172-6. |
platelet calcium amount |
not specified |
105.0 days
| 10 |
|
|
48.0 |
nmol/l |
2.53 |
8.0 |
Fura-2 intracellular calcium assay |
|
0 |
|
|
|
|
|
|
|
64975 |
301 |
| SS-Chr 3BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
3 |
|
|
458.32 |
beats/min |
23.26 |
40.29 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15939 |
381 |
| FHH-Chr 13BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
7 |
|
|
390.9 |
beats/min |
11.07 |
29.29 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15941 |
381 |
| SHR |
heart rate |
control condition (for 98 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
heart pumping trait |
male |
87.0 days
| 23 |
|
continuous mean |
365.0 |
beats/min |
3.0 |
14.39 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
|
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
|
65353 |
306 |
| MWF-Chr 6SHR/Rkb |
urine albumin level to urine low molecular weight protein ratio |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
urine albumin amount |
not specified |
168.0 days
| 19 |
|
|
159.0 |
% |
42.0 |
183.07 |
gel electrophoresis |
|
0.0 |
|
|
|
|
|
|
|
65356 |
117 |
| MWF-Chr 6SHR/Rkb |
both kidneys wet weight |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
kidney mass |
not specified |
168.0 days
| 19 |
|
|
2.11 |
g |
0.07 |
0.31 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
65362 |
117 |
| FHH-Chr 20BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
6 |
|
|
420.01 |
beats/min |
15.46 |
37.86 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15944 |
381 |
| FHH-Chr 11BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
3 |
|
|
466.66 |
beats/min |
34.17 |
59.19 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15963 |
381 |
| SS-Chr XBN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
6 |
|
|
444.42 |
beats/min |
16.2 |
39.69 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15971 |
381 |
| BB.SHR-(D6Rat184-D6Rat3)/K |
body weight |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
body mass |
female |
84.0 days
| 15 |
|
|
214.0 |
g |
3.36 |
13.0 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
66145 |
324 |
| SHR.WKY-(D1Rat420-D1Got161)/Njs |
systolic blood pressure |
control condition |
Clemitson JR, et al., Circ Res. 2007 Apr 13;100(7):992-9. Epub 2007 Mar 1. |
arterial blood pressure trait |
male |
140.0 days-142.0 days |
18 |
|
|
180.3 |
mmHg |
0.38 |
1.6 |
tail cuff plethysmography |
|
|
|
|
|
|
|
|
|
65255 |
564 |
| LEW/NIcoCrlf |
number of 20 x 20 cm floor squares crossed in the center of an open field apparatus |
control condition |
Ramos A, et al., Behav Brain Res. 1998 Nov;96(1-2):195-205 |
emotion/affect behavior trait |
female |
70.0 days-77.0 days |
5 |
|
|
1.3 |
null |
0.2 |
0.45 |
visual assessment of in vivo video recording |
|
300 |
|
|
|
|
number of 20 x 20 cm floor squares crossed in the center of an open field apparatus (CMO:0004017) |
|
|
65844 |
108 |
| SHR/NIcoCrlf |
total number of entries into the arms of an elevated plus maze |
control condition |
Ramos A, et al., Behav Brain Res. 1998 Nov;96(1-2):195-205 |
anxiety-related behavior trait |
male |
56.0 days-63.0 days |
12 |
|
|
6.8 |
null |
0.8 |
2.77 |
visual assessment of in vivo video recording |
|
300 |
|
|
|
|
total number of entries into the arms of an elevated plus maze (CMO:0004008) |
|
|
65851 |
108 |
| LEW/NIcoCrlf |
ratio of count of open arm entries to total count of arm entries in an elevated plus maze apparatus |
control condition |
Ramos A, et al., Behav Brain Res. 1998 Nov;96(1-2):195-205 |
anxiety-related behavior trait |
female |
56.0 days-63.0 days |
6 |
total arm entries-closed arm entries/total arm entries |
|
10.1 |
% |
6.8 |
16.66 |
visual assessment of in vivo video recording |
|
300 |
|
|
|
|
ratio of count of entries into an open arm of an elevated plus maze to total count of arm entries (CMO:0004023) |
|
|
65860 |
108 |
| SHR/NIcoCrlf |
ratio of count of open arm entries to total count of arm entries in an elevated plus maze apparatus |
control condition |
Ramos A, et al., Behav Brain Res. 1998 Nov;96(1-2):195-205 |
anxiety-related behavior trait |
female |
56.0 days-63.0 days |
12 |
total arm entries-closed arm entries/total arm entries |
|
35.3 |
% |
5.0 |
17.32 |
visual assessment of in vivo video recording |
|
300.0 |
|
|
|
|
ratio of count of entries into an open arm of an elevated plus maze to total count of arm entries (CMO:0004023) |
|
|
65861 |
108 |
| SHR/NIcoCrlf |
total amount of experiment time spent in an enclosed arm of an elevated plus maze |
control condition |
Ramos A, et al., Behav Brain Res. 1998 Nov;96(1-2):195-205 |
anxiety-related behavior trait |
female |
56.0 days-63.0 days |
12 |
|
|
145.0 |
s |
13.0 |
45.03 |
visual assessment of in vivo video recording |
|
300.0 |
|
|
|
|
total amount of experiment time spent in an enclosed arm of an elevated plus maze (CMO:0004012) |
|
|
65865 |
108 |
| LEW/NIcoCrlf |
total amount of experiment time spent in the open arms of an elevated plus maze |
control condition |
Ramos A, et al., Behav Brain Res. 1998 Nov;96(1-2):195-205 |
anxiety-related behavior trait |
male |
56.0 days-63.0 days |
5 |
|
|
5.8 |
s |
3.7 |
8.27 |
visual assessment of in vivo video recording |
|
300 |
|
|
|
|
total amount of experiment time spent in an open arm of an elevated plus maze (CMO:0004014) |
|
|
65866 |
108 |
| LEW/NIcoCrlf |
total amount of experiment time spent in the open arms of an elevated plus maze |
control condition |
Ramos A, et al., Behav Brain Res. 1998 Nov;96(1-2):195-205 |
anxiety-related behavior trait |
female |
56.0 days-63.0 days |
6 |
|
|
5.2 |
s |
2.4 |
5.88 |
visual assessment of in vivo video recording |
|
300 |
|
|
|
|
total amount of experiment time spent in an open arm of an elevated plus maze (CMO:0004014) |
|
|
65868 |
108 |
| F344/NRrrc |
blood neutrophil count |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
neutrophil quantity |
both |
132.0 days-139.0 days |
216 |
|
|
4.06 |
x 1000 cells/ul |
0.29 |
4.2 |
automated differential white blood cell count test |
|
0 |
|
|
|
|
|
|
|
65876 |
114 |
| N:HS |
blood CD4 cell count |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
CD4-positive T cell quantity |
both |
132.0 days-139.0 days |
203 |
|
|
2.69 |
x 1000 cells/ul |
0.06 |
0.88 |
automated differential white blood cell count test |
|
0 |
|
|
|
|
|
|
|
65880 |
114 |
| F344/NRrrc |
blood CD8 cell count |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
CD8-positive T cell quantity |
both |
132.0 days-139.0 days |
200 |
|
|
0.85 |
x 10E6 cells/ml |
0.01 |
0.14 |
automated differential white blood cell count test |
|
0 |
|
|
|
|
|
|
|
65887 |
114 |
| F344/NRrrc |
blood CD4 cell count to CD8 cell count ratio |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
CD4-positive T cell quantity |
both |
132.0 days-139.0 days |
211 |
|
|
181.0 |
% |
2.27 |
33.0 |
automated differential white blood cell count test |
|
0 |
|
|
|
|
|
|
|
65891 |
114 |
| N:HS |
blood CD25 cell count to CD8 cell count ratio |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
regulatory T cell quantity |
both |
132.0 days-139.0 days |
215 |
|
|
4.34 |
% |
0.22 |
3.25 |
automated cell/particle size/count analysis method |
|
0 |
|
|
|
|
|
|
|
65905 |
114 |
| F344/NRrrc |
blood CD25 cell count to CD4 cell count ratio |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
regulatory T cell quantity |
both |
132.0 days-139.0 days |
215 |
|
|
47.75 |
% |
1.23 |
18.1 |
automated differential white blood cell count test |
|
0 |
|
|
|
|
|
|
|
65904 |
114 |
| N:HS |
hematocrit |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
erythrocyte quantity |
both |
132.0 days-139.0 days |
208 |
|
|
42.2 |
% |
0.23 |
3.3 |
automated blood cell counting method |
|
0 |
|
|
|
|
|
|
|
65908 |
114 |
| N:HS |
blood hemoglobin level |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
blood hemoglobin amount |
both |
132.0 days-139.0 days |
208 |
|
|
14.44 |
g/dl |
0.07 |
1.03 |
automated blood cell counting method |
|
0 |
|
|
|
|
|
|
|
65914 |
114 |
| BN/SsN |
blood hemoglobin level |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
blood hemoglobin amount |
both |
132.0 days-139.0 days |
208 |
|
|
17.2 |
g/dl |
0.01 |
0.2 |
automated blood cell counting method |
|
0 |
|
|
|
|
|
|
|
65915 |
114 |
| ACI/N |
mean corpuscular volume |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
erythrocyte size trait |
both |
132.0 days-139.0 days |
208 |
|
|
55.5 |
fl |
0.03 |
0.5 |
automated blood cell counting method |
|
0 |
|
|
|
|
|
|
|
65922 |
114 |
| WKY/N |
red blood cell count |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
erythrocyte quantity |
both |
132.0 days-139.0 days |
208 |
|
|
8.89 |
x 10E6 cells/ul |
0.04 |
0.64 |
automated blood cell counting method |
|
0 |
|
|
|
|
|
|
|
65935 |
114 |
| WKY/N |
white blood cell count |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
leukocyte quantity |
both |
132.0 days-139.0 days |
208 |
|
|
4.7 |
x 1000 cells/ul |
0.06 |
0.8 |
automated total white blood cell count test |
|
0 |
|
|
|
|
|
|
|
65941 |
114 |
| SHR.WKY-(D1Wox19-D1Wox34)/Njs |
mean arterial blood pressure |
control condition |
Frantz SA, et al., Hypertension 1998 Oct;32(4):639-46 |
arterial blood pressure trait |
male |
140.0 days
| 31 |
|
continuous mean |
195.3 |
mmHg |
1.96 |
10.9 |
tail cuff plethysmography |
|
|
|
|
|
animals were prewarmed to 34 degrees C for 20 min before BP |
|
|
|
65087 |
206 |
| SS-Chr 18BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
9 |
|
|
0.31 |
ml |
0.03 |
0.08 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
14878 |
381 |
| FHH-Chr 12BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
10 |
|
|
107.63 |
breaths/min |
4.0 |
12.65 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14926 |
381 |
| FHH-Chr 8BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
10 |
|
|
97.55 |
breaths/min |
3.09 |
9.78 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14940 |
381 |
| SS-Chr 20BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
14 |
|
|
95.22 |
breaths/min |
3.21 |
12.0 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14946 |
381 |
| SS-Chr 13BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
9 |
|
|
97.17 |
breaths/min |
3.37 |
10.1 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14947 |
381 |
| SS-Chr 18BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
18 |
|
|
93.6 |
breaths/min |
3.54 |
15.03 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14952 |
381 |
| FHH-Chr 1BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
14 |
|
|
116.89 |
breaths/min |
7.15 |
26.74 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14961 |
381 |
| SS-Chr 14BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
10 |
|
|
88.86 |
breaths/min |
2.42 |
7.64 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14967 |
381 |
| SS-Chr 2BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
12 |
|
|
95.9 |
breaths/min |
4.33 |
15.0 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14962 |
381 |
| F344/Jcl |
both testes wet weight |
control condition |
Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. |
testis mass |
male |
900.0 days
| 8 |
|
|
6.62 |
g |
|
|
post excision weight measurement |
|
0 |
|
|
|
|
|
|
|
65821 |
341 |
| ACI/SegHsd |
prostate tumorous lesion number |
control condition |
Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. |
prostate integrity trait |
male |
900.0 days
| 12 |
|
|
5.3 |
null |
|
|
ex vivo light microscopy |
|
0 |
|
|
|
|
|
|
|
65822 |
341 |
| F344/Jcl |
percentage of study population developing ventral prostate tumorous lesions during a period of time |
control condition |
Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. |
prostate integrity trait |
male |
900.0 days
| 8 |
|
|
50.0 |
% |
|
|
ex vivo light microscopy |
|
0 |
|
|
|
|
|
|
|
65824 |
341 |
| F344/Jcl |
ventral prostate gland wet weight |
control condition |
Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. |
ventral prostate mass |
male |
900.0 days
| 8 |
|
|
0.27 |
g |
|
|
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
65827 |
341 |
| F344/Jcl |
area of individual prostate tumorous lesion |
control condition |
Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. |
prostate integrity trait |
male |
900.0 days
| 8 |
|
|
0.22 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
|
0 |
|
|
|
|
|
|
|
65839 |
341 |
| F344/Jcl |
percentage of study population developing testis tumors during a period of time |
control condition |
Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. |
testis integrity trait |
male |
900.0 days
| 8 |
|
|
100.0 |
% |
|
|
ex vivo light microscopy |
|
0.0 |
|
|
|
|
testis tumor incidence |
|
|
65841 |
341 |
| SHR.BN-(D5Wox12-D5Wox20)/Ipcv |
body weight |
control condition |
Pravenec M, et al., Physiol Res 2003;52(3):285-9. |
body mass |
male |
80.0 days-100.0 days |
8 |
|
|
325.5 |
g |
8.8 |
24.89 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
65506 |
612 |
| SHRSP.WKY-(D1Wox29-D1Arb21)/Izm |
head temperature |
control condition |
Yao H, et al., Physiol Genomics. 2007 Feb 27;. |
head temperature trait |
male |
150.0 days
| 9 |
|
|
36.5 |
degrees C |
0.07 |
0.2 |
in vivo thermometry |
|
0 |
|
|
|
|
|
|
|
65955 |
567 |
| SHRSP/Izm |
head temperature |
control condition |
Yao H, et al., Physiol Genomics. 2007 Feb 27;. |
head temperature trait |
male |
150.0 days
| 7 |
|
|
36.3 |
degrees C |
0.19 |
0.5 |
in vivo thermometry |
|
0 |
|
|
|
|
|
|
|
65961 |
567 |
| F344/NSlc |
serum total cholesterol level |
control condition |
Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8. |
blood cholesterol amount |
male |
217.0 days
| 9 |
|
|
52.4 |
mg/dl |
5.7 |
17.1 |
serum total cholesterol measurement test |
|
0 |
|
|
|
|
|
|
|
66180 |
716 |
| F344.OLETF-(D8Rat58-D8Mgh17)/Tj |
serum total cholesterol level |
control condition |
Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8. |
blood cholesterol amount |
male |
217.0 days
| 20 |
|
|
59.7 |
mg/dl |
2.8 |
12.52 |
serum total cholesterol measurement test |
|
0 |
|
|
|
|
|
|
|
66181 |
716 |
| F344/NSlc |
epididymal fat pad weight |
control condition |
Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8. |
epididymal fat pad mass |
male |
217.0 days
| 9 |
|
|
10.2 |
g |
0.9 |
2.7 |
post excision weight measurement |
|
0 |
|
|
|
|
|
|
|
66190 |
716 |
| F344/NSlc |
retroperitoneal fat pad weight to body weight ratio |
control condition |
Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8. |
retroperitoneal fat pad mass |
male |
217.0 days
| 9 |
|
|
2.65 |
% |
0.12 |
0.36 |
post excision weight measurement |
|
0 |
|
|
|
|
|
|
|
66194 |
716 |
| BN |
abdominal fat pad weight |
control condition (for 16 hours) |
Watanabe TK, et al., Genomics 1999 Jun 15;58(3):233-9. |
abdominal fat pad mass |
male |
210.0 days
| 5 |
|
|
6.4 |
g |
|
|
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
67221 |
312 |
| LEW/CrlCrlj |
heart left ventricle weight to body weight ratio |
control condition |
Tsujita Y, et al., Am J Physiol Heart Circ Physiol 2000 Nov;279(5):H2062-7 |
heart left ventricle mass |
male |
168.0 days
| 5 |
|
|
1.67 |
mg/g |
0.02 |
0.04 |
post excision weight measurement |
|
|
|
|
|
polyethylene catheter (PE-50) |
|
|
|
67218 |
103 |
| SS/JrHsdMcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
13 |
|
|
84.2 |
breaths/min |
4.55 |
16.41 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
13655 |
381 |
| GH/OmrMcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
4 |
|
|
134.71 |
breaths/min |
30.09 |
60.18 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
13658 |
381 |
| FHH/EurMcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
11 |
|
|
91.72 |
breaths/min |
4.84 |
16.05 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
13660 |
381 |
| SHRSP.WKY-(D2Rat13-D2Mit5)/Gcrc |
diastolic blood pressure |
control condition |
Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87. |
arterial blood pressure trait |
female |
91.0 days-126.0 days |
3 |
|
continuous mean |
115.5 |
mmHg |
4.2 |
7.27 |
intra-aortic abdominal radiotelemetry |
|
3024000 |
|
|
|
Nights (7 PM to 7 AM) |
|
|
|
65621 |
613 |
| WKY.SHRSP-(D2Mit5-D2Mgh12)/Gcrc |
mean arterial blood pressure |
control condition |
Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87. |
arterial blood pressure trait |
female |
91.0 days-126.0 days |
3 |
|
continuous mean |
107.5 |
mmHg |
4.0 |
6.93 |
intra-aortic abdominal radiotelemetry |
|
3024000 |
|
|
|
Days (7 AM to 7 PM) |
|
|
|
65636 |
613 |
| WKY.SHRSP-(Fst-Pklr)/Gcrc |
mean arterial blood pressure |
control condition |
Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87. |
arterial blood pressure trait |
female |
91.0 days-126.0 days |
3 |
|
continuous mean |
94.1 |
mmHg |
3.8 |
6.58 |
intra-aortic abdominal radiotelemetry |
|
3024000 |
|
|
|
Days (7 AM to 7 PM) |
|
|
|
65648 |
613 |
| FHH/EurMcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
male |
82.0 days-99.0 days |
4 |
|
|
7.47 |
null |
0.02 |
0.03 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
17318 |
381 |
| SS/JrHsdMcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
female |
82.0 days-99.0 days |
6 |
|
|
7.45 |
null |
0.01 |
0.02 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
17319 |
381 |
| LE/BluGill |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
10 |
|
|
116.4 |
breaths/min |
10.02 |
31.7 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
17327 |
381 |
| SS-Chr 16BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
male |
82.0 days-99.0 days |
7 |
|
|
35.65 |
mmHg |
1.52 |
4.03 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
13842 |
381 |
| SS/JrHsdMcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
female |
82.0 days-99.0 days |
9 |
|
|
34.17 |
mmHg |
0.86 |
2.59 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
13846 |
381 |
| SS/JrSeac |
body weight |
control condition |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
body mass |
not specified |
42.0 days
| 20 |
|
|
195.0 |
g |
3.35 |
15.0 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
67247 |
733 |
| SHRSP/Izm |
hematocrit |
control condition |
Yao H, et al., Physiol Genomics. 2007 Feb 27;. |
erythrocyte quantity |
male |
150.0 days
| 7 |
|
|
44.0 |
% |
1.13 |
3.0 |
hematocrit analysis |
|
0 |
|
|
|
|
|
|
|
65524 |
567 |
| SHRSP.WKY-(D1Wox29-D1Arb21)/Izm |
hematocrit |
control condition |
Yao H, et al., Physiol Genomics. 2007 Feb 27;. |
erythrocyte quantity |
male |
150.0 days
| 9 |
|
|
45.0 |
% |
0.67 |
2.0 |
hematocrit analysis |
|
0 |
|
|
|
|
|
|
|
65525 |
567 |
| Hsd:SD |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
male |
82.0 days-99.0 days |
1 |
|
|
99.75 |
mmHg |
|
|
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
14075 |
381 |
| LE/BluGill |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
female |
82.0 days-99.0 days |
8 |
|
|
103.54 |
mmHg |
2.75 |
7.77 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
14080 |
381 |
| WKY/NCrl |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
female |
82.0 days-99.0 days |
12 |
|
|
95.34 |
mmHg |
3.21 |
11.13 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
14082 |
381 |
| SHR/OlaIpcv |
heart weight to body weight ratio |
control condition |
Pravenec M, et al., J Hypertens 2001 Jun;19(6):1061-4. |
heart mass |
male |
100.0 days
| 12 |
|
|
4.15 |
g/kg |
0.1 |
0.35 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
11281 |
61 |
| ACI/Eur |
body weight |
control condition |
Van Dijk SJ, et al., Kidney Int. 2006 |
body mass |
male |
168.0 days-175.0 days |
12 |
|
|
309.0 |
g |
4.0 |
13.86 |
body weighing method |
|
|
|
|
|
|
|
|
|
11285 |
62 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
body weight |
control condition |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
body mass |
male |
168.0 days
| 13 |
|
|
309.0 |
g |
6.0 |
21.63 |
body weighing method |
|
|
|
|
|
|
|
|
|
11293 |
66 |
| BN.GK-(D2Wox49-D2Rat70)/Ox |
body weight |
control condition |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
body mass |
male |
90.0 days
| 27 |
|
|
247.0 |
g |
4.0 |
20.78 |
body weighing method |
|
|
|
|
|
|
|
|
|
11299 |
69 |
| BN.GK-(D2Wox30-D2Wox68)/Ox |
body weight |
control condition |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
body mass |
male |
90.0 days
| 16 |
|
|
250.0 |
g |
6.0 |
24.0 |
body weighing method |
|
|
|
|
|
|
|
|
|
11300 |
69 |
| WKY/NCruk |
mean arterial blood pressure |
control condition |
Frantz S, et al., Hypertension 2001 Aug;38(2):216-21 |
arterial blood pressure trait |
male |
140.0 days
| 19 |
|
|
121.1 |
mmHg |
0.92 |
4.0 |
tail cuff photoplethysmography |
|
|
|
|
|
3 times on 2 days |
|
|
|
11316 |
72 |
| WKY.SHR-(D1Rat56-D1M7Mit206)/Njs |
mean arterial blood pressure |
control condition |
Frantz S, et al., Hypertension 2001 Aug;38(2):216-21 |
arterial blood pressure trait |
male |
140.0 days
| 15 |
|
|
128.9 |
mmHg |
1.11 |
4.3 |
tail cuff photoplethysmography |
|
0.0 |
|
|
|
3 times on 2 days |
|
|
|
11318 |
72 |
| WKY.SHR-(D1Rat56-D1M7Mit206)/Njs |
systolic blood pressure |
control condition |
Frantz S, et al., Hypertension 2001 Aug;38(2):216-21 |
arterial blood pressure trait |
male |
196.0 days
| 15 |
|
|
139.6 |
mmHg |
3.1 |
12.0 |
vascular indwelling catheter method |
|
|
|
|
|
beat to beat for 1 hour |
|
|
|
11326 |
72 |
| SHR/NCruk |
systolic blood pressure |
control condition |
Frantz S, et al., Hypertension 2001 Aug;38(2):216-21 |
arterial blood pressure trait |
male |
196.0 days
| 15 |
|
|
205.3 |
mmHg |
3.3 |
12.8 |
vascular indwelling catheter method |
|
|
|
|
|
beat to beat for 1 hour |
|
|
|
11328 |
72 |
| SHR.WKY-(D1Wox34-D1Rat164)/Njs |
systolic blood pressure |
control condition |
Frantz S, et al., Hypertension 2001 Aug;38(2):216-21 |
arterial blood pressure trait |
male |
196.0 days
| 18 |
|
|
190.9 |
mmHg |
2.62 |
11.1 |
vascular indwelling catheter method |
|
|
|
|
|
beat to beat for 1 hour |
|
|
|
11330 |
72 |
| WKY/NCruk |
diastolic blood pressure |
control condition |
Frantz S, et al., Hypertension 2001 Aug;38(2):216-21 |
arterial blood pressure trait |
male |
196.0 days
| 19 |
|
|
95.8 |
mmHg |
2.2 |
9.6 |
vascular indwelling catheter method |
|
|
|
|
|
beat to beat for 1 hour |
|
|
|
11332 |
72 |
| SHR.WKY-(D1Wox19-D1Wox34)/Njs |
diastolic blood pressure |
control condition |
Frantz S, et al., Hypertension 2001 Aug;38(2):216-21 |
arterial blood pressure trait |
male |
196.0 days
| 20 |
|
|
137.3 |
mmHg |
2.33 |
10.4 |
vascular indwelling catheter method |
|
|
|
|
|
beat to beat for 1 hour |
|
|
|
11337 |
72 |
| ACI.COP-(D3Mgh16-D3Rat119)/Shul |
mammary tumor number |
control condition |
Kurz SG, et al., Endocrinology. 2008 Apr 17 |
mammary gland integrity trait |
female |
259.0 days
| 3 |
|
|
0.0 |
null |
|
|
necropsy |
|
|
|
|
|
|
|
|
|
11361 |
75 |
| COP/CrCrl |
mammary tumor number |
control condition |
Kurz SG, et al., Endocrinology. 2008 Apr 17 |
mammary gland integrity trait |
female |
259.0 days
| 5 |
|
|
0.0 |
null |
|
|
necropsy |
|
|
|
|
|
|
|
|
|
11369 |
75 |
| F344/DuCrlCrlj |
retroperitoneal fat pad weight |
control condition |
Ogino Genom 2000 Nov 15;70(1):19-25. |
retroperitoneal fat pad mass |
male |
252.0 days
| 15 |
|
|
10.7 |
g |
0.23 |
0.9 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
11414 |
83 |
| F344.GK-(D1Arb42a-D1Rat90)/Swe |
body weight |
control condition (for 65 days) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
body mass |
male |
65.0 days
| 11 |
|
|
197.0 |
g |
5.0 |
16.58 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
11464 |
85 |
| F344/DuCrlCrlj |
body weight |
control condition (for 65 days) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
body mass |
male |
65.0 days
| 15 |
|
|
207.0 |
g |
3.0 |
11.62 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
11465 |
85 |
| F344/DuCrlCrlj |
epididymal fat pad weight |
control condition |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
epididymal fat pad mass |
male |
185.0 days
| 9 |
|
|
10.5 |
g |
0.7 |
2.1 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
11483 |
85 |
| WKY/NCruk |
body weight |
control condition |
Zhao L et al., 2001, Circulation, 103(3), 442-7 |
body mass |
male |
105.0 days
| 12 |
|
median |
250.0 |
g |
|
|
body weighing method |
|
|
|
|
|
|
|
|
|
11570 |
102 |
| WKY/NCruk |
heart right ventricle wet weight |
control condition |
Zhao L et al., 2001, Circulation, 103(3), 442-7 |
heart right ventricle mass |
male |
105.0 days
| 12 |
|
median |
0.18 |
g |
|
|
post excision weight measurement |
|
|
|
|
|
|
|
|
|
11571 |
102 |
| SS/Jr |
systolic blood pressure |
control condition |
Garrett MR, et al., J Am Soc Nephrol 2003 May;14(5):1175-87 |
arterial blood pressure trait |
male |
84.0 days-85.0 days |
6 |
|
serial mean |
182.0 |
mmHg |
4.1 |
10.04 |
tail cuff plethysmography |
tail |
2 days between 7 am and 12 pm |
|
|
|
|
|
|
|
11588 |
104 |
| WKY/NHsd |
both adrenal glands wet weight |
control condition |
Solberg LC, et al., Physiol Genomics. 2006 Nov 27;27(3):362-9. Epub 2006 Aug 8 |
adrenal gland mass |
male |
112.0 days
| 24 |
|
|
43.0 |
mg |
1.2 |
5.88 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
11600 |
105 |
| F344/NHsd |
both adrenal glands wet weight |
control condition |
Solberg LC, et al., Physiol Genomics. 2006 Nov 27;27(3):362-9. Epub 2006 Aug 8 |
adrenal gland mass |
female |
112.0 days
| 17 |
|
|
51.5 |
mg |
1.9 |
7.83 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
11603 |
105 |
| WKY/NHsd |
both adrenal glands wet weight |
control condition |
Solberg LC, et al., Physiol Genomics. 2006 Nov 27;27(3):362-9. Epub 2006 Aug 8 |
adrenal gland mass |
female |
112.0 days
| 20 |
|
|
65.8 |
mg |
1.8 |
8.05 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
11602 |
105 |
| F344/NHsd |
both adrenal glands wet weight |
control condition |
Solberg LC, et al., Physiol Genomics. 2006 Nov 27;27(3):362-9. Epub 2006 Aug 8 |
adrenal gland mass |
male |
112.0 days
| 28 |
|
|
47.0 |
mg |
0.9 |
4.76 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
11601 |
105 |
| WKY/Gcrc |
diastolic blood pressure |
control condition |
Clark JS, et al., Hypertension 1996 Nov;28(5):898-906 |
arterial blood pressure trait |
female |
124.0 days-128.0 days |
6 |
|
continuous mean |
99.5 |
mmHg |
1.96 |
4.8 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
|
|
|
|
|
|
|
|
11627 |
109 |
| LH/Mav |
systolic blood pressure |
control condition |
Dubay C, et al., Nat Genet 1993 Apr;3(4):354-7 |
arterial blood pressure trait |
male |
203.0 days-217.0 days |
16 |
|
serial mean |
174.1 |
mmHg |
|
|
vascular indwelling catheter method |
abdominal aorta |
10800 |
|
|
|
|
|
|
|
11645 |
111 |
| WKY/Bbb |
systolic blood pressure |
control condition |
Hubner N, et al., Hypertension 1999 Oct;34(4 Pt 1):643-8 |
arterial blood pressure trait |
not specified |
112.0 days
| 12 |
|
|
130.7 |
mmHg |
0.89 |
3.1 |
radiotelemetry |
|
|
|
|
|
|
|
|
|
11653 |
112 |
| WKY.SHRSP-(Mt1pa-D1Rat57)/Bbb |
systolic blood pressure |
control condition |
Hubner N, et al., Hypertension 1999 Oct;34(4 Pt 1):643-8 |
arterial blood pressure trait |
not specified |
112.0 days
| 11 |
|
|
131.0 |
mmHg |
1.33 |
4.4 |
radiotelemetry |
|
|
|
|
|
|
|
|
|
11654 |
112 |
| M520/N |
systolic blood pressure |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
arterial blood pressure trait |
both |
125.0 days-132.0 days |
220 |
|
|
121.0 |
mmHg |
0.08 |
1.2 |
tail cuff piezoplethysmography |
|
|
|
|
|
6-8 readings per sitting |
|
|
|
11673 |
114 |
| MR/N |
systolic blood pressure |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
arterial blood pressure trait |
both |
125.0 days-132.0 days |
220 |
|
|
130.0 |
mmHg |
0.06 |
0.9 |
tail cuff piezoplethysmography |
|
|
|
|
|
6-8 readings per sitting |
|
|
|
11674 |
114 |
| BUF/N |
systolic blood pressure |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
arterial blood pressure trait |
both |
125.0 days-132.0 days |
220 |
|
|
132.0 |
mmHg |
0.07 |
1.1 |
tail cuff piezoplethysmography |
|
|
|
|
|
6-8 readings per sitting |
|
|
|
11675 |
114 |
| SHRSP/Izm |
systolic blood pressure |
control condition |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
arterial blood pressure trait |
female |
91.0 days
| 5 |
|
|
200.2 |
mmHg |
8.7 |
19.45 |
tail cuff plethysmography |
|
|
|
|
|
|
|
|
|
11681 |
115 |
| LEW |
systolic blood pressure |
control condition |
Ueno T, et al., Physiol Genomics 2004 Mar 12;17(1):38-47. |
arterial blood pressure trait |
male |
151.0 days-181.0 days |
9 |
|
|
124.3 |
mmHg |
3.9 |
11.7 |
vascular indwelling catheter method |
carotid artery and jugular vein |
|
|
|
|
polyethylene catheter |
|
|
|
11715 |
120 |
| HTG |
diastolic blood pressure |
control condition |
Ueno T, et al., Physiol Genomics 2004 Mar 12;17(1):38-47. |
arterial blood pressure trait |
female |
151.0 days-181.0 days |
10 |
|
|
91.8 |
mmHg |
2.8 |
8.85 |
vascular indwelling catheter method |
carotid artery and jugular vein |
|
|
|
|
polyethylene catheter |
|
|
|
11714 |
120 |
| LN/MavRrrc |
systolic blood pressure |
control condition |
Vincent M, et al., J Clin Invest 1997 Oct 15;100(8):2000-6 |
arterial blood pressure trait |
not specified |
203.0 days-217.0 days |
15 |
|
serial mean |
134.0 |
mmHg |
1.68 |
6.5 |
vascular indwelling catheter method |
abdominal aorta |
3600 |
|
|
|
|
|
|
|
11719 |
121 |
| MNS/Gib |
systolic blood pressure |
control condition |
Zagato et al., 2000, Hypertension, 36(5), 734-9 |
arterial blood pressure trait |
not specified |
112.0 days
| 14 |
|
continuous mean |
138.3 |
mmHg |
2.8 |
10.48 |
vascular indwelling catheter method |
carotid artery |
1 min tracing every 3-4 min for 1 h |
|
|
|
Gould BS3200 BP recorder |
|
|
|
11723 |
122 |
| MHS/Gib |
diastolic blood pressure |
control condition |
Zagato et al., 2000, Hypertension, 36(5), 734-9 |
arterial blood pressure trait |
not specified |
112.0 days
| 22 |
|
continuous mean |
113.4 |
mmHg |
5.3 |
24.86 |
vascular indwelling catheter method |
carotid artery |
1 min tracing every 3-4 min for 1 h |
|
|
|
Gould BS3200 BP recorder |
|
|
|
11727 |
122 |
| LEW/CrlCrlj |
heart left ventricle wet weight |
control condition |
Tsujita Y, et al., Am J Physiol Heart Circ Physiol 2000 Nov;279(5):H2062-7 |
heart left ventricle mass |
male |
168.0 days
| 5 |
|
|
0.7 |
g |
0.01 |
0.03 |
post excision weight measurement |
|
|
|
|
|
polyethylene catheter (PE-50) |
|
|
|
11582 |
103 |
| WKY/Bbb |
mean arterial blood pressure |
control condition |
Hubner N, et al., Hypertension 1999 Oct;34(4 Pt 1):643-8 |
arterial blood pressure trait |
not specified |
112.0 days
| 11 |
|
|
103.5 |
mmHg |
0.9 |
3.0 |
radiotelemetry |
|
|
|
|
|
|
|
|
|
11659 |
112 |
| OLETF/Got |
body weight |
control condition |
Ogino Genom 2000 Nov 15;70(1):19-25. |
body mass |
male |
245.0 days-252.0 days |
14 |
|
|
650.6 |
g |
8.61 |
32.2 |
body weighing method |
|
|
|
|
|
|
|
|
|
11406 |
83 |
| SHR/N |
mean arterial blood pressure |
control condition |
Innes BA, et al., Hypertension 1998 Mar;31(3):741-6 |
arterial blood pressure trait |
male |
140.0 days
| 34 |
|
continuous mean |
195.0 |
mmHg |
1.71 |
10.0 |
vascular fluid filled catheter |
carotid artery |
30 minutes |
|
|
|
|
|
|
|
11665 |
113 |
| LH/Mav |
diastolic blood pressure |
control condition |
Dubay C, et al., Nat Genet 1993 Apr;3(4):354-7 |
arterial blood pressure trait |
male |
203.0 days-217.0 days |
16 |
|
serial mean |
118.4 |
mmHg |
|
|
vascular indwelling catheter method |
abdominal aorta |
10800 |
|
|
|
|
|
|
|
11647 |
111 |
| BN.GH-(D6Mit12-D6Rat15)/Mcwi |
systolic blood pressure |
control condition |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
arterial blood pressure trait |
male |
127.0 days-143.0 days |
16 |
|
serial mean |
114.4 |
mmHg |
2.38 |
9.5 |
vascular indwelling catheter method |
left femoral artery and vein |
4 hrs/day for 3 days |
|
|
|
microrenathane catheter; recover for 1 week after surgery |
|
|
|
11536 |
101 |
| BN.GH-(D18Rat41-D18Mgh4)/Mcwi |
systolic blood pressure |
control condition |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
arterial blood pressure trait |
male |
127.0 days-143.0 days |
21 |
|
serial mean |
116.7 |
mmHg |
1.51 |
6.9 |
vascular indwelling catheter method |
left femoral artery and vein |
4 hrs/day for 3 days |
|
|
|
microrenathane catheter; recover for 1 week after surgery |
|
|
|
11543 |
101 |
| F344/NHsd |
mean arterial blood pressure |
control condition |
Sebkhi A, et al., Hypertension 1999 Apr;33(4):949-53. |
arterial blood pressure trait |
not specified |
84.0 days
| 9 |
|
|
86.0 |
mmHg |
2.0 |
6.0 |
vascular indwelling catheter method |
carotid artery |
0.0 |
|
|
|
pressure transducer (Cobe Laboratories Inc), MacLab 4 integrated data acquisition system (AD Instruments) |
|
|
|
12163 |
233 |
| WKY/NCruk |
heart right ventricle wet weight |
control condition |
Sebkhi A, et al., Hypertension 1999 Apr;33(4):949-53. |
heart right ventricle mass |
not specified |
84.0 days
| 22 |
|
|
0.21 |
g |
0.0 |
0.02 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
12188 |
233 |
| WKY/NCruk |
mean arterial blood pressure |
control condition |
Sebkhi A, et al., Hypertension 1999 Apr;33(4):949-53. |
arterial blood pressure trait |
not specified |
84.0 days
| 9 |
|
|
80.4 |
mmHg |
1.2 |
3.6 |
vascular indwelling catheter method |
carotid artery |
0.0 |
|
|
|
pressure transducer (Cobe Laboratories Inc), MacLab 4 integrated data acquisition system (AD Instruments) |
|
|
|
12197 |
233 |
| SBH.SBN-(D1Rat137-D1Rat83)/Ygl |
systolic blood pressure |
control condition |
Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95. |
arterial blood pressure trait |
male |
days
| 6 |
|
serial mean |
134.0 |
mmHg |
2.0 |
4.9 |
tail cuff photoplethysmography |
|
172800 |
|
|
|
photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA) |
|
|
|
12250 |
236 |
| SBH.SBN-(D1Rat137-D1Rat123)/Ygl |
systolic blood pressure |
control condition |
Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95. |
arterial blood pressure trait |
female |
days
| 9 |
|
serial mean |
129.0 |
mmHg |
1.0 |
3.0 |
tail cuff photoplethysmography |
|
172800 |
|
|
|
photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA) |
|
|
|
12263 |
236 |
| SBH.SBN-(D1Mgh2-D1Rat74)/Ygl |
systolic blood pressure |
control condition |
Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95. |
arterial blood pressure trait |
female |
days
| 13 |
|
serial mean |
128.0 |
mmHg |
1.0 |
3.61 |
tail cuff photoplethysmography |
|
172800 |
|
|
|
photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA) |
|
|
|
12271 |
236 |
| WKY |
systolic blood pressure |
control condition |
Frantz SA, et al., Hypertension 1998 Oct;32(4):639-46 |
arterial blood pressure trait |
male |
175.0 days
| 24 |
|
continuous mean |
167.3 |
mmHg |
2.37 |
11.6 |
vascular indwelling catheter method |
aorta |
|
|
|
|
|
|
|
|
11901 |
206 |
| ACI.FHH-(D3Wox2-D3Rat59)/Eur |
body weight |
control condition |
Van Dijk SJ, et al., Kidney Int. 2006 |
body mass |
male |
168.0 days-175.0 days |
12 |
|
|
314.0 |
g |
3.0 |
10.39 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
11926 |
62 |
| P.NP-(D4Rat119-D4Rat55)/Iusm |
body weight |
control condition |
Alam I, et al., J Bone Miner Res. 2010 Jan 8. |
body mass |
male |
180.0 days
| 8 |
|
|
597.0 |
g |
8.49 |
24.0 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
12757 |
308 |
| SHR/N |
body weight |
control condition |
Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. |
body mass |
male |
84.0 days
| 14 |
|
|
441.0 |
g |
26.0 |
97.28 |
body weighing method |
|
|
|
|
|
|
|
|
|
13046 |
327 |
| WKY/N |
systolic blood pressure |
control condition |
Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. |
arterial blood pressure trait |
male |
84.0 days
| 15 |
|
|
129.0 |
mmHg |
8.0 |
30.98 |
vascular fluid filled catheter |
right carotid |
|
|
|
|
|
|
|
|
13059 |
327 |
| WKY/N |
mean arterial blood pressure |
control condition |
Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. |
arterial blood pressure trait |
male |
84.0 days
| 15 |
|
|
110.0 |
mmHg |
8.0 |
30.98 |
vascular fluid filled catheter |
right carotid |
|
|
|
|
|
|
|
|
13061 |
327 |
| WKY/N |
heart left ventricle weight to body weight ratio |
control condition |
Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. |
heart left ventricle mass |
female |
84.0 days
| 22 |
|
|
1.68 |
mg/g |
0.14 |
0.66 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
13074 |
327 |
| WKY/NHsd |
plasma corticosterone level |
control condition |
Solberg LC, et al., Physiol Genomics. 2006 Nov 27;27(3):362-9. Epub 2006 Aug 8 |
blood corticosterone amount |
male |
105.0 days
| 24 |
|
|
31.7 |
ng/ml |
4.2 |
20.58 |
radioimmunoassay |
|
|
|
|
|
|
ng/ml |
|
|
13118 |
105 |
| WKY/NHsd |
plasma corticosterone level |
control condition |
Solberg LC, et al., Physiol Genomics. 2006 Nov 27;27(3):362-9. Epub 2006 Aug 8 |
blood corticosterone amount |
female |
105.0 days
| 20 |
|
|
113.0 |
ng/ml |
18.9 |
84.52 |
radioimmunoassay |
|
|
|
|
|
|
|
|
|
13121 |
105 |
| F344/DuCrlCrlj |
retroperitoneal fat pad weight |
control condition |
Muramatsu Y, et al., Biochem Biophys Res Commun 2005 Jun 17;331(4):1270-6. |
retroperitoneal fat pad mass |
male |
245.0 days
| 12 |
|
|
11.7 |
g |
0.2 |
0.7 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
12434 |
262 |
| F344.OLETF-(D1Rat166-D1Rat90)/Tj |
retroperitoneal fat pad weight |
control condition |
Muramatsu Y, et al., Biochem Biophys Res Commun 2005 Jun 17;331(4):1270-6. |
retroperitoneal fat pad mass |
male |
245.0 days
| 9 |
|
|
34.8 |
g |
0.87 |
2.6 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
12444 |
262 |
| F344.OLETF-(D1Rat166-D1Rat90)/Tj |
abdominal fat pad weight |
control condition |
Muramatsu Y, et al., Biochem Biophys Res Commun 2005 Jun 17;331(4):1270-6. |
abdominal fat pad mass |
male |
245.0 days
| 9 |
|
|
64.1 |
g |
1.73 |
5.2 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
12446 |
262 |
| BC/CpbU |
body weight |
control condition |
Bonne AC, et al., Arterioscler Thromb Vasc Biol 2002 Dec 1;22(12):2072-9. |
body mass |
male |
49.0 days
| 6 |
|
|
109.0 |
g |
5.31 |
13.0 |
body weighing method |
|
|
|
|
|
|
|
|
|
12598 |
271 |
| WOKW |
serum total cholesterol level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. |
blood cholesterol amount |
female |
196.0 days-224.0 days |
12 |
|
serial mean |
84.94 |
mg/dl |
|
|
serum total cholesterol measurement test |
ophthalmic venous plexus |
|
|
|
|
Roche Cobas Mira Plus (Roche, Switzerland) |
average of measures taken at 196 days, 210 days and 224 days |
|
|
12425 |
251 |
| DA/K |
body weight |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. |
body mass |
female |
210.0 days
| 12 |
|
|
199.0 |
g |
|
|
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
12429 |
251 |
| SHR/Mol |
systolic blood pressure |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 29;284(5):1126-33. |
arterial blood pressure trait |
not specified |
70.0 days-98.0 days |
24 |
|
|
196.0 |
mmHg |
2.04 |
10.0 |
tail cuff plethysmography |
tail |
0.0 |
|
|
|
|
|
|
|
12924 |
323 |
| SHR/Mol |
body weight |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 29;284(5):1126-33. |
body mass |
male |
56.0 days
| 12 |
|
|
221.0 |
g |
2.6 |
9.0 |
body weighing method |
|
|
|
|
|
|
|
|
|
12928 |
323 |
| SHR/Mol |
blood glucose level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 29;284(5):1126-33. |
blood glucose amount |
not specified |
84.0 days-98.0 days |
24 |
|
|
102.0 |
mg/dl |
1.02 |
5.0 |
automated blood analysis |
opthalmic plexus |
0.0 |
|
|
|
mean of samples at 12, 13 and 14 weeks |
|
|
|
12932 |
323 |
| BB.SHR-(D6Rat184-D6Rat3)/K |
body weight |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
body mass |
female |
84.0 days
| 24 |
|
|
200.0 |
g |
3.06 |
15.0 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
12976 |
324 |
| BB.SHR-(D6Rat184-D6Rat3)/K |
systolic blood pressure |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
arterial blood pressure trait |
both |
84.0 days-98.0 days |
46 |
|
serial mean |
120.0 |
mmHg |
1.47 |
10.0 |
tail cuff volume pressure recording |
tail |
0.0 |
|
|
|
average of 3 measurements, on 3 different days |
|
|
|
12992 |
324 |
| HTG |
mean arterial blood pressure |
control condition |
Ueno T, et al., J Mol Med 2003 Jan;81(1):51-60. Epub 2002 Nov 21. |
arterial blood pressure trait |
both |
151.0 days-181.0 days |
19 |
|
continuous mean |
125.0 |
mmHg |
3.0 |
13.08 |
vascular indwelling catheter method |
carotid artery, jugular vein |
1800 |
|
|
|
|
|
|
|
12391 |
249 |
| HTG |
plasma total cholesterol level |
control condition |
Ueno T, et al., Physiol Genomics 2004 Mar 12;17(1):38-47. |
blood cholesterol amount |
female |
150.0 days-180.0 days |
10 |
|
|
67.18 |
mg/dl |
4.25 |
13.43 |
plasma total cholesterol measurement test |
|
|
|
|
|
|
|
|
|
13148 |
120 |
| HTG |
body weight |
control condition |
Ueno T, et al., Physiol Genomics 2004 Mar 12;17(1):38-47. |
body mass |
male |
150.0 days-180.0 days |
10 |
|
|
309.3 |
g |
15.9 |
50.28 |
body weighing method |
|
|
|
|
|
|
|
|
|
13151 |
120 |
| F344/NHsd |
blood hemoglobin level |
control condition |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
blood hemoglobin amount |
female |
56.0 days-98.0 days |
8 |
|
|
13.8 |
g/dl |
0.92 |
2.6 |
automated blood cell counting method |
|
0.0 |
|
|
|
Anilytics |
|
|
|
13161 |
332 |
| DA/BklArbNsi |
mean corpuscular hemoglobin concentration |
control condition |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
blood hemoglobin amount |
female |
56.0 days-98.0 days |
7 |
|
|
34.6 |
g/dl |
0.19 |
0.5 |
automated blood analysis |
|
0.0 |
|
|
|
Anilytics |
|
|
|
13171 |
332 |
| F344.GK-(D1Swe4-D1Rat85)/Swe |
pancreas wet weight |
control condition |
Granhall C, et al., Diabetes. 2006 Dec;55(12):3494-500. |
pancreas mass |
male |
60.0 days
| 6 |
|
|
0.85 |
g |
0.02 |
0.05 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
13191 |
333 |
| MWF-Chr 6SHR/Rkb |
both kidneys wet weight to body weight ratio |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
kidney mass |
female |
168.0 days
| 20 |
|
|
6.06 |
g/kg |
0.16 |
0.72 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
12764 |
309 |
| MWF-Chr 6SHR/Rkb |
heart wet weight |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
heart mass |
female |
168.0 days
| 20 |
|
|
0.66 |
g |
0.03 |
0.13 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
12765 |
309 |
| MWF-Chr 6SHR/Rkb |
heart weight to body weight ratio |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
heart mass |
female |
168.0 days
| 20 |
|
|
3.08 |
g/kg |
0.1 |
0.45 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
12766 |
309 |
| MWF/FubRkb |
heart weight to body weight ratio |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
heart mass |
female |
168.0 days
| 18 |
|
|
2.98 |
g/kg |
0.02 |
0.08 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
12769 |
309 |
| SHRSP/Bbb |
heart rate |
control condition |
Kreutz R, et al., Circulation 1997 Aug 19;96(4):1078-81. |
heart pumping trait |
female |
112.0 days
| 11 |
|
serial mean |
416.0 |
beats/min |
9.65 |
32.0 |
vascular indwelling catheter method |
femoral artery |
|
|
|
|
|
3 sets of readings per day for two days |
|
|
13289 |
334 |
| BN/NHsdMcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
8 |
|
|
38.25 |
degrees C |
0.27 |
0.77 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
19754 |
381 |
| SS/JrHsdMcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
male |
82.0 days-99.0 days |
6 |
|
|
32.5 |
mmHg |
1.68 |
4.1 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
19832 |
381 |
| SS-Chr 16BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
female |
82.0 days-99.0 days |
4 |
|
|
43.7 |
mmHg |
1.22 |
2.45 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
19834 |
381 |
| FHH/EurMcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
male |
82.0 days-99.0 days |
4 |
|
|
37.4 |
mmHg |
3.71 |
7.43 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
19837 |
381 |
| SS-Chr 16BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
male |
82.0 days-99.0 days |
5 |
|
|
37.56 |
mmHg |
4.92 |
11.01 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
19836 |
381 |
| FHH-Chr 12BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
15 |
|
|
116.61 |
mmHg |
4.2 |
16.27 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19840 |
381 |
| SS-Chr 6BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
11 |
|
|
113.41 |
mmHg |
3.13 |
10.39 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19844 |
381 |
| SS-Chr 17BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
4 |
|
|
131.52 |
mmHg |
5.13 |
10.27 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19852 |
381 |
| FHH-Chr 19BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
6 |
|
|
138.57 |
mmHg |
11.25 |
27.57 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19867 |
381 |
| SS-Chr 20BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
13 |
|
|
121.09 |
mmHg |
3.34 |
12.03 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19866 |
381 |
| FHH/EurMcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
8 |
|
|
115.68 |
mmHg |
3.64 |
10.3 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19868 |
381 |
| FHH-Chr 8BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
7 |
|
|
125.5 |
mmHg |
3.88 |
10.26 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19875 |
381 |
| FHH-Chr 20BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
5 |
|
|
118.88 |
mmHg |
7.24 |
16.19 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19878 |
381 |
| FHH-Chr 13BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
4 |
|
|
111.94 |
mmHg |
4.39 |
8.78 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19876 |
381 |
| SS-Chr 3BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
3 |
|
|
114.48 |
mmHg |
5.52 |
9.57 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19877 |
381 |
| FHH-Chr 18BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
5 |
|
|
128.88 |
mmHg |
5.13 |
11.48 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19881 |
381 |
| FHH-Chr 13BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
7 |
|
|
121.61 |
mmHg |
4.79 |
12.68 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19879 |
381 |
| FHH/EurMcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
12 |
|
|
122.4 |
mmHg |
1.96 |
6.8 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19886 |
381 |
| SS-Chr YBN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
16 |
|
|
120.47 |
mmHg |
3.7 |
14.82 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19888 |
381 |
| FHH-Chr 1BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
8 |
|
|
116.27 |
mmHg |
6.93 |
19.61 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19893 |
381 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
50 |
|
|
122.9 |
mmHg |
2.03 |
14.37 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19891 |
381 |
| Hsd:SD |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
7 |
|
|
113.37 |
mmHg |
3.55 |
9.39 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
20845 |
381 |
| SS-Chr 9BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
8 |
|
|
419.61 |
beats/min |
11.2 |
31.67 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20899 |
381 |
| FHH-Chr 17BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
8 |
|
|
423.0 |
beats/min |
15.29 |
43.24 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20915 |
381 |
| SS-Chr 15BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
4 |
|
|
411.73 |
beats/min |
19.27 |
38.54 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20926 |
381 |
| SS-Chr 13BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
10 |
|
|
430.23 |
beats/min |
12.19 |
38.53 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20936 |
381 |
| FHH-Chr 18BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
10 |
|
|
400.95 |
beats/min |
13.32 |
42.11 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20940 |
381 |
| FHH/EurMcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
18 |
|
|
372.15 |
beats/min |
12.1 |
51.33 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20942 |
381 |
| SS/JrHsdMcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
62 |
|
|
413.02 |
beats/min |
4.88 |
38.45 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20947 |
381 |
| SS-Chr 18BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
11 |
|
|
431.53 |
beats/min |
10.68 |
35.44 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20950 |
381 |
| FHH-Chr 7BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
3 |
|
|
443.8 |
beats/min |
43.16 |
74.76 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20961 |
381 |
| FHH-Chr 11BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
7 |
|
|
379.42 |
beats/min |
20.52 |
54.3 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20958 |
381 |
| GH/OmrMcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
7 |
|
|
395.98 |
beats/min |
9.13 |
24.16 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
20978 |
381 |
| SS-Chr 12BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
2 |
|
|
103.15 |
mmHg |
1.51 |
2.14 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19900 |
381 |
| SS-Chr 2BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
8 |
|
|
124.86 |
mmHg |
3.65 |
10.31 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19911 |
381 |
| BN/NHsdMcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
11 |
|
|
112.33 |
mmHg |
4.1 |
13.59 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19908 |
381 |
| FHH-Chr 1BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
7 |
|
|
116.34 |
mmHg |
5.47 |
14.47 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19912 |
381 |
| F344/DuCrl |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
18 |
|
|
37.87 |
degrees C |
0.13 |
0.57 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
19949 |
381 |
| WKY/NCrl |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
20 |
|
|
37.33 |
degrees C |
0.15 |
0.67 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
19948 |
381 |
| SS-Chr 16BN/Mcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
female |
82.0 days-99.0 days |
8 |
|
|
7.46 |
null |
0.01 |
0.03 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
20025 |
381 |
| FHH/EurMcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
female |
82.0 days-99.0 days |
9 |
|
|
7.43 |
null |
0.01 |
0.02 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
20024 |
381 |
| SS-Chr 18BN/Mcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
female |
82.0 days-99.0 days |
6 |
|
|
7.47 |
null |
0.01 |
0.03 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
20027 |
381 |
| BN/NHsdMcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
male |
82.0 days-99.0 days |
4 |
|
|
7.46 |
null |
0.01 |
0.02 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
20030 |
381 |
| BN/NHsdMcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
female |
82.0 days-99.0 days |
7 |
|
|
7.45 |
null |
0.01 |
0.03 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
20031 |
381 |
| SS-Chr 6BN/Mcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
female |
82.0 days-99.0 days |
13 |
|
|
7.48 |
null |
0.01 |
0.03 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20601 |
381 |
| FHH-Chr 6BN/Mcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
male |
82.0 days-99.0 days |
2 |
|
|
7.39 |
null |
0.0 |
0.0 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20599 |
381 |
| FHH-Chr 17BN/Mcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
male |
82.0 days-99.0 days |
8 |
|
|
7.45 |
null |
0.0 |
0.01 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20613 |
381 |
| SS-Chr 7BN/Mcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
male |
82.0 days-99.0 days |
9 |
|
|
7.46 |
null |
0.01 |
0.01 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20611 |
381 |
| SS-Chr 5BN/Mcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
female |
82.0 days-99.0 days |
2 |
|
|
7.5 |
null |
0.0 |
0.0 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20616 |
381 |
| SS-Chr 16BN/Mcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
male |
82.0 days-99.0 days |
9 |
|
|
7.46 |
null |
0.01 |
0.02 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20632 |
381 |
| FHH-Chr 19BN/Mcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
female |
82.0 days-99.0 days |
7 |
|
|
7.45 |
null |
0.01 |
0.03 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20631 |
381 |
| SS-Chr YBN/Mcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
male |
82.0 days-99.0 days |
13 |
|
|
7.47 |
null |
0.01 |
0.03 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20646 |
381 |
| SS-Chr 18BN/Mcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
male |
82.0 days-99.0 days |
10 |
|
|
7.47 |
null |
0.0 |
0.02 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20648 |
381 |
| SS-Chr 12BN/Mcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
male |
82.0 days-99.0 days |
3 |
|
|
7.5 |
null |
0.02 |
0.04 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20659 |
381 |
| FHH/EurMcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
7 |
|
|
119.31 |
mmHg |
7.58 |
20.05 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
19520 |
381 |
| SS-Chr 16BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
6 |
|
|
121.82 |
mmHg |
1.31 |
3.2 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
19519 |
381 |
| BN/NHsdMcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
female |
82.0 days-99.0 days |
7 |
|
|
101.99 |
mmHg |
2.58 |
6.83 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
19534 |
381 |
| SS/JrHsdMcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
female |
82.0 days-99.0 days |
9 |
|
|
105.92 |
mmHg |
2.47 |
7.4 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
19535 |
381 |
| WKY/NCrl |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
14 |
|
|
353.66 |
beats/min |
12.59 |
47.13 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
19537 |
381 |
| SHR/NCrl |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
male |
82.0 days-99.0 days |
5 |
|
|
102.87 |
mmHg |
3.68 |
8.23 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
19536 |
381 |
| LE/BluGill |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
9 |
|
|
426.33 |
beats/min |
15.98 |
47.93 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
19543 |
381 |
| F344/DuCrl |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
11 |
|
|
405.3 |
beats/min |
10.77 |
35.73 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
19546 |
381 |
| SS/JrHsdMcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
14 |
|
|
37.76 |
degrees C |
0.13 |
0.49 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17567 |
381 |
| Hsd:SD |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
female |
82.0 days-99.0 days |
16 |
|
|
222.6 |
g |
2.1 |
8.6 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17590 |
381 |
| Hsd:SD |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
16 |
|
|
37.91 |
degrees C |
0.13 |
0.54 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
17592 |
381 |
| LEW/Crl |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
17 |
|
|
37.09 |
degrees C |
0.37 |
1.53 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
17781 |
381 |
| LE/BluGill |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
9 |
|
|
37.72 |
degrees C |
0.21 |
0.64 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
17785 |
381 |
| LE/BluGill |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
12 |
|
|
36.87 |
degrees C |
0.19 |
0.64 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
17789 |
381 |
| SS/JrHsdMcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
14 |
|
|
88.11 |
breaths/min |
4.86 |
18.18 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17791 |
381 |
| BN/NHsdMcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
9 |
|
|
94.32 |
breaths/min |
5.36 |
16.08 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17798 |
381 |
| BN/NHsdMcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
8 |
|
|
86.77 |
breaths/min |
5.42 |
15.33 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17799 |
381 |
| SHR/NCrl |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
male |
82.0 days-99.0 days |
20 |
|
|
265.2 |
g |
2.9 |
13.1 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17811 |
381 |
| SS-Chr 5BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
female |
82.0 days-99.0 days |
10 |
|
|
177.4 |
g |
7.1 |
22.4 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17812 |
381 |
| FHH-Chr 8BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
female |
82.0 days-99.0 days |
11 |
|
|
183.5 |
g |
5.2 |
17.2 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17818 |
381 |
| SS-Chr 15BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
male |
82.0 days-99.0 days |
15 |
|
|
210.2 |
g |
16.5 |
63.9 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17820 |
381 |
| FHH-Chr 18BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
male |
82.0 days-99.0 days |
9 |
|
|
229.6 |
g |
5.6 |
16.9 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17825 |
381 |
| SS-Chr 19BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
male |
82.0 days-99.0 days |
8 |
|
|
271.1 |
g |
7.0 |
19.9 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17837 |
381 |
| SS-Chr 10BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
male |
82.0 days-99.0 days |
11 |
|
|
299.2 |
g |
5.5 |
18.2 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17846 |
381 |
| SS-Chr 6BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
female |
82.0 days-99.0 days |
17 |
|
|
197.4 |
g |
3.9 |
15.9 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17851 |
381 |
| FHH-Chr 16BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
male |
82.0 days-99.0 days |
9 |
|
|
284.2 |
g |
7.9 |
23.7 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17869 |
381 |
| FHH-Chr 19BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
female |
82.0 days-99.0 days |
14 |
|
|
167.4 |
g |
2.9 |
10.8 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17875 |
381 |
| FHH-Chr 3BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
female |
82.0 days-99.0 days |
10 |
|
|
151.1 |
g |
2.8 |
8.7 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17872 |
381 |
| SS-Chr 11BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
female |
82.0 days-99.0 days |
10 |
|
|
198.3 |
g |
2.4 |
7.7 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17880 |
381 |
| SS-Chr 1BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
male |
82.0 days-99.0 days |
10 |
|
|
304.4 |
g |
5.9 |
18.8 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17886 |
381 |
| SS-Chr 1BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
female |
82.0 days-99.0 days |
10 |
|
|
202.9 |
g |
3.9 |
12.3 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17888 |
381 |
| WKY/NCrl |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
16 |
|
|
35.59 |
ml/min |
1.71 |
6.82 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
17901 |
381 |
| F344/DuCrl |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
16 |
|
|
30.33 |
ml/min |
1.04 |
4.16 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
17905 |
381 |
| Hsd:SD |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
5 |
|
|
37.83 |
ml/min |
3.24 |
7.25 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
17902 |
381 |
| F344/DuCrl |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
18 |
|
|
24.46 |
ml/min |
1.29 |
5.47 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
17910 |
381 |
| GH/OmrMcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
8 |
|
|
38.48 |
degrees C |
0.11 |
0.32 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
17949 |
381 |
| FHH/EurMcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
12 |
|
|
37.49 |
degrees C |
0.14 |
0.47 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
17951 |
381 |
| SS/JrHsdMcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
7 |
|
|
38.01 |
degrees C |
0.11 |
0.3 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
17952 |
381 |
| FHH-Chr 12BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
19 |
|
|
0.23 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
17967 |
381 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
12 |
|
|
0.35 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
17972 |
381 |
| FHH-Chr 6BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
7 |
|
|
0.32 |
ml |
0.03 |
0.08 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
17971 |
381 |
| SS-Chr 5BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
0.26 |
ml |
0.02 |
0.07 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
17977 |
381 |
| SS-Chr 5BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
9 |
|
|
0.34 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
17980 |
381 |
| FHH-Chr 10BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
10 |
|
|
0.2 |
ml |
0.01 |
0.03 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
17981 |
381 |
| SS-Chr 20BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
17 |
|
|
0.36 |
ml |
0.01 |
0.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
17984 |
381 |
| FHH-Chr YBN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
21 |
|
|
0.26 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
17995 |
381 |
| SS-Chr 12BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
11 |
|
|
0.28 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18003 |
381 |
| LEW/Crl |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
1 |
|
|
0.33 |
ml |
|
|
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18015 |
381 |
| SS-Chr 9BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
10 |
|
|
0.35 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18017 |
381 |
| SS-Chr 6BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
13 |
|
|
0.44 |
ml |
0.02 |
0.08 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18021 |
381 |
| SS-Chr 7BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
0.27 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18033 |
381 |
| FHH-Chr 19BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
14 |
|
|
0.32 |
ml |
0.02 |
0.08 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18036 |
381 |
| FHH-Chr 13BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
0.2 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18042 |
381 |
| SS-Chr 1BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
10 |
|
|
0.27 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18051 |
381 |
| SS-Chr 1BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
0.26 |
ml |
0.03 |
0.09 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18053 |
381 |
| FHH-Chr 11BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
9 |
|
|
0.34 |
ml |
0.03 |
0.08 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18057 |
381 |
| FHH-Chr 9BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
0.22 |
ml |
0.01 |
0.03 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18059 |
381 |
| FHH-Chr 7BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
11 |
|
|
0.26 |
ml |
0.02 |
0.08 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18060 |
381 |
| WKY/Izm |
epididymal fat pad weight to body weight ratio |
control condition |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
epididymal fat pad mass |
male |
91.0 days
| 5 |
|
|
1.34 |
% |
0.03 |
0.07 |
post excision weight measurement |
testis |
0 |
|
|
|
|
|
|
|
65000 |
115 |
| BN/NHsdMcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
18 |
|
|
37.34 |
degrees C |
0.17 |
0.71 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16892 |
381 |
| FHH/EurMcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
12 |
|
|
0.42 |
ml |
0.04 |
0.13 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
17002 |
381 |
| GH/OmrMcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
8 |
|
|
117.53 |
breaths/min |
8.13 |
22.98 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
18379 |
381 |
| SS-Chr 16BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
5 |
|
|
92.85 |
breaths/min |
5.86 |
13.11 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
18380 |
381 |
| FHH/EurMcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
12 |
|
|
94.56 |
breaths/min |
9.55 |
33.07 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
18381 |
381 |
| LE/BluGill |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
7 |
|
|
428.73 |
beats/min |
6.67 |
17.66 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
18390 |
381 |
| FHH-Chr 12BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
19 |
|
|
92.0 |
breaths/min |
3.0 |
13.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18395 |
381 |
| WKY/NCrl |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
6 |
|
|
379.95 |
beats/min |
14.64 |
35.87 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
18392 |
381 |
| F344/DuCrl |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
6 |
|
|
408.27 |
beats/min |
15.17 |
37.15 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
18393 |
381 |
| FHH-Chr 6BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
7 |
|
|
104.05 |
breaths/min |
11.11 |
29.4 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18399 |
381 |
| SHR/NCrl |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
20 |
|
|
112.64 |
breaths/min |
5.96 |
26.67 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18404 |
381 |
| FHH-Chr XBN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
10 |
|
|
117.85 |
breaths/min |
2.68 |
8.48 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18406 |
381 |
| SS-Chr 15BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
15 |
|
|
116.01 |
breaths/min |
6.7 |
25.96 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18413 |
381 |
| SS-Chr 5BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
9 |
|
|
105.76 |
breaths/min |
6.41 |
19.23 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18408 |
381 |
| SS-Chr 20BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
17 |
|
|
99.28 |
breaths/min |
5.11 |
21.09 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18412 |
381 |
| FHH-Chr 20BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
8 |
|
|
112.23 |
breaths/min |
8.87 |
25.09 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18419 |
381 |
| SS-Chr 13BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
10 |
|
|
96.1 |
breaths/min |
5.14 |
16.26 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18417 |
381 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
10 |
|
|
81.34 |
breaths/min |
3.94 |
12.47 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18429 |
381 |
| SS-Chr 12BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
8 |
|
|
103.8 |
breaths/min |
6.09 |
17.22 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18435 |
381 |
| SS-Chr 2BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
13 |
|
|
89.07 |
breaths/min |
4.06 |
14.66 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18437 |
381 |
| FHH-Chr 5BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
10 |
|
|
106.37 |
breaths/min |
2.01 |
6.34 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18440 |
381 |
| SS-Chr 14BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
12 |
|
|
87.84 |
breaths/min |
3.83 |
13.25 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18447 |
381 |
| SS-Chr 10BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
10 |
|
|
85.33 |
breaths/min |
6.83 |
21.59 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18451 |
381 |
| SS-Chr 6BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
13 |
|
|
93.55 |
breaths/min |
4.13 |
14.88 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18449 |
381 |
| FHH-Chr 16BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
14 |
|
|
103.32 |
breaths/min |
5.25 |
19.64 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18454 |
381 |
| FHH-Chr 19BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
14 |
|
|
107.14 |
breaths/min |
5.6 |
20.96 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18464 |
381 |
| FHH-Chr 3BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
10 |
|
|
116.79 |
breaths/min |
4.27 |
13.52 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18465 |
381 |
| FHH-Chr 13BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
11 |
|
|
108.32 |
breaths/min |
4.18 |
13.86 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18471 |
381 |
| FHH/EurMcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
49 |
|
|
110.26 |
breaths/min |
3.39 |
23.72 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18474 |
381 |
| SS/JrHsdMcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
74 |
|
|
99.2 |
breaths/min |
2.37 |
20.37 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18478 |
381 |
| SS-Chr 1BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
10 |
|
|
150.84 |
breaths/min |
13.55 |
42.84 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18481 |
381 |
| FHH-Chr 11BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
8 |
|
|
101.29 |
breaths/min |
6.78 |
19.16 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18484 |
381 |
| FHH-Chr 9BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
10 |
|
|
97.91 |
breaths/min |
4.03 |
12.74 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18487 |
381 |
| BN/NHsdMcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
18 |
|
|
88.49 |
breaths/min |
4.64 |
19.67 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18490 |
381 |
| Hsd:SD |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
8 |
|
|
415.31 |
beats/min |
4.45 |
12.59 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
18748 |
381 |
| Hsd:SD |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
12 |
|
|
467.01 |
beats/min |
10.73 |
37.15 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
18749 |
381 |
| LEW/Crl |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
11 |
|
|
104.01 |
mmHg |
4.13 |
13.71 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
18769 |
381 |
| GH/OmrMcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
male |
82.0 days-99.0 days |
5 |
|
|
89.91 |
mmHg |
2.41 |
5.39 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18862 |
381 |
| FHH-Chr 20BN/Mcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
male |
82.0 days-99.0 days |
3 |
|
|
101.62 |
mmHg |
4.33 |
7.49 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18880 |
381 |
| SS-Chr 11BN/Mcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
female |
82.0 days-99.0 days |
6 |
|
|
105.33 |
mmHg |
3.1 |
7.6 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18887 |
381 |
| SS-Chr XBN/Mcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
female |
82.0 days-99.0 days |
4 |
|
|
112.44 |
mmHg |
1.54 |
3.09 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18894 |
381 |
| FHH-Chr 11BN/Mcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
male |
82.0 days-99.0 days |
2 |
|
|
94.55 |
mmHg |
4.85 |
6.86 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18900 |
381 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
female |
82.0 days-99.0 days |
8 |
|
|
108.63 |
mmHg |
3.48 |
9.85 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18901 |
381 |
| SS-Chr 2BN/Mcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
female |
82.0 days-99.0 days |
9 |
|
|
104.08 |
mmHg |
2.24 |
6.71 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18908 |
381 |
| BN/NHsdMcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
male |
82.0 days-99.0 days |
14 |
|
|
98.82 |
mmHg |
2.35 |
8.79 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18911 |
381 |
| FHH-Chr 7BN/Mcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
male |
82.0 days-99.0 days |
2 |
|
|
94.4 |
mmHg |
2.35 |
3.32 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18914 |
381 |
| SS-Chr 2BN/Mcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
male |
82.0 days-99.0 days |
11 |
|
|
104.17 |
mmHg |
1.23 |
4.07 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18915 |
381 |
| SS/JrHsdMcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
male |
82.0 days-99.0 days |
6 |
|
|
103.79 |
mmHg |
3.04 |
7.45 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
18917 |
381 |
| SS/JrHsdMcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
female |
82.0 days-99.0 days |
6 |
|
|
101.48 |
mmHg |
3.12 |
7.63 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
18923 |
381 |
| SS-Chr 18BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
77.0 days-91.0 days |
9 |
|
|
0.2 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
36271 |
401 |
| Crl:CD(SD) |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
77.0 days-91.0 days |
9 |
|
|
1.47 |
x 1000 cells/ul |
0.14 |
0.43 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
36299 |
401 |
| LEW/Crl |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
77.0 days-91.0 days |
10 |
|
|
0.81 |
x 1000 cells/ul |
0.03 |
0.11 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
36298 |
401 |
| Crl:CD(SD) |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
77.0 days-91.0 days |
9 |
|
|
0.58 |
x 1000 cells/ul |
0.1 |
0.29 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
36301 |
401 |
| SS-Chr 18BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
8 |
|
|
32.25 |
g/dl |
0.12 |
0.34 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
36307 |
401 |
| GH/OmrMcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
9 |
|
|
32.61 |
g/dl |
0.22 |
0.65 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
36313 |
401 |
| SS/JrHsdMcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
9 |
|
|
32.09 |
g/dl |
0.13 |
0.39 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
36316 |
401 |
| GH/OmrMcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
9 |
|
|
32.7 |
g/dl |
0.14 |
0.43 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
36318 |
401 |
| SS/JrHsdMcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77.0 days-91.0 days |
4 |
|
|
9.48 |
mg/dl |
0.19 |
0.39 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
36329 |
401 |
| SS-Chr 16BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
female |
77.0 days-91.0 days |
7 |
|
|
9.2 |
mg/dl |
0.08 |
0.22 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
36330 |
401 |
| Hsd:SD |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
female |
77.0 days-91.0 days |
6 |
|
|
142.0 |
mmol/l |
1.1 |
2.68 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
36341 |
401 |
| FHH-Chr 16BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77.0 days-91.0 days |
9 |
|
|
3.35 |
x 1000 cells/ul |
0.22 |
0.65 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36875 |
401 |
| SS-Chr 20BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77.0 days-91.0 days |
13 |
|
|
5.07 |
x 1000 cells/ul |
0.41 |
1.49 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36890 |
401 |
| FHH/EurMcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77.0 days-91.0 days |
13 |
|
|
2.74 |
x 1000 cells/ul |
0.21 |
0.74 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36892 |
401 |
| FHH-Chr XBN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77.0 days-91.0 days |
8 |
|
|
2.94 |
x 1000 cells/ul |
0.31 |
0.88 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36887 |
401 |
| FHH-Chr 8BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77.0 days-91.0 days |
10 |
|
|
3.58 |
x 1000 cells/ul |
0.33 |
1.04 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36901 |
401 |
| FHH-Chr 13BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77.0 days-91.0 days |
10 |
|
|
4.59 |
x 1000 cells/ul |
0.28 |
0.88 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36904 |
401 |
| FHH-Chr YBN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77.0 days-91.0 days |
9 |
|
|
3.93 |
x 1000 cells/ul |
0.31 |
0.94 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36914 |
401 |
| SS-Chr 13BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77.0 days-91.0 days |
11 |
|
|
5.85 |
x 1000 cells/ul |
0.51 |
1.68 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36912 |
401 |
| SS-Chr YBN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77.0 days-91.0 days |
20 |
|
|
5.52 |
x 1000 cells/ul |
0.41 |
1.82 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36915 |
401 |
| SS/JrHsdMcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77.0 days-91.0 days |
89 |
|
|
5.52 |
x 1000 cells/ul |
0.14 |
1.35 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36918 |
401 |
| FHH-Chr 1BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77.0 days-91.0 days |
12 |
|
|
4.81 |
x 1000 cells/ul |
0.49 |
1.71 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36921 |
401 |
| SS-Chr 18BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77.0 days-91.0 days |
10 |
|
|
3.84 |
x 1000 cells/ul |
0.42 |
1.34 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36922 |
401 |
| FHH-Chr 4BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77.0 days-91.0 days |
9 |
|
|
3.04 |
x 1000 cells/ul |
0.16 |
0.47 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36923 |
401 |
| FHH-Chr 11BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77.0 days-91.0 days |
8 |
|
|
4.08 |
x 1000 cells/ul |
0.32 |
0.92 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36927 |
401 |
| SS-Chr 12BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77.0 days-91.0 days |
10 |
|
|
5.69 |
x 1000 cells/ul |
0.37 |
1.16 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36931 |
401 |
| SS-Chr 19BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77.0 days-91.0 days |
7 |
|
|
4.53 |
x 1000 cells/ul |
0.18 |
0.47 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36934 |
401 |
| BN/NHsdMcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77.0 days-91.0 days |
11 |
|
|
4.06 |
x 1000 cells/ul |
0.67 |
2.23 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36941 |
401 |
| FHH-Chr 9BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77.0 days-91.0 days |
8 |
|
|
3.93 |
x 1000 cells/ul |
0.19 |
0.53 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36944 |
401 |
| SS-Chr 2BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77.0 days-91.0 days |
6 |
|
|
4.76 |
x 1000 cells/ul |
0.5 |
1.23 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36945 |
401 |
| SS-Chr 18BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
77.0 days-91.0 days |
9 |
|
|
128.22 |
U/l |
8.24 |
24.71 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
37051 |
401 |
| SHR/NCrl |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
77.0 days-91.0 days |
10 |
|
|
144.7 |
U/l |
5.35 |
16.91 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
37055 |
401 |
| SHR/NCrl |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
77.0 days-91.0 days |
11 |
|
|
264.55 |
U/l |
6.56 |
21.76 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
37061 |
401 |
| Hsd:SD |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77.0 days-91.0 days |
8 |
|
|
24.38 |
mg/dl |
0.73 |
2.07 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
37063 |
401 |
| Hsd:SD |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
77.0 days-91.0 days |
6 |
|
|
21.83 |
mg/dl |
1.08 |
2.64 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
37064 |
401 |
| FHH-Chr 14BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
female |
77.0 days-91.0 days |
8 |
|
|
4.89 |
g/dl |
0.1 |
0.28 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37184 |
401 |
| FHH-Chr 2BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
female |
77.0 days-91.0 days |
8 |
|
|
5.03 |
g/dl |
0.14 |
0.4 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37185 |
401 |
| FHH-Chr 6BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
female |
77.0 days-91.0 days |
10 |
|
|
4.92 |
g/dl |
0.12 |
0.38 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37192 |
401 |
| GH/OmrMcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
female |
77.0 days-91.0 days |
6 |
|
|
6.25 |
g/dl |
0.1 |
0.23 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37206 |
401 |
| FHH-Chr 2BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77.0 days-91.0 days |
8 |
|
|
5.24 |
g/dl |
0.14 |
0.39 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37201 |
401 |
| SS-Chr 5BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
female |
77.0 days-91.0 days |
7 |
|
|
5.57 |
g/dl |
0.04 |
0.1 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37209 |
401 |
| FHH-Chr 10BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77.0 days-91.0 days |
10 |
|
|
4.56 |
g/dl |
0.08 |
0.26 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37215 |
401 |
| SS-Chr 16BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
female |
77.0 days-91.0 days |
8 |
|
|
6.5 |
g/dl |
0.07 |
0.2 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37222 |
401 |
| FHH/EurMcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
female |
77.0 days-91.0 days |
13 |
|
|
5.65 |
g/dl |
0.11 |
0.39 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37221 |
401 |
| FHH-Chr 18BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77.0 days-91.0 days |
9 |
|
|
5.39 |
g/dl |
0.08 |
0.25 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37235 |
401 |
| FHH-Chr 18BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
female |
77.0 days-91.0 days |
10 |
|
|
5.51 |
g/dl |
0.07 |
0.21 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37238 |
401 |
| SS-Chr 13BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77.0 days-91.0 days |
11 |
|
|
6.2 |
g/dl |
0.08 |
0.26 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37241 |
401 |
| FHH/EurMcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77.0 days-91.0 days |
49 |
|
|
5.41 |
g/dl |
0.08 |
0.53 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37240 |
401 |
| SS-Chr 11BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77.0 days-91.0 days |
13 |
|
|
6.05 |
g/dl |
0.08 |
0.28 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37245 |
401 |
| SS-Chr 18BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77.0 days-91.0 days |
9 |
|
|
6.16 |
g/dl |
0.06 |
0.17 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37246 |
401 |
| SS-Chr 1BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
female |
77.0 days-91.0 days |
7 |
|
|
5.64 |
g/dl |
0.08 |
0.21 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37253 |
401 |
| FHH-Chr 11BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
female |
77.0 days-91.0 days |
8 |
|
|
5.39 |
g/dl |
0.06 |
0.17 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37261 |
401 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77.0 days-91.0 days |
16 |
|
|
6.03 |
g/dl |
0.06 |
0.26 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37267 |
401 |
| BN/NHsdMcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
female |
77.0 days-91.0 days |
14 |
|
|
5.04 |
g/dl |
0.16 |
0.6 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37270 |
401 |
| FHH-Chr 7BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77.0 days-91.0 days |
9 |
|
|
5.09 |
g/dl |
0.06 |
0.19 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37272 |
401 |
| Crl:CD(SD) |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77.0 days-91.0 days |
9 |
|
|
15.89 |
mg/dl |
0.84 |
2.52 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
37284 |
401 |
| LEW/Crl |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77.0 days-91.0 days |
10 |
|
|
15.3 |
mg/dl |
0.96 |
3.02 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
37288 |
401 |
| LE/BluGill |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77.0 days-91.0 days |
11 |
|
|
16.45 |
mg/dl |
0.45 |
1.51 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
37291 |
401 |
| SHR/NCrl |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77.0 days-91.0 days |
11 |
|
|
3.79 |
x 1000 cells/ul |
0.38 |
1.27 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
37308 |
401 |
| GH/OmrMcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77.0 days-91.0 days |
9 |
|
|
3.86 |
x 1000 cells/ul |
0.49 |
1.46 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
37304 |
401 |
| SS-Chr 6BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
10 |
|
|
32.26 |
g/dl |
0.14 |
0.44 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37319 |
401 |
| FHH-Chr 6BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
10 |
|
|
32.26 |
g/dl |
0.13 |
0.4 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37322 |
401 |
| FHH-Chr 5BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
6 |
|
|
32.17 |
g/dl |
0.06 |
0.15 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37323 |
401 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
10 |
|
|
32.45 |
g/dl |
0.12 |
0.38 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37321 |
401 |
| FHH-Chr 12BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
12 |
|
|
32.02 |
g/dl |
0.14 |
0.49 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37327 |
401 |
| FHH-Chr 15BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
8 |
|
|
31.81 |
g/dl |
0.17 |
0.47 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37329 |
401 |
| SS-Chr 17BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
11 |
|
|
32.54 |
g/dl |
0.19 |
0.63 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37332 |
401 |
| SS-Chr 5BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
7 |
|
|
32.17 |
g/dl |
0.28 |
0.74 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37339 |
401 |
| SS-Chr 5BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
8 |
|
|
32.08 |
g/dl |
0.09 |
0.25 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37344 |
401 |
| FHH-Chr 3BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
8 |
|
|
34.15 |
g/dl |
0.12 |
0.33 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37353 |
401 |
| SS-Chr 20BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
23 |
|
|
32.74 |
g/dl |
0.28 |
1.35 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37367 |
401 |
| FHH-Chr 3BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
8 |
|
|
34.08 |
g/dl |
0.13 |
0.38 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37372 |
401 |
| SS/JrHsdMcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
89 |
|
|
32.35 |
g/dl |
0.05 |
0.44 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37377 |
401 |
| FHH-Chr 4BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
9 |
|
|
32.2 |
g/dl |
0.25 |
0.76 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37387 |
401 |
| SS-Chr 4BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
15 |
|
|
32.41 |
g/dl |
0.22 |
0.87 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37392 |
401 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
16 |
|
|
32.09 |
g/dl |
0.08 |
0.32 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37397 |
401 |
| FHH-Chr 7BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
9 |
|
|
32.39 |
g/dl |
0.13 |
0.39 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37402 |
401 |
| FHH-Chr 9BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
8 |
|
|
33.34 |
g/dl |
0.31 |
0.88 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37403 |
401 |
| LEW/Crl |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
female |
77.0 days-91.0 days |
10 |
|
|
5.82 |
g/dl |
0.15 |
0.48 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
37413 |
401 |
| FHH-Chr 12BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
77.0 days-91.0 days |
11 |
|
|
240.91 |
U/l |
9.71 |
32.19 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37433 |
401 |
| FHH-Chr 6BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
77.0 days-91.0 days |
10 |
|
|
329.9 |
U/l |
9.36 |
29.61 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37440 |
401 |
| SS-Chr 14BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
77.0 days-91.0 days |
10 |
|
|
140.6 |
U/l |
14.81 |
46.82 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37439 |
401 |
| SS-Chr 5BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
77.0 days-91.0 days |
7 |
|
|
152.57 |
U/l |
7.2 |
19.04 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37461 |
401 |
| FHH-Chr XBN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
77.0 days-91.0 days |
8 |
|
|
399.0 |
U/l |
14.95 |
42.29 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37465 |
401 |
| FHH-Chr 3BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
77.0 days-91.0 days |
8 |
|
|
268.63 |
U/l |
20.75 |
58.68 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37475 |
401 |
| FHH-Chr 8BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
77.0 days-91.0 days |
10 |
|
|
280.4 |
U/l |
16.37 |
51.78 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37482 |
401 |
| SS-Chr 3BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
77.0 days-91.0 days |
10 |
|
|
102.0 |
U/l |
11.89 |
37.59 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37483 |
401 |
| FHH-Chr 18BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
77.0 days-91.0 days |
10 |
|
|
233.6 |
U/l |
10.77 |
34.07 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37490 |
401 |
| FHH-Chr 20BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
77.0 days-91.0 days |
10 |
|
|
235.1 |
U/l |
8.46 |
26.76 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37488 |
401 |
| FHH-Chr 20BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
77.0 days-91.0 days |
10 |
|
|
334.0 |
U/l |
20.22 |
63.93 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37486 |
401 |
| LEW/Crl |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
20 |
|
|
0.31 |
ml |
0.01 |
0.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
19042 |
381 |
| Crl:CD(SD) |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
11 |
|
|
0.3 |
ml |
0.02 |
0.07 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
19040 |
381 |
| F344/DuCrl |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
18 |
|
|
0.23 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
19044 |
381 |
| FHH-Chr 6BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
6 |
|
|
37.18 |
degrees C |
0.2 |
0.5 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19058 |
381 |
| FHH-Chr XBN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
10 |
|
|
37.18 |
degrees C |
0.21 |
0.67 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19065 |
381 |
| SHR/NCrl |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
15 |
|
|
37.69 |
degrees C |
0.17 |
0.67 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19066 |
381 |
| FHH-Chr XBN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
10 |
|
|
37.17 |
degrees C |
0.24 |
0.76 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19069 |
381 |
| SS-Chr 15BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
15 |
|
|
37.45 |
degrees C |
0.2 |
0.78 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19072 |
381 |
| SS-Chr 20BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
16 |
|
|
37.7 |
degrees C |
0.1 |
0.39 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19071 |
381 |
| FHH-Chr 18BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
8 |
|
|
37.01 |
degrees C |
0.25 |
0.69 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19077 |
381 |
| FHH-Chr 8BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
10 |
|
|
36.57 |
degrees C |
0.11 |
0.36 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19074 |
381 |
| FHH-Chr 4BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
13 |
|
|
36.68 |
degrees C |
0.13 |
0.45 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19085 |
381 |
| SS-Chr 20BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
14 |
|
|
37.66 |
degrees C |
0.08 |
0.28 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19080 |
381 |
| SS-Chr 18BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
18 |
|
|
37.58 |
degrees C |
0.11 |
0.47 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19086 |
381 |
| SS-Chr 12BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
9 |
|
|
37.89 |
degrees C |
0.21 |
0.62 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19090 |
381 |
| FHH-Chr 15BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
10 |
|
|
36.73 |
degrees C |
0.23 |
0.73 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19097 |
381 |
| SS-Chr 2BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
12 |
|
|
37.04 |
degrees C |
0.37 |
1.29 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19096 |
381 |
| SS-Chr 14BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
10 |
|
|
37.56 |
degrees C |
0.2 |
0.64 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19101 |
381 |
| SS-Chr 17BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
8 |
|
|
37.26 |
degrees C |
0.36 |
1.03 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19112 |
381 |
| SS-Chr 16BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
12 |
|
|
37.78 |
degrees C |
0.15 |
0.51 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19125 |
381 |
| SS-Chr 3BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
11 |
|
|
37.35 |
degrees C |
0.21 |
0.7 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19126 |
381 |
| SS-Chr 16BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
7 |
|
|
0.42 |
ml |
0.04 |
0.1 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
18633 |
381 |
| SS-Chr 6BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
female |
77.0 days-91.0 days |
10 |
|
|
145.6 |
mmol/l |
0.52 |
1.65 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36481 |
401 |
| SS-Chr 7BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77.0 days-91.0 days |
11 |
|
|
145.64 |
mmol/l |
0.41 |
1.36 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36497 |
401 |
| FHH-Chr 17BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
female |
77.0 days-91.0 days |
10 |
|
|
142.7 |
mmol/l |
0.6 |
1.89 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36502 |
401 |
| SS-Chr 5BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77.0 days-91.0 days |
8 |
|
|
144.13 |
mmol/l |
1.03 |
2.9 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36506 |
401 |
| FHH-Chr 19BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77.0 days-91.0 days |
8 |
|
|
141.75 |
mmol/l |
0.84 |
2.38 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36512 |
401 |
| SS-Chr 16BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
female |
77.0 days-91.0 days |
8 |
|
|
145.5 |
mmol/l |
1.0 |
2.83 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36514 |
401 |
| FHH-Chr 3BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
female |
77.0 days-91.0 days |
8 |
|
|
144.25 |
mmol/l |
0.37 |
1.04 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36515 |
401 |
| FHH-Chr 19BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
female |
77.0 days-91.0 days |
7 |
|
|
143.57 |
mmol/l |
0.57 |
1.51 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36519 |
401 |
| FHH-Chr 13BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
female |
77.0 days-91.0 days |
9 |
|
|
144.11 |
mmol/l |
0.68 |
2.03 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36521 |
401 |
| FHH-Chr 8BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77.0 days-91.0 days |
10 |
|
|
142.0 |
mmol/l |
0.65 |
2.05 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36522 |
401 |
| SS-Chr 3BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
female |
77.0 days-91.0 days |
10 |
|
|
142.2 |
mmol/l |
0.49 |
1.55 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36523 |
401 |
| FHH-Chr 13BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77.0 days-91.0 days |
10 |
|
|
144.0 |
mmol/l |
0.37 |
1.15 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36525 |
401 |
| SS-Chr 20BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77.0 days-91.0 days |
24 |
|
|
140.79 |
mmol/l |
0.51 |
2.52 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36529 |
401 |
| FHH-Chr 3BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77.0 days-91.0 days |
8 |
|
|
144.38 |
mmol/l |
0.65 |
1.85 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36534 |
401 |
| SS-Chr YBN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77.0 days-91.0 days |
20 |
|
|
144.0 |
mmol/l |
0.27 |
1.21 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36536 |
401 |
| SS/JrHsdMcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77.0 days-91.0 days |
92 |
|
|
143.62 |
mmol/l |
0.31 |
2.97 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36539 |
401 |
| SS-Chr 4BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77.0 days-91.0 days |
12 |
|
|
142.67 |
mmol/l |
0.38 |
1.3 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36546 |
401 |
| FHH-Chr 4BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77.0 days-91.0 days |
9 |
|
|
143.22 |
mmol/l |
0.95 |
2.86 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36544 |
401 |
| SS-Chr 12BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77.0 days-91.0 days |
10 |
|
|
142.4 |
mmol/l |
0.6 |
1.9 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36552 |
401 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77.0 days-91.0 days |
16 |
|
|
145.63 |
mmol/l |
0.87 |
3.46 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36559 |
401 |
| FHH-Chr 1BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
female |
77.0 days-91.0 days |
18 |
|
|
143.89 |
mmol/l |
0.4 |
1.68 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36567 |
401 |
| LEW/Crl |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
8 |
|
|
9.24 |
x 10E6 cells/ul |
0.08 |
0.23 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
36576 |
401 |
| Crl:CD(SD) |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
9 |
|
|
7.97 |
x 10E6 cells/ul |
0.17 |
0.5 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
36574 |
401 |
| Hsd:SD |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
1 |
|
|
32.7 |
g/dl |
|
|
automated blood cell counting method |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
36582 |
401 |
| SS-Chr 16BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
7 |
|
|
31.79 |
g/dl |
0.16 |
0.42 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
36581 |
401 |
| SHR/NCrl |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
female |
77.0 days-91.0 days |
10 |
|
|
9.42 |
mg/dl |
0.17 |
0.54 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
36601 |
401 |
| FHH/EurMcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77.0 days-91.0 days |
7 |
|
|
9.3 |
mg/dl |
0.1 |
0.28 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
36605 |
401 |
| FHH-Chr 15BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77.0 days-91.0 days |
8 |
|
|
9.57 |
mg/dl |
0.16 |
0.45 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36741 |
401 |
| FHH-Chr 5BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
female |
77.0 days-91.0 days |
8 |
|
|
9.48 |
mg/dl |
0.14 |
0.4 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36747 |
401 |
| SS-Chr 9BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
female |
77.0 days-91.0 days |
9 |
|
|
9.21 |
mg/dl |
0.08 |
0.25 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36756 |
401 |
| FHH-Chr 14BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77.0 days-91.0 days |
8 |
|
|
9.23 |
mg/dl |
0.1 |
0.27 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36761 |
401 |
| FHH-Chr 15BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
female |
77.0 days-91.0 days |
8 |
|
|
9.41 |
mg/dl |
0.07 |
0.2 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36760 |
401 |
| FHH-Chr 17BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
female |
77.0 days-91.0 days |
10 |
|
|
9.98 |
mg/dl |
0.17 |
0.53 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36771 |
401 |
| SS-Chr 3BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77.0 days-91.0 days |
10 |
|
|
9.64 |
mg/dl |
0.08 |
0.26 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36786 |
401 |
| SS-Chr 3BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
female |
77.0 days-91.0 days |
10 |
|
|
9.42 |
mg/dl |
0.09 |
0.29 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36792 |
401 |
| SS-Chr 20BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77.0 days-91.0 days |
24 |
|
|
9.52 |
mg/dl |
0.12 |
0.6 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36798 |
401 |
| SS-Chr 13BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77.0 days-91.0 days |
11 |
|
|
9.56 |
mg/dl |
0.14 |
0.48 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36802 |
401 |
| SS-Chr 18BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77.0 days-91.0 days |
9 |
|
|
9.56 |
mg/dl |
0.17 |
0.5 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36807 |
401 |
| SS-Chr 11BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77.0 days-91.0 days |
13 |
|
|
9.87 |
mg/dl |
0.13 |
0.46 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36806 |
401 |
| SS-Chr 1BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77.0 days-91.0 days |
6 |
|
|
9.63 |
mg/dl |
0.11 |
0.27 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36809 |
401 |
| SS-Chr 18BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
female |
77.0 days-91.0 days |
10 |
|
|
9.4 |
mg/dl |
0.13 |
0.4 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36812 |
401 |
| SS-Chr 1BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
female |
77.0 days-91.0 days |
7 |
|
|
9.29 |
mg/dl |
0.16 |
0.43 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36814 |
401 |
| FHH-Chr 4BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77.0 days-91.0 days |
9 |
|
|
9.41 |
mg/dl |
0.14 |
0.43 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36813 |
401 |
| SS-Chr 12BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77.0 days-91.0 days |
10 |
|
|
9.82 |
mg/dl |
0.13 |
0.41 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36821 |
401 |
| FHH-Chr 11BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
female |
77.0 days-91.0 days |
8 |
|
|
9.76 |
mg/dl |
0.08 |
0.21 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36822 |
401 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77.0 days-91.0 days |
15 |
|
|
9.42 |
mg/dl |
0.19 |
0.75 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36828 |
401 |
| SS-Chr 2BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
female |
77.0 days-91.0 days |
9 |
|
|
9.39 |
mg/dl |
0.16 |
0.49 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36827 |
401 |
| FHH-Chr 7BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
female |
77.0 days-91.0 days |
9 |
|
|
9.52 |
mg/dl |
0.13 |
0.38 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36825 |
401 |
| SS-Chr 16BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77.0 days-91.0 days |
6 |
|
|
6.89 |
x 1000 cells/ul |
0.63 |
1.55 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
36843 |
401 |
| SS-Chr 10BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77.0 days-91.0 days |
15 |
|
|
6.3 |
x 1000 cells/ul |
0.25 |
0.96 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36853 |
401 |
| SS-Chr 9BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77.0 days-91.0 days |
10 |
|
|
5.24 |
x 1000 cells/ul |
0.4 |
1.27 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36861 |
401 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77.0 days-91.0 days |
10 |
|
|
3.76 |
x 1000 cells/ul |
0.27 |
0.86 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36862 |
401 |
| FHH-Chr 6BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77.0 days-91.0 days |
10 |
|
|
2.67 |
x 1000 cells/ul |
0.21 |
0.67 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36863 |
401 |
| FHH-Chr 12BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77.0 days-91.0 days |
12 |
|
|
3.47 |
x 1000 cells/ul |
0.35 |
1.22 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36868 |
401 |
| Hsd:SD |
blood pH |
control condition |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
male |
82.0 days-99.0 days |
1 |
|
|
7.47 |
null |
|
|
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
19317 |
381 |
| F344/DuCrl |
blood pH |
control condition |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
male |
82.0 days-99.0 days |
10 |
|
|
7.48 |
null |
0.01 |
0.02 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
19320 |
381 |
| F344/DuCrl |
blood pH |
control condition |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
female |
82.0 days-99.0 days |
7 |
|
|
7.5 |
null |
0.01 |
0.02 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
19325 |
381 |
| SS-Chr 16BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
8 |
|
|
127.2 |
mmHg |
2.95 |
8.35 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
19516 |
381 |
| MWF-Chr 6SHR/Rkb |
urine albumin excretion rate |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
urine albumin amount |
not specified |
98.0 days
| 19 |
|
|
2.9 |
mg/d |
3.5 |
15.26 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
|
|
|
65274 |
117 |
| MWF-Chr 6SHR/Rkb |
both kidneys wet weight to body weight ratio |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
kidney mass |
not specified |
168.0 days
| 19 |
|
|
5.62 |
g/kg |
0.18 |
0.78 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
65365 |
117 |
| MWF-Chr 6SHR/Rkb |
heart wet weight |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
heart mass |
not specified |
168.0 days
| 19 |
|
|
0.93 |
g |
0.02 |
0.09 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
65368 |
117 |
| MWF-Chr 6SHR/Rkb |
creatinine clearance to body weight ratio |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
glomerular filtration trait |
not specified |
168.0 days
| 19 |
|
|
0.59 |
ml/min/100g |
0.04 |
0.17 |
blood creatinine analysis |
|
0.0 |
|
|
|
|
|
|
|
65378 |
117 |
| SHR/FubRkb |
serum triglyceride level |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
blood triglyceride amount |
not specified |
168.0 days
| 10 |
|
|
61.95 |
mg/dl |
3.54 |
11.19 |
serum triglyceride analysis |
|
0.0 |
|
|
|
serum triglyceride analysis |
|
|
|
65384 |
117 |
| MWF-Chr 6SHR/Rkb |
serum total cholesterol level |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
blood cholesterol amount |
not specified |
168.0 days
| 19 |
|
|
74.52 |
mg/dl |
2.32 |
10.1 |
serum total cholesterol measurement test |
|
0.0 |
|
|
|
serum triglyceride analysis |
|
|
|
65390 |
117 |
| SHR.BN-(D4Rat33-D4Rat54)/Jk |
diastolic blood pressure |
control condition |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
arterial blood pressure trait |
male |
99.0 days
| 22 |
|
continuous mean |
125.0 |
mmHg |
2.0 |
9.38 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
|
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
|
65405 |
306 |
| SS/Jr |
calculated kidney weight |
control condition |
Garrett MR, et al., J Am Soc Nephrol 2003 May;14(5):1175-87 |
kidney mass |
male |
183.0 days
| 6 |
adjusted organ weight for differences in body weight by regression analysis using programs from SPSS |
|
3.31 |
g |
0.14 |
0.34 |
post excision weight measurement |
|
0 |
|
|
|
|
|
|
|
65450 |
104 |
| MWF-Chr 6SHR/Rkb |
count of superficial glomeruli directly contacting the kidney surface |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
kidney glomerulus quantity |
not specified |
168.0 days
| 19 |
|
|
1.6 |
null |
0.4 |
1.74 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
per section |
|
|
65460 |
117 |
| SHRSP/Gcrc |
systolic blood pressure |
control condition |
Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87. |
arterial blood pressure trait |
female |
91.0 days-126.0 days |
3 |
|
continuous mean |
166.5 |
mmHg |
3.8 |
6.58 |
intra-aortic abdominal radiotelemetry |
|
3024000 |
|
|
|
Nights (7 PM to 7 AM) |
|
|
|
65582 |
613 |
| SHRSP/Gcrc |
mean arterial blood pressure |
control condition |
Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87. |
arterial blood pressure trait |
male |
91.0 days-126.0 days |
3 |
|
continuous mean |
142.1 |
mmHg |
2.3 |
3.98 |
intra-aortic abdominal radiotelemetry |
|
3024000 |
|
|
|
Days (7 AM to 7 PM) |
|
|
|
65586 |
613 |
| WKY/Gcrc |
mean arterial blood pressure |
control condition |
Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87. |
arterial blood pressure trait |
female |
91.0 days-126.0 days |
3 |
|
continuous mean |
99.6 |
mmHg |
3.1 |
5.37 |
intra-aortic abdominal radiotelemetry |
|
3024000 |
|
|
|
Days (7 AM to 7 PM) |
|
|
|
65592 |
613 |
| WKY/Gcrc |
mean arterial blood pressure |
control condition |
Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87. |
arterial blood pressure trait |
female |
91.0 days-126.0 days |
3 |
|
continuous mean |
104.0 |
mmHg |
3.4 |
5.89 |
intra-aortic abdominal radiotelemetry |
|
3024000 |
|
|
|
Nights (7 PM to 7 AM) |
|
|
|
65593 |
613 |
| WKY/Gcrc |
diastolic blood pressure |
control condition |
Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87. |
arterial blood pressure trait |
male |
91.0 days-126.0 days |
4 |
|
continuous mean |
91.2 |
mmHg |
6.0 |
12.0 |
intra-aortic abdominal radiotelemetry |
|
3024000 |
|
|
|
Days (7 AM to 7 PM) |
|
|
|
65594 |
613 |
| WKY/Gcrc |
systolic blood pressure |
control condition |
Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87. |
arterial blood pressure trait |
female |
91.0 days-126.0 days |
3 |
|
continuous mean |
123.8 |
mmHg |
3.4 |
5.89 |
intra-aortic abdominal radiotelemetry |
|
3024000 |
|
|
|
Days (7 AM to 7 PM) |
|
|
|
65600 |
613 |
| WKY/Gcrc |
systolic blood pressure |
control condition |
Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87. |
arterial blood pressure trait |
female |
91.0 days-126.0 days |
3 |
|
continuous mean |
128.0 |
mmHg |
3.3 |
5.72 |
intra-aortic abdominal radiotelemetry |
|
3024000 |
|
|
|
Nights (7 PM to 7 AM) |
|
|
|
65601 |
613 |
| Hsd:SD |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
5 |
|
|
98.87 |
breaths/min |
13.75 |
30.75 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
18155 |
381 |
| LE/BluGill |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
9 |
|
|
109.15 |
breaths/min |
5.89 |
17.68 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
18160 |
381 |
| FHH/EurMcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
9 |
|
|
44.56 |
ml/min |
3.3 |
9.9 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
18188 |
381 |
| BN/NHsdMcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
8 |
|
|
24.21 |
ml/min |
1.5 |
4.25 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
18190 |
381 |
| SS/JrHsdMcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
30.46 |
ml/min |
2.03 |
6.41 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
18191 |
381 |
| Hsd:SD |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
15 |
|
|
0.39 |
ml |
0.02 |
0.07 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
18248 |
381 |
| SS/JrHsdMcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
10 |
|
|
452.61 |
beats/min |
5.11 |
16.16 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
20443 |
381 |
| FHH-Chr 3BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
10 |
|
|
37.16 |
degrees C |
0.12 |
0.38 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19134 |
381 |
| SS-Chr 11BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
9 |
|
|
36.88 |
degrees C |
0.76 |
2.27 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19132 |
381 |
| SS-Chr YBN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
19 |
|
|
37.41 |
degrees C |
0.2 |
0.89 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19136 |
381 |
| SS-Chr 1BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
10 |
|
|
38.56 |
degrees C |
0.15 |
0.46 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19138 |
381 |
| FHH-Chr 9BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
10 |
|
|
37.38 |
degrees C |
0.17 |
0.55 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19146 |
381 |
| SHR/NCrl |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
10 |
|
|
0.94 |
g |
0.03 |
0.08 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49054 |
461 |
| FHH-Chr 10BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
10 |
|
|
0.61 |
g |
0.06 |
0.19 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49059 |
461 |
| SS-Chr 20BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
17 |
|
|
1.06 |
g |
0.06 |
0.23 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49071 |
461 |
| FHH-Chr 1BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
10 |
|
|
0.78 |
g |
0.04 |
0.12 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49075 |
461 |
| FHH-Chr 4BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
10 |
|
|
0.75 |
g |
0.02 |
0.06 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49076 |
461 |
| SS-Chr 2BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49.0 days-63.0 days |
15 |
|
|
0.77 |
g |
0.03 |
0.11 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49083 |
461 |
| FHH-Chr 15BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
10 |
|
|
0.69 |
g |
0.03 |
0.1 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49088 |
461 |
| SS-Chr 9BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49.0 days-63.0 days |
17 |
|
|
0.83 |
g |
0.02 |
0.1 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49097 |
461 |
| SS-Chr 10BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49.0 days-63.0 days |
9 |
|
|
0.93 |
g |
0.05 |
0.14 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49100 |
461 |
| SS-Chr 17BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
10 |
|
|
0.8 |
g |
0.08 |
0.26 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49102 |
461 |
| SS-Chr 16BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
14 |
|
|
1.03 |
g |
0.05 |
0.19 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49118 |
461 |
| FHH-Chr 13BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49.0 days-63.0 days |
10 |
|
|
0.77 |
g |
0.02 |
0.06 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49119 |
461 |
| SS-Chr 11BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49.0 days-63.0 days |
10 |
|
|
0.89 |
g |
0.03 |
0.08 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49122 |
461 |
| SS/JrHsdMcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
98 |
|
|
1.06 |
g |
0.02 |
0.16 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49127 |
461 |
| FHH-Chr 9BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
10 |
|
|
0.7 |
g |
0.05 |
0.15 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49141 |
461 |
| SS/JrHsdMcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
12 |
|
|
1.45 |
g |
0.03 |
0.09 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
49599 |
461 |
| LEW/Crl |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
10 |
|
|
5.1 |
g/kg |
0.23 |
0.74 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
49671 |
461 |
| LE/BluGill |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49.0 days-63.0 days |
11 |
|
|
4.1 |
g/kg |
0.19 |
0.64 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
49670 |
461 |
| SS-Chr 16BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
6 |
|
|
37.7 |
degrees C |
0.21 |
0.52 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
19180 |
381 |
| SS-Chr 16BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
6 |
|
|
38.25 |
degrees C |
0.18 |
0.44 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
19178 |
381 |
| Hsd:SD |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
77.0 days-91.0 days |
3 |
|
|
0.02 |
x 1000 cells/ul |
0.02 |
0.03 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
38858 |
401 |
| Hsd:SD |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
77.0 days-91.0 days |
1 |
|
|
0.0 |
x 1000 cells/ul |
|
|
automated blood cell counting method |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
38857 |
401 |
| LE/BluGill |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
13 |
|
|
45.84 |
% |
0.49 |
1.76 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
38867 |
401 |
| WKY/NCrl |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
13 |
|
|
44.69 |
% |
0.51 |
1.84 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
38869 |
401 |
| FHH-Chr 15BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
77.0 days-91.0 days |
8 |
|
|
0.81 |
x 1000 cells/ul |
0.09 |
0.24 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38878 |
401 |
| FHH-Chr 2BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
77.0 days-91.0 days |
8 |
|
|
0.4 |
x 1000 cells/ul |
0.09 |
0.25 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38883 |
401 |
| SS-Chr 5BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
77.0 days-91.0 days |
8 |
|
|
0.57 |
x 1000 cells/ul |
0.06 |
0.16 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38912 |
401 |
| FHH-Chr 16BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
77.0 days-91.0 days |
10 |
|
|
0.81 |
x 1000 cells/ul |
0.08 |
0.25 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38915 |
401 |
| SS-Chr 20BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
77.0 days-91.0 days |
23 |
|
|
0.71 |
x 1000 cells/ul |
0.04 |
0.21 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38935 |
401 |
| FHH-Chr 20BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
77.0 days-91.0 days |
10 |
|
|
0.56 |
x 1000 cells/ul |
0.13 |
0.41 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38934 |
401 |
| SS-Chr 16BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
77.0 days-91.0 days |
7 |
|
|
96.29 |
U/l |
11.08 |
29.31 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
42148 |
401 |
| GH/OmrMcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77.0 days-91.0 days |
9 |
|
|
121.78 |
U/l |
11.3 |
33.9 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
42156 |
401 |
| SS-Chr 16BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
male |
77.0 days-91.0 days |
11 |
|
|
4.22 |
mmol/l |
0.08 |
0.28 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
42164 |
401 |
| SS-Chr 18BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
male |
77.0 days-91.0 days |
9 |
|
|
4.23 |
mmol/l |
0.21 |
0.63 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
42157 |
401 |
| SHR/NCrl |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
male |
77.0 days-91.0 days |
11 |
|
|
4.59 |
mmol/l |
0.11 |
0.36 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
42167 |
401 |
| LEW/Crl |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
77.0 days-91.0 days |
10 |
|
|
0.19 |
mg/dl |
0.01 |
0.03 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
42176 |
401 |
| Crl:CD(SD) |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
77.0 days-91.0 days |
9 |
|
|
0.21 |
mg/dl |
0.01 |
0.03 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
42179 |
401 |
| LEW/Crl |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
77.0 days-91.0 days |
10 |
|
|
0.13 |
mg/dl |
0.02 |
0.07 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
42181 |
401 |
| WKY/NCrl |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
77.0 days-91.0 days |
14 |
|
|
0.14 |
mg/dl |
0.01 |
0.05 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
42182 |
401 |
| SS-Chr 16BN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
77.0 days-91.0 days |
11 |
|
|
17.45 |
mmol/l |
0.84 |
2.77 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
42203 |
401 |
| LEW/Crl |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
10 |
|
|
32.65 |
g/dl |
0.28 |
0.88 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
42209 |
401 |
| LE/BluGill |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
11 |
|
|
32.56 |
g/dl |
0.13 |
0.45 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
42217 |
401 |
| F344/DuCrl |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
8 |
|
|
32.13 |
g/dl |
0.28 |
0.8 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
42211 |
401 |
| SHRSP/Izm |
heart weight to body weight ratio |
control condition (0 null) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
heart mass |
female |
91.0 days
| 5 |
|
|
4.84 |
g/kg |
0.24 |
0.54 |
post excision weight measurement |
|
0 |
|
|
|
|
|
|
|
64838 |
115 |
| SS-Chr XBN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
77.0 days-91.0 days |
8 |
|
|
0.32 |
x 1000 cells/ul |
0.05 |
0.15 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38947 |
401 |
| SS/JrHsdMcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
77.0 days-91.0 days |
11 |
|
|
0.52 |
x 1000 cells/ul |
0.09 |
0.28 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38953 |
401 |
| FHH-Chr 11BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
77.0 days-91.0 days |
8 |
|
|
0.6 |
x 1000 cells/ul |
0.06 |
0.16 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38954 |
401 |
| SS-Chr 19BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
77.0 days-91.0 days |
7 |
|
|
0.97 |
x 1000 cells/ul |
0.26 |
0.7 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38957 |
401 |
| FHH-Chr 1BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
77.0 days-91.0 days |
14 |
|
|
0.58 |
x 1000 cells/ul |
0.07 |
0.25 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38973 |
401 |
| SS-Chr 18BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77.0 days-91.0 days |
9 |
|
|
144.22 |
mmol/l |
0.7 |
2.11 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
39074 |
401 |
| SS-Chr 16BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77.0 days-91.0 days |
11 |
|
|
140.91 |
mmol/l |
0.46 |
1.51 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
39081 |
401 |
| Hsd:SD |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
6 |
|
|
8.04 |
x 10E6 cells/ul |
0.41 |
1.0 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
42323 |
401 |
| SS/JrHsdMcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77.0 days-91.0 days |
12 |
|
|
24.5 |
mg/dl |
0.96 |
3.32 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
42325 |
401 |
| SS-Chr 16BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
77.0 days-91.0 days |
7 |
|
|
22.14 |
mg/dl |
0.96 |
2.54 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
42327 |
401 |
| SS-Chr 16BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77.0 days-91.0 days |
11 |
|
|
20.36 |
mg/dl |
0.88 |
2.91 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
42331 |
401 |
| SS/JrHsdMcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
77.0 days-91.0 days |
9 |
|
|
23.89 |
mg/dl |
1.7 |
5.09 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
42333 |
401 |
| LEW/Crl |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
female |
77.0 days-91.0 days |
10 |
|
|
17.2 |
mmol/l |
0.71 |
2.25 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
42357 |
401 |
| LEW/Crl |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
77.0 days-91.0 days |
10 |
|
|
15.4 |
mmol/l |
0.54 |
1.71 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
42362 |
401 |
| LE/BluGill |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
77.0 days-91.0 days |
11 |
|
|
23.73 |
mmol/l |
0.51 |
1.68 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
42365 |
401 |
| FHH/EurMcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
8 |
|
|
8.51 |
x 10E6 cells/ul |
0.19 |
0.53 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
42378 |
401 |
| SHR/NCrl |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
11 |
|
|
9.24 |
x 10E6 cells/ul |
0.16 |
0.53 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
42386 |
401 |
| FHH-Chr 15BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77.0 days-91.0 days |
8 |
|
|
111.13 |
U/l |
6.83 |
19.32 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42399 |
401 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77.0 days-91.0 days |
10 |
|
|
78.3 |
U/l |
6.16 |
19.48 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42402 |
401 |
| SS-Chr 9BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
77.0 days-91.0 days |
9 |
|
|
68.89 |
U/l |
4.05 |
12.15 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42414 |
401 |
| SS-Chr 14BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77.0 days-91.0 days |
10 |
|
|
76.1 |
U/l |
2.92 |
9.23 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42413 |
401 |
| FHH-Chr 6BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
77.0 days-91.0 days |
10 |
|
|
92.0 |
U/l |
3.82 |
12.06 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42411 |
401 |
| FHH-Chr 2BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77.0 days-91.0 days |
8 |
|
|
102.88 |
U/l |
7.3 |
20.65 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42420 |
401 |
| FHH-Chr 16BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
77.0 days-91.0 days |
8 |
|
|
77.13 |
U/l |
5.45 |
15.41 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42423 |
401 |
| SS-Chr 7BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77.0 days-91.0 days |
11 |
|
|
80.18 |
U/l |
4.95 |
16.43 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42424 |
401 |
| SS-Chr 5BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77.0 days-91.0 days |
7 |
|
|
92.14 |
U/l |
10.97 |
29.01 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42433 |
401 |
| SS-Chr 20BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
77.0 days-91.0 days |
14 |
|
|
70.79 |
U/l |
6.46 |
24.16 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42438 |
401 |
| FHH-Chr 16BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77.0 days-91.0 days |
10 |
|
|
93.6 |
U/l |
5.88 |
18.6 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42436 |
401 |
| FHH-Chr 3BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
77.0 days-91.0 days |
8 |
|
|
95.88 |
U/l |
2.83 |
8.01 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42442 |
401 |
| SS-Chr 3BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77.0 days-91.0 days |
10 |
|
|
90.4 |
U/l |
6.73 |
21.29 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42444 |
401 |
| FHH-Chr 20BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
77.0 days-91.0 days |
10 |
|
|
110.1 |
U/l |
10.71 |
33.88 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42455 |
401 |
| FHH-Chr 18BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
77.0 days-91.0 days |
9 |
|
|
95.89 |
U/l |
6.08 |
18.24 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42457 |
401 |
| SHRSP.WKY-(Klk1-D1Rat116)/Izm |
retroperitoneal fat pad weight to body weight ratio |
control condition (0 null) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
retroperitoneal fat pad mass |
female |
91.0 days
| 5 |
|
|
0.56 |
% |
0.04 |
0.09 |
post excision weight measurement |
|
0 |
|
|
|
|
|
|
|
64846 |
115 |
| SS/Jr |
body weight |
control condition |
Garrett MR, et al., J Am Soc Nephrol 2003 May;14(5):1175-87 |
body mass |
male |
84.0 days-85.0 days |
6 |
|
|
384.0 |
g |
8.9 |
21.8 |
body weighing method |
|
0 |
|
|
|
|
|
|
|
65442 |
104 |
| SS/Jr |
body weight |
control condition |
Garrett MR, et al., J Am Soc Nephrol 2003 May;14(5):1175-87 |
body mass |
male |
140.0 days-141.0 days |
6 |
|
|
451.0 |
g |
18.5 |
45.32 |
body weighing method |
|
0 |
|
|
|
|
|
|
|
65444 |
104 |
| ACI/N |
both adrenal glands wet weight |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
adrenal gland mass |
both |
167.0 days-174.0 days |
210 |
|
|
36.0 |
mg |
0.27 |
3.9 |
post excision weight measurement |
|
0 |
|
|
|
|
|
|
|
65987 |
114 |
| BN/SsN |
both adrenal glands wet weight |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
adrenal gland mass |
both |
167.0 days-174.0 days |
210 |
|
|
58.0 |
mg |
0.37 |
5.3 |
post excision weight measurement |
|
0 |
|
|
|
|
|
|
|
65985 |
114 |
| BUF/N |
both adrenal glands wet weight |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
adrenal gland mass |
both |
167.0 days-174.0 days |
210 |
|
|
32.9 |
mg |
0.22 |
3.2 |
post excision weight measurement |
|
0 |
|
|
|
|
|
|
|
65989 |
114 |
| RHA/Verh |
total horizontal distance resulting from voluntary locomotion during initial exposure in a novel cage |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
fear-related behavior trait |
both |
104.0 days-111.0 days |
19 |
|
|
1647.18 |
cm |
91.74 |
399.9 |
computerized assessment of automated movement detection |
|
300 |
cage entry |
|
min |
first 5 minutes of 30 minute test |
|
|
|
66016 |
114 |
| RLA/Verh |
total horizontal distance resulting from voluntary locomotion during habituated time in a novel cage |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
exploratory behavior trait |
both |
104.0 days-111.0 days |
18 |
|
|
466.6 |
cm |
45.09 |
191.3 |
computerized assessment of automated movement detection |
|
300 |
cage entry |
25 |
min |
last 5 minutes of 30 minute test |
|
|
|
66019 |
114 |
| N:HS |
defecation rate |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
defecation behavior trait |
both |
111.0 days-118.0 days |
20 |
|
|
2.87 |
/5 min |
3.65 |
16.34 |
ex vivo visual assessment |
|
300 |
|
|
|
video monitoring |
|
|
|
66023 |
114 |
| BN-Lx/Cub |
diastolic blood pressure |
control condition |
Pravenec M, et al., J Hypertens 1989 Mar;7(3):217-21. |
arterial blood pressure trait |
male |
days
| 8 |
|
|
93.0 |
mmHg |
3.0 |
8.49 |
vascular indwelling catheter method |
carotid artery segment |
0.0 |
|
|
|
|
|
|
|
66037 |
651 |
| BN-Lx/Cub |
mean arterial blood pressure |
control condition |
Pravenec M, et al., J Hypertens 1989 Mar;7(3):217-21. |
arterial blood pressure trait |
male |
days
| 8 |
|
|
113.0 |
mmHg |
3.0 |
16.16 |
vascular indwelling catheter method |
carotid artery segment |
0.0 |
|
|
|
|
|
|
|
66038 |
651 |
| WKY/NCruk |
mean arterial blood pressure |
control condition |
Zhao L et al., 2001, Circulation, 103(3), 442-7 |
arterial blood pressure trait |
male |
105.0 days
| 12 |
|
median |
91.0 |
mmHg |
|
|
vascular indwelling catheter method |
left common carotid artery |
0 |
|
|
|
|
|
|
|
66129 |
102 |
| ACI/SegHsd |
percentage of study population developing leukemia during a period of time |
control condition |
Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. |
leukocyte integrity trait |
male |
900.0 days
| 12 |
|
|
0.0 |
% |
|
|
ex vivo light microscopy |
|
0 |
|
|
|
|
leukemia incidence |
|
|
66143 |
341 |
| SHR/NCrl |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
77.0 days-91.0 days |
10 |
|
|
79.7 |
mg/dl |
2.7 |
8.55 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
39204 |
401 |
| GH/OmrMcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
77.0 days-91.0 days |
9 |
|
|
96.44 |
mg/dl |
2.03 |
6.09 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
39206 |
401 |
| SS-Chr 16BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77.0 days-91.0 days |
11 |
|
|
82.0 |
mg/dl |
2.18 |
7.24 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
39207 |
401 |
| FHH/EurMcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77.0 days-91.0 days |
7 |
|
|
91.71 |
mg/dl |
4.56 |
12.05 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
39208 |
401 |
| GH/OmrMcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77.0 days-91.0 days |
9 |
|
|
111.89 |
mg/dl |
3.63 |
10.9 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
39211 |
401 |
| WKY/NCrl |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77.0 days-91.0 days |
10 |
|
|
143.1 |
mmol/l |
0.67 |
2.13 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
39337 |
401 |
| LE/BluGill |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
female |
77.0 days-91.0 days |
14 |
|
|
145.86 |
mmol/l |
0.47 |
1.75 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
39342 |
401 |
| LE/BluGill |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77.0 days-91.0 days |
11 |
|
|
145.45 |
mmol/l |
0.82 |
2.73 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
39346 |
401 |
| Crl:CD(SD) |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
male |
77.0 days-91.0 days |
9 |
|
|
3.79 |
g/dl |
0.05 |
0.15 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
39349 |
401 |
| Crl:CD(SD) |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
female |
77.0 days-91.0 days |
9 |
|
|
4.54 |
g/dl |
0.07 |
0.22 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
39351 |
401 |
| FHH-Chr 3BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77.0 days-91.0 days |
8 |
|
|
107.25 |
U/l |
3.37 |
9.53 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42461 |
401 |
| WKY/NCrl |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
female |
77.0 days-91.0 days |
13 |
|
|
3.83 |
g/dl |
0.06 |
0.21 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
39354 |
401 |
| SS-Chr 18BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
77.0 days-91.0 days |
10 |
|
|
73.9 |
U/l |
7.26 |
22.96 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42470 |
401 |
| FHH-Chr 4BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77.0 days-91.0 days |
9 |
|
|
115.67 |
U/l |
6.9 |
20.69 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42471 |
401 |
| FHH-Chr 7BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
77.0 days-91.0 days |
9 |
|
|
104.78 |
U/l |
9.65 |
28.95 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42483 |
401 |
| FHH-Chr 9BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77.0 days-91.0 days |
8 |
|
|
94.75 |
U/l |
7.57 |
21.4 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42492 |
401 |
| Hsd:SD |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77.0 days-91.0 days |
2 |
|
|
16.0 |
mg/dl |
2.0 |
2.83 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
42497 |
401 |
| FHH/EurMcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
77.0 days-91.0 days |
8 |
|
|
22.13 |
mmol/l |
1.55 |
4.39 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
42510 |
401 |
| FHH-Chr 15BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
77.0 days-91.0 days |
8 |
|
|
0.24 |
mg/dl |
0.03 |
0.09 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42628 |
401 |
| FHH-Chr 12BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
77.0 days-91.0 days |
11 |
|
|
0.18 |
mg/dl |
0.02 |
0.06 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42629 |
401 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
77.0 days-91.0 days |
10 |
|
|
0.23 |
mg/dl |
0.02 |
0.05 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42631 |
401 |
| FHH-Chr 5BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
77.0 days-91.0 days |
8 |
|
|
0.2 |
mg/dl |
0.03 |
0.08 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42634 |
401 |
| SS-Chr 6BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
77.0 days-91.0 days |
10 |
|
|
0.21 |
mg/dl |
0.01 |
0.03 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42637 |
401 |
| FHH-Chr 14BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
77.0 days-91.0 days |
8 |
|
|
0.2 |
mg/dl |
0.0 |
0.0 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42632 |
401 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
77.0 days-91.0 days |
10 |
|
|
0.23 |
mg/dl |
0.02 |
0.05 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42639 |
401 |
| FHH-Chr 6BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
77.0 days-91.0 days |
10 |
|
|
0.24 |
mg/dl |
0.02 |
0.05 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42640 |
401 |
| GH/OmrMcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
77.0 days-91.0 days |
5 |
|
|
0.22 |
mg/dl |
0.02 |
0.04 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42659 |
401 |
| SS-Chr 5BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
77.0 days-91.0 days |
8 |
|
|
0.26 |
mg/dl |
0.03 |
0.09 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42662 |
401 |
| SS/JrHsdMcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
77.0 days-91.0 days |
12 |
|
|
0.73 |
x 1000 cells/ul |
0.1 |
0.35 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
39358 |
401 |
| SHR/NCrl |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
77.0 days-91.0 days |
9 |
|
|
0.73 |
x 1000 cells/ul |
0.15 |
0.45 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
39361 |
401 |
| GH/OmrMcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
77.0 days-91.0 days |
9 |
|
|
0.71 |
x 1000 cells/ul |
0.16 |
0.47 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
39363 |
401 |
| SS/JrHsdMcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
77.0 days-91.0 days |
9 |
|
|
0.48 |
x 1000 cells/ul |
0.07 |
0.2 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
39366 |
401 |
| Hsd:SD |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77.0 days-91.0 days |
6 |
|
|
11.55 |
mg/dl |
0.92 |
2.26 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
39482 |
401 |
| SS-Chr 18BN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
female |
77.0 days-91.0 days |
9 |
|
|
0.14 |
x 1000 cells/ul |
0.06 |
0.17 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
39504 |
401 |
| FHH/EurMcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
female |
77.0 days-91.0 days |
8 |
|
|
3.99 |
g/dl |
0.05 |
0.15 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
39523 |
401 |
| FHH/EurMcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
male |
77.0 days-91.0 days |
7 |
|
|
3.86 |
g/dl |
0.06 |
0.16 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
39529 |
401 |
| SS-Chr 16BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
77.0 days-91.0 days |
8 |
|
|
0.26 |
mg/dl |
0.02 |
0.05 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42670 |
401 |
| SS-Chr 3BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
77.0 days-91.0 days |
10 |
|
|
0.25 |
mg/dl |
0.02 |
0.07 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42673 |
401 |
| SS-Chr 16BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
77.0 days-91.0 days |
6 |
|
|
0.28 |
mg/dl |
0.03 |
0.08 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42676 |
401 |
| SS-Chr 3BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
77.0 days-91.0 days |
10 |
|
|
0.22 |
mg/dl |
0.01 |
0.04 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42679 |
401 |
| FHH-Chr 13BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
77.0 days-91.0 days |
9 |
|
|
0.19 |
mg/dl |
0.01 |
0.03 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42677 |
401 |
| SS-Chr 13BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
77.0 days-91.0 days |
12 |
|
|
0.21 |
mg/dl |
0.01 |
0.03 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42680 |
401 |
| SS-Chr 11BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
77.0 days-91.0 days |
12 |
|
|
0.31 |
mg/dl |
0.03 |
0.1 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42687 |
401 |
| FHH-Chr 20BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
77.0 days-91.0 days |
10 |
|
|
0.19 |
mg/dl |
0.01 |
0.03 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42684 |
401 |
| FHH-Chr 3BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
77.0 days-91.0 days |
8 |
|
|
0.23 |
mg/dl |
0.02 |
0.05 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42690 |
401 |
| SS-Chr XBN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
77.0 days-91.0 days |
8 |
|
|
0.24 |
mg/dl |
0.02 |
0.05 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42697 |
401 |
| FHH-Chr 1BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
77.0 days-91.0 days |
18 |
|
|
0.2 |
mg/dl |
0.01 |
0.05 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42698 |
401 |
| FHH-Chr 9BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
77.0 days-91.0 days |
8 |
|
|
0.2 |
mg/dl |
0.03 |
0.09 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42713 |
401 |
| SS-Chr XBN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
77.0 days-91.0 days |
8 |
|
|
0.24 |
mg/dl |
0.03 |
0.07 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42719 |
401 |
| SS/JrHsdMcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
4 |
|
|
8.0 |
x 10E6 cells/ul |
0.14 |
0.27 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
42724 |
401 |
| SS-Chr 16BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
6 |
|
|
7.86 |
x 10E6 cells/ul |
0.1 |
0.26 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
42728 |
401 |
| Crl:CD(SD) |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
9 |
|
|
15.06 |
g/dl |
0.27 |
0.81 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
42743 |
401 |
| WKY/NCrl |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
13 |
|
|
14.33 |
g/dl |
0.11 |
0.39 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
42746 |
401 |
| LE/BluGill |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
77.0 days-91.0 days |
11 |
|
|
4.61 |
x 1000 cells/ul |
0.3 |
1.0 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
42862 |
401 |
| F344/DuCrl |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77.0 days-91.0 days |
18 |
|
|
3.43 |
x 1000 cells/ul |
0.23 |
0.98 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
42861 |
401 |
| FHH-Chr 14BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
77.0 days-91.0 days |
8 |
|
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42869 |
401 |
| F344/DuCrlSwe |
pancreatic islet area to total pancreatic area ratio |
control condition |
Granhall C, et al., Diabetes. 2006 Dec;55(12):3494-500. |
islet of Langerhans morphology trait |
male |
60.0 days
| 3 |
|
|
1.28 |
% |
0.12 |
0.21 |
ex vivo light microscopy with digital image analysis |
pancreas |
0.0 |
|
|
|
|
|
|
|
67178 |
333 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
77.0 days-91.0 days |
10 |
|
|
0.11 |
mg/dl |
0.01 |
0.03 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42876 |
401 |
| GH/OmrMcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
77.0 days-91.0 days |
6 |
|
|
0.17 |
mg/dl |
0.03 |
0.08 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42891 |
401 |
| GH/OmrMcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
77.0 days-91.0 days |
5 |
|
|
0.16 |
mg/dl |
0.02 |
0.05 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42896 |
401 |
| SS-Chr 7BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
77.0 days-91.0 days |
11 |
|
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42897 |
401 |
| FHH-Chr 10BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
77.0 days-91.0 days |
10 |
|
|
0.09 |
mg/dl |
0.01 |
0.02 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42900 |
401 |
| FHH-Chr XBN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
77.0 days-91.0 days |
8 |
|
|
0.07 |
mg/dl |
0.01 |
0.03 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42901 |
401 |
| FHH-Chr 19BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
77.0 days-91.0 days |
8 |
|
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42905 |
401 |
| FHH-Chr 13BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
77.0 days-91.0 days |
9 |
|
|
0.11 |
mg/dl |
0.01 |
0.03 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42914 |
401 |
| SS-Chr 11BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
77.0 days-91.0 days |
12 |
|
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42924 |
401 |
| SS-Chr YBN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
77.0 days-91.0 days |
19 |
|
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42929 |
401 |
| SS-Chr 18BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
77.0 days-91.0 days |
9 |
|
|
0.09 |
mg/dl |
0.01 |
0.02 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42931 |
401 |
| SS/JrHsdMcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
77.0 days-91.0 days |
92 |
|
|
0.12 |
mg/dl |
0.01 |
0.05 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42932 |
401 |
| SS-Chr 18BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
77.0 days-91.0 days |
10 |
|
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42936 |
401 |
| FHH-Chr 4BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
77.0 days-91.0 days |
9 |
|
|
0.11 |
mg/dl |
0.01 |
0.04 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42937 |
401 |
| FHH-Chr 7BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
77.0 days-91.0 days |
9 |
|
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42949 |
401 |
| SS-Chr 4BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
77.0 days-91.0 days |
15 |
|
|
0.12 |
mg/dl |
0.01 |
0.04 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42947 |
401 |
| BN/NHsdMcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
77.0 days-91.0 days |
14 |
|
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42955 |
401 |
| SS-Chr XBN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
77.0 days-91.0 days |
8 |
|
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42956 |
401 |
| Hsd:SD |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77.0 days-91.0 days |
2 |
|
|
5.95 |
g/dl |
0.25 |
0.35 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
42969 |
401 |
| SS-Chr 10BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
77.0 days-91.0 days |
12 |
|
|
28.58 |
mmol/l |
0.56 |
1.93 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42990 |
401 |
| SS-Chr 14BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77.0 days-91.0 days |
10 |
|
|
22.2 |
mmol/l |
0.47 |
1.48 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42986 |
401 |
| SS-Chr 7BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77.0 days-91.0 days |
11 |
|
|
21.27 |
mmol/l |
0.36 |
1.19 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42997 |
401 |
| FHH-Chr 17BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77.0 days-91.0 days |
9 |
|
|
24.33 |
mmol/l |
1.44 |
4.33 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42999 |
401 |
| SS-Chr 17BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
77.0 days-91.0 days |
12 |
|
|
27.42 |
mmol/l |
0.54 |
1.88 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43000 |
401 |
| SS-Chr 3BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77.0 days-91.0 days |
10 |
|
|
29.2 |
mmol/l |
0.36 |
1.14 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43017 |
401 |
| SS-Chr 15BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77.0 days-91.0 days |
10 |
|
|
27.2 |
mmol/l |
0.93 |
2.94 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43016 |
401 |
| FHH-Chr 8BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77.0 days-91.0 days |
10 |
|
|
20.8 |
mmol/l |
2.16 |
6.83 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43022 |
401 |
| FHH-Chr 20BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77.0 days-91.0 days |
10 |
|
|
23.5 |
mmol/l |
0.6 |
1.9 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43026 |
401 |
| SS-Chr 16BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77.0 days-91.0 days |
6 |
|
|
19.33 |
mmol/l |
1.5 |
3.67 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43020 |
401 |
| SS-Chr 3BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
77.0 days-91.0 days |
10 |
|
|
29.7 |
mmol/l |
0.6 |
1.89 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43023 |
401 |
| SS-Chr 13BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
77.0 days-91.0 days |
12 |
|
|
22.33 |
mmol/l |
0.63 |
2.19 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43024 |
401 |
| FHH-Chr 20BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
77.0 days-91.0 days |
10 |
|
|
24.8 |
mmol/l |
0.95 |
3.01 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43028 |
401 |
| FHH/EurMcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77.0 days-91.0 days |
49 |
|
|
23.96 |
mmol/l |
0.55 |
3.82 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43032 |
401 |
| FHH-Chr 3BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77.0 days-91.0 days |
8 |
|
|
24.63 |
mmol/l |
0.98 |
2.77 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43034 |
401 |
| FHH-Chr YBN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77.0 days-91.0 days |
9 |
|
|
25.89 |
mmol/l |
1.06 |
3.18 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43035 |
401 |
| SS-Chr 1BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77.0 days-91.0 days |
6 |
|
|
25.33 |
mmol/l |
1.05 |
2.58 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43040 |
401 |
| WKY/NCrl |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77.0 days-91.0 days |
10 |
|
|
26.5 |
mmol/l |
1.11 |
3.5 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
43068 |
401 |
| F344/DuCrl |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77.0 days-91.0 days |
8 |
|
|
24.0 |
mmol/l |
1.39 |
3.93 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
43071 |
401 |
| LE/BluGill |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77.0 days-91.0 days |
11 |
|
|
20.82 |
mmol/l |
0.44 |
1.47 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
43077 |
401 |
| LEW/Crl |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
female |
77.0 days-91.0 days |
10 |
|
|
0.15 |
x 1000 cells/ul |
0.03 |
0.1 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
43079 |
401 |
| Crl:CD(SD) |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
male |
77.0 days-91.0 days |
9 |
|
|
0.37 |
x 1000 cells/ul |
0.06 |
0.19 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
43080 |
401 |
| Hsd:SD |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77.0 days-91.0 days |
2 |
|
|
99.0 |
mmol/l |
1.0 |
1.41 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
39862 |
401 |
| Hsd:SD |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
6 |
|
|
18.62 |
pg |
0.21 |
0.5 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
39866 |
401 |
| SS-Chr 6BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77.0 days-91.0 days |
10 |
|
|
4.57 |
x 1000 cells/ul |
0.19 |
0.59 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39876 |
401 |
| SS-Chr 9BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77.0 days-91.0 days |
9 |
|
|
4.76 |
x 1000 cells/ul |
0.22 |
0.67 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39882 |
401 |
| FHH-Chr 2BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
77.0 days-91.0 days |
8 |
|
|
5.95 |
x 1000 cells/ul |
0.55 |
1.56 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39888 |
401 |
| SS-Chr 5BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77.0 days-91.0 days |
7 |
|
|
5.21 |
x 1000 cells/ul |
0.27 |
0.73 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39896 |
401 |
| FHH-Chr XBN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
77.0 days-91.0 days |
8 |
|
|
4.53 |
x 1000 cells/ul |
0.4 |
1.13 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39900 |
401 |
| SS-Chr 5BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
77.0 days-91.0 days |
8 |
|
|
7.74 |
x 1000 cells/ul |
0.25 |
0.72 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39901 |
401 |
| SS-Chr 20BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77.0 days-91.0 days |
13 |
|
|
5.72 |
x 1000 cells/ul |
0.46 |
1.65 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39906 |
401 |
| FHH/EurMcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77.0 days-91.0 days |
13 |
|
|
3.21 |
x 1000 cells/ul |
0.21 |
0.77 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39908 |
401 |
| SS-Chr 15BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77.0 days-91.0 days |
10 |
|
|
4.82 |
x 1000 cells/ul |
0.17 |
0.55 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39913 |
401 |
| FHH-Chr 13BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77.0 days-91.0 days |
9 |
|
|
3.69 |
x 1000 cells/ul |
0.38 |
1.15 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39916 |
401 |
| FHH-Chr 8BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
77.0 days-91.0 days |
10 |
|
|
4.49 |
x 1000 cells/ul |
0.33 |
1.06 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39917 |
401 |
| FHH-Chr 20BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
77.0 days-91.0 days |
10 |
|
|
6.3 |
x 1000 cells/ul |
1.0 |
3.17 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39921 |
401 |
| FHH/EurMcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
77.0 days-91.0 days |
48 |
|
|
4.23 |
x 1000 cells/ul |
0.16 |
1.14 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39927 |
401 |
| SS-Chr 11BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
77.0 days-91.0 days |
13 |
|
|
8.58 |
x 1000 cells/ul |
0.6 |
2.17 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39932 |
401 |
| SS/JrHsdMcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
77.0 days-91.0 days |
89 |
|
|
6.77 |
x 1000 cells/ul |
0.15 |
1.38 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39934 |
401 |
| SS/JrHsdMcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77.0 days-91.0 days |
11 |
|
|
5.73 |
x 1000 cells/ul |
0.23 |
0.77 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39942 |
401 |
| SS-Chr 19BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77.0 days-91.0 days |
7 |
|
|
5.04 |
x 1000 cells/ul |
0.18 |
0.49 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39950 |
401 |
| FHH-Chr 9BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77.0 days-91.0 days |
8 |
|
|
3.66 |
x 1000 cells/ul |
0.48 |
1.36 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39952 |
401 |
| BN/NHsdMcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77.0 days-91.0 days |
11 |
|
|
5.52 |
x 1000 cells/ul |
0.58 |
1.91 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39957 |
401 |
| BN/NHsdMcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
77.0 days-91.0 days |
18 |
|
|
6.54 |
x 1000 cells/ul |
0.48 |
2.05 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39956 |
401 |
| SS-Chr XBN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
77.0 days-91.0 days |
8 |
|
|
6.75 |
x 1000 cells/ul |
0.39 |
1.11 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39958 |
401 |
| FHH-Chr 9BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
77.0 days-91.0 days |
8 |
|
|
5.13 |
x 1000 cells/ul |
0.26 |
0.73 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39960 |
401 |
| Hsd:SD |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
male |
77.0 days-91.0 days |
8 |
|
|
0.23 |
x 1000 cells/ul |
0.05 |
0.15 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
39974 |
401 |
| SS/JrHsdMcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
77.0 days-91.0 days |
12 |
|
|
0.29 |
mg/dl |
0.04 |
0.13 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
43089 |
401 |
| SS-Chr 18BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
77.0 days-91.0 days |
10 |
|
|
0.23 |
mg/dl |
0.02 |
0.07 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
43093 |
401 |
| SS-Chr 16BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
77.0 days-91.0 days |
11 |
|
|
0.36 |
mg/dl |
0.03 |
0.09 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
43095 |
401 |
| FHH/EurMcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
77.0 days-91.0 days |
7 |
|
|
0.31 |
mg/dl |
0.03 |
0.09 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
43096 |
401 |
| SS-Chr 16BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77.0 days-91.0 days |
6 |
|
|
24.67 |
mmol/l |
0.21 |
0.52 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
43112 |
401 |
| FHH-Chr 12BN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
77.0 days-91.0 days |
11 |
|
|
23.27 |
mmol/l |
0.68 |
2.24 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43130 |
401 |
| FHH-Chr 10BN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
female |
77.0 days-91.0 days |
7 |
|
|
15.57 |
mmol/l |
1.48 |
3.91 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43136 |
401 |
| SS-Chr 15BN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
female |
77.0 days-91.0 days |
10 |
|
|
16.0 |
mmol/l |
0.61 |
1.94 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43159 |
401 |
| SS-Chr 3BN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
77.0 days-91.0 days |
10 |
|
|
15.6 |
mmol/l |
0.37 |
1.17 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43158 |
401 |
| FHH-Chr 8BN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
77.0 days-91.0 days |
10 |
|
|
20.8 |
mmol/l |
1.78 |
5.63 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43163 |
401 |
| FHH-Chr 20BN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
77.0 days-91.0 days |
10 |
|
|
19.6 |
mmol/l |
0.78 |
2.46 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43167 |
401 |
| SS-Chr YBN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
77.0 days-91.0 days |
20 |
|
|
22.7 |
mmol/l |
0.39 |
1.75 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43177 |
401 |
| SS-Chr 12BN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
77.0 days-91.0 days |
10 |
|
|
17.9 |
mmol/l |
0.55 |
1.73 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43193 |
401 |
| SS-Chr 19BN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
77.0 days-91.0 days |
7 |
|
|
19.43 |
mmol/l |
0.43 |
1.13 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43192 |
401 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
77.0 days-91.0 days |
15 |
|
|
23.87 |
mmol/l |
1.19 |
4.63 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43200 |
401 |
| FHH-Chr 7BN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
77.0 days-91.0 days |
9 |
|
|
17.11 |
mmol/l |
0.68 |
2.03 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43205 |
401 |
| BN/NHsdMcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
female |
77.0 days-91.0 days |
14 |
|
|
21.36 |
mmol/l |
0.83 |
3.1 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43203 |
401 |
| SS-Chr 2BN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
77.0 days-91.0 days |
6 |
|
|
23.83 |
mmol/l |
0.65 |
1.6 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43207 |
401 |
| LEW/Crl |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77.0 days-91.0 days |
10 |
|
|
1.73 |
g/dl |
0.06 |
0.18 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
39977 |
401 |
| WKY/NCrl |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
male |
77.0 days-91.0 days |
10 |
|
|
1.68 |
g/dl |
0.05 |
0.15 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
39976 |
401 |
| Crl:CD(SD) |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77.0 days-91.0 days |
9 |
|
|
2.09 |
g/dl |
0.1 |
0.29 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
39980 |
401 |
| FHH-Chr 14BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77.0 days-91.0 days |
8 |
|
|
106.75 |
mmol/l |
0.7 |
1.98 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39992 |
401 |
| FHH-Chr 6BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77.0 days-91.0 days |
10 |
|
|
105.3 |
mmol/l |
0.37 |
1.16 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39996 |
401 |
| SS-Chr 9BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77.0 days-91.0 days |
9 |
|
|
103.89 |
mmol/l |
0.39 |
1.17 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40003 |
401 |
| FHH-Chr 2BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77.0 days-91.0 days |
8 |
|
|
103.5 |
mmol/l |
0.53 |
1.51 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40009 |
401 |
| FHH-Chr 10BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77.0 days-91.0 days |
7 |
|
|
107.43 |
mmol/l |
0.81 |
2.15 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40011 |
401 |
| FHH-Chr 16BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77.0 days-91.0 days |
9 |
|
|
104.56 |
mmol/l |
0.6 |
1.81 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40012 |
401 |
| SS-Chr 5BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77.0 days-91.0 days |
8 |
|
|
103.88 |
mmol/l |
0.69 |
1.96 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40022 |
401 |
| FHH-Chr 8BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77.0 days-91.0 days |
10 |
|
|
105.6 |
mmol/l |
0.52 |
1.65 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40026 |
401 |
| SS-Chr 20BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77.0 days-91.0 days |
14 |
|
|
100.43 |
mmol/l |
0.56 |
2.1 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40027 |
401 |
| SS-Chr 16BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77.0 days-91.0 days |
8 |
|
|
104.75 |
mmol/l |
0.9 |
2.55 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40030 |
401 |
| SS-Chr 15BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77.0 days-91.0 days |
10 |
|
|
102.1 |
mmol/l |
0.77 |
2.42 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40032 |
401 |
| FHH-Chr 18BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77.0 days-91.0 days |
10 |
|
|
103.4 |
mmol/l |
0.27 |
0.84 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40046 |
401 |
| FHH-Chr YBN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77.0 days-91.0 days |
9 |
|
|
103.22 |
mmol/l |
0.57 |
1.72 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40051 |
401 |
| SS-Chr 1BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77.0 days-91.0 days |
6 |
|
|
101.67 |
mmol/l |
0.84 |
2.07 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40056 |
401 |
| FHH-Chr 4BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77.0 days-91.0 days |
9 |
|
|
102.44 |
mmol/l |
0.65 |
1.94 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40060 |
401 |
| FHH-Chr 1BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77.0 days-91.0 days |
18 |
|
|
105.28 |
mmol/l |
0.5 |
2.14 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40058 |
401 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77.0 days-91.0 days |
12 |
|
|
103.67 |
mmol/l |
0.88 |
3.06 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40066 |
401 |
| SS-Chr 19BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77.0 days-91.0 days |
7 |
|
|
103.71 |
mmol/l |
1.32 |
3.5 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40071 |
401 |
| FHH-Chr 7BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77.0 days-91.0 days |
9 |
|
|
104.89 |
mmol/l |
0.61 |
1.83 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40072 |
401 |
| SS-Chr XBN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77.0 days-91.0 days |
8 |
|
|
102.0 |
mmol/l |
0.85 |
2.39 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40079 |
401 |
| SS-Chr 10BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
15 |
|
|
13.21 |
g/dl |
0.1 |
0.4 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40086 |
401 |
| FHH-Chr 14BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
8 |
|
|
13.39 |
g/dl |
0.29 |
0.82 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40104 |
401 |
| FHH-Chr 17BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
9 |
|
|
12.86 |
g/dl |
0.19 |
0.57 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40114 |
401 |
| SS-Chr 7BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
11 |
|
|
14.15 |
g/dl |
0.12 |
0.39 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40116 |
401 |
| FHH-Chr 16BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
10 |
|
|
13.75 |
g/dl |
0.23 |
0.74 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40121 |
401 |
| FHH-Chr XBN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
8 |
|
|
12.45 |
g/dl |
0.3 |
0.86 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40120 |
401 |
| SS-Chr 16BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
7 |
|
|
14.83 |
g/dl |
0.17 |
0.46 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40126 |
401 |
| SS-Chr 15BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
10 |
|
|
14.28 |
g/dl |
0.19 |
0.62 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40130 |
401 |
| SS-Chr 3BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
10 |
|
|
13.6 |
g/dl |
0.18 |
0.57 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40129 |
401 |
| SS-Chr 16BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
6 |
|
|
14.5 |
g/dl |
0.12 |
0.28 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40132 |
401 |
| FHH-Chr 20BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
10 |
|
|
13.29 |
g/dl |
0.21 |
0.67 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40138 |
401 |
| FHH-Chr 18BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
9 |
|
|
14.0 |
g/dl |
0.47 |
1.4 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40139 |
401 |
| FHH-Chr 18BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
10 |
|
|
13.81 |
g/dl |
0.16 |
0.51 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40142 |
401 |
| SS-Chr 11BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
12 |
|
|
14.43 |
g/dl |
0.1 |
0.34 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40143 |
401 |
| SS-Chr 11BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
13 |
|
|
14.27 |
g/dl |
0.1 |
0.37 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40149 |
401 |
| SS/JrHsdMcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
88 |
|
|
14.38 |
g/dl |
0.07 |
0.62 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40151 |
401 |
| SS-Chr 18BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
10 |
|
|
15.26 |
g/dl |
0.17 |
0.55 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40155 |
401 |
| SS-Chr 4BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
12 |
|
|
14.21 |
g/dl |
0.13 |
0.45 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40158 |
401 |
| FHH-Chr 4BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
9 |
|
|
13.64 |
g/dl |
0.2 |
0.61 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40156 |
401 |
| FHH-Chr 7BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
9 |
|
|
13.34 |
g/dl |
0.36 |
1.08 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40168 |
401 |
| SS-Chr 19BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
7 |
|
|
13.9 |
g/dl |
0.13 |
0.36 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40167 |
401 |
| FHH-Chr 11BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
8 |
|
|
13.63 |
g/dl |
0.18 |
0.52 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40165 |
401 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
16 |
|
|
15.08 |
g/dl |
0.17 |
0.69 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40171 |
401 |
| SS-Chr 12BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
8 |
|
|
13.3 |
g/dl |
0.12 |
0.35 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40172 |
401 |
| FHH-Chr 7BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
9 |
|
|
13.57 |
g/dl |
0.19 |
0.56 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40176 |
401 |
| FHH-Chr 15BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
male |
77.0 days-91.0 days |
8 |
|
|
4.08 |
mmol/l |
0.12 |
0.34 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43309 |
401 |
| SS-Chr 6BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77.0 days-91.0 days |
10 |
|
|
4.08 |
mmol/l |
0.12 |
0.39 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43318 |
401 |
| FHH-Chr 12BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
male |
77.0 days-91.0 days |
11 |
|
|
4.77 |
mmol/l |
0.11 |
0.37 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43326 |
401 |
| SS-Chr 17BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77.0 days-91.0 days |
12 |
|
|
3.86 |
mmol/l |
0.25 |
0.87 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43337 |
401 |
| SS-Chr 7BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77.0 days-91.0 days |
11 |
|
|
3.96 |
mmol/l |
0.11 |
0.37 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43341 |
401 |
| FHH-Chr 17BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77.0 days-91.0 days |
10 |
|
|
4.19 |
mmol/l |
0.26 |
0.81 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43339 |
401 |
| FHH-Chr 16BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
male |
77.0 days-91.0 days |
10 |
|
|
4.32 |
mmol/l |
0.09 |
0.29 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43346 |
401 |
| FHH/EurMcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77.0 days-91.0 days |
13 |
|
|
5.04 |
mmol/l |
0.51 |
1.85 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43350 |
401 |
| SS-Chr 16BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77.0 days-91.0 days |
8 |
|
|
3.88 |
mmol/l |
0.13 |
0.36 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43351 |
401 |
| SS-Chr 13BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77.0 days-91.0 days |
12 |
|
|
4.15 |
mmol/l |
0.1 |
0.34 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43361 |
401 |
| FHH-Chr 20BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77.0 days-91.0 days |
10 |
|
|
4.76 |
mmol/l |
0.19 |
0.59 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43365 |
401 |
| SS-Chr 20BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
male |
77.0 days-91.0 days |
18 |
|
|
4.56 |
mmol/l |
0.08 |
0.33 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43366 |
401 |
| SS-Chr 11BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77.0 days-91.0 days |
12 |
|
|
4.05 |
mmol/l |
0.1 |
0.35 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43368 |
401 |
| FHH-Chr YBN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
male |
77.0 days-91.0 days |
8 |
|
|
4.72 |
mmol/l |
0.36 |
1.01 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43372 |
401 |
| SS-Chr YBN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
male |
77.0 days-91.0 days |
19 |
|
|
5.18 |
mmol/l |
0.16 |
0.69 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43373 |
401 |
| SS-Chr 18BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77.0 days-91.0 days |
8 |
|
|
4.7 |
mmol/l |
0.18 |
0.51 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43380 |
401 |
| FHH-Chr 9BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77.0 days-91.0 days |
8 |
|
|
4.11 |
mmol/l |
0.22 |
0.62 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43394 |
401 |
| Hsd:SD |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77.0 days-91.0 days |
3 |
|
|
4.0 |
mmol/l |
0.06 |
0.1 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
43420 |
401 |
| SS-Chr 16BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
7 |
|
|
45.64 |
% |
1.0 |
2.64 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
58857 |
526 |
| SS/JrHsdMcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
4 |
|
|
46.28 |
% |
0.54 |
1.08 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
58856 |
526 |
| MWF/FubRkb |
serum creatinine level |
control condition |
Schulz A, et al., J Am Soc Nephrol 2002 Nov;13(11):2706-14. |
blood creatinine amount |
not specified |
days
| 8 |
|
|
0.49 |
mg/dl |
0.0 |
0.01 |
serum creatinine analysis |
|
0.0 |
|
|
|
|
|
|
|
67605 |
769 |
| FHH-Chr 14BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
8 |
|
|
17.81 |
pg |
0.08 |
0.22 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40184 |
401 |
| SS-Chr 9BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
10 |
|
|
18.08 |
pg |
0.1 |
0.31 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40190 |
401 |
| SS-Chr 6BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
9 |
|
|
18.86 |
pg |
0.08 |
0.25 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40196 |
401 |
| FHH-Chr 14BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
8 |
|
|
17.5 |
pg |
0.13 |
0.36 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40200 |
401 |
| SS-Chr 10BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
12 |
|
|
19.41 |
pg |
0.14 |
0.47 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40198 |
401 |
| FHH-Chr XBN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
8 |
|
|
17.58 |
pg |
0.06 |
0.17 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40216 |
401 |
| FHH-Chr 16BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
10 |
|
|
18.44 |
pg |
0.11 |
0.35 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40217 |
401 |
| FHH-Chr 10BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
10 |
|
|
17.17 |
pg |
0.12 |
0.37 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40215 |
401 |
| SS-Chr 15BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
10 |
|
|
18.51 |
pg |
0.08 |
0.25 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40224 |
401 |
| FHH-Chr 13BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
9 |
|
|
18.04 |
pg |
0.08 |
0.24 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40229 |
401 |
| SS-Chr 16BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
6 |
|
|
19.08 |
pg |
0.05 |
0.12 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40228 |
401 |
| FHH-Chr 20BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
10 |
|
|
18.15 |
pg |
0.12 |
0.37 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40236 |
401 |
| SS-Chr 11BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
12 |
|
|
19.5 |
pg |
0.08 |
0.29 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40239 |
401 |
| SS-Chr 11BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
13 |
|
|
18.77 |
pg |
0.1 |
0.35 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40245 |
401 |
| SS-Chr YBN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
20 |
|
|
18.45 |
pg |
0.07 |
0.31 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40244 |
401 |
| FHH-Chr 1BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
12 |
|
|
17.28 |
pg |
0.09 |
0.3 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40250 |
401 |
| SS-Chr 1BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
7 |
|
|
19.46 |
pg |
0.06 |
0.16 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40253 |
401 |
| BN/NHsdMcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
18 |
|
|
17.92 |
pg |
0.08 |
0.32 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40269 |
401 |
| SS-Chr 19BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
7 |
|
|
18.77 |
pg |
0.11 |
0.3 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40263 |
401 |
| SS-Chr 12BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
8 |
|
|
18.93 |
pg |
0.13 |
0.37 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40268 |
401 |
| FHH-Chr 9BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
8 |
|
|
17.24 |
pg |
0.13 |
0.36 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40273 |
401 |
| FHH-Chr 12BN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
female |
77.0 days-91.0 days |
11 |
|
|
0.21 |
x 1000 cells/ul |
0.05 |
0.17 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40277 |
401 |
| FHH-Chr 14BN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
female |
77.0 days-91.0 days |
8 |
|
|
0.1 |
x 1000 cells/ul |
0.02 |
0.06 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40280 |
401 |
| FHH-Chr 6BN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
male |
77.0 days-91.0 days |
10 |
|
|
0.22 |
x 1000 cells/ul |
0.1 |
0.31 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40284 |
401 |
| FHH-Chr 12BN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
male |
77.0 days-91.0 days |
12 |
|
|
0.29 |
x 1000 cells/ul |
0.05 |
0.19 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40293 |
401 |
| SS-Chr 7BN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
male |
77.0 days-91.0 days |
11 |
|
|
0.45 |
x 1000 cells/ul |
0.08 |
0.26 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40301 |
401 |
| GH/OmrMcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
female |
77.0 days-91.0 days |
6 |
|
|
0.25 |
x 1000 cells/ul |
0.11 |
0.28 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40302 |
401 |
| FHH-Chr XBN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
male |
77.0 days-91.0 days |
8 |
|
|
0.22 |
x 1000 cells/ul |
0.04 |
0.1 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40309 |
401 |
| FHH/EurMcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
female |
77.0 days-91.0 days |
13 |
|
|
0.14 |
x 1000 cells/ul |
0.02 |
0.09 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40317 |
401 |
| SS-Chr 15BN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
male |
77.0 days-91.0 days |
10 |
|
|
0.37 |
x 1000 cells/ul |
0.05 |
0.16 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40320 |
401 |
| FHH-Chr 20BN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
male |
77.0 days-91.0 days |
10 |
|
|
0.07 |
x 1000 cells/ul |
0.03 |
0.1 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40330 |
401 |
| FHH/EurMcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
male |
77.0 days-91.0 days |
48 |
|
|
0.19 |
x 1000 cells/ul |
0.02 |
0.17 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40336 |
401 |
| SS-Chr 1BN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
male |
77.0 days-91.0 days |
6 |
|
|
0.4 |
x 1000 cells/ul |
0.12 |
0.3 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40344 |
401 |
| SS-Chr XBN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
female |
77.0 days-91.0 days |
8 |
|
|
0.11 |
x 1000 cells/ul |
0.02 |
0.07 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40345 |
401 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
female |
77.0 days-91.0 days |
12 |
|
|
0.09 |
x 1000 cells/ul |
0.02 |
0.08 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40354 |
401 |
| SS/JrHsdMcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
female |
77.0 days-91.0 days |
11 |
|
|
0.32 |
x 1000 cells/ul |
0.04 |
0.12 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40351 |
401 |
| FHH-Chr 9BN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
female |
77.0 days-91.0 days |
8 |
|
|
0.14 |
x 1000 cells/ul |
0.05 |
0.15 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40361 |
401 |
| SS-Chr 4BN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
female |
77.0 days-91.0 days |
15 |
|
|
0.23 |
x 1000 cells/ul |
0.04 |
0.14 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40358 |
401 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
male |
77.0 days-91.0 days |
16 |
|
|
0.26 |
x 1000 cells/ul |
0.07 |
0.3 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40363 |
401 |
| FHH-Chr 9BN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
male |
77.0 days-91.0 days |
8 |
|
|
0.34 |
x 1000 cells/ul |
0.1 |
0.28 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40369 |
401 |
| SS-Chr XBN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
male |
77.0 days-91.0 days |
8 |
|
|
0.23 |
x 1000 cells/ul |
0.07 |
0.2 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40367 |
401 |
| Hsd:SD |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
male |
77.0 days-91.0 days |
2 |
|
|
3.85 |
g/dl |
0.15 |
0.21 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
40374 |
401 |
| SS-Chr 18BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
male |
77.0 days-91.0 days |
9 |
|
|
0.73 |
g/kg |
0.01 |
0.04 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
59013 |
526 |
| GH/OmrMcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
female |
77.0 days-91.0 days |
9 |
|
|
0.91 |
g/kg |
0.03 |
0.1 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
59019 |
526 |
| FHH-Chr 14BN/Mcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
male |
77.0 days-91.0 days |
8 |
|
|
2.99 |
g/dl |
0.08 |
0.24 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40409 |
401 |
| FHH-Chr XBN/Mcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
female |
77.0 days-91.0 days |
8 |
|
|
3.48 |
g/dl |
0.1 |
0.27 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40425 |
401 |
| SS-Chr 15BN/Mcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
male |
77.0 days-91.0 days |
10 |
|
|
3.69 |
g/dl |
0.04 |
0.14 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40433 |
401 |
| FHH-Chr 13BN/Mcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
male |
77.0 days-91.0 days |
10 |
|
|
4.0 |
g/dl |
0.04 |
0.13 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40442 |
401 |
| SS-Chr 20BN/Mcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
male |
77.0 days-91.0 days |
24 |
|
|
3.65 |
g/dl |
0.05 |
0.24 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40446 |
401 |
| SS/JrHsdMcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
male |
77.0 days-91.0 days |
92 |
|
|
3.77 |
g/dl |
0.03 |
0.29 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40456 |
401 |
| SS-Chr 19BN/Mcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
male |
77.0 days-91.0 days |
7 |
|
|
3.73 |
g/dl |
0.08 |
0.22 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40468 |
401 |
| SS-Chr 4BN/Mcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
female |
77.0 days-91.0 days |
15 |
|
|
3.73 |
g/dl |
0.05 |
0.18 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40471 |
401 |
| FHH-Chr 11BN/Mcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
female |
77.0 days-91.0 days |
8 |
|
|
3.9 |
g/dl |
0.03 |
0.09 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40470 |
401 |
| SS-Chr XBN/Mcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
male |
77.0 days-91.0 days |
8 |
|
|
3.96 |
g/dl |
0.05 |
0.15 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40480 |
401 |
| LE/BluGill |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77.0 days-91.0 days |
14 |
|
|
153.5 |
mg/dl |
3.11 |
11.65 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
40490 |
401 |
| Crl:CD(SD) |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
male |
77.0 days-91.0 days |
9 |
|
|
169.0 |
mg/dl |
6.0 |
18.01 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
40487 |
401 |
| LEW/Crl |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
male |
77.0 days-91.0 days |
10 |
|
|
177.3 |
mg/dl |
7.12 |
22.53 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
40491 |
401 |
| GH/OmrMcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77.0 days-91.0 days |
9 |
|
|
104.22 |
mmol/l |
0.55 |
1.64 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
40523 |
401 |
| SS-Chr 18BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77.0 days-91.0 days |
10 |
|
|
99.2 |
mmol/l |
0.36 |
1.14 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
40522 |
401 |
| SS-Chr 16BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77.0 days-91.0 days |
11 |
|
|
100.55 |
mmol/l |
0.45 |
1.51 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
40524 |
401 |
| GH/OmrMcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77.0 days-91.0 days |
9 |
|
|
102.78 |
mmol/l |
0.49 |
1.48 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
40528 |
401 |
| SS-Chr 18BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77.0 days-91.0 days |
9 |
|
|
4.52 |
x 1000 cells/ul |
0.29 |
0.88 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
40638 |
401 |
| SS-Chr 16BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
77.0 days-91.0 days |
7 |
|
|
8.84 |
x 1000 cells/ul |
0.52 |
1.39 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
40640 |
401 |
| LE/BluGill |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77.0 days-91.0 days |
14 |
|
|
4.76 |
mmol/l |
0.09 |
0.33 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
40650 |
401 |
| Hsd:SD |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77.0 days-91.0 days |
8 |
|
|
100.25 |
mmol/l |
0.94 |
2.66 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
40661 |
401 |
| SS-Chr 16BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77.0 days-91.0 days |
7 |
|
|
172.71 |
mg/dl |
10.74 |
28.41 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
40668 |
401 |
| SS/JrHsdMcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77.0 days-91.0 days |
9 |
|
|
206.33 |
mg/dl |
12.47 |
37.4 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
40674 |
401 |
| SS-Chr 18BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
8 |
|
|
46.48 |
% |
0.55 |
1.56 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
40677 |
401 |
| GH/OmrMcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
9 |
|
|
49.49 |
% |
0.49 |
1.46 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
40688 |
401 |
| SHR/NCrl |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
11 |
|
|
47.76 |
% |
0.78 |
2.6 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
40687 |
401 |
| SS-Chr 1BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
77.0 days-91.0 days |
6 |
|
|
219.83 |
U/l |
12.59 |
30.85 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37500 |
401 |
| SS-Chr 18BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
77.0 days-91.0 days |
9 |
|
|
168.67 |
U/l |
8.8 |
26.39 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37498 |
401 |
| SS-Chr 19BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
77.0 days-91.0 days |
7 |
|
|
99.29 |
U/l |
4.88 |
12.91 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37515 |
401 |
| FHH-Chr 7BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
77.0 days-91.0 days |
9 |
|
|
192.89 |
U/l |
6.99 |
20.97 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37516 |
401 |
| SS-Chr XBN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
77.0 days-91.0 days |
8 |
|
|
159.25 |
U/l |
6.03 |
17.06 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37523 |
401 |
| Hsd:SD |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77.0 days-91.0 days |
8 |
|
|
6.49 |
g/dl |
0.13 |
0.36 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
37567 |
401 |
| SHR/NCrl |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77.0 days-91.0 days |
11 |
|
|
60.0 |
U/l |
3.34 |
11.06 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
37687 |
401 |
| FHH-Chr 15BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77.0 days-91.0 days |
8 |
|
|
65.13 |
U/l |
1.84 |
5.19 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37689 |
401 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77.0 days-91.0 days |
10 |
|
|
53.4 |
U/l |
5.64 |
17.82 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37692 |
401 |
| FHH-Chr 2BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
77.0 days-91.0 days |
8 |
|
|
42.88 |
U/l |
3.06 |
8.66 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37694 |
401 |
| FHH-Chr 6BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
female |
77.0 days-91.0 days |
10 |
|
|
1.15 |
g/kg |
0.02 |
0.06 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59448 |
526 |
| SS-Chr 9BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
female |
77.0 days-91.0 days |
10 |
|
|
1.07 |
g/kg |
0.03 |
0.09 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59451 |
526 |
| FHH-Chr 16BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
female |
77.0 days-91.0 days |
10 |
|
|
1.11 |
g/kg |
0.02 |
0.07 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59460 |
526 |
| GH/OmrMcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
female |
77.0 days-91.0 days |
19 |
|
|
1.03 |
g/kg |
0.04 |
0.17 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59462 |
526 |
| SS-Chr 5BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
male |
77.0 days-91.0 days |
10 |
|
|
0.96 |
g/kg |
0.02 |
0.07 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59470 |
526 |
| SS-Chr 15BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
female |
77.0 days-91.0 days |
10 |
|
|
1.21 |
g/kg |
0.05 |
0.16 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59482 |
526 |
| FHH-Chr 3BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
male |
77.0 days-91.0 days |
10 |
|
|
0.99 |
g/kg |
0.05 |
0.15 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59498 |
526 |
| FHH-Chr 1BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
male |
77.0 days-91.0 days |
18 |
|
|
0.9 |
g/kg |
0.03 |
0.11 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59506 |
526 |
| SS-Chr 1BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
female |
77.0 days-91.0 days |
10 |
|
|
0.99 |
g/kg |
0.01 |
0.04 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59509 |
526 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
female |
77.0 days-91.0 days |
11 |
|
|
1.09 |
g/kg |
0.03 |
0.11 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59514 |
526 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
male |
77.0 days-91.0 days |
17 |
|
|
0.89 |
g/kg |
0.02 |
0.09 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59523 |
526 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
77.0 days-91.0 days |
10 |
|
|
37.1 |
U/l |
2.42 |
7.64 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37700 |
401 |
| SS-Chr 10BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
77.0 days-91.0 days |
12 |
|
|
48.17 |
U/l |
3.11 |
10.77 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37707 |
401 |
| GH/OmrMcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77.0 days-91.0 days |
5 |
|
|
55.6 |
U/l |
5.6 |
12.52 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37720 |
401 |
| SS-Chr 3BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77.0 days-91.0 days |
10 |
|
|
50.0 |
U/l |
3.01 |
9.51 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37734 |
401 |
| SS-Chr 15BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77.0 days-91.0 days |
10 |
|
|
57.5 |
U/l |
3.08 |
9.73 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37733 |
401 |
| SS-Chr 16BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77.0 days-91.0 days |
5 |
|
|
68.0 |
U/l |
7.53 |
16.84 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37737 |
401 |
| SS-Chr 3BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
77.0 days-91.0 days |
10 |
|
|
35.4 |
U/l |
3.59 |
11.35 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37740 |
401 |
| FHH-Chr 20BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77.0 days-91.0 days |
10 |
|
|
61.6 |
U/l |
3.65 |
11.53 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37743 |
401 |
| SS-Chr 20BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77.0 days-91.0 days |
24 |
|
|
53.04 |
U/l |
2.53 |
12.39 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37746 |
401 |
| SS-Chr 13BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77.0 days-91.0 days |
11 |
|
|
57.09 |
U/l |
3.58 |
11.89 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37750 |
401 |
| FHH-Chr 3BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77.0 days-91.0 days |
8 |
|
|
70.63 |
U/l |
4.24 |
11.99 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37751 |
401 |
| FHH/EurMcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77.0 days-91.0 days |
49 |
|
|
68.41 |
U/l |
1.51 |
10.57 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37749 |
401 |
| FHH-Chr 4BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
77.0 days-91.0 days |
9 |
|
|
53.11 |
U/l |
2.52 |
7.57 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37766 |
401 |
| SS-Chr 19BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77.0 days-91.0 days |
7 |
|
|
45.0 |
U/l |
1.2 |
3.16 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37768 |
401 |
| FHH-Chr 11BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
77.0 days-91.0 days |
8 |
|
|
46.75 |
U/l |
5.22 |
14.75 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37770 |
401 |
| FHH-Chr 7BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
77.0 days-91.0 days |
9 |
|
|
45.0 |
U/l |
1.62 |
4.87 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37773 |
401 |
| SS-Chr XBN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77.0 days-91.0 days |
7 |
|
|
54.43 |
U/l |
2.06 |
5.44 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37780 |
401 |
| FHH-Chr 14BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77.0 days-91.0 days |
8 |
|
|
8.88 |
mg/dl |
0.28 |
0.8 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37813 |
401 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
77.0 days-91.0 days |
10 |
|
|
8.69 |
mg/dl |
0.21 |
0.66 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37812 |
401 |
| SS-Chr 14BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77.0 days-91.0 days |
10 |
|
|
8.86 |
mg/dl |
0.31 |
0.98 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37816 |
401 |
| FHH-Chr 15BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77.0 days-91.0 days |
8 |
|
|
8.59 |
mg/dl |
0.15 |
0.43 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37828 |
401 |
| FHH-Chr XBN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77.0 days-91.0 days |
8 |
|
|
9.91 |
mg/dl |
0.57 |
1.63 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37845 |
401 |
| FHH-Chr 19BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
77.0 days-91.0 days |
8 |
|
|
11.04 |
mg/dl |
1.31 |
3.7 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37849 |
401 |
| SS-Chr 16BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77.0 days-91.0 days |
8 |
|
|
7.94 |
mg/dl |
0.21 |
0.58 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37851 |
401 |
| SS-Chr 15BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
77.0 days-91.0 days |
10 |
|
|
9.81 |
mg/dl |
0.29 |
0.91 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37853 |
401 |
| SS-Chr 3BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77.0 days-91.0 days |
10 |
|
|
9.69 |
mg/dl |
0.29 |
0.93 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37860 |
401 |
| SS-Chr 13BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77.0 days-91.0 days |
11 |
|
|
7.85 |
mg/dl |
0.16 |
0.52 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37861 |
401 |
| SS/JrHsdMcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
77.0 days-91.0 days |
92 |
|
|
8.83 |
mg/dl |
0.1 |
1.0 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37876 |
401 |
| SS/JrHsdMcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77.0 days-91.0 days |
11 |
|
|
8.0 |
mg/dl |
0.25 |
0.83 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37884 |
401 |
| FHH-Chr 11BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77.0 days-91.0 days |
8 |
|
|
9.19 |
mg/dl |
0.25 |
0.69 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37890 |
401 |
| SS-Chr 4BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77.0 days-91.0 days |
15 |
|
|
9.12 |
mg/dl |
0.42 |
1.64 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37891 |
401 |
| BN/NHsdMcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77.0 days-91.0 days |
14 |
|
|
7.74 |
mg/dl |
0.27 |
1.03 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37899 |
401 |
| FHH-Chr 7BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
77.0 days-91.0 days |
9 |
|
|
9.09 |
mg/dl |
0.14 |
0.43 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37901 |
401 |
| SS-Chr 10BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
male |
77.0 days-91.0 days |
15 |
|
|
1.41 |
g/dl |
0.02 |
0.1 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Teklad |
41011 |
401 |
| WKY/NCrl |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77.0 days-91.0 days |
10 |
|
|
102.1 |
mg/dl |
2.8 |
8.85 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
37905 |
401 |
| FHH-Chr 2BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77.0 days-91.0 days |
8 |
|
|
1.27 |
g/dl |
0.07 |
0.19 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Teklad |
41014 |
401 |
| FHH-Chr 5BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77.0 days-91.0 days |
8 |
|
|
1.43 |
g/dl |
0.05 |
0.13 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Teklad |
41015 |
401 |
| SS-Chr 9BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77.0 days-91.0 days |
9 |
|
|
2.1 |
g/dl |
0.03 |
0.1 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Teklad |
41024 |
401 |
| FHH-Chr 5BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
male |
77.0 days-91.0 days |
6 |
|
|
1.37 |
g/dl |
0.02 |
0.05 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Teklad |
41022 |
401 |
| FHH-Chr 14BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
male |
77.0 days-91.0 days |
8 |
|
|
1.84 |
g/dl |
0.04 |
0.11 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Teklad |
41029 |
401 |
| FHH-Chr 17BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
male |
77.0 days-91.0 days |
9 |
|
|
1.42 |
g/dl |
0.06 |
0.17 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Teklad |
41036 |
401 |
| FHH-Chr 17BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77.0 days-91.0 days |
10 |
|
|
1.31 |
g/dl |
0.05 |
0.14 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Teklad |
41039 |
401 |
| FHH-Chr XBN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
male |
77.0 days-91.0 days |
8 |
|
|
1.25 |
g/dl |
0.04 |
0.11 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Teklad |
41042 |
401 |
| FHH-Chr XBN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77.0 days-91.0 days |
8 |
|
|
1.13 |
g/dl |
0.05 |
0.13 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Teklad |
41045 |
401 |
| SS-Chr 13BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77.0 days-91.0 days |
12 |
|
|
2.04 |
g/dl |
0.03 |
0.11 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Teklad |
41061 |
401 |
| SS-Chr 13BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
male |
77.0 days-91.0 days |
11 |
|
|
2.28 |
g/dl |
0.05 |
0.18 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Teklad |
41070 |
401 |
| SS-Chr 18BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
male |
77.0 days-91.0 days |
9 |
|
|
2.38 |
g/dl |
0.04 |
0.13 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Teklad |
41075 |
401 |
| SS-Chr 18BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77.0 days-91.0 days |
10 |
|
|
2.29 |
g/dl |
0.05 |
0.17 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Teklad |
41080 |
401 |
| FHH-Chr 4BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77.0 days-91.0 days |
9 |
|
|
1.32 |
g/dl |
0.07 |
0.2 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Teklad |
41086 |
401 |
| FHH-Chr 11BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77.0 days-91.0 days |
8 |
|
|
1.49 |
g/dl |
0.05 |
0.14 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Teklad |
41090 |
401 |
| WKY/NCrl |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77.0 days-91.0 days |
10 |
|
|
102.0 |
mmol/l |
0.75 |
2.36 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
41105 |
401 |
| LEW/Crl |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77.0 days-91.0 days |
10 |
|
|
101.9 |
mmol/l |
0.95 |
3.0 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
41106 |
401 |
| WKY/NCrl |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77.0 days-91.0 days |
14 |
|
|
104.93 |
mmol/l |
1.26 |
4.71 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
41112 |
401 |
| Hsd:SD |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77.0 days-91.0 days |
1 |
|
|
60.1 |
fl |
|
|
automated blood cell counting method |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
41149 |
401 |
| SS/JrHsdMcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77.0 days-91.0 days |
4 |
|
|
57.9 |
fl |
0.38 |
0.76 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
41147 |
401 |
| SS/JrHsdMcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
male |
77.0 days-91.0 days |
4 |
|
|
0.27 |
x 1000 cells/ul |
0.02 |
0.03 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
41171 |
401 |
| FHH-Chr 15BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
male |
77.0 days-91.0 days |
8 |
|
|
133.25 |
mg/dl |
2.83 |
8.0 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41176 |
401 |
| FHH-Chr 14BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77.0 days-91.0 days |
8 |
|
|
140.38 |
mg/dl |
3.95 |
11.19 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41180 |
401 |
| FHH-Chr 5BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77.0 days-91.0 days |
8 |
|
|
131.75 |
mg/dl |
15.61 |
44.16 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41182 |
401 |
| SS-Chr 14BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
male |
77.0 days-91.0 days |
10 |
|
|
158.3 |
mg/dl |
3.94 |
12.45 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41190 |
401 |
| SS-Chr 7BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
male |
77.0 days-91.0 days |
11 |
|
|
153.64 |
mg/dl |
3.34 |
11.08 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41201 |
401 |
| FHH-Chr 10BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77.0 days-91.0 days |
6 |
|
|
145.67 |
mg/dl |
5.41 |
13.25 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41199 |
401 |
| FHH-Chr 10BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
male |
77.0 days-91.0 days |
10 |
|
|
149.3 |
mg/dl |
4.49 |
14.19 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41211 |
401 |
| FHH-Chr 19BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
male |
77.0 days-91.0 days |
8 |
|
|
194.38 |
mg/dl |
38.65 |
109.31 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41216 |
401 |
| LEW/NIcoCrlf |
number of fecal boluses during experiment time in open field apparatus |
control condition |
Ramos A, et al., Behav Brain Res. 1998 Nov;96(1-2):195-205 |
emotion/affect behavior trait |
male |
56.0 days-63.0 days |
5 |
|
|
0.6 |
/5 min |
0.6 |
1.34 |
ex vivo visual assessment |
|
300 |
|
|
|
video monitoring |
number of fecal boluses during experiment time in open field apparatus (CMO:0004064) |
|
|
65137 |
108 |
| LEW/NIcoCrlf |
number of fecal boluses during experiment time in open field apparatus |
control condition |
Ramos A, et al., Behav Brain Res. 1998 Nov;96(1-2):195-205 |
emotion/affect behavior trait |
female |
56.0 days-63.0 days |
6 |
|
|
0.0 |
/5 min |
0.0 |
0.0 |
ex vivo visual assessment |
|
300 |
|
|
|
video monitoring |
number of fecal boluses during experiment time in open field apparatus (CMO:0004064) |
|
|
65139 |
108 |
| Crl:CD(SD) |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77.0 days-91.0 days |
9 |
|
|
76.78 |
mg/dl |
3.27 |
9.8 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
37907 |
401 |
| LE/BluGill |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77.0 days-91.0 days |
11 |
|
|
114.73 |
mg/dl |
4.41 |
14.64 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
37914 |
401 |
| Hsd:SD |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77.0 days-91.0 days |
3 |
|
|
7.8 |
mg/dl |
0.57 |
0.98 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
37924 |
401 |
| LE/BluGill |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
female |
77.0 days-91.0 days |
14 |
|
|
9.92 |
mg/dl |
0.11 |
0.43 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
37931 |
401 |
| LEW/Crl |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77.0 days-91.0 days |
10 |
|
|
9.3 |
mg/dl |
0.11 |
0.36 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
37932 |
401 |
| SS-Chr 16BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
77.0 days-91.0 days |
6 |
|
|
0.74 |
x 1000 cells/ul |
0.21 |
0.5 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
37952 |
401 |
| SS-Chr 15BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77.0 days-91.0 days |
10 |
|
|
166.8 |
mg/dl |
8.81 |
27.84 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41222 |
401 |
| SS-Chr 11BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77.0 days-91.0 days |
12 |
|
|
147.33 |
mg/dl |
2.89 |
10.0 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41235 |
401 |
| SS-Chr 1BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77.0 days-91.0 days |
7 |
|
|
127.43 |
mg/dl |
11.2 |
29.62 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41249 |
401 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77.0 days-91.0 days |
12 |
|
|
158.92 |
mg/dl |
4.91 |
17.01 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41254 |
401 |
| SS-Chr 19BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77.0 days-91.0 days |
7 |
|
|
149.29 |
mg/dl |
3.17 |
8.38 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41259 |
401 |
| FHH-Chr 9BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77.0 days-91.0 days |
8 |
|
|
138.13 |
mg/dl |
9.36 |
26.47 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41261 |
401 |
| SS-Chr 2BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77.0 days-91.0 days |
9 |
|
|
159.33 |
mg/dl |
3.1 |
9.29 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41262 |
401 |
| SS-Chr XBN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
male |
77.0 days-91.0 days |
7 |
|
|
148.0 |
mg/dl |
2.85 |
7.55 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41267 |
401 |
| SS-Chr 2BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
male |
77.0 days-91.0 days |
6 |
|
|
161.17 |
mg/dl |
4.63 |
11.34 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41270 |
401 |
| F344/DuCrl |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
8 |
|
|
17.3 |
pg |
0.08 |
0.22 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
41275 |
401 |
| SS-Chr 10BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
15 |
|
|
40.68 |
% |
0.32 |
1.25 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41286 |
401 |
| SS-Chr 9BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
10 |
|
|
43.36 |
% |
1.7 |
5.36 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41294 |
401 |
| FHH-Chr 14BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
8 |
|
|
40.2 |
% |
0.95 |
2.69 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41304 |
401 |
| GH/OmrMcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
5 |
|
|
44.98 |
% |
3.77 |
8.43 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41315 |
401 |
| FHH-Chr 10BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
10 |
|
|
37.81 |
% |
0.9 |
2.85 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41319 |
401 |
| FHH-Chr 3BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
8 |
|
|
39.73 |
% |
0.51 |
1.43 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41327 |
401 |
| SS-Chr 3BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
10 |
|
|
42.57 |
% |
0.56 |
1.78 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41329 |
401 |
| SS-Chr 3BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
10 |
|
|
41.76 |
% |
0.51 |
1.62 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41335 |
401 |
| FHH-Chr 13BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
10 |
|
|
42.92 |
% |
0.51 |
1.62 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41337 |
401 |
| SS-Chr YBN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
20 |
|
|
45.72 |
% |
0.4 |
1.77 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41348 |
401 |
| SS/JrHsdMcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
88 |
|
|
44.42 |
% |
0.22 |
2.04 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41351 |
401 |
| FHH-Chr 4BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
9 |
|
|
41.92 |
% |
0.67 |
2.02 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41356 |
401 |
| SS-Chr 4BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
12 |
|
|
43.68 |
% |
0.44 |
1.52 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41358 |
401 |
| SS/JrHsdMcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
11 |
|
|
46.33 |
% |
0.55 |
1.81 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41359 |
401 |
| FHH-Chr 4BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
9 |
|
|
41.41 |
% |
1.12 |
3.36 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41361 |
401 |
| FHH-Chr 2BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
77.0 days-91.0 days |
8 |
|
|
0.01 |
x 1000 cells/ul |
0.01 |
0.03 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41391 |
401 |
| SS-Chr 9BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
77.0 days-91.0 days |
10 |
|
|
0.01 |
x 1000 cells/ul |
0.01 |
0.02 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41396 |
401 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
77.0 days-91.0 days |
10 |
|
|
0.0 |
x 1000 cells/ul |
0.0 |
0.0 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41397 |
401 |
| FHH-Chr 5BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
77.0 days-91.0 days |
6 |
|
|
0.03 |
x 1000 cells/ul |
0.03 |
0.06 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41399 |
401 |
| FHH-Chr 14BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
77.0 days-91.0 days |
8 |
|
|
0.03 |
x 1000 cells/ul |
0.01 |
0.04 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41406 |
401 |
| FHH-Chr 2BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
77.0 days-91.0 days |
8 |
|
|
0.07 |
x 1000 cells/ul |
0.04 |
0.13 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41407 |
401 |
| FHH-Chr 16BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
77.0 days-91.0 days |
9 |
|
|
0.03 |
x 1000 cells/ul |
0.01 |
0.03 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41410 |
401 |
| SS-Chr 7BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
77.0 days-91.0 days |
11 |
|
|
0.01 |
x 1000 cells/ul |
0.01 |
0.03 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41411 |
401 |
| SS-Chr 5BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
77.0 days-91.0 days |
7 |
|
|
0.04 |
x 1000 cells/ul |
0.01 |
0.03 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41415 |
401 |
| FHH-Chr 16BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
77.0 days-91.0 days |
10 |
|
|
0.05 |
x 1000 cells/ul |
0.01 |
0.04 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41423 |
401 |
| SS-Chr 16BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
77.0 days-91.0 days |
7 |
|
|
34.71 |
U/l |
2.84 |
7.52 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
38160 |
401 |
| SS-Chr 16BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77.0 days-91.0 days |
6 |
|
|
39.83 |
U/l |
5.21 |
12.77 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
38163 |
401 |
| Crl:CD(SD) |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
77.0 days-91.0 days |
9 |
|
|
248.78 |
U/l |
19.94 |
59.82 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
38172 |
401 |
| SS-Chr 18BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77.0 days-91.0 days |
8 |
|
|
56.18 |
fl |
0.26 |
0.74 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
38202 |
401 |
| GH/OmrMcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
77.0 days-91.0 days |
9 |
|
|
54.6 |
fl |
0.29 |
0.88 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
38208 |
401 |
| SHR/NCrl |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77.0 days-91.0 days |
11 |
|
|
51.72 |
fl |
0.25 |
0.84 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
38212 |
401 |
| SS/JrHsdMcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
77.0 days-91.0 days |
9 |
|
|
58.62 |
fl |
0.22 |
0.67 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
38211 |
401 |
| SS/JrHsdMcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
77.0 days-91.0 days |
12 |
|
|
7.88 |
mg/dl |
0.22 |
0.78 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
38225 |
401 |
| SS-Chr 16BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77.0 days-91.0 days |
7 |
|
|
7.61 |
mg/dl |
0.46 |
1.22 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
38227 |
401 |
| FHH/EurMcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
77.0 days-91.0 days |
7 |
|
|
7.89 |
mg/dl |
0.19 |
0.51 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
38232 |
401 |
| SS-Chr 18BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77.0 days-91.0 days |
10 |
|
|
7.47 |
mg/dl |
0.27 |
0.84 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
38229 |
401 |
| SS-Chr 13BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
77.0 days-91.0 days |
11 |
|
|
0.01 |
x 1000 cells/ul |
0.01 |
0.02 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41447 |
401 |
| FHH/EurMcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
77.0 days-91.0 days |
48 |
|
|
0.02 |
x 1000 cells/ul |
0.0 |
0.03 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41446 |
401 |
| SS-Chr XBN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
77.0 days-91.0 days |
8 |
|
|
0.02 |
x 1000 cells/ul |
0.02 |
0.05 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41455 |
401 |
| FHH-Chr 11BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
77.0 days-91.0 days |
8 |
|
|
0.01 |
x 1000 cells/ul |
0.01 |
0.02 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41462 |
401 |
| FHH-Chr 7BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
77.0 days-91.0 days |
9 |
|
|
0.05 |
x 1000 cells/ul |
0.02 |
0.07 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41478 |
401 |
| SS-Chr 18BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
male |
77.0 days-91.0 days |
9 |
|
|
2.59 |
g/dl |
0.04 |
0.12 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Dyets |
41586 |
401 |
| SS/JrHsdMcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
male |
77.0 days-91.0 days |
12 |
|
|
2.48 |
g/dl |
0.12 |
0.41 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Dyets |
41587 |
401 |
| FHH/EurMcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77.0 days-91.0 days |
8 |
|
|
1.88 |
g/dl |
0.06 |
0.17 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Dyets |
41588 |
401 |
| SS-Chr 16BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
male |
77.0 days-91.0 days |
11 |
|
|
2.21 |
g/dl |
0.06 |
0.21 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Dyets |
41593 |
401 |
| SS-Chr 18BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77.0 days-91.0 days |
10 |
|
|
2.09 |
g/dl |
0.08 |
0.25 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Dyets |
41591 |
401 |
| WKY/NCrl |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
77.0 days-91.0 days |
14 |
|
|
85.07 |
U/l |
3.89 |
14.56 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
41617 |
401 |
| F344/DuCrl |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
77.0 days-91.0 days |
17 |
|
|
88.82 |
U/l |
10.15 |
41.84 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
41618 |
401 |
| GH/OmrMcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
9 |
|
|
15.62 |
g/dl |
0.15 |
0.45 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
41626 |
401 |
| SS-Chr 18BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
9 |
|
|
14.86 |
g/dl |
0.21 |
0.62 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
41625 |
401 |
| GH/OmrMcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
9 |
|
|
16.17 |
g/dl |
0.18 |
0.54 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
41631 |
401 |
| F344/DuCrl |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
77.0 days-91.0 days |
8 |
|
|
0.01 |
x 1000 cells/ul |
0.01 |
0.01 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
38347 |
401 |
| LE/BluGill |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
77.0 days-91.0 days |
13 |
|
|
0.02 |
x 1000 cells/ul |
0.01 |
0.03 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
38349 |
401 |
| Hsd:SD |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
77.0 days-91.0 days |
6 |
|
|
93.83 |
U/l |
9.19 |
22.52 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
38361 |
401 |
| SS-Chr 16BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
female |
77.0 days-91.0 days |
7 |
|
|
143.57 |
mmol/l |
0.69 |
1.81 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
38379 |
401 |
| Hsd:SD |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
77.0 days-91.0 days |
5 |
|
|
109.6 |
mg/dl |
8.05 |
18.01 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
38377 |
401 |
| Hsd:SD |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77.0 days-91.0 days |
2 |
|
|
136.5 |
mmol/l |
0.5 |
0.71 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
38380 |
401 |
| SS-Chr 16BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77.0 days-91.0 days |
6 |
|
|
143.5 |
mmol/l |
0.76 |
1.87 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
38382 |
401 |
| SS-Chr 16BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
5 |
|
|
19.1 |
pg |
0.15 |
0.33 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
38386 |
401 |
| Hsd:SD |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77.0 days-91.0 days |
6 |
|
|
1.57 |
x 1000 cells/ul |
0.31 |
0.77 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
38396 |
401 |
| FHH-Chr 15BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77.0 days-91.0 days |
8 |
|
|
97.38 |
mg/dl |
3.33 |
9.43 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38415 |
401 |
| SS-Chr 14BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77.0 days-91.0 days |
10 |
|
|
91.3 |
mg/dl |
1.62 |
5.12 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38429 |
401 |
| SS-Chr 9BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
77.0 days-91.0 days |
9 |
|
|
95.67 |
mg/dl |
2.24 |
6.71 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38430 |
401 |
| FHH-Chr 12BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77.0 days-91.0 days |
12 |
|
|
100.08 |
mg/dl |
3.64 |
12.62 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38432 |
401 |
| FHH-Chr 15BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
77.0 days-91.0 days |
8 |
|
|
81.13 |
mg/dl |
2.01 |
5.69 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38434 |
401 |
| GH/OmrMcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77.0 days-91.0 days |
5 |
|
|
89.0 |
mg/dl |
9.59 |
21.45 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38446 |
401 |
| FHH-Chr XBN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
77.0 days-91.0 days |
8 |
|
|
77.5 |
mg/dl |
3.28 |
9.29 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38451 |
401 |
| FHH-Chr 3BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
77.0 days-91.0 days |
8 |
|
|
81.0 |
mg/dl |
1.55 |
4.38 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38458 |
401 |
| SS-Chr 15BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
77.0 days-91.0 days |
10 |
|
|
109.1 |
mg/dl |
2.37 |
7.49 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38461 |
401 |
| FHH-Chr 19BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
77.0 days-91.0 days |
7 |
|
|
82.29 |
mg/dl |
2.34 |
6.18 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38462 |
401 |
| FHH-Chr 13BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
77.0 days-91.0 days |
9 |
|
|
83.0 |
mg/dl |
2.69 |
8.08 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38464 |
401 |
| SS-Chr 13BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
77.0 days-91.0 days |
12 |
|
|
96.75 |
mg/dl |
1.53 |
5.29 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38467 |
401 |
| SS-Chr 11BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
77.0 days-91.0 days |
12 |
|
|
102.08 |
mg/dl |
1.75 |
6.07 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38474 |
401 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
77.0 days-91.0 days |
12 |
|
|
100.42 |
mg/dl |
2.42 |
8.39 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38493 |
401 |
| FHH-Chr 9BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
77.0 days-91.0 days |
8 |
|
|
86.13 |
mg/dl |
1.53 |
4.32 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38500 |
401 |
| FHH-Chr 1BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
77.0 days-91.0 days |
18 |
|
|
73.83 |
mg/dl |
1.31 |
5.55 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38510 |
401 |
| FHH-Chr 5BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
77.0 days-91.0 days |
8 |
|
|
17.88 |
mg/dl |
0.67 |
1.89 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41740 |
401 |
| FHH-Chr 6BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77.0 days-91.0 days |
10 |
|
|
17.4 |
mg/dl |
0.95 |
2.99 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41742 |
401 |
| FHH-Chr 6BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
77.0 days-91.0 days |
10 |
|
|
20.0 |
mg/dl |
1.89 |
5.96 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41746 |
401 |
| SS-Chr 14BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77.0 days-91.0 days |
10 |
|
|
17.4 |
mg/dl |
0.97 |
3.06 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41748 |
401 |
| FHH-Chr 5BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77.0 days-91.0 days |
6 |
|
|
18.83 |
mg/dl |
1.05 |
2.56 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41747 |
401 |
| FHH-Chr 2BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77.0 days-91.0 days |
8 |
|
|
20.25 |
mg/dl |
1.63 |
4.62 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41755 |
401 |
| FHH-Chr 16BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
77.0 days-91.0 days |
9 |
|
|
14.78 |
mg/dl |
0.6 |
1.79 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41758 |
401 |
| FHH-Chr XBN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77.0 days-91.0 days |
8 |
|
|
22.38 |
mg/dl |
2.0 |
5.66 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41767 |
401 |
| SS-Chr 5BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77.0 days-91.0 days |
8 |
|
|
20.13 |
mg/dl |
1.19 |
3.36 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41768 |
401 |
| GH/OmrMcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77.0 days-91.0 days |
5 |
|
|
17.4 |
mg/dl |
2.25 |
5.03 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41765 |
401 |
| SS-Chr 15BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77.0 days-91.0 days |
10 |
|
|
20.0 |
mg/dl |
0.54 |
1.7 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41778 |
401 |
| FHH-Chr 8BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77.0 days-91.0 days |
10 |
|
|
13.8 |
mg/dl |
0.84 |
2.66 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41784 |
401 |
| SS-Chr 20BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77.0 days-91.0 days |
24 |
|
|
18.33 |
mg/dl |
0.49 |
2.41 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41791 |
401 |
| FHH-Chr 20BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
77.0 days-91.0 days |
10 |
|
|
16.4 |
mg/dl |
0.88 |
2.8 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41790 |
401 |
| SS-Chr XBN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
77.0 days-91.0 days |
8 |
|
|
20.75 |
mg/dl |
1.0 |
2.82 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41803 |
401 |
| SS-Chr 19BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77.0 days-91.0 days |
7 |
|
|
17.71 |
mg/dl |
0.99 |
2.63 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41813 |
401 |
| SS-Chr 2BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
77.0 days-91.0 days |
9 |
|
|
17.78 |
mg/dl |
1.4 |
4.21 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41820 |
401 |
| BN/NHsdMcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77.0 days-91.0 days |
19 |
|
|
17.58 |
mg/dl |
0.54 |
2.34 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41823 |
401 |
| SS-Chr 2BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77.0 days-91.0 days |
6 |
|
|
15.67 |
mg/dl |
0.71 |
1.75 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41828 |
401 |
| SS-Chr 18BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77.0 days-91.0 days |
9 |
|
|
6.24 |
g/dl |
0.09 |
0.26 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
41832 |
401 |
| GH/OmrMcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
female |
77.0 days-91.0 days |
9 |
|
|
6.89 |
g/dl |
0.09 |
0.28 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
41838 |
401 |
| LEW |
mean arterial blood pressure |
control condition |
Ueno T, et al., J Mol Med 2003 Jan;81(1):51-60. Epub 2002 Nov 21. |
arterial blood pressure trait |
both |
151.0 days-181.0 days |
21 |
|
continuous mean |
107.0 |
mmHg |
2.0 |
9.17 |
vascular indwelling catheter method |
carotid artery, jugular vein |
1800 |
|
|
|
|
|
|
|
64701 |
249 |
| SS-Chr 6BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
77.0 days-91.0 days |
10 |
|
|
60.05 |
fl |
0.43 |
1.36 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38638 |
401 |
| FHH-Chr 6BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77.0 days-91.0 days |
10 |
|
|
54.1 |
fl |
0.51 |
1.6 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38637 |
401 |
| SS-Chr 17BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77.0 days-91.0 days |
11 |
|
|
55.9 |
fl |
0.25 |
0.83 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38651 |
401 |
| SS-Chr 7BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77.0 days-91.0 days |
11 |
|
|
58.37 |
fl |
0.36 |
1.18 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38654 |
401 |
| GH/OmrMcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
77.0 days-91.0 days |
6 |
|
|
56.52 |
fl |
0.29 |
0.71 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38655 |
401 |
| SS-Chr 5BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
77.0 days-91.0 days |
7 |
|
|
59.23 |
fl |
0.18 |
0.48 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38658 |
401 |
| SS-Chr 5BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77.0 days-91.0 days |
8 |
|
|
56.76 |
fl |
0.25 |
0.69 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38663 |
401 |
| SS-Chr 7BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
77.0 days-91.0 days |
11 |
|
|
59.81 |
fl |
0.28 |
0.93 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38661 |
401 |
| SS-Chr 3BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77.0 days-91.0 days |
10 |
|
|
55.2 |
fl |
0.68 |
2.17 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38674 |
401 |
| FHH-Chr 13BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77.0 days-91.0 days |
10 |
|
|
54.41 |
fl |
0.2 |
0.64 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38682 |
401 |
| SS-Chr 16BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77.0 days-91.0 days |
6 |
|
|
57.93 |
fl |
0.18 |
0.45 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38677 |
401 |
| FHH-Chr 20BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77.0 days-91.0 days |
10 |
|
|
54.34 |
fl |
0.34 |
1.08 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38683 |
401 |
| SS-Chr 20BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77.0 days-91.0 days |
23 |
|
|
56.48 |
fl |
0.17 |
0.79 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38686 |
401 |
| FHH-Chr YBN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77.0 days-91.0 days |
9 |
|
|
53.53 |
fl |
0.27 |
0.81 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38692 |
401 |
| SS-Chr 18BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77.0 days-91.0 days |
9 |
|
|
55.33 |
fl |
0.21 |
0.63 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38695 |
401 |
| SS/JrHsdMcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77.0 days-91.0 days |
89 |
|
|
57.47 |
fl |
0.14 |
1.36 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38696 |
401 |
| SS/JrHsdMcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
77.0 days-91.0 days |
11 |
|
|
59.75 |
fl |
0.29 |
0.97 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38704 |
401 |
| SS-Chr 19BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77.0 days-91.0 days |
7 |
|
|
54.84 |
fl |
0.19 |
0.5 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38708 |
401 |
| FHH-Chr 11BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
77.0 days-91.0 days |
8 |
|
|
55.35 |
fl |
0.26 |
0.72 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38710 |
401 |
| SS-Chr 4BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
77.0 days-91.0 days |
15 |
|
|
61.35 |
fl |
0.45 |
1.73 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38711 |
401 |
| BN/NHsdMcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77.0 days-91.0 days |
18 |
|
|
55.2 |
fl |
0.23 |
0.99 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38718 |
401 |
| SS-Chr XBN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77.0 days-91.0 days |
8 |
|
|
55.48 |
fl |
0.31 |
0.88 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38720 |
401 |
| FHH-Chr 9BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77.0 days-91.0 days |
8 |
|
|
51.75 |
fl |
0.48 |
1.36 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38722 |
401 |
| Hsd:SD |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
77.0 days-91.0 days |
3 |
|
|
105.0 |
mg/dl |
7.94 |
13.75 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
38728 |
401 |
| Hsd:SD |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77.0 days-91.0 days |
2 |
|
|
104.5 |
mg/dl |
4.5 |
6.36 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
38727 |
401 |
| SS-Chr 16BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77.0 days-91.0 days |
6 |
|
|
78.17 |
mg/dl |
5.52 |
13.53 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
38729 |
401 |
| FHH-Chr 15BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
8 |
|
|
7.62 |
x 10E6 cells/ul |
0.12 |
0.35 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41970 |
401 |
| FHH-Chr XBN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
8 |
|
|
8.11 |
x 10E6 cells/ul |
0.17 |
0.48 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41984 |
401 |
| FHH-Chr 16BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
10 |
|
|
7.46 |
x 10E6 cells/ul |
0.13 |
0.42 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41988 |
401 |
| FHH-Chr XBN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
8 |
|
|
7.09 |
x 10E6 cells/ul |
0.17 |
0.48 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41987 |
401 |
| FHH-Chr 3BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
8 |
|
|
7.69 |
x 10E6 cells/ul |
0.12 |
0.35 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41994 |
401 |
| SS-Chr 16BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
7 |
|
|
7.83 |
x 10E6 cells/ul |
0.08 |
0.21 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41993 |
401 |
| FHH/EurMcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
13 |
|
|
7.96 |
x 10E6 cells/ul |
0.17 |
0.6 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41992 |
401 |
| FHH-Chr 19BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
7 |
|
|
7.23 |
x 10E6 cells/ul |
0.19 |
0.49 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41998 |
401 |
| SS-Chr 13BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
12 |
|
|
7.34 |
x 10E6 cells/ul |
0.1 |
0.33 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42003 |
401 |
| FHH-Chr 18BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
10 |
|
|
7.86 |
x 10E6 cells/ul |
0.1 |
0.33 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42009 |
401 |
| FHH-Chr 1BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
12 |
|
|
8.76 |
x 10E6 cells/ul |
0.12 |
0.43 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42021 |
401 |
| FHH-Chr 4BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
9 |
|
|
7.53 |
x 10E6 cells/ul |
0.12 |
0.36 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42023 |
401 |
| SS-Chr 4BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
12 |
|
|
7.39 |
x 10E6 cells/ul |
0.08 |
0.29 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42025 |
401 |
| FHH-Chr 11BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
8 |
|
|
8.41 |
x 10E6 cells/ul |
0.12 |
0.35 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42027 |
401 |
| SS-Chr 19BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
7 |
|
|
7.67 |
x 10E6 cells/ul |
0.13 |
0.35 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42030 |
401 |
| FHH-Chr 11BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
8 |
|
|
7.71 |
x 10E6 cells/ul |
0.11 |
0.31 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42032 |
401 |
| FHH-Chr 7BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
9 |
|
|
7.32 |
x 10E6 cells/ul |
0.2 |
0.6 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42035 |
401 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
16 |
|
|
8.53 |
x 10E6 cells/ul |
0.12 |
0.49 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42038 |
401 |
| SS-Chr 6BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
10 |
|
|
44.47 |
% |
0.87 |
2.76 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57478 |
526 |
| FHH-Chr 6BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
10 |
|
|
42.98 |
% |
0.79 |
2.49 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57477 |
526 |
| SS-Chr 20BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
21 |
|
|
44.57 |
% |
0.53 |
2.43 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57508 |
526 |
| SS-Chr 16BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
6 |
|
|
44.03 |
% |
0.47 |
1.14 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57517 |
526 |
| FHH-Chr 20BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
13 |
|
|
42.58 |
% |
0.55 |
1.99 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57525 |
526 |
| FHH/EurMcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
48 |
|
|
43.47 |
% |
0.55 |
3.8 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57529 |
526 |
| SS-Chr 11BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
13 |
|
|
43.88 |
% |
0.35 |
1.26 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57534 |
526 |
| SS-Chr 19BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
7 |
|
|
42.49 |
% |
0.54 |
1.43 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57552 |
526 |
| SS-Chr 12BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
10 |
|
|
40.1 |
% |
0.38 |
1.21 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57549 |
526 |
| FHH-Chr 7BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
9 |
|
|
41.9 |
% |
0.67 |
2.0 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57561 |
526 |
| SS-Chr 2BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
8 |
|
|
45.44 |
% |
0.56 |
1.58 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57563 |
526 |
| FHH-Chr 1BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
14 |
|
|
46.29 |
% |
0.49 |
1.82 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57564 |
526 |
| SS/JrHsdMcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
female |
82.0 days-99.0 days |
9 |
|
|
35.12 |
mmHg |
1.18 |
3.53 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16098 |
381 |
| FHH-Chr 11BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
female |
82.0 days-99.0 days |
5 |
|
|
32.18 |
mmHg |
2.58 |
5.76 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16104 |
381 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
female |
82.0 days-99.0 days |
8 |
|
|
31.41 |
mmHg |
0.28 |
0.78 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16101 |
381 |
| SS-Chr 2BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
female |
82.0 days-99.0 days |
9 |
|
|
33.23 |
mmHg |
1.23 |
3.7 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16108 |
381 |
| SS-Chr 12BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
female |
82.0 days-99.0 days |
3 |
|
|
31.83 |
mmHg |
0.68 |
1.17 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16110 |
381 |
| FHH-Chr 6BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
6 |
|
|
26.12 |
ml/min |
2.0 |
4.91 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16136 |
381 |
| SS-Chr 5BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
9 |
|
|
30.48 |
ml/min |
1.84 |
5.53 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16142 |
381 |
| SS-Chr 15BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
8 |
|
|
24.08 |
ml/min |
2.61 |
7.37 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16151 |
381 |
| FHH-Chr 18BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
7 |
|
|
25.5 |
ml/min |
2.42 |
6.41 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16155 |
381 |
| FHH-Chr YBN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
21 |
|
|
26.86 |
ml/min |
1.49 |
6.82 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16160 |
381 |
| FHH-Chr 18BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
8 |
|
|
20.91 |
ml/min |
1.04 |
2.95 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16157 |
381 |
| SS-Chr 12BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
9 |
|
|
24.68 |
ml/min |
1.79 |
5.36 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16168 |
381 |
| FHH-Chr 4BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
25.92 |
ml/min |
2.19 |
6.94 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16165 |
381 |
| SS-Chr 12BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
7 |
|
|
23.36 |
ml/min |
2.49 |
6.59 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16172 |
381 |
| FHH-Chr 14BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
23.94 |
ml/min |
1.82 |
5.76 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16178 |
381 |
| LEW/Crl |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
1 |
|
|
38.2 |
ml/min |
|
|
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16180 |
381 |
| SS-Chr 9BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
17 |
|
|
28.08 |
ml/min |
1.79 |
7.36 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16185 |
381 |
| SS-Chr 14BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
12 |
|
|
26.64 |
ml/min |
2.05 |
7.09 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16184 |
381 |
| FHH-Chr 15BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
9 |
|
|
29.06 |
ml/min |
2.46 |
7.39 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16187 |
381 |
| FHH-Chr 16BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
14 |
|
|
27.77 |
ml/min |
1.37 |
5.12 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16191 |
381 |
| SS-Chr 10BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
9 |
|
|
22.35 |
ml/min |
1.82 |
5.46 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16188 |
381 |
| FHH-Chr 3BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
18.87 |
ml/min |
0.97 |
3.07 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16202 |
381 |
| SS-Chr 3BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
11 |
|
|
26.4 |
ml/min |
1.43 |
4.75 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16204 |
381 |
| SS-Chr 11BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
10 |
|
|
26.86 |
ml/min |
3.0 |
9.48 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16213 |
381 |
| FHH-Chr 7BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
24.41 |
ml/min |
1.38 |
4.35 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16225 |
381 |
| FHH-Chr 11BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
7 |
|
|
30.71 |
ml/min |
2.66 |
7.05 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16221 |
381 |
| SS-Chr XBN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
11 |
|
|
24.79 |
ml/min |
2.07 |
6.86 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16228 |
381 |
| GH/OmrMcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
6 |
|
|
36.96 |
ml/min |
1.99 |
4.87 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
16250 |
381 |
| FHH-Chr 15BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70.0 days-84.0 days |
10 |
|
|
178.1 |
g |
6.7 |
21.3 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55392 |
522 |
| FHH-Chr 12BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70.0 days-84.0 days |
21 |
|
|
179.4 |
g |
2.8 |
12.9 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55393 |
522 |
| WKY/NCrl |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77.0 days-91.0 days |
9 |
|
|
192.0 |
g |
4.1 |
12.3 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
57701 |
526 |
| F344/DuCrl |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77.0 days-91.0 days |
10 |
|
|
210.8 |
g |
3.5 |
11.0 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
57704 |
526 |
| LE/BluGill |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77.0 days-91.0 days |
17 |
|
|
340.4 |
g |
11.5 |
47.4 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
57710 |
526 |
| SS/JrHsdMcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77.0 days-91.0 days |
21 |
|
|
0.23 |
null |
0.01 |
0.04 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
57726 |
526 |
| GH/OmrMcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77.0 days-91.0 days |
9 |
|
|
0.18 |
null |
0.02 |
0.05 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
57723 |
526 |
| SHR/NCrl |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
6 |
|
|
383.91 |
beats/min |
11.96 |
29.29 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
16361 |
381 |
| SS/JrHsdMcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
9 |
|
|
447.76 |
beats/min |
12.54 |
37.63 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
16360 |
381 |
| SS-Chr 10BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70.0 days-84.0 days |
10 |
|
|
305.8 |
g |
11.0 |
34.9 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55394 |
522 |
| SS-Chr 14BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70.0 days-84.0 days |
10 |
|
|
190.1 |
g |
2.7 |
8.5 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55399 |
522 |
| SS-Chr 6BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70.0 days-84.0 days |
10 |
|
|
184.9 |
g |
3.9 |
12.3 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55401 |
522 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70.0 days-84.0 days |
14 |
|
|
211.1 |
g |
7.0 |
26.0 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55402 |
522 |
| SS-Chr 14BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70.0 days-84.0 days |
10 |
|
|
274.8 |
g |
9.1 |
28.8 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55405 |
522 |
| FHH-Chr 5BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70.0 days-84.0 days |
10 |
|
|
273.0 |
g |
22.4 |
70.9 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55404 |
522 |
| SS-Chr 10BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70.0 days-84.0 days |
10 |
|
|
196.2 |
g |
4.3 |
13.5 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55408 |
522 |
| SS-Chr 17BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70.0 days-84.0 days |
10 |
|
|
188.3 |
g |
5.0 |
16.0 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55417 |
522 |
| SS-Chr 5BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70.0 days-84.0 days |
10 |
|
|
273.4 |
g |
8.3 |
26.2 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55422 |
522 |
| SS-Chr 7BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70.0 days-84.0 days |
12 |
|
|
180.2 |
g |
2.8 |
9.6 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55420 |
522 |
| FHH-Chr 20BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70.0 days-84.0 days |
10 |
|
|
269.1 |
g |
9.1 |
28.8 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55441 |
522 |
| FHH-Chr 20BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70.0 days-84.0 days |
10 |
|
|
170.9 |
g |
4.3 |
13.7 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55443 |
522 |
| FHH-Chr 18BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70.0 days-84.0 days |
10 |
|
|
172.1 |
g |
2.3 |
7.4 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55445 |
522 |
| SS-Chr 18BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70.0 days-84.0 days |
10 |
|
|
261.4 |
g |
12.1 |
38.3 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55453 |
522 |
| SS-Chr 4BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70.0 days-84.0 days |
15 |
|
|
264.3 |
g |
4.6 |
17.6 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55461 |
522 |
| SS-Chr 19BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70.0 days-84.0 days |
8 |
|
|
295.0 |
g |
12.5 |
35.3 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55466 |
522 |
| FHH-Chr 9BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70.0 days-84.0 days |
8 |
|
|
143.9 |
g |
3.2 |
9.0 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55472 |
522 |
| BN/NHsdMcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70.0 days-84.0 days |
20 |
|
|
147.9 |
g |
2.3 |
10.4 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55477 |
522 |
| FHH-Chr 7BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70.0 days-84.0 days |
14 |
|
|
273.1 |
g |
8.8 |
32.9 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55479 |
522 |
| SS-Chr XBN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70.0 days-84.0 days |
10 |
|
|
186.5 |
g |
12.0 |
37.8 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55478 |
522 |
| FHH-Chr 5BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77.0 days-91.0 days |
10 |
|
|
0.27 |
null |
0.01 |
0.04 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57889 |
526 |
| SS-Chr 6BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77.0 days-91.0 days |
10 |
|
|
0.25 |
null |
0.01 |
0.03 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57892 |
526 |
| SS-Chr 6BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
male |
77.0 days-91.0 days |
10 |
|
|
0.25 |
null |
0.01 |
0.02 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57899 |
526 |
| FHH-Chr 15BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77.0 days-91.0 days |
10 |
|
|
0.28 |
null |
0.02 |
0.05 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57902 |
526 |
| SS-Chr 7BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
male |
77.0 days-91.0 days |
12 |
|
|
0.24 |
null |
0.01 |
0.03 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57908 |
526 |
| FHH-Chr 14BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
male |
77.0 days-91.0 days |
10 |
|
|
0.31 |
null |
0.01 |
0.04 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57903 |
526 |
| SS-Chr 5BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77.0 days-91.0 days |
10 |
|
|
0.27 |
null |
0.01 |
0.04 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57912 |
526 |
| FHH-Chr 10BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
male |
77.0 days-91.0 days |
10 |
|
|
0.29 |
null |
0.02 |
0.05 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57918 |
526 |
| FHH-Chr 8BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77.0 days-91.0 days |
10 |
|
|
0.24 |
null |
0.02 |
0.05 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57921 |
526 |
| SS-Chr 16BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77.0 days-91.0 days |
10 |
|
|
0.19 |
null |
0.01 |
0.03 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57925 |
526 |
| FHH-Chr 13BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
male |
77.0 days-91.0 days |
10 |
|
|
0.25 |
null |
0.01 |
0.05 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57936 |
526 |
| SS-Chr 3BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77.0 days-91.0 days |
10 |
|
|
0.22 |
null |
0.01 |
0.03 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57934 |
526 |
| FHH-Chr 20BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77.0 days-91.0 days |
14 |
|
|
0.27 |
null |
0.01 |
0.05 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57939 |
526 |
| FHH-Chr 20BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
male |
77.0 days-91.0 days |
13 |
|
|
0.24 |
null |
0.01 |
0.05 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57937 |
526 |
| SS/JrHsdMcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
male |
77.0 days-91.0 days |
105 |
|
|
0.21 |
null |
0.0 |
0.05 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57950 |
526 |
| SS-Chr 18BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
male |
77.0 days-91.0 days |
10 |
|
|
0.23 |
null |
0.0 |
0.01 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57949 |
526 |
| FHH-Chr 1BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
male |
77.0 days-91.0 days |
18 |
|
|
0.23 |
null |
0.01 |
0.06 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57953 |
526 |
| SS-Chr 1BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77.0 days-91.0 days |
10 |
|
|
0.24 |
null |
0.01 |
0.03 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57956 |
526 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77.0 days-91.0 days |
11 |
|
|
0.2 |
null |
0.01 |
0.03 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57961 |
526 |
| FHH-Chr 9BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
male |
77.0 days-91.0 days |
9 |
|
|
0.32 |
null |
0.03 |
0.08 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57976 |
526 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
15 |
|
|
41.21 |
ml/min |
1.76 |
6.83 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16676 |
381 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
12 |
|
|
36.91 |
ml/min |
2.34 |
8.1 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16680 |
381 |
| FHH-Chr 6BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
7 |
|
|
34.04 |
ml/min |
6.2 |
16.39 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16679 |
381 |
| FHH-Chr XBN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
31.46 |
ml/min |
2.61 |
8.26 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16690 |
381 |
| SS-Chr 5BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
27.5 |
ml/min |
3.15 |
9.96 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16685 |
381 |
| SS-Chr 5BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
9 |
|
|
36.6 |
ml/min |
3.75 |
11.24 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16688 |
381 |
| SS-Chr 20BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
17 |
|
|
35.69 |
ml/min |
2.65 |
10.92 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16692 |
381 |
| SS-Chr 18BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
18 |
|
|
32.1 |
ml/min |
2.56 |
10.84 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16707 |
381 |
| SS-Chr 2BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
12 |
|
|
26.73 |
ml/min |
2.24 |
7.77 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16713 |
381 |
| SS-Chr 10BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
11 |
|
|
27.33 |
ml/min |
2.09 |
6.94 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16719 |
381 |
| SS-Chr 14BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
22.86 |
ml/min |
1.62 |
5.14 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16722 |
381 |
| GH/OmrMcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
7 |
|
|
36.56 |
ml/min |
4.36 |
11.54 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16735 |
381 |
| FHH-Chr 16BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
14 |
|
|
27.97 |
ml/min |
1.43 |
5.34 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16734 |
381 |
| FHH-Chr 17BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
9 |
|
|
25.96 |
ml/min |
2.17 |
6.52 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16739 |
381 |
| SS-Chr 11BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
27.24 |
ml/min |
1.91 |
6.04 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16753 |
381 |
| SS-Chr 3BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
11 |
|
|
25.0 |
ml/min |
1.5 |
4.97 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16752 |
381 |
| SS-Chr 16BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
13 |
|
|
37.53 |
ml/min |
2.37 |
8.56 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16749 |
381 |
| SS-Chr 11BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
9 |
|
|
30.57 |
ml/min |
2.43 |
7.29 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16756 |
381 |
| FHH-Chr 7BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
11 |
|
|
23.56 |
ml/min |
2.56 |
8.49 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16768 |
381 |
| WKY/NCrl |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
male |
82.0 days-99.0 days |
23 |
|
|
242.3 |
g |
6.1 |
29.1 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
16786 |
381 |
| Crl:CD(SD) |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
female |
82.0 days-99.0 days |
14 |
|
|
231.4 |
g |
7.9 |
29.5 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
16791 |
381 |
| Crl:CD(SD) |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
male |
82.0 days-99.0 days |
15 |
|
|
388.3 |
g |
9.2 |
35.5 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
16789 |
381 |
| WKY/NCrl |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
female |
82.0 days-99.0 days |
22 |
|
|
174.4 |
g |
3.5 |
16.4 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
16794 |
381 |
| LEW/Crl |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
male |
82.0 days-99.0 days |
22 |
|
|
300.2 |
g |
5.0 |
23.3 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
16793 |
381 |
| FHH-Chr 12BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
19 |
|
|
36.87 |
degrees C |
0.38 |
1.64 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16797 |
381 |
| LE/BluGill |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
male |
82.0 days-99.0 days |
15 |
|
|
345.4 |
g |
10.0 |
38.7 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
16796 |
381 |
| FHH-Chr 6BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
7 |
|
|
36.8 |
degrees C |
0.35 |
0.93 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16801 |
381 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
12 |
|
|
37.71 |
degrees C |
0.24 |
0.84 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16802 |
381 |
| FHH-Chr 12BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
11 |
|
|
36.76 |
degrees C |
0.27 |
0.9 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16803 |
381 |
| SHR/NCrl |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
20 |
|
|
37.61 |
degrees C |
0.15 |
0.67 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16806 |
381 |
| FHH-Chr 2BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
10 |
|
|
37.26 |
degrees C |
0.2 |
0.65 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16804 |
381 |
| FHH-Chr 10BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
10 |
|
|
37.11 |
degrees C |
0.13 |
0.41 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16805 |
381 |
| SS-Chr 5BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
9 |
|
|
36.69 |
degrees C |
0.18 |
0.53 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16810 |
381 |
| FHH-Chr XBN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
10 |
|
|
37.1 |
degrees C |
0.3 |
0.95 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16808 |
381 |
| SHR/NCrl |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
18 |
|
|
38.21 |
degrees C |
0.14 |
0.59 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16809 |
381 |
| FHH-Chr 20BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
9 |
|
|
37.62 |
degrees C |
0.23 |
0.68 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16821 |
381 |
| SS-Chr 13BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
10 |
|
|
37.12 |
degrees C |
0.66 |
2.1 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16819 |
381 |
| SS-Chr 18BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
16 |
|
|
37.47 |
degrees C |
0.12 |
0.49 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16826 |
381 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
14 |
|
|
37.62 |
degrees C |
0.14 |
0.54 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16836 |
381 |
| FHH-Chr 1BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
16 |
|
|
37.61 |
degrees C |
0.13 |
0.51 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16838 |
381 |
| SS-Chr 6BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
13 |
|
|
37.95 |
degrees C |
0.23 |
0.84 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16851 |
381 |
| FHH-Chr 5BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
10 |
|
|
36.46 |
degrees C |
0.13 |
0.4 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16848 |
381 |
| SS-Chr 9BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
19 |
|
|
37.72 |
degrees C |
0.12 |
0.51 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16850 |
381 |
| FHH-Chr 16BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
14 |
|
|
36.86 |
degrees C |
0.14 |
0.51 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16856 |
381 |
| FHH-Chr 16BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
9 |
|
|
37.43 |
degrees C |
0.26 |
0.77 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16864 |
381 |
| FHH-Chr 13BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
10 |
|
|
37.15 |
degrees C |
0.12 |
0.39 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16872 |
381 |
| SS-Chr 3BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
12 |
|
|
37.25 |
degrees C |
0.12 |
0.43 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16869 |
381 |
| SS-Chr 11BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
10 |
|
|
36.85 |
degrees C |
0.37 |
1.17 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16875 |
381 |
| SS-Chr 10BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77.0 days-91.0 days |
15 |
|
|
225.8 |
g |
3.7 |
14.3 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58322 |
526 |
| FHH-Chr 6BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77.0 days-91.0 days |
10 |
|
|
197.7 |
g |
4.5 |
14.3 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58328 |
526 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
female |
77.0 days-91.0 days |
10 |
|
|
190.9 |
g |
1.5 |
4.8 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58331 |
526 |
| SS-Chr 14BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77.0 days-91.0 days |
10 |
|
|
268.8 |
g |
8.4 |
26.6 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58334 |
526 |
| FHH-Chr 15BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
female |
77.0 days-91.0 days |
10 |
|
|
151.2 |
g |
4.0 |
12.5 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58339 |
526 |
| FHH-Chr 10BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
female |
77.0 days-91.0 days |
10 |
|
|
93.0 |
g |
3.5 |
11.0 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58343 |
526 |
| GH/OmrMcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
female |
77.0 days-91.0 days |
19 |
|
|
163.3 |
g |
2.4 |
10.7 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58346 |
526 |
| SS-Chr 5BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77.0 days-91.0 days |
10 |
|
|
223.7 |
g |
8.1 |
25.6 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58354 |
526 |
| FHH-Chr XBN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77.0 days-91.0 days |
10 |
|
|
166.4 |
g |
4.6 |
14.7 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58353 |
526 |
| SS-Chr 20BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
female |
77.0 days-91.0 days |
25 |
|
|
182.7 |
g |
2.5 |
12.7 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58359 |
526 |
| FHH-Chr 13BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77.0 days-91.0 days |
10 |
|
|
220.9 |
g |
7.6 |
23.9 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58373 |
526 |
| SS-Chr 11BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
female |
77.0 days-91.0 days |
12 |
|
|
179.0 |
g |
2.0 |
6.9 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58379 |
526 |
| SS-Chr 13BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77.0 days-91.0 days |
11 |
|
|
276.2 |
g |
8.7 |
28.7 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58381 |
526 |
| FHH-Chr 3BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77.0 days-91.0 days |
10 |
|
|
171.9 |
g |
8.5 |
26.8 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58382 |
526 |
| SS-Chr 20BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77.0 days-91.0 days |
26 |
|
|
251.6 |
g |
4.8 |
24.3 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58377 |
526 |
| SS-Chr YBN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77.0 days-91.0 days |
20 |
|
|
281.9 |
g |
3.2 |
14.1 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58384 |
526 |
| SS-Chr 4BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77.0 days-91.0 days |
13 |
|
|
241.1 |
g |
5.1 |
18.3 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58394 |
526 |
| FHH-Chr 11BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
female |
77.0 days-91.0 days |
10 |
|
|
187.3 |
g |
4.9 |
15.5 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58401 |
526 |
| FHH-Chr 4BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
female |
77.0 days-91.0 days |
10 |
|
|
154.2 |
g |
6.0 |
19.1 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58397 |
526 |
| SS-Chr 19BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77.0 days-91.0 days |
9 |
|
|
267.9 |
g |
6.7 |
20.1 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58399 |
526 |
| SS-Chr 19BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
female |
77.0 days-91.0 days |
10 |
|
|
187.1 |
g |
4.7 |
15.0 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58403 |
526 |
| BN/NHsdMcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77.0 days-91.0 days |
20 |
|
|
211.5 |
g |
2.5 |
11.0 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58409 |
526 |
| FHH-Chr 7BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77.0 days-91.0 days |
10 |
|
|
207.1 |
g |
7.0 |
22.2 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58412 |
526 |
| FHH-Chr 9BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77.0 days-91.0 days |
9 |
|
|
123.4 |
g |
4.8 |
14.4 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58413 |
526 |
| SS/JrHsdMcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
male |
77.0 days-91.0 days |
4 |
|
|
0.76 |
g/kg |
0.01 |
0.02 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
58421 |
526 |
| Hsd:SD |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
male |
77.0 days-91.0 days |
8 |
|
|
0.22 |
null |
0.01 |
0.02 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
58424 |
526 |
| SS-Chr 16BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77.0 days-91.0 days |
9 |
|
|
311.1 |
g |
12.2 |
36.6 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
58457 |
526 |
| SHR/NCrl |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77.0 days-91.0 days |
11 |
|
|
282.7 |
g |
3.6 |
11.9 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
58460 |
526 |
| Crl:CD(SD) |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70.0 days-84.0 days |
20 |
|
|
399.8 |
g |
9.9 |
44.1 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
54871 |
522 |
| WKY/NCrl |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70.0 days-84.0 days |
20 |
|
|
177.6 |
g |
3.0 |
13.6 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
54876 |
522 |
| F344/DuCrl |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70.0 days-84.0 days |
10 |
|
|
141.2 |
g |
1.6 |
4.9 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
54877 |
522 |
| Crl:CD(SD) |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
male |
77.0 days-91.0 days |
10 |
|
|
0.82 |
g/kg |
0.04 |
0.11 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
58826 |
526 |
| WKY/NCrl |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
male |
77.0 days-91.0 days |
9 |
|
|
0.86 |
g/kg |
0.04 |
0.12 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
58824 |
526 |
| LE/BluGill |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
female |
77.0 days-91.0 days |
16 |
|
|
0.94 |
g/kg |
0.04 |
0.16 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
58829 |
526 |
| LE/BluGill |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
13 |
|
|
45.84 |
% |
0.49 |
1.76 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
59855 |
526 |
| Hsd:SD |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
8 |
|
|
45.95 |
% |
1.28 |
3.61 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
60072 |
526 |
| SS-Chr 18BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
8 |
|
|
46.48 |
% |
0.55 |
1.56 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
60116 |
526 |
| SS-Chr 18BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
9 |
|
|
45.88 |
% |
0.63 |
1.9 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
60121 |
526 |
| SS-Chr 10BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
male |
82.0 days-99.0 days |
9 |
|
|
33.33 |
mmHg |
0.5 |
1.51 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16043 |
381 |
| FHH-Chr 12BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
female |
82.0 days-99.0 days |
13 |
|
|
37.04 |
mmHg |
0.85 |
3.07 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16042 |
381 |
| SS-Chr 9BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
female |
82.0 days-99.0 days |
12 |
|
|
34.4 |
mmHg |
1.06 |
3.68 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16051 |
381 |
| SS-Chr 14BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
male |
82.0 days-99.0 days |
8 |
|
|
36.06 |
mmHg |
0.65 |
1.84 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16050 |
381 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
female |
82.0 days-99.0 days |
10 |
|
|
32.1 |
mmHg |
0.85 |
2.7 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16049 |
381 |
| FHH-Chr 8BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
female |
82.0 days-99.0 days |
8 |
|
|
37.19 |
mmHg |
1.29 |
3.64 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16067 |
381 |
| SS-Chr 3BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
female |
82.0 days-99.0 days |
4 |
|
|
32.45 |
mmHg |
2.26 |
4.53 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16079 |
381 |
| FHH-Chr 18BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
male |
82.0 days-99.0 days |
8 |
|
|
37.83 |
mmHg |
1.19 |
3.35 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16083 |
381 |
| FHH-Chr 18BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
female |
82.0 days-99.0 days |
8 |
|
|
38.59 |
mmHg |
1.27 |
3.58 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16086 |
381 |
| SS-Chr 10BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
male |
49.0 days-63.0 days |
11 |
|
|
257.5 |
g |
7.8 |
25.9 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47788 |
461 |
| SS-Chr 14BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
female |
49.0 days-63.0 days |
10 |
|
|
158.8 |
g |
4.0 |
12.7 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47793 |
461 |
| FHH-Chr 5BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
male |
49.0 days-63.0 days |
10 |
|
|
181.3 |
g |
9.3 |
29.4 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47799 |
461 |
| SS-Chr 9BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
male |
49.0 days-63.0 days |
9 |
|
|
161.7 |
g |
2.8 |
8.4 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47796 |
461 |
| SS-Chr 10BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
female |
49.0 days-63.0 days |
9 |
|
|
185.8 |
g |
5.0 |
14.9 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47804 |
461 |
| FHH-Chr 2BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
male |
49.0 days-63.0 days |
10 |
|
|
139.6 |
g |
5.5 |
17.4 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47807 |
461 |
| SS-Chr 17BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
male |
49.0 days-63.0 days |
10 |
|
|
167.5 |
g |
15.6 |
49.4 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47808 |
461 |
| SHR/NCrl |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
male |
49.0 days-63.0 days |
10 |
|
|
188.2 |
g |
4.1 |
12.8 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47814 |
461 |
| SS-Chr 17BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
female |
49.0 days-63.0 days |
10 |
|
|
148.5 |
g |
5.8 |
18.2 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47813 |
461 |
| SS-Chr 7BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
female |
49.0 days-63.0 days |
25 |
|
|
166.9 |
g |
2.3 |
11.6 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47817 |
461 |
| SS-Chr 15BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
male |
49.0 days-63.0 days |
10 |
|
|
193.2 |
g |
3.1 |
9.8 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47830 |
461 |
| FHH-Chr 8BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
male |
49.0 days-63.0 days |
10 |
|
|
215.4 |
g |
6.9 |
21.9 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47836 |
461 |
| FHH-Chr 20BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
male |
49.0 days-63.0 days |
10 |
|
|
145.1 |
g |
9.9 |
31.2 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47840 |
461 |
| FHH-Chr YBN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
male |
49.0 days-63.0 days |
10 |
|
|
123.9 |
g |
9.3 |
29.3 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47849 |
461 |
| SS-Chr YBN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
male |
49.0 days-63.0 days |
26 |
|
|
228.1 |
g |
5.7 |
29.0 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47850 |
461 |
| SS/JrHsdMcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
male |
49.0 days-63.0 days |
87 |
|
|
217.3 |
g |
3.4 |
31.3 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47853 |
461 |
| SS-Chr XBN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
female |
49.0 days-63.0 days |
10 |
|
|
147.1 |
g |
5.1 |
16.2 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47855 |
461 |
| SS-Chr 18BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
female |
49.0 days-63.0 days |
5 |
|
|
144.4 |
g |
3.7 |
8.4 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47857 |
461 |
| FHH-Chr 11BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
male |
49.0 days-63.0 days |
10 |
|
|
172.2 |
g |
5.2 |
16.5 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47862 |
461 |
| SS-Chr 19BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
male |
49.0 days-63.0 days |
10 |
|
|
218.5 |
g |
11.6 |
36.8 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47865 |
461 |
| FHH-Chr 11BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
female |
49.0 days-63.0 days |
10 |
|
|
149.8 |
g |
2.8 |
8.9 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47867 |
461 |
| SS-Chr 4BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
female |
49.0 days-63.0 days |
10 |
|
|
147.1 |
g |
2.0 |
6.2 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47868 |
461 |
| SS-Chr 2BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
female |
49.0 days-63.0 days |
15 |
|
|
147.7 |
g |
2.2 |
8.3 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47872 |
461 |
| SS-Chr 19BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
female |
49.0 days-63.0 days |
10 |
|
|
159.6 |
g |
7.4 |
23.3 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47869 |
461 |
| SS-Chr 12BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
female |
49.0 days-63.0 days |
10 |
|
|
149.2 |
g |
2.8 |
9.0 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47874 |
461 |
| SS-Chr 6BN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49.0 days-63.0 days |
10 |
|
|
5.53 |
g/kg |
0.16 |
0.49 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
46973 |
461 |
| SS-Chr 9BN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49.0 days-63.0 days |
8 |
|
|
5.83 |
g/kg |
0.21 |
0.59 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
46979 |
461 |
| SS-Chr 17BN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49.0 days-63.0 days |
10 |
|
|
5.35 |
g/kg |
0.19 |
0.61 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
46991 |
461 |
| SS-Chr 16BN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
9 |
|
|
4.78 |
g/kg |
0.2 |
0.61 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47012 |
461 |
| FHH-Chr 20BN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
10 |
|
|
5.53 |
g/kg |
0.2 |
0.62 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47018 |
461 |
| FHH-Chr 3BN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
8 |
|
|
5.15 |
g/kg |
0.58 |
1.65 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47026 |
461 |
| FHH-Chr 18BN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49.0 days-63.0 days |
10 |
|
|
5.18 |
g/kg |
0.3 |
0.94 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47022 |
461 |
| SS-Chr 13BN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
18 |
|
|
4.42 |
g/kg |
0.14 |
0.59 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47025 |
461 |
| SS-Chr 1BN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
10 |
|
|
3.74 |
g/kg |
0.1 |
0.32 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47032 |
461 |
| SS-Chr XBN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49.0 days-63.0 days |
10 |
|
|
5.02 |
g/kg |
0.14 |
0.43 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47033 |
461 |
| SS-Chr 18BN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49.0 days-63.0 days |
5 |
|
|
6.16 |
g/kg |
0.28 |
0.64 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47035 |
461 |
| FHH-Chr 11BN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
10 |
|
|
5.37 |
g/kg |
0.18 |
0.57 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47040 |
461 |
| SS-Chr 2BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
male |
49.0 days-63.0 days |
10 |
|
|
222.4 |
g |
4.9 |
15.6 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47880 |
461 |
| F344/DuCrl |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
male |
49.0 days-63.0 days |
10 |
|
|
157.3 |
g |
4.3 |
13.6 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
47162 |
461 |
| LE/BluGill |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
male |
49.0 days-63.0 days |
10 |
|
|
341.4 |
g |
7.7 |
24.4 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
47168 |
461 |
| LE/BluGill |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
female |
49.0 days-63.0 days |
11 |
|
|
221.7 |
g |
4.8 |
15.9 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
47164 |
461 |
| WKY/NCrl |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
10 |
|
|
0.95 |
g |
0.06 |
0.18 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
48141 |
461 |
| Crl:CD(SD) |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
10 |
|
|
1.19 |
g |
0.08 |
0.25 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
48143 |
461 |
| F344/DuCrl |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
10 |
|
|
0.77 |
g |
0.02 |
0.06 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
48144 |
461 |
| Crl:CD(SD) |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49.0 days-63.0 days |
10 |
|
|
0.83 |
g |
0.06 |
0.18 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
48145 |
461 |
| LEW/Crl |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
10 |
|
|
0.98 |
g |
0.02 |
0.06 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
48148 |
461 |
| SHR/NHsdMco |
timed urine volume |
control condition (for 140 days) |
Garrett MR, et al., Physiol Genomics. 2007 May 15;. |
urine output |
male |
140.0 days
| 6 |
|
|
14.2 |
ml/d |
3.4 |
8.33 |
urine volume measurement method |
|
0.0 |
|
|
|
|
|
|
|
68008 |
834 |
| SS.SHR-(D2Rat61-D2Mco18)/Mco |
urine pH |
control condition (for 140 days) |
Garrett MR, et al., Physiol Genomics. 2007 May 15;. |
urine pH trait |
male |
140.0 days
| 6 |
|
|
6.8 |
null |
0.07 |
0.17 |
unspecified method |
|
0.0 |
|
|
|
|
|
|
|
68015 |
834 |
| SHR/NHsdMco |
urine pH |
control condition (for 140 days) |
Garrett MR, et al., Physiol Genomics. 2007 May 15;. |
urine pH trait |
male |
140.0 days
| 6 |
|
|
7.2 |
null |
0.1 |
0.24 |
unspecified method |
|
0.0 |
|
|
|
|
|
|
|
68014 |
834 |
| SS.SHR-(D2Rat61-D2Mco18)/Mco |
creatinine clearance to total kidney weight ratio |
control condition (for 140 days) |
Garrett MR, et al., Physiol Genomics. 2007 May 15;. |
glomerular filtration trait |
male |
140.0 days
| 6 |
|
|
0.78 |
ml/min/g |
0.03 |
0.06 |
urine creatinine analysis |
|
0.0 |
|
|
|
|
creatinine clearance to total kidney weight ratio |
|
|
68019 |
834 |
| SS/JrTol |
creatinine clearance to total kidney weight ratio |
control condition (for 140 days) |
Garrett MR, et al., Physiol Genomics. 2007 May 15;. |
glomerular filtration trait |
male |
140.0 days
| 6 |
|
|
0.75 |
ml/min/g |
0.02 |
0.04 |
urine creatinine analysis |
|
0.0 |
|
|
|
|
creatinine clearance to total kidney weight ratio |
|
|
68020 |
834 |
| LEW/Rj |
blood CD45RC(high) CD8 T cell count to total CD8 T cell count ratio |
control condition |
Xystrakis E, et al., J Immunol 2004 Sep 1;173(5):3140-7. |
CD8-positive T cell quantity |
male |
days
| |
|
|
80.0 |
% |
|
3.0 |
fluorescence-activated cell sorting method |
|
0.0 |
|
|
|
|
CD45RC high CD8 to total ratio |
|
|
70571 |
1479 |
| SHRSP/A3 |
serum total cholesterol level |
control condition |
Kato N, et al., Arterioscler Thromb Vasc Biol 2000 Jan;20(1):223-9 |
blood cholesterol amount |
female |
112.0 days
| 5 |
|
|
55.72 |
mg/dl |
0.62 |
1.38 |
serum total cholesterol measurement test |
|
0.0 |
|
|
|
|
|
|
|
68956 |
1033 |
| WKY/Izm |
serum total cholesterol level |
control condition |
Kato N, et al., Arterioscler Thromb Vasc Biol 2000 Jan;20(1):223-9 |
blood cholesterol amount |
female |
112.0 days
| 5 |
|
|
80.6 |
mg/dl |
2.45 |
5.48 |
serum total cholesterol measurement test |
|
0.0 |
|
|
|
|
some flavor of WKY |
|
|
68958 |
1033 |
| BB/OK |
serum total cholesterol level |
control condition |
Kovacs P and Kloting I, Arch Biochem Biophys 1998 Jun 1;354(1):139-43. |
blood cholesterol amount |
male |
84.0 days
| |
|
|
88.8 |
mg/dl |
|
11.58 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
68960 |
1034 |
| HTG |
diastolic blood pressure |
control condition |
Klimes I, et al., Diabetologia 2003 Mar;46(3):352-8. |
arterial blood pressure trait |
not specified |
120.0 days
| 10 |
|
|
130.5 |
mmHg |
1.23 |
3.9 |
vascular fluid filled catheter |
right common carotid artery |
0.0 |
|
|
|
|
|
|
|
68982 |
1037 |
| SHR/NCrl |
brain campesterol level |
control condition |
Yu H, et al., BMC Cardiovasc Disord 2003 Jun 3;3(1):4. |
brain campesterol amount |
not specified |
77.0 days
| 2 |
|
|
0.02 |
mg/g |
|
|
unspecified method |
|
0.0 |
|
|
|
tissue campesterol measurement test |
|
|
|
70531 |
1300 |
| WKY/NCrlCrlj |
plasma sitosterol level |
control condition |
Yu H, et al., BMC Cardiovasc Disord 2003 Jun 3;3(1):4. |
blood sitosterol amount |
not specified |
77.0 days
| 2 |
|
|
8.65 |
mg/dl |
|
|
unspecified method |
|
0.0 |
|
|
|
|
|
|
|
70534 |
1300 |
| BBDP/WorBrm |
percentage of study population developing type 1 diabetes mellitus during a period of time |
control condition |
Wallis RH, et al., Diabetes. 2007 Jun;56(6):1731-6. Epub 2007 Mar 27 |
glucose metabolism trait |
not specified |
60.0 days-120.0 days |
14 |
|
|
86.0 |
% |
|
|
blood glucose analysis |
pancreas |
0.0 |
|
|
|
|
|
|
|
68167 |
891 |
| MWF-Chr 6SHR/Rkb |
serum urea nitrogen level |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
blood urea nitrogen amount |
female |
168.0 days
| 20 |
|
|
19.27 |
mg/dl |
0.67 |
3.01 |
serum urea nitrogen analysis |
|
0.0 |
|
|
|
|
|
|
|
68179 |
309 |
| MWF-Chr 6SHR/Rkb |
creatinine clearance to body weight ratio |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
glomerular filtration trait |
female |
168.0 days
| 20 |
|
|
0.37 |
ml/min/100g |
0.04 |
0.18 |
blood creatinine analysis |
|
0.0 |
|
|
|
|
|
|
|
68182 |
309 |
| BN/Rj |
blood CD45RC(high) CD8 T cell count to CD45RC(low) CD8 T cell count ratio |
control condition |
Xystrakis E, et al., J Immunol 2004 Sep 1;173(5):3140-7. |
CD8-positive T cell quantity |
male |
days
| |
|
|
0.9 |
null |
|
0.1 |
fluorescence-activated cell sorting method |
|
0.0 |
|
|
|
|
|
|
|
70573 |
1479 |
| BN/OrlIcoCrlf |
brain spike-and-wave discharge rate |
control condition |
Rudolf G, et al., Epilepsia 2004 Apr;45(4):301-8. |
brain electrophysiology trait |
both |
90.0 days
| 6 |
|
|
0.0 |
/h |
|
|
electroencephalography (EEG) |
|
0.0 |
|
|
|
|
spike and wave discharge rate |
|
|
69075 |
1118 |
| BBDP.WF-(D8Rat73-D8Sunn1467)(D13Rat124-D13Mgh5)/Sunn |
percentage of study population developing type 1 diabetes mellitus during a period of time |
control condition |
Wallis RH, et al., Diabetes. 2007 Jun;56(6):1731-6. Epub 2007 Mar 27 |
glucose metabolism trait |
not specified |
60.0 days-120.0 days |
36 |
|
|
31.0 |
% |
|
|
blood glucose analysis |
pancreas |
0.0 |
|
|
|
|
|
|
|
68168 |
891 |
| BBDP.WF-(D8Rat73-D8Sunn1467)/Sunn |
percentage of study population developing type 1 diabetes mellitus during a period of time |
control condition |
Wallis RH, et al., Diabetes. 2007 Jun;56(6):1731-6. Epub 2007 Mar 27 |
glucose metabolism trait |
not specified |
60.0 days-120.0 days |
61 |
|
|
41.0 |
% |
|
|
blood glucose analysis |
pancreas |
0.0 |
|
|
|
|
|
|
|
68187 |
891 |
| BBDP.WF-(D8Rat59-D8Sunn1467)/Sunn |
percentage of study population developing type 1 diabetes mellitus during a period of time |
control condition |
Wallis RH, et al., Diabetes. 2007 Jun;56(6):1731-6. Epub 2007 Mar 27 |
glucose metabolism trait |
not specified |
60.0 days-120.0 days |
49 |
|
|
33.0 |
% |
|
|
blood glucose analysis |
pancreas |
0.0 |
|
|
|
|
|
|
|
68192 |
891 |
| SHR/NHsd |
artery lumen area |
control condition |
Nestor AL, et al., Physiol Genomics. 2006 Apr 13;25(2):286-93. Epub 2006 Jan 24. |
iliac artery morphology trait |
male |
133.0 days-140.0 days |
18 |
CA = (IEL)2/4π |
|
0.34 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
error - % coefficient of variation |
|
|
68088 |
329 |
| BN/SsNHsd |
artery tunica media thickness |
control condition |
Nestor AL, et al., Physiol Genomics. 2006 Apr 13;25(2):286-93. Epub 2006 Jan 24. |
iliac artery morphology trait |
male |
133.0 days-140.0 days |
12 |
MW=radius of entire vessel minus radius of circular area |
|
0.04 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
error - % coefficient of variation |
|
|
68091 |
329 |
| BN-Lx |
adipocyte volume |
control condition |
Aitman TJ, et al., Nat Genet 1997 Jun;16(2):197-201 |
adipocyte size trait |
not specified |
days
| |
|
|
59.0 |
pl |
|
25.0 |
Coulter counter cell/particle size/count analysis method |
|
0.0 |
|
|
|
|
|
|
|
67823 |
223 |
| SHR/Ola |
adipocyte volume |
control condition |
Aitman TJ, et al., Nat Genet 1997 Jun;16(2):197-201 |
adipocyte size trait |
not specified |
days
| |
|
|
207.0 |
pl |
|
26.0 |
Coulter counter cell/particle size/count analysis method |
|
0.0 |
|
|
|
|
|
|
|
67822 |
223 |
| BN/Cub |
body weight |
control condition |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
body mass |
male |
300.0 days
| 6 |
|
|
274.1 |
g |
8.37 |
20.5 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
70206 |
1318 |
| BB.WOKW-(D4Got41-Fabp1)/K |
inguinal fat pad weight to body weight ratio |
control condition |
Kloting N, et al., Obes Res 2005 Mar;13(3):589-95. |
inguinal fat pad mass |
male |
224.0 days
| 16 |
|
|
1.7 |
% |
0.33 |
1.32 |
post excision weight measurement |
|
0.0 |
|
|
|
|
both sides fat pads to bw ratio |
|
|
67945 |
227 |
| WAG/RijKyo |
both kidneys wet weight to body weight ratio |
control condition |
Redina OE, et al., Clin Exp Pharmacol Physiol. 2006 May-Jun;33(5-6):456-64. |
kidney mass |
not specified |
180.0 days
| 9 |
|
|
5.2 |
g/kg |
0.1 |
0.3 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
68057 |
835 |
| ISIAH |
both kidneys wet weight |
control condition |
Redina OE, et al., Clin Exp Pharmacol Physiol. 2006 May-Jun;33(5-6):456-64. |
kidney mass |
not specified |
180.0 days
| 11 |
|
|
2.11 |
g |
0.03 |
0.1 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
68056 |
835 |
| ISIAH |
body weight |
control condition |
Redina OE, et al., Clin Exp Pharmacol Physiol. 2006 May-Jun;33(5-6):456-64. |
body mass |
not specified |
180.0 days
| 11 |
|
|
302.0 |
g |
4.5 |
14.92 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
68062 |
835 |
| F344/NRrrc |
body weight |
control condition |
Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25 |
body mass |
male |
210.0 days
| 7 |
|
|
374.1 |
g |
8.0 |
21.17 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
68067 |
836 |
| LOU/Ins |
percentage of study population developing hematuria during a period of time |
control condition |
Kota LT, et al., Physiol Genomics. 2008 Jun 3;. |
kidney integrity trait |
male |
126.0 days
| 20 |
|
|
0.0 |
% |
|
|
ex vivo light microscopy |
|
0.0 |
|
|
|
|
|
|
|
68637 |
870 |
| WKY/Izm |
heart rate |
control condition |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
heart pumping trait |
male |
98.0 days
| 6 |
|
|
317.0 |
beats/min |
14.0 |
34.29 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
|
|
|
|
69086 |
1120 |
| SHRSP/Izm |
heart rate |
control condition |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
heart pumping trait |
male |
98.0 days
| 6 |
|
|
287.0 |
beats/min |
5.0 |
12.25 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
|
|
|
|
69088 |
1120 |
| SS/JrTol |
both kidneys wet weight |
control condition (for 140 days) |
Garrett MR, et al., Physiol Genomics. 2007 May 15;. |
kidney mass |
male |
140.0 days
| 6 |
|
|
2.8 |
g |
0.11 |
0.27 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
67967 |
834 |
| SS.SHR-(D2Rat61-D2Mco18)/Mco |
serum total protein level |
control condition (for 140 days) |
Garrett MR, et al., Physiol Genomics. 2007 May 15;. |
blood total protein amount |
male |
140.0 days
| 6 |
|
|
6.4 |
g/dl |
0.17 |
0.42 |
automated serum protein analysis |
|
0.0 |
|
|
|
|
|
|
|
67983 |
834 |
| SS.SHR-(D2Rat61-D2Mco18)/Mco |
serum triglyceride level |
control condition (for 140 days) |
Garrett MR, et al., Physiol Genomics. 2007 May 15;. |
blood triglyceride amount |
male |
140.0 days
| 6 |
|
|
90.9 |
mg/dl |
7.5 |
18.37 |
serum triglyceride analysis |
|
0.0 |
|
|
|
|
|
|
|
67986 |
834 |
| SS.SHR-(D2Rat61-D2Mco18)/Mco |
serum potassium level |
control condition (for 140 days) |
Garrett MR, et al., Physiol Genomics. 2007 May 15;. |
blood potassium amount |
male |
140.0 days
| 6 |
|
|
5.4 |
mmol/l |
0.22 |
0.54 |
automated serum potassium test |
|
0.0 |
|
|
|
|
|
|
|
67995 |
834 |
| SS/JrTol |
serum sodium level |
control condition (for 140 days) |
Garrett MR, et al., Physiol Genomics. 2007 May 15;. |
blood sodium amount |
male |
140.0 days
| 6 |
|
|
149.6 |
mmol/l |
2.36 |
5.78 |
automated serum sodium test |
|
0.0 |
|
|
|
|
|
|
|
67999 |
834 |
| SHRSP.WKY-(D1Wox29-D1Arb21)/Izm |
systolic blood pressure |
control condition |
Xiao B, et al., J Hypertens. 2010 Nov 8. |
arterial blood pressure trait |
male |
84.0 days
| 14 |
|
serial mean |
194.0 |
mmHg |
|
|
tail cuff plethysmography |
|
0.0 |
|
|
|
|
avg of 5 measurements |
|
|
68738 |
990 |
| WKY.SHRSP-(D1Rat171-D1Wox33)/Izm |
systolic blood pressure |
control condition |
Xiao B, et al., J Hypertens. 2010 Nov 8. |
arterial blood pressure trait |
male |
84.0 days
| 10 |
|
serial mean |
124.0 |
mmHg |
|
|
tail cuff plethysmography |
|
0.0 |
|
|
|
|
avg of 5 measurements for |
|
|
68745 |
990 |
| SHRSP.WKY-(D1Smu13-D1Wox33)/Izm |
systolic blood pressure |
control condition |
Xiao B, et al., J Hypertens. 2010 Nov 8. |
arterial blood pressure trait |
male |
84.0 days
| 10 |
|
serial mean |
205.0 |
mmHg |
|
|
tail cuff plethysmography |
|
0.0 |
|
|
|
|
avg of 5 measurements for SPwch1.72 |
|
|
68744 |
990 |
| SR/JrHsd |
total horizontal distance resulting from voluntary locomotion in pursuit of a target in a Morris water maze apparatus |
control condition |
Ruiz-Opazo N and Tonkiss J, Physiol Genomics. 2006 Jul 12;26(2):145-51. |
spatial reference memory trait |
male |
49.0 days
| 11 |
|
|
14312.0 |
cm |
1064.34 |
3530.0 |
computerized assessment of in vivo video recording |
|
1440.0 |
|
|
|
Morris water maze with computer analysis of video recording (MMO:0000761) |
total horizontal distance resulting from voluntary locomotion in pursuit of a target in a Morris water maze apparatus (CMO:0004100) |
|
|
70291 |
1338 |
| WKY/NHsd |
serum thyroid stimulating hormone level |
control condition |
Baum AE, et al., Endocrinology 2004 Oct 28;. |
blood thyroid-stimulating hormone amount |
female |
70.0 days- days |
15 |
|
|
3.0 |
ng/ml |
0.05 |
0.21 |
radioimmunoassay |
|
0.0 |
|
|
|
|
serum tsh |
|
|
67898 |
252 |
| DA/K |
both inguinal fat pads weight to body weight ratio |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. |
inguinal fat pad mass |
female |
224.0 days
| 12 |
|
|
0.6 |
% |
|
|
post excision weight measurement |
|
0.0 |
|
|
|
|
both sides fat pads |
|
|
67916 |
251 |
| WOKW |
serum insulin level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. |
blood insulin amount |
female |
196.0 days-224.0 days |
12 |
|
serial mean |
0.0 |
mg/dl |
|
|
radioimmunoassay |
ophthalmic venous plexus |
0.0 |
|
|
|
Roche Cobas Mira Plus (Roche, Switzerland) |
average of measures taken at 196 days, 210 days and 224 days |
|
|
67919 |
251 |
| BB/OK |
serum leptin level |
control condition |
Kloting N, et al., Obes Res 2005 Mar;13(3):589-95. |
blood leptin amount |
male |
224.0 days
| 20 |
|
|
7.7 |
ng/ml |
1.7 |
7.6 |
radioimmunoassay |
|
0.0 |
|
|
|
|
|
|
|
67940 |
227 |
| F344/Jcl |
percentage of study population developing bilateral testis tumors during a period of time |
control condition |
Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. |
testis integrity trait |
male |
900.0 days
| 8 |
|
|
88.0 |
% |
|
|
ex vivo light microscopy |
|
0.0 |
|
|
|
necropsy |
bilateral testis tumor incidence |
|
|
67949 |
341 |
| COP.DA-(D16Rat12-D16Rat90)/Mco |
abdominal fat pad weight |
control condition |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
abdominal fat pad mass |
not specified |
105.0 days
| 8 |
|
|
6.47 |
g |
0.24 |
0.68 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
69256 |
933 |
| RLA/Verh |
number of stretched attend postures in elevated zero maze |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
anxiety-related behavior trait |
both |
111.0 days-118.0 days |
18 |
|
|
6.61 |
null |
0.71 |
3.0 |
visual assessment of in vivo video recording |
|
300.0 |
|
|
|
|
number of stretched attend posture movements during experiment time in elevated zero maze (CMO:0004057) |
|
|
68358 |
114 |
| RLA/Verh |
number of entries into opposite side of a two-way shuttle box during intertrial time |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
contextual fear conditioning behavior trait |
both |
97.0 days-104.0 days |
18 |
|
|
19.25 |
null |
2.95 |
12.5 |
in vivo visual assessment |
|
0.0 |
|
|
|
|
number of entries into opposite side of a two-way shuttle box during intertrial time (CMO:0004052) |
|
|
68367 |
114 |
| DA/BklArbNsi |
total white blood cell count |
control condition |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
leukocyte quantity |
female |
56.0 days-98.0 days |
7 |
|
|
10.8 |
x 1000 cells/ul |
1.02 |
2.7 |
automated blood analysis |
blood |
0.0 |
|
|
|
Anilytics |
|
|
|
68377 |
332 |
| DA/BklArbNsi |
blood lymphocyte count |
control condition |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
lymphocyte quantity |
female |
56.0 days-98.0 days |
7 |
|
|
7.19 |
x 1000 cells/ul |
0.68 |
1.8 |
automated blood analysis |
blood |
0.0 |
|
|
|
Anilytics |
|
|
|
68381 |
332 |
| DA/BklArbNsi |
blood neutrophil count |
control condition |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
neutrophil quantity |
female |
56.0 days-98.0 days |
7 |
|
|
2.32 |
x 1000 cells/ul |
0.49 |
1.3 |
automated blood analysis |
heart or retroorbital sinus |
0.0 |
|
|
|
Anilytics |
|
|
|
68379 |
332 |
| ACI/SegHsd |
percentage of study population developing unilateral renal agenesis during a period of time |
control condition |
Shull JD, et al., Mamm Genome. 2006 Jul;17(7):751-9. Epub 2006 Jul 14. |
kidney integrity trait |
female |
days
| 96 |
|
|
13.5 |
% |
|
|
necropsy |
|
0.0 |
|
|
|
|
|
|
|
69372 |
1157 |
| SHR.BN-(D3Rat159-D3Rat1)(D6Rat40-D6Rat170)/Mco |
artery lumen area |
control condition |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery morphology trait |
male |
126.0 days-140.0 days |
17 |
|
|
0.52 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
|
|
|
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
|
|
69343 |
1136 |
| ACI.FHH-(D3Wox2-D3Rat59)/Eur |
kidney sclerotic glomeruli count to total glomeruli count ratio |
control condition |
Van Dijk SJ, et al., Kidney Int. 2006 |
kidney glomerulus integrity trait |
male |
168.0 days-175.0 days |
12 |
|
|
13.0 |
% |
2.0 |
6.93 |
ex vivo light microscopy |
|
0.0 |
|
|
|
|
|
|
|
67709 |
62 |
| ACI/Eur |
kidney sclerotic glomeruli count to total glomeruli count ratio |
control condition |
Van Dijk SJ, et al., Kidney Int. 2006 |
kidney glomerulus integrity trait |
male |
168.0 days-175.0 days |
12 |
|
|
9.0 |
% |
2.0 |
6.93 |
ex vivo light microscopy |
|
0.0 |
|
|
|
|
|
|
|
67708 |
62 |
| ACI.FHH-(D1Rat298-D1Rat90)/Eur |
creatinine clearance to body weight ratio |
control condition |
Van Dijk SJ, et al., Kidney Int. 2006 |
glomerular filtration trait |
male |
168.0 days-175.0 days |
12 |
|
|
0.51 |
ml/min/100g |
0.03 |
0.1 |
blood creatinine analysis |
|
0.0 |
|
|
|
|
|
|
|
67728 |
62 |
| WKY/NCruk |
systolic blood pressure |
control condition |
Clemitson JR, et al., Hypertension 2002 Sep;40(3):292-7 |
arterial blood pressure trait |
male |
42.0 days
| 16 |
|
|
93.9 |
mmHg |
0.73 |
2.9 |
tail cuff photoplethysmography |
|
0.0 |
|
|
|
|
|
|
|
67766 |
110 |
| RHA/Verh |
total number of entries into an open section of an elevated zero maze during experiment |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
anxiety-related behavior trait |
both |
111.0 days-118.0 days |
19 |
|
|
6.26 |
null |
1.08 |
4.7 |
visual assessment of in vivo video recording |
|
300.0 |
|
|
|
elevated zero maze open section |
total number of entries into an open section of an elevated zero maze during experiment (CMO:0004063) |
|
|
69404 |
114 |
| BN-Lx/Cub |
seminal vesicle wet weight |
control condition |
Zidek V, et al., J Reprod Fertil 1999 Jul;116(2):329-33. |
seminal gland mass |
male |
90.0 days
| 9 |
|
|
0.94 |
g |
0.03 |
0.09 |
post excision weight measurement |
|
0.0 |
|
|
|
|
seminal vesicles wet weight |
|
|
69014 |
1076 |
| BN-Lx/Cub |
sperm count to epididymis weight ratio |
control condition |
Zidek V, et al., J Reprod Fertil 1999 Jul;116(2):329-33. |
sperm quantity |
male |
90.0 days
| 9 |
|
|
0.86 |
x 10E7 cells/ml/g |
0.03 |
0.08 |
hemocytometer |
|
0.0 |
|
|
|
|
sperm count to body weight ratio |
|
|
69018 |
1076 |
| SHR/OlaIpcv |
daily sperm count to epididymis weight ratio |
control condition |
Zidek V, et al., J Reprod Fertil 1999 Jul;116(2):329-33. |
sperm quantity |
male |
90.0 days
| 9 |
|
|
1.62 |
x 10E7 cells/ml/g |
0.03 |
0.09 |
hemocytometer |
|
0.0 |
|
|
|
|
daily sperm count to body weight ratio |
|
|
69019 |
1076 |
| SHR/NCrl |
liver sitosterol level |
control condition |
Yu H, et al., BMC Cardiovasc Disord 2003 Jun 3;3(1):4. |
liver sitosterol amount |
not specified |
77.0 days
| 2 |
|
|
0.12 |
mg/g |
|
|
unspecified method |
|
0.0 |
|
|
|
tissue lipid analysis |
|
|
|
70540 |
1300 |
| MWF/FubRkb |
urine albumin excretion rate |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
urine albumin amount |
female |
168.0 days
| |
|
|
24.0 |
mg/d |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
|
|
|
69947 |
309 |
| Crlj:WI |
plasma campesterol level |
control condition |
Yu H, et al., BMC Cardiovasc Disord 2003 Jun 3;3(1):4. |
blood campesterol amount |
not specified |
77.0 days
| 2 |
|
|
1.9 |
mg/dl |
|
|
unspecified method |
|
0.0 |
|
|
|
plasma campesterol measurement test |
|
|
|
70516 |
1300 |
| DA.PVG.1AV1-(D17Rat8-D17Rat37)/Kini |
body weight |
control condition |
Stridh P, et al., PLoS One. 2010 Sep 15;5(9):e12716. |
body mass |
female |
56.0 days-77.0 days |
|
|
|
153.5 |
g |
|
16.7 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
68121 |
837 |
| DA/ZtmKini |
body weight |
control condition |
Stridh P, et al., PLoS One. 2010 Sep 15;5(9):e12716. |
body mass |
female |
56.0 days-77.0 days |
|
|
|
162.9 |
g |
|
9.5 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
68120 |
837 |
| COP/OlaHsd |
body weight |
control condition |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
body mass |
not specified |
105.0 days
| 15 |
|
|
271.0 |
g |
5.5 |
21.3 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
68485 |
933 |
| COP/OlaHsd |
pancreas wet weight |
control condition |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
pancreas mass |
not specified |
105.0 days
| 15 |
|
|
0.62 |
g |
0.03 |
0.12 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
68489 |
933 |
| COP/OlaHsd |
liver wet weight |
control condition |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
liver mass |
not specified |
105.0 days
| 15 |
|
|
9.55 |
g |
0.16 |
0.62 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
68493 |
933 |
| COP.DA-(D3Rat233-D3Mgh14)/Mco |
pancreas wet weight |
control condition |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
pancreas mass |
not specified |
105.0 days
| 18 |
|
|
0.52 |
g |
0.02 |
0.08 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
68492 |
933 |
| COP.DA-(D3Rat233-D3Mgh14)/Mco |
liver wet weight |
control condition |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
liver mass |
not specified |
105.0 days
| 18 |
|
|
9.24 |
g |
0.31 |
1.32 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
68496 |
933 |
| COP.DA-(D16Rat12-D16Rat90)/Mco |
heart left ventricle weight to body weight ratio |
control condition |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
heart left ventricle mass |
not specified |
105.0 days
| 8 |
|
|
1.75 |
mg/g |
0.02 |
0.06 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
68519 |
933 |
| WKY.SHRSP-(D1Wox29-D1Arb21)/Izm |
body weight |
control condition |
Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. |
body mass |
not specified |
112.0 days
| 10 |
|
|
393.0 |
g |
5.66 |
17.9 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
68692 |
971 |
| WKY.SHRSP-(D1Wox29-D1Arb21)/Izm |
heart weight to body weight ratio |
control condition |
Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. |
heart mass |
not specified |
112.0 days
| 10 |
|
|
3.03 |
g/kg |
0.06 |
0.18 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
68695 |
971 |
| WKY.SHRSP-(D1Wox29-D1Arb21)/Izm |
both adrenal glands weight to body weight ratio |
control condition |
Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. |
adrenal gland mass |
not specified |
112.0 days
| 10 |
|
|
16.0 |
mg/100g |
0.63 |
2.0 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
68703 |
971 |
| SHRSR.SHRSP-(Klk1-D1Mit3)/Bbb |
systolic blood pressure |
control condition |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
arterial blood pressure trait |
not specified |
42.0 days
| 31 |
|
|
108.0 |
mmHg |
0.9 |
5.0 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
|
|
69172 |
1126 |
| SHRSP.SHRSR-(Klk1-D1Mit3)/Bbb |
systolic blood pressure |
control condition |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
arterial blood pressure trait |
not specified |
42.0 days
| 31 |
|
|
106.0 |
mmHg |
0.18 |
1.0 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
|
|
69191 |
1126 |
| SHR/NCrl |
brain cholesterol level |
control condition |
Yu H, et al., BMC Cardiovasc Disord 2003 Jun 3;3(1):4. |
brain cholesterol amount |
not specified |
77.0 days
| 2 |
|
|
11.76 |
mg/g |
|
|
unspecified method |
|
0.0 |
|
|
|
tissue lipid analysis |
|
|
|
70527 |
1300 |
| Crlj:WI |
brain cholesterol level |
control condition |
Yu H, et al., BMC Cardiovasc Disord 2003 Jun 3;3(1):4. |
brain cholesterol amount |
not specified |
77.0 days
| 2 |
|
|
13.73 |
mg/g |
|
|
unspecified method |
|
0.0 |
|
|
|
tissue lipid analysis |
|
|
|
70525 |
1300 |
| SHR/NCrl |
brain sitosterol level |
control condition |
Yu H, et al., BMC Cardiovasc Disord 2003 Jun 3;3(1):4. |
brain sitosterol amount |
not specified |
77.0 days
| 2 |
|
|
0.01 |
mg/g |
|
|
unspecified method |
|
0.0 |
|
|
|
tissue lipid analysis |
|
|
|
70544 |
1300 |
| Crlj:WI |
plasma phytosterol level |
control condition |
Yu H, et al., BMC Cardiovasc Disord 2003 Jun 3;3(1):4. |
blood phytosterol amount |
not specified |
77.0 days
| 2 |
|
|
4.3 |
mg/dl |
|
|
unspecified method |
|
0.0 |
|
|
|
|
|
|
|
70546 |
1300 |
| Crlj:WI |
brain phytosterol level |
control condition |
Yu H, et al., BMC Cardiovasc Disord 2003 Jun 3;3(1):4. |
brain phytosterol amount |
not specified |
77.0 days
| 2 |
|
|
0.06 |
mg/g |
|
|
unspecified method |
|
0.0 |
|
|
|
tissue lipid analysis |
|
|
|
70555 |
1300 |
| F344/NHsd |
total accumulated grooming time in an open field apparatus |
control condition |
Baum AE, et al., Behav Brain Res. 2006 Feb 17;. |
anxiety-related behavior trait |
female |
77.0 days-88.0 days |
22 |
|
|
178.5 |
s |
18.83 |
88.3 |
visual assessment of in vivo video recording |
|
600.0 |
|
|
|
|
in 10min |
|
|
68651 |
972 |
| F344/NHsd |
total accumulated grooming time in an open field apparatus |
control condition |
Baum AE, et al., Behav Brain Res. 2006 Feb 17;. |
anxiety-related behavior trait |
male |
77.0 days-88.0 days |
28 |
|
|
151.9 |
s |
12.64 |
66.9 |
visual assessment of in vivo video recording |
|
600.0 |
|
|
|
|
in 10min |
|
|
68653 |
972 |
| BB.SHR-(Gnal-D18Mit9)/K |
body weight |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
body mass |
female |
84.0 days
| 10 |
|
|
206.0 |
g |
9.49 |
30.0 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
70098 |
324 |
| BB.SHR-(Gnal-D18Mit9)/K |
serum insulin level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
blood insulin amount |
both |
84.0 days
| 25 |
|
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
opthalmic venous plexus |
0.0 |
|
|
|
|
ng/ml is unit |
|
|
70100 |
324 |
| BB.SHR-(Gnal-D18Mit9)/K |
serum total cholesterol level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
blood cholesterol amount |
female |
84.0 days
| 10 |
|
|
108.11 |
mg/dl |
1.34 |
4.25 |
automated blood analysis |
opthalmic venous plexus |
0.0 |
|
|
|
|
|
|
|
70104 |
324 |
| BB.SHR-(Gnal-D18Mit9)/K |
serum triglyceride level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
blood triglyceride amount |
female |
84.0 days
| 10 |
|
|
168.14 |
mg/dl |
20.99 |
66.37 |
automated blood analysis |
opthalmic venous plexus |
0.0 |
|
|
|
|
|
|
|
70108 |
324 |
| BB.SHR-(Gnal-D18Mit9)/K |
systolic blood pressure |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
arterial blood pressure trait |
both |
84.0 days-98.0 days |
25 |
|
serial mean |
122.0 |
mmHg |
2.8 |
14.0 |
tail cuff volume pressure recording |
tail |
0.0 |
|
|
|
average of 3 measurements, on 3 different days |
|
|
|
70109 |
324 |
| BN/SsNHsd |
thymus wet weight |
control condition |
Gould KA, et al., Mamm Genome. 2006 May;17(5):451-64. |
thymus mass |
male |
63.0 days
| 7 |
|
|
508.0 |
mg |
23.81 |
63.0 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
69092 |
1121 |
| IER/Ihr |
percentage of study population developing cataract during a period of time |
control condition |
Yokoyama M, et al., Mamm Genome 2001 Mar;12(3):207-11. |
lens clarity trait |
female |
days-120.0 days |
70 |
|
|
100.0 |
% |
|
|
in vivo visual assessment |
|
0.0 |
|
|
|
|
|
|
|
69906 |
1239 |
| IER/Ihr |
percentage of study population developing cataract during a period of time |
control condition |
Yokoyama M, et al., Mamm Genome 2001 Mar;12(3):207-11. |
lens clarity trait |
male |
days-120.0 days |
73 |
|
|
100.0 |
% |
|
|
in vivo visual assessment |
|
0.0 |
|
|
|
|
|
|
|
69907 |
1239 |
| BB.SHR-(D6Rat184-D6Rat3)/K |
percentage of study population developing diabetes mellitus during a period of time |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
glucose metabolism trait |
female |
210.0 days
| 45 |
|
|
13.0 |
% |
|
|
manually read urine glucose test strip |
|
0.0 |
|
|
|
|
|
|
|
70115 |
324 |
| BB.SHR-(D6Rat184-D6Rat3)/K |
age at onset/diagnosis of diabetes mellitus |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
glucose metabolism trait |
male |
210.0 days
| 43 |
|
|
136.0 |
d |
1.98 |
13.0 |
manually read urine glucose test strip |
|
0.0 |
|
|
|
|
|
|
|
70120 |
324 |
| Crlj:WI |
plasma total cholesterol level |
control condition |
Yu H, et al., BMC Cardiovasc Disord 2003 Jun 3;3(1):4. |
blood cholesterol amount |
not specified |
77.0 days
| 2 |
|
|
92.0 |
mg/dl |
|
|
unspecified method |
|
0.0 |
|
|
|
|
|
|
|
70159 |
1300 |
| Crl:SD |
plasma total cholesterol level |
control condition |
Yu H, et al., BMC Cardiovasc Disord 2003 Jun 3;3(1):4. |
blood cholesterol amount |
not specified |
77.0 days
| 2 |
|
|
54.6 |
mg/dl |
|
|
unspecified method |
|
0.0 |
|
|
|
|
|
|
|
70158 |
1300 |
| WKY/NCrlCrlj |
liver cholesterol level |
control condition |
Yu H, et al., BMC Cardiovasc Disord 2003 Jun 3;3(1):4. |
liver cholesterol amount |
not specified |
77.0 days
| 2 |
|
|
2.1 |
mg/g |
|
|
unspecified method |
|
0.0 |
|
|
|
tissue total cholesterol analysis |
|
|
|
70165 |
1300 |
| NP.P-(D4Rat119-D4Rat55)/Iusm |
bone polar moment of inertia to body weight ratio |
control condition |
Alam I, et al., J Bone Miner Res. 2010 Jan 8. |
femur strength trait |
male |
180.0 days
| 8 |
|
|
0.0 |
mm4/g |
0.0 |
0.0 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
|
|
|
75629 |
308 |
| iNP/Iusm |
bone mineral content to body weight ratio |
control condition |
Alam I, et al., J Bone Miner Res. 2010 Jan 8. |
bone mineral mass |
male |
180.0 days
| 8 |
|
|
0.02 |
null |
0.0 |
0.0 |
dual-energy x-ray absorptiometry |
|
0.0 |
|
|
|
|
whole body |
|
|
75639 |
308 |
| SD |
blood sodium level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood sodium amount |
male |
71.0 days-85.0 days |
6 |
|
|
143.8 |
mmol/l |
0.6 |
1.47 |
automated blood analysis |
|
0.0 |
|
|
|
Siemens biochemical analyzer |
|
|
|
85119 |
1602 |
| SD |
blood sodium level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood sodium amount |
male |
85.0 days-99.0 days |
6 |
|
|
123.26 |
mmol/l |
24.32 |
59.56 |
automated blood analysis |
|
0.0 |
|
|
|
Siemens biochemical analyzer |
|
|
|
85123 |
1602 |
| SD |
blood phosphate level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood phosphate amount |
male |
71.0 days-85.0 days |
6 |
|
|
6.3 |
mg/dl |
0.07 |
0.18 |
automated blood analysis |
|
0.0 |
|
|
|
Siemens biochemical analyzer |
|
|
|
85155 |
1602 |
| SD |
both kidneys wet weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
kidney mass |
male |
85.0 days-99.0 days |
6 |
|
|
0.76 |
g |
0.04 |
0.1 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
85210 |
1602 |
| SD |
spleen wet weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
spleen mass |
male |
85.0 days-99.0 days |
6 |
|
|
0.17 |
g |
0.01 |
0.02 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
85246 |
1602 |
| SD |
brain wet weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
brain mass |
male |
85.0 days-99.0 days |
6 |
|
|
0.67 |
g |
0.01 |
0.03 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
85258 |
1602 |
| SD |
adrenal gland wet weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
adrenal gland mass |
male |
71.0 days-85.0 days |
6 |
|
|
0.02 |
g |
0.0 |
0.0 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
85266 |
1602 |
| BN/Rj |
arterial internal elastic lamina rupture composite score |
control condition |
Kota L, et al., Physiol Genomics. 2007 Jun 19;30(1):17-25. Epub 2007 Mar 13. |
artery integrity trait |
male |
120.0 days-126.0 days |
7 |
|
|
118.7 |
null |
7.14 |
18.9 |
ex vivo light microscopy |
|
0.0 |
|
|
|
|
internal elastic lamina rupture score |
|
|
96769 |
1680 |
| BN/Rj |
arterial internal elastic lamina rupture composite score |
control condition |
Kota L, et al., Physiol Genomics. 2007 Jun 19;30(1):17-25. Epub 2007 Mar 13. |
artery integrity trait |
female |
120.0 days-126.0 days |
3 |
|
|
65.0 |
null |
21.82 |
37.8 |
ex vivo light microscopy |
|
0.0 |
|
|
|
|
internal elastic lamina rupture score |
|
|
96770 |
1680 |
| WOKW/K |
serum total cholesterol level |
control condition |
Kovacs P, et al., Biochem Biophys Res Commun 2000 Mar 24;269(3):660-5. |
blood cholesterol amount |
not specified |
196.0 days-224.0 days |
12 |
|
|
93.44 |
mg/dl |
2.67 |
9.27 |
automated serum analysis |
|
0.0 |
|
|
|
|
|
|
|
96842 |
1123 |
| WOKW/K |
serum leptin level |
control condition |
Kovacs P, et al., Biochem Biophys Res Commun 2000 Mar 24;269(3):660-5. |
blood leptin amount |
not specified |
196.0 days-224.0 days |
12 |
|
|
7.26 |
ng/ml |
0.85 |
2.94 |
radioimmunoassay |
|
0.0 |
|
|
|
|
|
|
|
96844 |
1123 |
| PCK-Pkhd1pck/CrljCrl |
liver weight |
control condition |
O'Meara CC, et al., Physiol Genomics. 2012 Aug 1;44(15):741-53. doi: 10.1152/physiolgenomics.00187.2011. Epub 2012 Jun 5. |
liver mass |
male |
189.0 days
| 7 |
|
|
53.83 |
g |
8.08 |
21.38 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
96911 |
1738 |
| FHH.PCK-(D9Rat35-D9Rat70)/Mcwi |
liver weight |
control condition |
O'Meara CC, et al., Physiol Genomics. 2012 Aug 1;44(15):741-53. doi: 10.1152/physiolgenomics.00187.2011. Epub 2012 Jun 5. |
liver mass |
male |
189.0 days
| 15 |
|
|
36.22 |
g |
2.68 |
10.38 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
96910 |
1738 |
| Crl:CD(SD) |
plasma creatinine level |
control condition |
O'Meara CC, et al., Physiol Genomics. 2012 Aug 1;44(15):741-53. doi: 10.1152/physiolgenomics.00187.2011. Epub 2012 Jun 5. |
blood creatinine amount |
male |
189.0 days
| 6 |
|
|
0.47 |
mg/dl |
0.03 |
0.07 |
automated blood analysis |
|
0.0 |
|
|
|
ACE Autoanalyzer Clinical Chemistry System |
|
|
|
96916 |
1738 |
| PCK-Pkhd1pck/CrljCrl |
area of liver occupied by fibrotic lesions to total liver area ratio |
control condition |
O'Meara CC, et al., Physiol Genomics. 2012 Aug 1;44(15):741-53. doi: 10.1152/physiolgenomics.00187.2011. Epub 2012 Jun 5. |
liver integrity trait |
male |
120.0 days
| 8 |
|
|
23.5 |
% |
4.8 |
13.58 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
Masson¿s Trichrome staining |
|
|
|
96913 |
1738 |
| FHH/EurMcwi |
plasma creatinine level |
control condition |
O'Meara CC, et al., Physiol Genomics. 2012 Aug 1;44(15):741-53. doi: 10.1152/physiolgenomics.00187.2011. Epub 2012 Jun 5. |
blood creatinine amount |
male |
189.0 days
| 7 |
|
|
0.8 |
mg/dl |
0.1 |
0.26 |
automated blood analysis |
|
0.0 |
|
|
|
ACE Autoanalyzer Clinical Chemistry System |
|
|
|
96915 |
1738 |
| PCK-Pkhd1pck/CrljCrl |
plasma creatinine level |
control condition |
O'Meara CC, et al., Physiol Genomics. 2012 Aug 1;44(15):741-53. doi: 10.1152/physiolgenomics.00187.2011. Epub 2012 Jun 5. |
blood creatinine amount |
male |
189.0 days
| 6 |
|
|
0.8 |
mg/dl |
0.1 |
0.24 |
automated blood analysis |
|
0.0 |
|
|
|
ACE Autoanalyzer Clinical Chemistry System |
|
|
|
96914 |
1738 |
| WKY/NHsd |
number of rearing movements in an open field apparatus |
control condition |
Baum AE, et al., Behav Brain Res. 2006 Feb 17;. |
exploratory behavior trait |
female |
77.0 days-88.0 days |
22 |
|
|
20.5 |
null |
2.26 |
10.6 |
visual assessment of in vivo video recording |
|
600.0 |
|
|
|
|
in 10min |
|
|
75692 |
972 |
| F344/NHsd |
number of rearing movements in an open field apparatus |
control condition |
Baum AE, et al., Behav Brain Res. 2006 Feb 17;. |
exploratory behavior trait |
male |
77.0 days-88.0 days |
28 |
|
|
25.9 |
null |
2.46 |
13.0 |
visual assessment of in vivo video recording |
|
600.0 |
|
|
|
|
in 10min |
|
|
75697 |
972 |
| BB.SHR-(D6Rat184-D6Rat3)/K |
white blood cell count |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
leukocyte quantity |
both |
90.0 days
| 10 |
|
|
2.98 |
x 1000 cells/ul |
0.28 |
0.87 |
fluorescence-activated cell sorting method |
opthalmic venous plexus |
0.0 |
|
|
|
|
|
|
|
75605 |
324 |
| BB.SHR-(D6Rat184-D6Rat3)/K |
white blood cell count |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
leukocyte quantity |
both |
90.0 days
| 30 |
|
|
3.77 |
x 1000 cells/ul |
214.34 |
1174.0 |
fluorescence-activated cell sorting method |
opthalmic venous plexus |
0.0 |
|
|
|
|
|
|
|
75604 |
324 |
| LEW |
volumetric bone mineral density |
control condition |
Koller DL, et al., Mamm Genome 2005 Aug;16(8):578-86. Epub 2005 Sep 14. |
lumbar vertebra mineral mass |
female |
182.0 days
| 16 |
|
|
746.0 |
mg/cm3 |
7.25 |
29.0 |
ex vivo peripheral quantitative computed tomography |
lumbar vertebrae 3-5 |
0.0 |
|
|
|
|
L3-L5 |
|
|
76300 |
1578 |
| NP.P-(D4Rat119-D4Rat55)/Iusm |
total volumetric bone mineral density |
control condition |
Alam I, et al., J Bone Miner Res. 2010 Jan 8. |
bone mineral mass |
male |
180.0 days
| 8 |
|
|
582.0 |
mg/cm3 |
8.49 |
24.0 |
ex vivo peripheral quantitative computed tomography |
diaphysis of femur |
0.0 |
|
|
|
1 mm from distal epiphysis |
1 mm from distal epiphysis |
|
|
75613 |
308 |
| P.NP-(D4Rat119-D4Rat55)/Iusm |
total volumetric bone mineral density |
control condition |
Alam I, et al., J Bone Miner Res. 2010 Jan 8. |
bone mineral mass |
male |
180.0 days
| 8 |
|
|
618.0 |
mg/cm3 |
6.01 |
17.0 |
ex vivo peripheral quantitative computed tomography |
diaphysis of femur |
0.0 |
|
|
|
1 mm from distal epiphysis |
1 mm from distal epiphysis |
|
|
75614 |
308 |
| iP/Iusm |
total volumetric bone mineral density |
control condition |
Alam I, et al., J Bone Miner Res. 2010 Jan 8. |
bone mineral mass |
male |
180.0 days
| 8 |
|
|
1082.0 |
mg/cm3 |
12.37 |
35.0 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
|
|
|
75616 |
308 |
| P.NP-(D4Rat119-D4Rat55)/Iusm |
total volumetric bone mineral density |
control condition |
Alam I, et al., J Bone Miner Res. 2010 Jan 8. |
bone mineral mass |
male |
180.0 days
| 8 |
|
|
1033.0 |
mg/cm3 |
11.67 |
33.0 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
|
|
|
75618 |
308 |
| F344/NHsd |
body weight |
control condition |
Mach J, et al., J Gerontol A Biol Sci Med Sci. 2013 Jul 17. |
body mass |
male |
714.0 days-882.0 days |
5 |
|
|
429.1 |
g |
30.0 |
67.08 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
84702 |
1599 |
| F344/NHsd |
body weight |
control condition |
Mach J, et al., J Gerontol A Biol Sci Med Sci. 2013 Jul 17. |
body mass |
male |
132.0 days-264.0 days |
5 |
|
|
381.2 |
g |
9.4 |
21.02 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
84708 |
1599 |
| SD |
body weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
male |
70.0 days-84.0 days |
6 |
|
|
255.5 |
g |
|
|
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
84788 |
1602 |
| SD |
food intake rate |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
eating behavior trait |
male |
50.0 days-64.0 days |
6 |
|
|
33.1 |
g/d |
|
|
unspecified method |
|
0.0 |
|
|
|
|
|
|
|
84824 |
1602 |
| SD |
food intake rate |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
eating behavior trait |
female |
57.0 days-71.0 days |
6 |
|
|
21.4 |
g/d |
|
|
unspecified method |
|
0.0 |
|
|
|
|
|
|
|
84865 |
1602 |
| SD |
red blood cell count |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
erythrocyte quantity |
male |
71.0 days-85.0 days |
6 |
|
|
8.31 |
x 10E6 cells/ul |
0.22 |
0.53 |
unspecified method |
|
0.0 |
|
|
|
|
|
|
|
84894 |
1602 |
| SD |
blood hemoglobin level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood hemoglobin amount |
male |
71.0 days-85.0 days |
6 |
|
|
13.8 |
g/dl |
0.16 |
0.38 |
unspecified method |
|
0.0 |
|
|
|
|
|
|
|
84939 |
1602 |
| SD |
blood albumin level to blood globulin level ratio |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood albumin amount |
male |
85.0 days-99.0 days |
6 |
|
|
0.77 |
null |
0.15 |
0.36 |
automated blood analysis |
|
0.0 |
|
|
|
Siemens biochemical analyzer |
|
|
|
85051 |
1602 |
| SD |
blood albumin level to blood globulin level ratio |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood albumin amount |
female |
85.0 days-99.0 days |
6 |
|
|
0.93 |
null |
0.06 |
0.15 |
automated blood analysis |
|
0.0 |
|
|
|
Siemens biochemical analyzer |
|
|
|
85057 |
1602 |
| SD |
blood aspartate aminotransferase activity level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood aspartate transaminase amount |
male |
71.0 days-85.0 days |
6 |
|
|
169.7 |
U/l |
11.38 |
27.88 |
automated blood analysis |
|
0.0 |
|
|
|
Siemens biochemical analyzer |
|
|
|
85071 |
1602 |
| SD |
blood bilirubin level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood bilirubin amount |
male |
71.0 days-85.0 days |
6 |
|
|
0.3 |
mg/dl |
0.04 |
0.09 |
automated blood analysis |
|
0.0 |
|
|
|
Siemens biochemical analyzer |
|
|
|
85107 |
1602 |
| SD |
blood bilirubin level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood bilirubin amount |
male |
85.0 days-99.0 days |
6 |
|
|
0.52 |
mg/dl |
0.09 |
0.22 |
automated blood analysis |
|
0.0 |
|
|
|
Siemens biochemical analyzer |
|
|
|
85111 |
1602 |
| NP.P-(D4Rat119-D4Rat55)/Iusm |
bone mineral content to body weight ratio |
control condition |
Alam I, et al., J Bone Miner Res. 2010 Jan 8. |
bone mineral mass |
male |
180.0 days
| 8 |
|
|
0.0 |
null |
0.0 |
0.0 |
dual-energy x-ray absorptiometry |
|
0.0 |
|
|
|
|
1-6 |
|
|
75665 |
308 |
| BB.SHR-(D6Rat184-D6Rat3)/K |
blood CD4 lymphocyte count to total lymphocyte count ratio |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
CD4-positive T cell quantity |
both |
90.0 days
| 10 |
|
|
43.3 |
% |
1.9 |
6.0 |
fluorescence-activated cell sorting method |
opthalmic venous plexus |
0.0 |
|
|
|
|
|
|
|
84626 |
324 |
| BB.SHR-(Gnal-D18Mit9)/K |
blood CD4 lymphocyte count to total lymphocyte count ratio |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
CD4-positive T cell quantity |
both |
90.0 days
| 14 |
|
|
34.1 |
% |
2.14 |
8.0 |
fluorescence-activated cell sorting method |
opthalmic venous plexus |
0.0 |
|
|
|
|
|
|
|
84627 |
324 |
| BB.SHR-(D6Rat184-D6Rat3)/K |
blood CD8 lymphocyte count to total lymphocyte count ratio |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
CD8-positive T cell quantity |
both |
90.0 days
| 30 |
|
|
0.7 |
% |
0.13 |
0.7 |
fluorescence-activated cell sorting method |
opthalmic venous plexus |
0.0 |
|
|
|
|
|
|
|
84628 |
324 |
| BB.SHR-(D6Rat184-D6Rat3)/K |
blood natural killer cell count to total lymphocyte count ratio |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
natural killer cell quantity |
both |
90.0 days
| 10 |
|
|
14.7 |
% |
0.7 |
2.2 |
fluorescence-activated cell sorting method |
opthalmic venous plexus |
0.0 |
|
|
|
|
|
|
|
84632 |
324 |
| BB.SHR-(D6Rat184-D6Rat3)/K |
blood CD25 lymphocyte count to total lymphocyte count ratio |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
lymphocyte quantity |
both |
90.0 days
| 10 |
|
|
36.6 |
% |
2.18 |
6.9 |
fluorescence-activated cell sorting method |
opthalmic venous plexus |
0.0 |
|
|
|
|
|
|
|
84638 |
324 |
| SD |
blood potassium level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood potassium amount |
male |
85.0 days-99.0 days |
6 |
|
|
4.6 |
mmol/l |
0.87 |
2.14 |
automated blood analysis |
|
0.0 |
|
|
|
Siemens biochemical analyzer |
|
|
|
85135 |
1602 |
| SD |
blood calcium level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood calcium amount |
male |
71.0 days-85.0 days |
6 |
|
|
10.0 |
mg/dl |
0.1 |
0.25 |
automated blood analysis |
|
0.0 |
|
|
|
Siemens biochemical analyzer |
|
|
|
85143 |
1602 |
| SD |
blood calcium level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood calcium amount |
female |
71.0 days-85.0 days |
6 |
|
|
9.95 |
mg/dl |
0.08 |
0.19 |
automated blood analysis |
|
0.0 |
|
|
|
Siemens biochemical analyzer |
|
|
|
85149 |
1602 |
| COP/OlaHsd |
body weight |
control condition |
Ways JA, et al., Genomics 2002 Jul;80(1):13-20. |
body mass |
male |
77.0 days-84.0 days |
|
|
|
228.0 |
g |
7.0 |
|
body weighing method |
|
|
|
|
|
timing method |
|
|
|
84622 |
932 |
| BB.SHR-(Gnal-D18Mit9)/K |
blood RT6.1 positive cell count to total lymphocyte count ratio |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
T cell quantity |
both |
90.0 days
| 14 |
|
|
3.4 |
% |
0.67 |
2.5 |
fluorescence-activated cell sorting method |
opthalmic venous plexus |
0.0 |
|
|
|
|
|
|
|
84636 |
324 |
| SD |
blood globulin level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood globulin amount |
male |
71.0 days-85.0 days |
6 |
|
|
2.9 |
g/dl |
0.03 |
0.08 |
automated blood analysis |
|
0.0 |
|
|
|
Siemens biochemical analyzer |
|
|
|
85023 |
1602 |
| SD |
blood alkaline phosphatase activity level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood alkaline phosphatase amount |
female |
71.0 days-85.0 days |
6 |
|
|
206.0 |
U/l |
27.48 |
67.31 |
automated blood analysis |
|
0.0 |
|
|
|
Siemens biochemical analyzer |
|
|
|
85101 |
1602 |
| BB.SHR-(Gnal-D18Mit9)/K |
blood B lymphocyte count to total leukocyte count ratio |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
B cell quantity |
both |
90.0 days
| 14 |
|
|
37.4 |
% |
2.75 |
10.3 |
fluorescence-activated cell sorting method |
opthalmic venous plexus |
0.0 |
|
|
|
|
|
|
|
75600 |
324 |
| P.NP-(D4Rat119-D4Rat55)/Iusm |
femur ultimate force |
control condition |
Alam I, et al., J Bone Miner Res. 2010 Jan 8. |
femur strength trait |
male |
180.0 days
| 8 |
|
|
153.0 |
N |
1.77 |
5.0 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
|
|
|
75634 |
308 |
| SD |
food intake rate |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
eating behavior trait |
male |
64.0 days-78.0 days |
6 |
|
|
33.7 |
g/d |
|
|
unspecified method |
|
0.0 |
|
|
|
|
|
|
|
84842 |
1602 |
| Hsd:WI |
serum creatinine level |
control condition |
Erman F, et al., Biol Trace Elem Res. 2014 Feb 16. |
blood creatinine amount |
not specified |
78.0 days
| 7 |
|
|
0.29 |
mg/dl |
0.01 |
0.03 |
serum creatinine analysis |
|
0.0 |
|
|
|
|
|
|
|
76038 |
1546 |
| NP.P-(D4Rat119-D4Rat55)/Iusm |
total volumetric bone mineral density |
control condition |
Alam I, et al., J Bone Miner Res. 2010 Jan 8. |
bone mineral mass |
male |
180.0 days
| 8 |
|
|
966.0 |
mg/cm3 |
8.84 |
25.0 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
midshaft |
|
|
75609 |
308 |
| iNP/Iusm |
total volumetric bone mineral density |
control condition |
Alam I, et al., J Bone Miner Res. 2010 Jan 8. |
bone mineral mass |
male |
180.0 days
| 8 |
|
|
584.0 |
mg/cm3 |
8.49 |
24.0 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
|
|
|
75619 |
308 |
| NP.P-(D4Rat119-D4Rat55)/Iusm |
total volumetric bone mineral density |
control condition |
Alam I, et al., J Bone Miner Res. 2010 Jan 8. |
bone mineral mass |
male |
180.0 days
| 8 |
|
|
571.0 |
mg/cm3 |
6.72 |
19.0 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
|
|
|
75621 |
308 |
| iP/Iusm |
total volumetric bone mineral density |
control condition |
Alam I, et al., J Bone Miner Res. 2010 Jan 8. |
bone mineral mass |
male |
180.0 days
| 8 |
|
|
685.0 |
mg/cm3 |
10.96 |
31.0 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
|
|
|
75620 |
308 |
| NP.P-(D4Rat119-D4Rat55)/Iusm |
bone mineral content to body weight ratio |
control condition |
Alam I, et al., J Bone Miner Res. 2010 Jan 8. |
bone mineral mass |
male |
180.0 days
| 8 |
|
|
0.01 |
null |
0.0 |
0.0 |
dual-energy x-ray absorptiometry |
|
0.0 |
|
|
|
|
|
|
|
75649 |
308 |
| iNP/Iusm |
bone mineral density |
control condition |
Alam I, et al., J Bone Miner Res. 2010 Jan 8. |
bone mineral mass |
male |
180.0 days
| 8 |
|
|
0.37 |
g/cm2 |
0.0 |
0.01 |
dual-energy x-ray absorptiometry |
|
0.0 |
|
|
|
|
|
|
|
75651 |
308 |
| P.NP-(D4Rat119-D4Rat55)/Iusm |
bone mineral density |
control condition |
Alam I, et al., J Bone Miner Res. 2010 Jan 8. |
bone mineral mass |
male |
180.0 days
| 8 |
|
|
0.39 |
g/cm2 |
0.0 |
0.01 |
dual-energy x-ray absorptiometry |
|
0.0 |
|
|
|
|
|
|
|
75654 |
308 |
| OXYS/Nov |
percentage of study population developing retinopathy during a period of time |
control condition |
Korbolina EE, et al., Aging (Albany NY). 2012 Jan;4(1):49-59. |
retina integrity trait |
male |
90.0 days
| 36 |
|
|
0.02 |
% |
0.0 |
0.01 |
slit-lamp direct ophthalmoscopy |
|
0.0 |
|
|
|
Beta direct ophthalmoscope (Germany) |
|
|
|
85622 |
1638 |
| SD |
food intake rate |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
eating behavior trait |
male |
70.0 days-84.0 days |
6 |
|
|
31.9 |
g/d |
|
|
unspecified method |
|
0.0 |
|
|
|
|
|
|
|
84827 |
1602 |
| SD |
blood differential white blood cell count |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
leukocyte quantity |
female |
85.0 days-99.0 days |
6 |
|
|
8.24 |
x 1000 cells/ul |
0.77 |
1.88 |
unspecified method |
|
0.0 |
|
|
|
|
|
|
|
84906 |
1602 |
| SBN/Ygl |
creatinine clearance |
control condition |
Yagil Y, et al., Physiol Genomics. 2014 Jan 1;46(1):29-38. doi: 10.1152/physiolgenomics.00133.2013. Epub 2013 Nov 5. |
glomerular filtration trait |
male |
49.0 days-199.0 days |
15 |
|
|
1.87 |
ml/min |
0.1 |
0.39 |
automated plasma analysis using Beckman analyzer |
|
0.0 |
|
|
|
|
every 2wks for 5 months |
|
|
96750 |
1678 |
| BN/Rj |
patent ductus arteriosus score |
control condition |
Kota L, et al., Physiol Genomics. 2007 Jun 19;30(1):17-25. Epub 2007 Mar 13. |
artery integrity trait |
male |
120.0 days-126.0 days |
61 |
|
|
3.78 |
null |
0.37 |
2.86 |
ex vivo light microscopy |
|
0.0 |
|
|
|
|
score of PDA |
|
|
96773 |
1680 |
| BB.SHR-(D6Rat184-D6Rat3)/K |
blood CD45RC(low) CD4 T lymphocyte count to total lymphocyte count ratio |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
CD4-positive T cell quantity |
both |
90.0 days
| 10 |
|
|
70.9 |
% |
1.93 |
6.1 |
fluorescence-activated cell sorting method |
opthalmic venous plexus |
0.0 |
|
|
|
|
|
|
|
84686 |
324 |
| BB.SHR-(D6Rat184-D6Rat3)/K |
blood CD45RC(high) CD4 T cell count to CD45RC(low) CD4 T cell count ratio |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
CD4-positive T cell quantity |
both |
90.0 days
| 10 |
|
|
0.05 |
% |
0.01 |
0.02 |
fluorescence-activated cell sorting method |
opthalmic venous plexus |
0.0 |
|
|
|
|
|
|
|
84689 |
324 |
| SD |
body weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
male |
70.0 days-84.0 days |
6 |
|
|
257.3 |
g |
|
|
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
84764 |
1602 |
| SD |
body weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
male |
42.0 days-56.0 days |
6 |
|
|
184.1 |
g |
|
|
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
84781 |
1602 |
| SD |
blood differential white blood cell count |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
leukocyte quantity |
male |
85.0 days-99.0 days |
6 |
|
|
8.19 |
x 1000 cells/ul |
0.53 |
1.31 |
unspecified method |
|
0.0 |
|
|
|
|
|
|
|
84891 |
1602 |
| DA/ZtmKini |
plasma orosomucoid 1 level |
control condition |
Ribbhammar U, et al., Hum Mol Genet 2003 Sep 1;12(17):2087-96. |
orosomucoid 1 amount |
male |
days
| 8 |
|
|
93.0 |
mg/l |
8.13 |
23.0 |
radial immunodiffusion assay |
|
0.0 |
|
|
|
|
|
|
|
84934 |
1301 |
| SD |
blood hemoglobin level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood hemoglobin amount |
female |
85.0 days-99.0 days |
6 |
|
|
11.02 |
g/dl |
0.23 |
0.57 |
unspecified method |
|
0.0 |
|
|
|
|
|
|
|
84949 |
1602 |
| SD |
red blood cell distribution width-coefficient of variation |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
erythrocyte size trait |
female |
71.0 days-85.0 days |
6 |
|
|
10.98 |
% |
0.32 |
0.78 |
unspecified method |
|
0.0 |
|
|
|
|
|
|
|
84969 |
1602 |
| SD |
blood albumin level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood albumin amount |
male |
71.0 days-85.0 days |
6 |
|
|
3.3 |
g/dl |
0.05 |
0.13 |
automated blood analysis |
|
0.0 |
|
|
|
Siemens biochemical analyzer |
|
|
|
84999 |
1602 |
| SD |
blood total cholesterol level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood cholesterol amount |
female |
85.0 days-99.0 days |
6 |
|
|
112.17 |
mg/dl |
3.51 |
8.59 |
automated blood analysis |
|
0.0 |
|
|
|
Siemens biochemical analyzer |
|
|
|
85177 |
1602 |
| iP/Iusm |
femur ultimate force |
control condition |
Alam I, et al., J Bone Miner Res. 2010 Jan 8. |
femur strength trait |
male |
180.0 days
| 8 |
|
|
159.0 |
N |
4.6 |
13.0 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
|
|
|
75632 |
308 |
| NP.P-(D4Rat119-D4Rat55)/Iusm |
femur ultimate force |
control condition |
Alam I, et al., J Bone Miner Res. 2010 Jan 8. |
femur strength trait |
male |
180.0 days
| 8 |
|
|
157.0 |
N |
5.66 |
16.0 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
|
|
|
75633 |
308 |
| iNP/Iusm |
bone mineral density |
control condition |
Alam I, et al., J Bone Miner Res. 2010 Jan 8. |
bone mineral mass |
male |
180.0 days
| 8 |
|
|
0.19 |
g/cm2 |
0.0 |
0.0 |
dual-energy x-ray absorptiometry |
|
0.0 |
|
|
|
|
|
|
|
75643 |
308 |
| CrlCembe:WI |
urine specific gravity |
control condition |
Personal communication between Dr. Luisa Maria Gomes de Macedo Braga at CeMBE and RGD curators |
urine solute amount |
both |
63.0 days-77.0 days |
59 |
|
|
1.01 |
null |
|
|
urine test strip |
|
0.0 |
|
|
|
visual or instrument test strip (ChoiceLine 10 TM, Roche) |
|
|
|
97817 |
1898 |
| CrlCembe:WI |
mean corpuscular hemoglobin concentration |
control condition |
Personal communication between Dr. Luisa Maria Gomes de Macedo Braga at CeMBE and RGD curators |
blood hemoglobin amount |
female |
63.0 days-77.0 days |
29 |
|
|
37.6 |
g/dl |
0.06 |
0.31 |
automated hematology analysis |
|
0.0 |
|
|
|
Sysmex pocH-100i¿ Automated Hematology Analyzer |
|
|
|
97799 |
1898 |
| CrlCembe:WI |
mean corpuscular hemoglobin concentration |
control condition |
Personal communication between Dr. Luisa Maria Gomes de Macedo Braga at CeMBE and RGD curators |
blood hemoglobin amount |
male |
63.0 days-77.0 days |
30 |
|
|
36.96 |
g/dl |
0.09 |
0.5 |
automated hematology analysis |
|
0.0 |
|
|
|
Sysmex pocH-100i¿ Automated Hematology Analyzer |
|
|
|
97800 |
1898 |
| WAG/Nov |
both adrenal glands wet weight |
control condition |
Redina OE, et al., Clin Exp Hypertens. 2010;32(6):364-71. doi: 10.3109/10641961003628502. |
adrenal gland mass |
male |
180.0 days
| 13 |
|
|
41.9 |
mg |
2.6 |
9.37 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
97065 |
1818 |
| ISIAH |
both adrenal glands wet weight to body weight ratio |
control condition |
Redina OE, et al., Clin Exp Hypertens. 2010;32(6):364-71. doi: 10.3109/10641961003628502. |
adrenal gland mass |
male |
180.0 days
| 10 |
|
|
15.8 |
mg/100g |
0.6 |
1.9 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
97066 |
1818 |
| CrlCembe:WI |
blood hemoglobin level |
control condition |
Personal communication between Dr. Luisa Maria Gomes de Macedo Braga at CeMBE and RGD curators |
blood hemoglobin amount |
female |
63.0 days-77.0 days |
29 |
|
|
16.82 |
g/dl |
0.13 |
0.72 |
automated hematology analysis |
|
0.0 |
|
|
|
Sysmex pocH-100i¿ Automated Hematology Analyzer |
|
|
|
97710 |
1898 |
| F344/NSlc |
mesenteric fat pad weight |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
mesenteric fat pad mass |
male |
168.0 days-175.0 days |
10 |
|
|
7.67 |
g |
0.3 |
0.95 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
97726 |
1918 |
| F344.OLETF-(D14Rat23-D14Rat12)/Tj |
retroperitoneal fat pad weight |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
retroperitoneal fat pad mass |
male |
168.0 days-175.0 days |
12 |
|
|
7.81 |
g |
0.41 |
1.42 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
97723 |
1918 |
| F344/NSlc |
serum total cholesterol level |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
blood cholesterol amount |
male |
168.0 days-175.0 days |
7 |
|
|
45.77 |
mg/dl |
4.03 |
10.66 |
serum total cholesterol measurement test |
|
0.0 |
|
|
|
T-CHO-E test kits, Wako Chem. Ltd. Osaka, Japan |
|
|
|
97746 |
1918 |
| CrlCembe:WI |
white blood cell count |
control condition |
Personal communication between Dr. Luisa Maria Gomes de Macedo Braga at CeMBE and RGD curators |
leukocyte quantity |
female |
63.0 days-77.0 days |
29 |
|
|
13.0 |
x 1000 cells/ul |
0.45 |
2.45 |
automated hematology analysis |
|
0.0 |
|
|
|
Sysmex pocH-100i¿ Automated Hematology Analyzer |
|
|
|
97658 |
1898 |
| CrlCembe:WI |
plasma glucose level |
control condition |
Personal communication between Dr. Luisa Maria Gomes de Macedo Braga at CeMBE and RGD curators |
blood glucose amount |
both |
63.0 days-77.0 days |
59 |
|
|
178.0 |
mg/dl |
|
|
automated plasma analysis |
|
0.0 |
|
|
|
Basic microanalyzer (Reflotron Plus Roche) |
|
|
|
97714 |
1898 |
| CrlCembe:WI |
urine ketone body level |
control condition |
Personal communication between Dr. Luisa Maria Gomes de Macedo Braga at CeMBE and RGD curators |
urine ketone body amount |
both |
63.0 days-77.0 days |
59 |
|
|
0.5 |
mg/d |
|
|
urine test strip |
|
0.0 |
|
|
|
visual or instrument test strip (ChoiceLine 10 TM, Roche) |
|
|
|
97837 |
1898 |
| F344/NHsd |
lactotroph count to total pituicyte count ratio in prolactinoma |
control condition |
Pandey J and Wendell DL, Mamm Genome. 2006 Jan;17(1):49-57. Epub 2006 Jan 13. |
pituitary gland integrity trait |
female |
91.0 days
| |
|
|
91.1 |
% |
|
|
ex vivo light microscopy with immunohistochemistry |
|
0.0 |
subcutaneous implant |
70 |
days |
|
|
|
|
97078 |
1838 |
| F344.ZUC-Leprfa/Tj |
serum total cholesterol level |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
blood cholesterol amount |
male |
168.0 days-175.0 days |
10 |
|
|
426.24 |
mg/dl |
30.04 |
94.99 |
serum total cholesterol measurement test |
|
0.0 |
|
|
|
T-CHO-E test kits, Wako Chem. Ltd. Osaka, Japan |
|
|
|
97748 |
1918 |
| F344/NSlc |
adipocyte basal free fatty acid secretion |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
adipocyte free fatty acid secretion trait |
male |
168.0 days-175.0 days |
7 |
|
|
0.44 |
mEq/l |
0.03 |
0.08 |
lipolysis assay measuring free fatty acid release |
|
0.0 |
|
|
|
NEFA-C test kits, Wako Chem. Ltd. Osaka, Japan |
|
|
|
97754 |
1918 |
| F344.ZUC-(Leprfa),OLETF-(D14Rat23-D14Rat12)/Tj |
adipocyte basal free fatty acid secretion |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
adipocyte free fatty acid secretion trait |
male |
168.0 days-175.0 days |
10 |
|
|
1.23 |
mEq/l |
0.24 |
0.76 |
lipolysis assay measuring free fatty acid release |
|
0.0 |
|
|
|
NEFA-C test kits, Wako Chem. Ltd. Osaka, Japan |
|
|
|
97757 |
1918 |
| MWF/ZtmRrrc |
glomerular filtration rate to body weight ratio |
control condition |
Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9. |
glomerular filtration trait |
male |
246.0 days
| 8 |
|
|
0.44 |
ml/min/100g |
0.04 |
0.11 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
|
|
|
|
|
|
|
100933 |
2541 |
| MWF/ZtmRrrc |
efferent arteriolar resistance |
control condition |
Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9. |
kidney blood vessel physiology trait |
male |
126.0 days
| 8 |
|
|
0.88 |
x 10E10 dyne x s/cm5 |
0.04 |
0.11 |
servo-null micropipette transducer method |
renal efferent arteriole |
0.0 |
|
|
|
|
|
|
|
100977 |
2541 |
| LH/Mav |
systolic blood pressure |
control condition |
Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x. |
arterial blood pressure trait |
male |
112.0 days
| 8 |
undefined |
|
169.0 |
mmHg |
5.0 |
14.14 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
|
|
102808 |
2723 |
| LH/Mav |
urine total protein excretion rate |
control condition |
Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x. |
total urine protein amount |
male |
112.0 days
| 4 |
|
|
191.0 |
mg/d |
13.0 |
26.0 |
urine protein analysis |
|
0.0 |
|
|
|
|
|
|
|
102811 |
2723 |
| Crl:WI |
plasma renin activity level |
control condition |
Korkmaz-Ic�z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. |
renin activity |
male |
112.0 days
| 10 |
|
|
2.8 |
ng/ml/h |
0.7 |
2.21 |
radioimmunoassay |
|
0.0 |
|
|
|
|
|
|
|
102946 |
2783 |
| Crl:WI |
heart rate |
control condition |
Korkmaz-Ic�z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. |
heart pumping trait |
male |
112.0 days
| 10 |
|
|
461.0 |
beats/min |
12.0 |
37.95 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
|
|
102954 |
2783 |
| Crl:WI |
diastolic blood pressure |
control condition |
Korkmaz-Ic�z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. |
arterial blood pressure trait |
male |
112.0 days
| 10 |
|
|
120.0 |
mmHg |
4.0 |
12.65 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
|
|
102958 |
2783 |
| Crl:WI |
stroke volume |
control condition |
Korkmaz-Ic�z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. |
cardiac output trait |
male |
112.0 days
| 10 |
|
|
60000.0 |
ml |
8000.0 |
25298.22 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
|
|
102968 |
2783 |
| GK/MolTac |
stroke volume |
control condition |
Korkmaz-Ic�z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. |
cardiac output trait |
male |
112.0 days
| 8 |
|
|
65000.0 |
ml |
11000.0 |
31112.7 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
|
|
102969 |
2783 |
| SS-Nppbem2Mcwi+/+ |
heart interventricular end-diastolic septal wall thickness |
control condition (for 252 days) |
Holditch SJ, et al., Sci Rep. 2016 May 10;6:25623. doi: 10.1038/srep25623. |
heart ventricle septum thickness |
female |
252.0 days
| 4 |
|
|
1.98 |
mm |
0.04 |
0.08 |
echocardiography |
|
0.0 |
|
|
|
|
IVSd |
|
|
101641 |
2621 |
| SS-Nppbem2Mcwi+/+ |
heart left ventricle end-systolic diameter |
control condition (for 252 days) |
Holditch SJ, et al., Sci Rep. 2016 May 10;6:25623. doi: 10.1038/srep25623. |
heart left ventricle end-systolic diameter |
female |
252.0 days
| 4 |
|
|
3.66 |
mm |
0.15 |
0.3 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
101649 |
2621 |
| SS-Nppbem2Mcwi+/+ |
diastolic blood pressure |
control condition (for 222 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
arterial blood pressure trait |
male |
222.0 days
| 3 |
|
|
72.0 |
mmHg |
2.0 |
3.46 |
intra-aortic abdominal radiotelemetry via abdominal aorta cannulation |
|
0.0 |
|
|
|
|
|
|
|
99529 |
2319 |
| SS-Nppbem2Mcwi+/+ |
mean arterial blood pressure |
control condition (for 84 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
arterial blood pressure trait |
male |
84.0 days
| 2 |
|
|
106.0 |
mmHg |
4.0 |
5.66 |
intra-aortic abdominal radiotelemetry via abdominal aorta cannulation |
|
0.0 |
|
|
|
|
|
|
|
99531 |
2319 |
| SS-Nppbem2Mcwi+/+ |
pulse pressure |
control condition (for 84 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
arterial blood pressure trait |
male |
84.0 days
| 2 |
|
|
36.0 |
mmHg |
1.0 |
1.41 |
intra-aortic abdominal radiotelemetry via abdominal aorta cannulation |
|
0.0 |
|
|
|
|
|
|
|
99537 |
2319 |
| SS-Nppbem2Mcwi+/+ |
pulse pressure |
control condition (for 168 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
arterial blood pressure trait |
male |
168.0 days
| 5 |
|
|
45.0 |
mmHg |
8.0 |
17.89 |
intra-aortic abdominal radiotelemetry via abdominal aorta cannulation |
|
0.0 |
|
|
|
|
|
|
|
99539 |
2319 |
| SS-Nppbem2Mcwi+/+ |
body weight |
control condition (for 28 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
body mass |
male |
28.0 days
| 5 |
|
|
96.0 |
g |
7.0 |
15.65 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
99543 |
2319 |
| SS-Nppbem2Mcwi-/- |
pulse pressure |
control condition (for 222 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
arterial blood pressure trait |
male |
222.0 days
| 3 |
|
|
57.0 |
mmHg |
4.0 |
6.93 |
intra-aortic abdominal radiotelemetry via abdominal aorta cannulation |
|
0.0 |
|
|
|
|
|
|
|
99542 |
2319 |
| SS-Nppbem2Mcwi+/+ |
pulse pressure |
control condition (for 222 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
arterial blood pressure trait |
male |
222.0 days
| 3 |
|
|
52.0 |
mmHg |
1.0 |
1.73 |
intra-aortic abdominal radiotelemetry via abdominal aorta cannulation |
|
0.0 |
|
|
|
|
|
|
|
99541 |
2319 |
| SS-Nppbem2Mcwi-/- |
body weight |
control condition (for 56 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
body mass |
male |
56.0 days
| 6 |
|
|
253.0 |
g |
30.0 |
73.48 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
99546 |
2319 |
| SS-Nppbem2Mcwi-/- |
body weight |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
body mass |
male |
252.0 days
| 5 |
|
|
452.0 |
g |
21.0 |
46.96 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
99552 |
2319 |
| SS-Nppbem2Mcwi-/- |
heart rate |
control condition (for 84 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart pumping trait |
male |
84.0 days
| 10 |
|
|
382.0 |
beats/min |
45.0 |
142.3 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99558 |
2319 |
| SS-Nppbem2Mcwi+/+ |
heart interventricular end-systolic septal wall thickness |
control condition (for 28 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart ventricle septum thickness |
male |
28.0 days
| 5 |
|
|
0.82 |
mm |
0.07 |
0.16 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99563 |
2319 |
| SS-Nppbem2Mcwi-/- |
heart interventricular end-systolic septal wall thickness |
control condition (for 84 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart ventricle septum thickness |
male |
84.0 days
| 10 |
|
|
2.01 |
mm |
0.08 |
0.25 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99568 |
2319 |
| SS-Nppbem2Mcwi+/+ |
heart interventricular end-systolic septal wall thickness |
control condition (for 84 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart ventricle septum thickness |
male |
84.0 days
| 6 |
|
|
1.7 |
mm |
0.1 |
0.24 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99567 |
2319 |
| SS-Nppbem2Mcwi+/+ |
heart left ventricle end-diastolic diameter |
control condition (for 84 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
84.0 days
| 6 |
|
|
7.53 |
mm |
0.07 |
0.17 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99577 |
2319 |
| SS-Nppbem2Mcwi-/- |
heart left ventricle end-diastolic posterior wall thickness |
control condition (for 28 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle posterior wall thickness |
male |
28.0 days
| 7 |
|
|
0.8 |
mm |
0.16 |
0.42 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99584 |
2319 |
| SS-Nppbem2Mcwi-/- |
heart left ventricle end-diastolic diameter |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
252.0 days
| 5 |
|
|
8.88 |
mm |
0.22 |
0.49 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99582 |
2319 |
| SS-Nppbem2Mcwi-/- |
heart left ventricle end-diastolic posterior wall thickness |
control condition (for 168 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle posterior wall thickness |
male |
168.0 days
| 5 |
|
|
1.81 |
mm |
0.09 |
0.2 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99590 |
2319 |
| SS-Nppbem2Mcwi+/+ |
heart left ventricle end-diastolic posterior wall thickness |
control condition (for 168 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle posterior wall thickness |
male |
168.0 days
| 5 |
|
|
2.02 |
mm |
0.08 |
0.18 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99589 |
2319 |
| SS-Nppbem2Mcwi-/- |
heart left ventricle end-diastolic posterior wall thickness |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle posterior wall thickness |
male |
252.0 days
| 5 |
|
|
1.85 |
mm |
0.14 |
0.31 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99592 |
2319 |
| SS-Nppbem2Mcwi+/+ |
heart interventricular end-systolic septal wall thickness |
control condition (for 56 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart ventricle septum thickness |
male |
56.0 days
| 5 |
|
|
2.51 |
mm |
0.08 |
0.18 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99595 |
2319 |
| SS-Nppbem2Mcwi-/- |
heart interventricular end-systolic septal wall thickness |
control condition (for 56 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart ventricle septum thickness |
male |
56.0 days
| 6 |
|
|
2.53 |
mm |
0.24 |
0.59 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99596 |
2319 |
| SS-Nppbem2Mcwi+/+ |
heart interventricular end-systolic septal wall thickness |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart ventricle septum thickness |
male |
252.0 days
| 6 |
|
|
3.81 |
mm |
0.16 |
0.39 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99601 |
2319 |
| SS-Nppbem2Mcwi-/- |
heart interventricular end-systolic septal wall thickness |
control condition (for 84 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart ventricle septum thickness |
male |
84.0 days
| 10 |
|
|
3.19 |
mm |
0.2 |
0.63 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99598 |
2319 |
| SS-Nppbem2Mcwi-/- |
heart left ventricle end-systolic diameter |
control condition (for 28 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-systolic diameter |
male |
28.0 days
| 7 |
|
|
2.4 |
mm |
0.45 |
1.19 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99604 |
2319 |
| SS-Nppbem2Mcwi-/- |
heart interventricular end-systolic septal wall thickness |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart ventricle septum thickness |
male |
252.0 days
| 5 |
|
|
3.58 |
mm |
0.12 |
0.27 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99602 |
2319 |
| SS-Nppbem2Mcwi+/+ |
heart left ventricle end-systolic diameter |
control condition (for 56 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-systolic diameter |
male |
56.0 days
| 5 |
|
|
4.21 |
mm |
0.41 |
0.92 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99605 |
2319 |
| SS-Nppbem2Mcwi-/- |
heart left ventricle end-systolic diameter |
control condition (for 56 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-systolic diameter |
male |
56.0 days
| 6 |
|
|
4.23 |
mm |
0.65 |
1.59 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99606 |
2319 |
| SS-Nppbem2Mcwi+/+ |
heart left ventricle end-systolic diameter |
control condition (for 84 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-systolic diameter |
male |
84.0 days
| 6 |
|
|
3.98 |
mm |
0.16 |
0.39 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99607 |
2319 |
| SS-Nppbem2Mcwi+/+ |
heart left ventricle end-systolic diameter |
control condition (for 168 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-systolic diameter |
male |
168.0 days
| 5 |
|
|
4.51 |
mm |
0.13 |
0.29 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99609 |
2319 |
| SS-Nppbem2Mcwi-/- |
heart left ventricle end-systolic diameter |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-systolic diameter |
male |
252.0 days
| 5 |
|
|
5.46 |
mm |
0.37 |
0.83 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99612 |
2319 |
| SS-Nppbem2Mcwi-/- |
heart left ventricle end-systolic posterior wall thickness |
control condition (for 168 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle posterior wall thickness |
male |
168.0 days
| 5 |
|
|
3.01 |
mm |
0.05 |
0.11 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99620 |
2319 |
| SS-Nppbem2Mcwi-/- |
heart left ventricle end-systolic posterior wall thickness |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle posterior wall thickness |
male |
252.0 days
| 5 |
|
|
2.88 |
mm |
0.25 |
0.56 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99622 |
2319 |
| GK/MolTac |
red blood cell count |
rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) |
Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. |
erythrocyte quantity |
male |
122.0 days-129.0 days |
5 |
|
|
9.0 |
x 10E6 cells/ul |
0.22 |
0.5 |
automated blood cell counting method |
|
0.0 |
|
|
|
|
|
|
|
103846 |
2864 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
control condition (0.4 %) (between 50 and 52 days) |
Cowley AW Jr, et al., Hypertension. 2016 Feb;67(2):440-50. doi: 10.1161/HYPERTENSIONAHA.115.06280. Epub 2015 Dec 7. |
arterial blood pressure trait |
male |
50.0 days-52.0 days |
8 |
|
serial mean |
108.0 |
mmHg |
1.0 |
2.83 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
86400.0 |
|
|
|
|
|
|
|
98645 |
2118 |
| LETO |
body weight |
control condition (for 84 days) |
Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. |
body mass |
male |
364.0 days
| 11 |
|
|
546.8 |
g |
6.5 |
21.56 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
99415 |
2298 |
| FHH/EurMcwi |
body weight |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
body mass |
male |
56.0 days
| 6 |
|
|
207.0 |
g |
3.1 |
7.59 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
99451 |
2318 |
| FHH/EurMcwi |
body weight |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
body mass |
male |
168.0 days
| 6 |
|
|
429.0 |
g |
9.5 |
23.27 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
99455 |
2318 |
| FHH/EurMcwi |
both kidneys wet weight to body weight ratio |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
kidney mass |
male |
112.0 days
| 6 |
|
|
9.2 |
g/kg |
0.27 |
0.66 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
99459 |
2318 |
| FHH-Nr4a1m1Mcwi |
heart weight to body weight ratio |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
heart mass |
male |
112.0 days
| 6 |
|
|
3.9 |
g/kg |
0.8 |
0.34 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
99466 |
2318 |
| FHH/EurMcwi |
water drink intake rate |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
drinking behavior trait |
male |
56.0 days
| 6 |
|
|
48.0 |
ml/d |
4.8 |
11.76 |
graduated cylinder |
|
0.0 |
|
|
|
|
|
|
|
99471 |
2318 |
| FHH/EurMcwi |
timed urine volume |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
urine output |
male |
56.0 days
| 6 |
|
|
47.0 |
ml/d |
3.4 |
8.33 |
urine volume measurement method |
|
0.0 |
|
|
|
|
|
|
|
99477 |
2318 |
| FHH/EurMcwi |
timed urine volume |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
urine output |
male |
112.0 days
| 6 |
|
|
39.0 |
ml/d |
5.3 |
12.98 |
urine volume measurement method |
|
0.0 |
|
|
|
|
|
|
|
99479 |
2318 |
| FHH-Nr4a1m1Mcwi |
water drink intake rate |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
drinking behavior trait |
male |
112.0 days
| 6 |
|
|
28.0 |
ml/d |
4.4 |
10.78 |
graduated cylinder |
|
0.0 |
|
|
|
|
|
|
|
99474 |
2318 |
| FHH-Nr4a1m1Mcwi |
timed urine volume |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
urine output |
male |
56.0 days
| 6 |
|
|
37.0 |
ml/d |
2.1 |
5.14 |
urine volume measurement method |
|
0.0 |
|
|
|
|
|
|
|
99478 |
2318 |
| FHH-Nr4a1m1Mcwi |
timed urine volume |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
urine output |
male |
112.0 days
| 6 |
|
|
31.0 |
ml/d |
3.7 |
9.06 |
urine volume measurement method |
|
0.0 |
|
|
|
|
|
|
|
99480 |
2318 |
| FHH-Nr4a1m1Mcwi |
urine albumin excretion rate to body weight ratio |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
urine albumin amount |
male |
112.0 days
| 6 |
|
|
32.0 |
mg/d/100 g |
5.5 |
13.47 |
urine albumin analysis |
|
0.0 |
|
|
|
|
|
|
|
99486 |
2318 |
| FHH-Nr4a1m1Mcwi |
creatinine clearance to total kidney weight ratio |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
glomerular filtration trait |
male |
56.0 days
| 6 |
|
|
1.0 |
ml/min/g |
0.12 |
0.29 |
serum creatinine analysis |
|
0.0 |
|
|
|
|
|
|
|
99490 |
2318 |
| FHH-Nr4a1m1Mcwi |
creatinine clearance to total kidney weight ratio |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
glomerular filtration trait |
male |
112.0 days
| 6 |
|
|
0.7 |
ml/min/g |
0.06 |
0.15 |
serum creatinine analysis |
|
0.0 |
|
|
|
|
|
|
|
99492 |
2318 |
| FHH-Nr4a1m1Mcwi |
serum total cholesterol level |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
blood cholesterol amount |
male |
168.0 days
| 6 |
|
|
283.0 |
mg/dl |
29.4 |
72.01 |
serum total cholesterol measurement test |
|
0.0 |
|
|
|
|
|
|
|
99506 |
2318 |
| FHH-Nr4a1m1Mcwi |
serum triglyceride level |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
blood triglyceride amount |
male |
56.0 days
| 6 |
|
|
82.0 |
mg/dl |
12.6 |
30.86 |
serum triglyceride analysis |
|
0.0 |
|
|
|
|
|
|
|
99510 |
2318 |
| FHH-Nr4a1m1Mcwi |
serum triglyceride level |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
blood triglyceride amount |
male |
56.0 days
| 6 |
|
|
192.0 |
mg/dl |
43.3 |
106.06 |
serum triglyceride analysis |
|
0.0 |
|
|
|
|
|
|
|
99512 |
2318 |
| GK/MolTac |
hematocrit |
control condition (between 70 and 77 days) |
Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. |
erythrocyte quantity |
male |
70.0 days-77.0 days |
7 |
|
|
50.0 |
% |
1.06 |
2.8 |
automated hematology analysis |
|
0.0 |
|
|
|
|
|
|
|
103863 |
2864 |
| GK/MolTac |
blood hemoglobin A1c level |
control condition (between 70 and 77 days) |
Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. |
blood hemoglobin amount |
male |
70.0 days-77.0 days |
6 |
|
|
4.75 |
% |
0.06 |
0.14 |
automated hematology analysis |
|
0.0 |
|
|
|
|
|
|
|
103876 |
2864 |
| F344.OLETF-(D5Rat166-D5Rat90)/Tj |
body weight |
control condition |
Kotoh J, et al., J Vet Med Sci. 2016 Aug 11. |
body mass |
male |
175.0 days
| 8 |
|
|
400.67 |
g |
5.22 |
14.76 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
98032 |
1978 |
| GK/MolTac |
blood hemoglobin A1c level |
rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) |
Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. |
blood hemoglobin amount |
male |
122.0 days-129.0 days |
5 |
|
|
5.2 |
% |
0.1 |
0.22 |
automated hematology analysis |
|
0.0 |
|
|
|
|
|
|
|
103882 |
2864 |
| GK/MolTac |
blood hemoglobin A1c level |
rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 60 days) then fasting (for 12 hours) |
Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. |
blood hemoglobin amount |
male |
164.0 days-171.0 days |
7 |
|
|
5.61 |
% |
0.12 |
0.32 |
automated hematology analysis |
|
0.0 |
|
|
|
|
|
|
|
103886 |
2864 |
| SD |
glomerular filtration rate to body weight ratio |
control condition |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
glomerular filtration trait |
male |
days
| 8 |
|
|
0.67 |
ml/min/100g |
0.02 |
0.06 |
inulin analysis by thiourea-resorcinol assay |
|
0.0 |
|
|
|
|
|
|
|
99904 |
2358 |
| MWF |
systolic blood pressure |
control condition (for 280 days) |
Macconi D, et al., Am J Pathol. 2009 Mar;174(3):797-807. Epub 2009 Jan 22. |
arterial blood pressure trait |
male |
280.0 days
| 10 |
undefined |
|
171.0 |
mmHg |
1.26 |
4.0 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
|
|
100230 |
2459 |
| SD |
plasma angiotensin II level |
control condition |
Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. |
blood angiotensin II amount |
male |
180.0 days
| 3 |
|
|
50.0 |
pg/ml |
5.77 |
10.0 |
enzyme immunoassay |
|
0.0 |
|
|
|
|
|
|
|
100229 |
2439 |
| MWF |
kidney sclerotic glomeruli count to total glomeruli count ratio |
control condition (for 280 days) |
Macconi D, et al., Am J Pathol. 2009 Mar;174(3):797-807. Epub 2009 Jan 22. |
kidney glomerulus integrity trait |
male |
280.0 days
| 10 |
|
|
87.0 |
% |
2.21 |
7.0 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
100255 |
2459 |
| SD |
serum creatinine level |
control condition |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
blood creatinine amount |
female |
days
| 8 |
|
|
0.58 |
mg/dl |
0.03 |
0.08 |
serum creatinine analysis |
|
0.0 |
|
|
days |
|
|
|
|
100636 |
2499 |
| MW |
mean arterial blood pressure |
nephrectomy (for 28 days) then control condition |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
arterial blood pressure trait |
male |
days
| 8 |
undefined |
|
154.0 |
mmHg |
8.0 |
22.63 |
vascular indwelling catheter method |
|
0.0 |
5/6 nephrectomy |
28 |
days |
|
|
|
|
100995 |
2561 |
| PCK-Pkhd1pck/CrljCrl |
plasma angiotensin II level |
control condition |
Jia G, et al., Pediatr Nephrol. 2010 Jun;25(6):1139-46. Epub 2010 Mar 13. |
blood angiotensin II amount |
male |
28.0 days
| 6 |
|
|
72.5 |
pg/ml |
14.9 |
36.5 |
automated plasma analysis |
|
0.0 |
|
|
|
|
|
|
|
100761 |
2521 |
| PCK-Pkhd1pck/CrljCrl |
blood urea nitrogen level |
control condition (for 28 days) then vehicle control condition (for 84 days) |
Jia G, et al., Pediatr Nephrol. 2010 Jun;25(6):1139-46. Epub 2010 Mar 13. |
blood urea nitrogen amount |
male |
112.0 days
| 5 |
|
|
20.6 |
mg/dl |
1.8 |
4.02 |
blood urea nitrogen analysis |
|
0.0 |
|
|
|
|
|
|
|
100763 |
2521 |
| LH/Mav |
systolic blood pressure |
control condition (between 147 and 154 days) |
Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001. |
arterial blood pressure trait |
male |
84.0 days
| 12 |
between 9a-1p |
|
152.0 |
mmHg |
3.0 |
10.39 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
|
|
103432 |
2825 |
| WKY |
heart left ventricle weight to body weight ratio |
control condition (for 0 hours) |
Cerutti C, et al., Physiol Genomics. 2006 Nov 27;27(3):295-308. doi: 10.1152/physiolgenomics.00318.2005. Epub 2006 Aug 1. |
heart left ventricle mass |
male |
84.0 days
| 5 |
|
|
2.29 |
mg/g |
0.03 |
0.07 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
103482 |
2826 |
| WKY/NCrl |
systolic blood pressure |
control condition and dark phase of controlled light/dark cycle (for 12 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
arterial blood pressure trait |
male |
133.0 days-140.0 days |
6 |
|
|
126.0 |
mmHg |
4.0 |
9.8 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
|
|
measured 12 hr/night for 1 week |
nighttime measurement |
|
|
103530 |
2827 |
| LH/Mav |
body weight |
control condition |
Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x. |
body mass |
male |
161.0 days
| 8 |
|
|
442.0 |
g |
8.0 |
22.63 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
102801 |
2723 |
| GK |
systolic blood pressure |
control condition and dark phase of controlled light/dark cycle (for 12 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
arterial blood pressure trait |
male |
133.0 days-140.0 days |
6 |
|
|
143.0 |
mmHg |
4.0 |
9.8 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
|
|
measured 12 hr/night for 1 week |
nighttime measurement |
|
|
103532 |
2827 |
| GK |
diastolic blood pressure |
control condition and light phase of controlled light/dark cycle (for 12 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
arterial blood pressure trait |
male |
133.0 days-140.0 days |
5 |
|
|
95.0 |
mmHg |
2.0 |
4.47 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
|
|
measured 12 hr/day for 1 week |
daytime measurement |
|
|
103541 |
2827 |
| GK |
diastolic blood pressure |
control condition and dark phase of controlled light/dark cycle (for 12 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
arterial blood pressure trait |
male |
133.0 days-140.0 days |
5 |
|
|
104.0 |
mmHg |
2.0 |
4.47 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
|
|
measured 12 hr/night for 1 week |
nighttime measurement |
|
|
103549 |
2827 |
| WKY/NCrl |
heart rate |
control condition and light phase of controlled light/dark cycle (for 12 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
heart pumping trait |
male |
130.0 days-140.0 days |
6 |
|
|
290.0 |
beats/min |
4.0 |
9.8 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
|
|
measured 12 hr/day for 1 week |
daytime measurement |
|
|
103554 |
2827 |
| GK |
heart rate |
control condition and light phase of controlled light/dark cycle (for 12 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
heart pumping trait |
male |
130.0 days-140.0 days |
6 |
|
|
272.0 |
beats/min |
2.0 |
4.9 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
|
|
measured 12 hr/day for 1 week |
daytime measurement |
|
|
103556 |
2827 |
| GK |
heart rate |
control condition and dark phase of controlled light/dark cycle (for 12 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
heart pumping trait |
male |
133.0 days-140.0 days |
6 |
|
|
324.0 |
beats/min |
7.0 |
17.15 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
|
|
measured 12 hr/night for 1 week |
nighttime measurement |
|
|
103564 |
2827 |
| WKY/NCrl |
heart rate |
control condition and dark phase of controlled light/dark cycle (for 12 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
heart pumping trait |
male |
133.0 days-140.0 days |
6 |
|
|
337.0 |
beats/min |
3.0 |
7.35 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
|
|
measured 12 hr/night for 1 week |
nighttime measurement |
|
|
103563 |
2827 |
| GK |
number of spontaneous locomotor movements per unit time |
control condition and light phase of controlled light/dark cycle (for 12 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
locomotor behavior trait |
male |
140.0 days
| 5 |
|
|
0.9 |
/min |
0.1 |
0.22 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
|
|
|
number of spontaneous locomotor movements per unit time (CMO:0003644) |
|
|
103573 |
2827 |
| GK |
number of spontaneous locomotor movements per unit time |
control condition and dark phase of controlled light/dark cycle (for 3 days) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
locomotor behavior trait |
male |
140.0 days
| 5 |
|
|
4.2 |
/min |
0.5 |
1.12 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
|
|
measured 12 hr/night |
number of spontaneous locomotor movements per unit time (CMO:0003644) |
|
|
103581 |
2827 |
| W/Nov |
femur stiffness |
control condition (for 60 days) |
Muraleva NA, et al., Indian J Med Res. 2012;135:221-7. |
femur strength trait |
male |
314.0 days
| 15 |
|
|
7.32 |
GPa |
0.29 |
1.13 |
computer-aided tensile strength and compression test |
|
0.0 |
|
|
|
|
w/nov rats |
|
|
103707 |
2845 |
| OXYS/Nov |
serum calcium level |
control condition (for 60 days) |
Muraleva NA, et al., Indian J Med Res. 2012;135:221-7. |
blood calcium amount |
male |
314.0 days
| 15 |
|
|
10.02 |
mg/dl |
0.05 |
0.2 |
automated serum calcium test |
|
0.0 |
|
|
|
|
|
|
|
103735 |
2845 |
| MW |
systolic blood pressure |
control condition |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
arterial blood pressure trait |
male |
days
| 18 |
undefined |
|
119.0 |
mmHg |
5.0 |
21.21 |
tail cuff plethysmography |
|
0.0 |
control |
29 |
days |
|
|
|
|
101171 |
2581 |
| MW |
blood urea nitrogen level |
control condition |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
blood urea nitrogen amount |
male |
days
| 18 |
|
|
20.0 |
mg/dl |
1.0 |
4.24 |
blood urea nitrogen analysis |
|
0.0 |
control |
17 |
days |
|
|
|
|
101185 |
2581 |
| SD |
mean arterial blood pressure |
control condition |
Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. |
arterial blood pressure trait |
male |
90.0 days
| 9 |
|
|
118.0 |
mmHg |
5.0 |
15.0 |
vascular fluid filled catheter |
|
0.0 |
|
|
|
|
|
|
|
101222 |
2582 |
| MW |
glomerular filtration rate |
control condition |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
glomerular filtration trait |
male |
days
| 18 |
|
|
0.99 |
ml/min |
0.08 |
0.34 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
control |
29 |
days |
|
|
|
|
101208 |
2581 |
| SD |
hematocrit |
control condition |
Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. |
erythrocyte quantity |
male |
90.0 days
| 9 |
|
|
46.0 |
% |
1.0 |
3.0 |
hematocrit analysis |
|
0.0 |
|
|
|
|
|
|
|
101220 |
2582 |
| SD |
renal plasma flow to body weight ratio |
control condition |
Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. |
kidney plasma flow trait |
male |
90.0 days
| 9 |
|
|
0.97 |
ml/min/100g |
0.05 |
0.15 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
|
|
|
|
|
|
|
101230 |
2582 |
| SD |
urine sodium excretion rate |
control condition |
Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. |
urine sodium amount |
male |
90.0 days
| 9 |
|
|
1.4 |
mEq/d |
0.4 |
1.2 |
urine sodium analysis |
|
0.0 |
|
|
|
|
|
|
|
101236 |
2582 |
| SS-Nppbem2Mcwi-/- |
heart left ventricle weight |
control condition (for 28 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle mass |
male |
28.0 days
| 7 |
|
|
0.75 |
g |
0.05 |
0.13 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99669 |
2319 |
| SS-Nppbem2Mcwi+/+ |
heart left ventricle weight |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle mass |
male |
252.0 days
| 6 |
|
|
1.94 |
g |
0.06 |
0.15 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99676 |
2319 |
| SS-Nppbem2Mcwi+/+ |
PR interval |
control condition (for 84 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart electrical impulse conduction trait |
male |
84.0 days
| 2 |
|
|
46.4 |
ms |
0.0 |
0.0 |
electrocardiography |
|
0.0 |
|
|
|
|
|
|
|
99684 |
2319 |
| SS-Nppbem2Mcwi-/- |
QRS duration |
control condition (for 84 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart electrical impulse conduction trait |
male |
84.0 days
| 2 |
|
|
21.5 |
ms |
1.2 |
1.7 |
electrocardiography |
|
0.0 |
|
|
|
|
|
|
|
99691 |
2319 |
| SS-Nppbem2Mcwi-/- |
RR interval |
control condition (for 84 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart electrical impulse conduction trait |
male |
84.0 days
| 2 |
|
|
148.0 |
ms |
3.0 |
4.24 |
electrocardiography |
|
0.0 |
|
|
|
|
|
|
|
99697 |
2319 |
| SS-Nppbem2Mcwi+/+ |
serum creatinine level |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
blood creatinine amount |
male |
252.0 days
| 6 |
|
|
0.3 |
mg/dl |
0.1 |
0.24 |
serum creatinine analysis |
|
0.0 |
|
|
|
|
|
|
|
99750 |
2319 |
| GK/MolTac |
whole body insulin sensitivity index |
sodium chloride solution (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) |
Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. |
blood insulin amount |
male |
122.0 days-129.0 days |
4 |
10,000/√(FG x FI) x (Ḡ x Ī) |
|
1.49 |
null |
0.31 |
0.62 |
oral glucose tolerance test |
|
7200.0 |
|
|
|
measured at -5,15,30,45,60,90,120 min |
|
|
|
103829 |
2864 |
| GK/MolTac |
whole body insulin sensitivity index |
rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) |
Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. |
blood insulin amount |
male |
122.0 days-129.0 days |
4 |
10,000/√(FG x FI) x (Ḡ x Ī) |
|
2.04 |
null |
0.21 |
0.42 |
oral glucose tolerance test |
|
7200.0 |
|
|
|
measured at -5,15,30,45,60,90,120 min |
|
|
|
103831 |
2864 |
| GK/MolTac |
Homeostatic Model Assessment of Insulin Resistance |
rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) |
Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. |
blood insulin amount |
male |
122.0 days-129.0 days |
4 |
(fasting glucose x fasting insulin)/22.5 |
|
8.2 |
null |
1.35 |
2.7 |
oral glucose tolerance test |
|
7200.0 |
|
|
|
|
|
|
|
103838 |
2864 |
| MNS |
urine total protein excretion rate |
control condition |
Ge Y, et al., Physiol Rep. 2017 Feb;5(3). pii: 5/3/e13089. doi: 10.14814/phy2.13089. |
total urine protein amount |
male |
330.0 days
| 6 |
|
|
245.0 |
mg/d |
36.0 |
88.18 |
urine protein analysis |
|
0.0 |
|
|
|
|
|
|
|
104036 |
2886 |
| F344.ZUC-Leprfa/Tj |
mesenteric fat pad weight |
control condition |
Kotoh J, et al., J Vet Med Sci. 2016 Aug 11. |
mesenteric fat pad mass |
male |
175.0 days
| 7 |
|
|
17.37 |
g |
1.01 |
2.67 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
98053 |
1978 |
| F344.ZUC-Leprfa/Tj |
epididymal fat pad weight |
control condition |
Kotoh J, et al., J Vet Med Sci. 2016 Aug 11. |
epididymal fat pad mass |
male |
175.0 days
| 7 |
|
|
16.97 |
g |
0.31 |
0.82 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
98061 |
1978 |
| F344/NSlc |
mesenteric fat pad weight to body weight ratio |
control condition |
Kotoh J, et al., J Vet Med Sci. 2016 Aug 11. |
mesenteric fat pad mass |
male |
175.0 days
| 7 |
|
|
2.6 |
% |
0.18 |
0.48 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
98063 |
1978 |
| F344.ZUC-Leprfa/Tj |
retroperitoneal fat pad weight to body weight ratio |
control condition |
Kotoh J, et al., J Vet Med Sci. 2016 Aug 11. |
retroperitoneal fat pad mass |
male |
175.0 days
| 7 |
|
|
5.34 |
% |
0.34 |
0.9 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
98070 |
1978 |
| F344.OLETF-(D5Rat166-D5Rat90)/Tj |
epididymal fat pad weight to body weight ratio |
control condition |
Kotoh J, et al., J Vet Med Sci. 2016 Aug 11. |
epididymal fat pad mass |
male |
175.0 days
| 6 |
|
|
2.79 |
% |
0.07 |
0.17 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
98073 |
1978 |
| F344.ZUC-(Leprfa),OLETF-(D5Rat166-D5Rat90)/Tj |
epididymal fat pad weight to body weight ratio |
control condition |
Kotoh J, et al., J Vet Med Sci. 2016 Aug 11. |
epididymal fat pad mass |
male |
175.0 days
| 5 |
|
|
2.97 |
% |
0.19 |
0.42 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
98075 |
1978 |
| SS-Nppbem2Mcwi+/+ |
ejection fraction |
control condition (for 252 days) |
Holditch SJ, et al., Sci Rep. 2016 May 10;6:25623. doi: 10.1038/srep25623. |
cardiac output trait |
female |
252.0 days
| 4 |
|
|
87.0 |
% |
1.8 |
3.6 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
101653 |
2621 |
| SS-Nppbem2Mcwi-/- |
heart left ventricle weight |
control condition (for 252 days) |
Holditch SJ, et al., Sci Rep. 2016 May 10;6:25623. doi: 10.1038/srep25623. |
heart left ventricle mass |
female |
252.0 days
| 5 |
|
|
1.44 |
g |
0.03 |
0.07 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
101658 |
2621 |
| BN/NHsdMcwi |
creatinine clearance to body weight ratio |
control condition |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
glomerular filtration trait |
male |
133.0 days
| 10 |
|
|
0.46 |
ml/min/100g |
0.03 |
0.09 |
automated blood creatinine analysis |
|
0.0 |
|
|
|
|
. |
|
|
102028 |
2645 |
| SS-Nppbem2Mcwi-/- |
heart rate |
control condition (for 252 days) |
Holditch SJ, et al., Sci Rep. 2016 May 10;6:25623. doi: 10.1038/srep25623. |
heart pumping trait |
female |
252.0 days
| 5 |
|
|
355.0 |
beats/min |
10.0 |
22.36 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
101660 |
2621 |
| MW |
efferent arteriolar hydraulic pressure |
nephrectomy (for 28 days) then control condition |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
blood molecular composition trait |
male |
days
| 8 |
|
|
21.0 |
mmHg |
1.0 |
2.83 |
servo-null micropipette transducer method |
|
0.0 |
5/6 nephrectomy |
28 |
days |
|
|
|
|
101013 |
2561 |
| GK/CskCrljCrl |
body weight |
control condition |
Devanathan S, et al., PLoS One. 2013 Oct 21;8(10):e78477. doi: 10.1371/journal.pone.0078477. eCollection 2013. |
body mass |
male |
168.0 days
| 4 |
|
|
334.17 |
g |
8.89 |
17.78 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
103088 |
2786 |
| Crl:WI |
plasma insulin level |
control condition |
Devanathan S, et al., PLoS One. 2013 Oct 21;8(10):e78477. doi: 10.1371/journal.pone.0078477. eCollection 2013. |
blood insulin amount |
male |
168.0 days
| 4 |
|
|
14.5 |
mU/l |
4.99 |
9.98 |
plasma insulin analysis |
|
0.0 |
|
|
|
|
|
|
|
103089 |
2786 |
| Crl:WI |
plasma free fatty acids level |
control condition |
Devanathan S, et al., PLoS One. 2013 Oct 21;8(10):e78477. doi: 10.1371/journal.pone.0078477. eCollection 2013. |
blood free fatty acid amount |
male |
168.0 days
| 4 |
|
|
1.08 |
mmol/l |
0.14 |
0.27 |
plasma free fatty acid analysis |
|
0.0 |
|
|
|
|
|
|
|
103101 |
2786 |
| GK/CskCrljCrl |
heart left ventricle end-diastolic diameter to body weight ratio |
control condition |
Devanathan S, et al., PLoS One. 2013 Oct 21;8(10):e78477. doi: 10.1371/journal.pone.0078477. eCollection 2013. |
heart left ventricle end-diastolic diameter |
male |
168.0 days
| 4 |
|
|
21.91 |
mm/kg |
1.06 |
2.11 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
103110 |
2786 |
| Jcl:WI |
body weight |
control condition |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
body mass |
male |
52.0 days
| 6 |
|
|
190.46 |
g |
14.37 |
35.2 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
103908 |
2884 |
| MWF/ZtmRrrc |
renal plasma flow (PAH) |
control condition |
Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9. |
kidney plasma flow trait |
male |
246.0 days
| 8 |
|
|
7.4 |
ml/min |
0.28 |
0.8 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
|
|
|
|
|
|
|
100937 |
2541 |
| MWF/ZtmRrrc |
glomerular transcapillary hydraulic pressure gradient |
control condition |
Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9. |
blood molecular composition trait |
male |
126.0 days
| 8 |
|
|
38.0 |
mmHg |
0.71 |
2.0 |
servo-null micropipette transducer method |
|
0.0 |
|
|
|
|
|
|
|
100957 |
2541 |
| SS-Nppbem2Mcwi+/+ |
heart left ventricle fractional shortening |
control condition (for 28 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
28.0 days
| 5 |
|
|
46.0 |
% |
8.4 |
18.78 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99633 |
2319 |
| SS-Nppbem2Mcwi+/+ |
heart left ventricle fractional shortening |
control condition (for 84 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
84.0 days
| 6 |
|
|
47.0 |
% |
2.1 |
5.14 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99637 |
2319 |
| SD |
body weight |
control condition |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
body mass |
male |
days
| 8 |
|
|
675.0 |
g |
12.37 |
35.0 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
99892 |
2358 |
| SD |
left kidney wet weight |
control condition |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
kidney mass |
male |
days
| 8 |
|
|
1.66 |
g |
0.03 |
0.08 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
99895 |
2358 |
| SD |
body weight |
control condition |
Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. |
body mass |
male |
90.0 days
| 9 |
|
|
396.0 |
g |
7.6 |
22.8 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
101214 |
2582 |
| SD |
body weight |
control condition |
Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. |
body mass |
male |
420.0 days-450.0 days |
9 |
|
|
572.0 |
g |
14.4 |
43.2 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
101215 |
2582 |
| SD |
left kidney wet weight |
control condition |
Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. |
kidney mass |
male |
420.0 days-450.0 days |
9 |
|
|
1.8 |
g |
0.12 |
0.36 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
101217 |
2582 |
| LH/Mav |
body weight |
control condition |
Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x. |
body mass |
male |
112.0 days
| 8 |
|
|
391.0 |
g |
6.0 |
16.97 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
102787 |
2723 |
| Crl:WI |
maximum rate of positive change in left ventricular blood pressure |
control condition |
Korkmaz-Ic�z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. |
heart left ventricular blood pressure trait |
male |
112.0 days
| 10 |
|
|
11765.0 |
mmHg/s |
568.0 |
1796.17 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
|
|
102976 |
2783 |
| GK/MolTac |
maximum rate of negative change in left ventricular blood pressure |
control condition |
Korkmaz-Ic�z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. |
heart left ventricular blood pressure trait |
male |
112.0 days
| 8 |
|
|
-12940.0 |
mmHg/s |
1112.0 |
3145.21 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
|
|
102979 |
2783 |
| Crl:WI |
time constant of left ventricular pressure decay |
control condition |
Korkmaz-Ic�z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. |
heart left ventricular blood pressure trait |
male |
112.0 days
| 10 |
|
|
7.95 |
ms |
0.54 |
1.71 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
|
|
102980 |
2783 |
| Crl:WI |
heart left ventricle end-diastolic anterior wall index |
control condition |
Korkmaz-Ic�z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. |
heart left ventricle anterior wall thickness |
male |
112.0 days
| 10 |
|
|
4.94 |
mm/kg |
0.15 |
0.47 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
102993 |
2783 |
| GK/Jcl |
serum adiponectin level |
control condition |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood adiponectin amount |
male |
52.0 days
| 6 |
|
|
10.38 |
ng/ml |
1.62 |
3.97 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
|
|
|
103941 |
2884 |
| Jcl:WI |
serum adiponectin level |
control condition |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood adiponectin amount |
male |
52.0 days
| 6 |
|
|
14.52 |
ng/ml |
1.36 |
3.33 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
|
|
|
103940 |
2884 |
| GK/Jcl |
calculated liver glutathione level |
control condition |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
liver glutathione amount |
male |
52.0 days
| 6 |
|
|
694.27 |
umol/min/mg |
46.04 |
112.77 |
enzyme or transport activity assay |
|
0.0 |
|
|
|
|
|
|
|
103951 |
2884 |
| Jcl:WI |
calculated liver glutathione level |
control condition |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
liver glutathione amount |
male |
52.0 days
| 6 |
|
|
484.66 |
umol/min/mg |
28.35 |
69.44 |
enzyme or transport activity assay |
|
0.0 |
|
|
|
|
|
|
|
103950 |
2884 |
| Jcl:WI |
liver glucokinase level |
control condition |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
liver glucokinase activity |
male |
52.0 days
| 6 |
|
|
347.71 |
umol/min/mg |
34.09 |
83.5 |
enzyme or transport activity assay |
|
0.0 |
|
|
|
|
|
|
|
103954 |
2884 |
| Jcl:WI |
serum triglyceride level |
control condition |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood triglyceride amount |
male |
52.0 days
| 6 |
|
|
75.06 |
mg/dl |
6.98 |
17.1 |
serum triglyceride analysis |
|
0.0 |
|
|
|
|
|
|
|
103958 |
2884 |
| GK/Jcl |
serum triglyceride level |
control condition |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood triglyceride amount |
male |
52.0 days
| 6 |
|
|
114.12 |
mg/dl |
14.21 |
34.81 |
serum triglyceride analysis |
|
0.0 |
|
|
|
|
|
|
|
103959 |
2884 |
| SS-Nppbem2Mcwi-/- |
blood hemoglobin level |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
blood hemoglobin amount |
male |
252.0 days
| 6 |
|
|
16.3 |
g/dl |
0.51 |
1.25 |
blood hemoglobin analysis |
|
0.0 |
|
|
|
|
|
|
|
99735 |
2319 |
| SS-Nppbem2Mcwi+/+ |
blood hemoglobin level |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
blood hemoglobin amount |
male |
252.0 days
| 6 |
|
|
16.42 |
g/dl |
0.24 |
0.59 |
blood hemoglobin analysis |
|
0.0 |
|
|
|
|
|
|
|
99734 |
2319 |
| GK/MolTac |
body weight |
control condition |
Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170. |
body mass |
male |
147.0 days
| 6 |
|
|
382.0 |
g |
13.0 |
31.84 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
103981 |
2885 |
| GK/MolTac |
body weight |
control condition then controlled saxagliptin content diet (10 mg/kg/d) (for 12 days) |
Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170. |
body mass |
male |
147.0 days
| |
|
|
389.0 |
g |
7.0 |
|
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
103985 |
2885 |
| Crl:WI |
blood glucose level |
control condition |
Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170. |
blood glucose amount |
male |
144.0 days
| 6 |
|
|
170.0 |
mg/dl |
16.0 |
39.19 |
blood glucose analysis |
|
0.0 |
|
|
|
|
|
|
|
103987 |
2885 |
| Crl:WI |
blood glucose level |
control condition then controlled saxagliptin content diet (10 mg/kg/d) (for 12 days) |
Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170. |
blood glucose amount |
male |
144.0 days
| 6 |
|
|
153.0 |
mg/dl |
7.0 |
17.15 |
blood glucose analysis |
|
0.0 |
|
|
|
|
|
|
|
103989 |
2885 |
| Crl:WI |
blood insulin level |
control condition |
Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170. |
blood insulin amount |
male |
147.0 days
| 6 |
|
|
77.65 |
mU/l |
21.76 |
53.31 |
blood insulin analysis |
|
0.0 |
|
|
|
|
|
|
|
103996 |
2885 |
| GK/MolTac |
plasma insulin level |
rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) |
Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. |
blood insulin amount |
male |
122.0 days-129.0 days |
4 |
|
|
27.3 |
mU/l |
4.16 |
8.32 |
oral glucose tolerance test |
|
0.0 |
|
|
|
|
|
|
|
103817 |
2864 |
| Crl:WI |
heart ventricle end-diastolic septal wall index |
control condition |
Devanathan S, et al., PLoS One. 2013 Oct 21;8(10):e78477. doi: 10.1371/journal.pone.0078477. eCollection 2013. |
heart ventricle septum thickness |
male |
168.0 days
| 4 |
|
|
4.03 |
mm/kg |
0.31 |
0.62 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
103115 |
2786 |
| Crl:WI |
E/A wave ratio |
control condition |
Devanathan S, et al., PLoS One. 2013 Oct 21;8(10):e78477. doi: 10.1371/journal.pone.0078477. eCollection 2013. |
heart pumping trait |
male |
168.0 days
| 4 |
|
|
1.29 |
null |
0.06 |
0.11 |
echocardiography |
|
0.0 |
|
|
|
|
e/a wave |
|
|
103125 |
2786 |
| GK/CskCrljCrl |
A' wave velocity |
control condition |
Devanathan S, et al., PLoS One. 2013 Oct 21;8(10):e78477. doi: 10.1371/journal.pone.0078477. eCollection 2013. |
heart pumping trait |
male |
168.0 days
| 4 |
|
|
52.27 |
mm/s |
5.98 |
11.95 |
echocardiography |
|
0.0 |
|
|
|
|
a' wave |
|
|
103130 |
2786 |
| Crl:WI |
left ventricular isovolumetric relaxation time |
control condition |
Devanathan S, et al., PLoS One. 2013 Oct 21;8(10):e78477. doi: 10.1371/journal.pone.0078477. eCollection 2013. |
heart pumping trait |
male |
168.0 days
| 4 |
|
|
19.09 |
ms |
1.55 |
3.1 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
103137 |
2786 |
| GK/MolTac |
blood dipeptidyl peptidase 4 activity level |
control condition then controlled saxagliptin content diet (10 mg/kg/d) (for 12 days) |
Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170. |
blood enzyme amount |
male |
147.0 days
| |
|
|
35.0 |
pmol/min |
14.0 |
|
blood enzyme activity assay |
|
0.0 |
|
|
|
|
|
|
|
104011 |
2885 |
| GK/MolTac |
blood malondialdehyde level |
control condition |
Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170. |
blood malondialdehyde amount |
male |
147.0 days
| |
|
|
6.7 |
umol/l |
1.7 |
|
thiobarbituric acid assay |
|
0.0 |
|
|
|
|
|
|
|
104015 |
2885 |
| GK/MolTac |
blood malondialdehyde level |
control condition |
Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170. |
blood malondialdehyde amount |
male |
147.0 days
| |
|
|
6.7 |
umol/l |
1.6 |
|
thiobarbituric acid assay |
|
0.0 |
|
|
|
|
|
|
|
104017 |
2885 |
| LH-Chr 13BN/Mav |
urine sodium level to urine potassium level ratio |
control condition |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
urine sodium amount |
male |
133.0 days
| 10 |
|
|
0.11 |
null |
0.01 |
0.03 |
flame photometry |
|
0.0 |
|
|
|
|
|
|
|
102066 |
2645 |
| SS.ZUC-Leprfa+/+/Slc |
heart left ventricle weight to tibia length ratio |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
heart left ventricle mass |
male |
91.0 days
| 8 |
|
|
0.24 |
g/cm |
0.01 |
0.02 |
post excision weight measurement |
|
0.0 |
|
|
|
|
lv/tl |
|
|
101759 |
2641 |
| SS.ZUC-Leprfa-/-/Slc |
pancreas weight to tibia length |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
pancreas mass |
male |
91.0 days
| 7 |
|
|
28.68 |
mg/mm |
1.66 |
4.39 |
post excision weight measurement |
|
0.0 |
|
|
|
|
p/tl |
|
|
101835 |
2641 |
| SS.ZUC-Leprfa+/+/Slc |
urine protein level |
control condition |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
total urine protein amount |
male |
126.0 days
| 6 |
|
|
336.29 |
mg/d |
19.58 |
47.96 |
urine protein analysis |
|
0.0 |
|
|
|
|
|
|
|
101935 |
2642 |
| SS-Leprem2Mcwi |
body weight |
control condition |
McPherson KC, et al., Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F793-F804. doi: 10.1152/ajprenal.00590.2015. Epub 2016 Jul 27. |
body mass |
male |
126.0 days
| 19 |
|
|
528.0 |
g |
15.0 |
65.38 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
100070 |
2418 |
| SS-Leprem2Mcwi |
plasma leptin level |
control condition |
McPherson KC, et al., Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F793-F804. doi: 10.1152/ajprenal.00590.2015. Epub 2016 Jul 27. |
blood leptin amount |
male |
42.0 days
| 5 |
|
|
84.7 |
ng/ml |
4.5 |
10.06 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
|
|
|
100072 |
2418 |
| SS/JrHsdMcwi |
plasma triglyceride level |
control condition |
McPherson KC, et al., Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F793-F804. doi: 10.1152/ajprenal.00590.2015. Epub 2016 Jul 27. |
blood triglyceride amount |
male |
42.0 days
| 9 |
|
|
0.46 |
mmol/l |
0.07 |
0.2 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
|
|
|
100075 |
2418 |
| SS-Leprem2Mcwi |
plasma triglyceride level |
control condition |
McPherson KC, et al., Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F793-F804. doi: 10.1152/ajprenal.00590.2015. Epub 2016 Jul 27. |
blood triglyceride amount |
male |
126.0 days
| 7 |
|
|
17.52 |
mmol/l |
5.9 |
15.61 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
|
|
|
100078 |
2418 |
| PCK-Pkhd1pck/CrljCrl |
systolic blood pressure |
control condition |
Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. |
arterial blood pressure trait |
male |
60.0 days
| 3 |
mean of 3 samples - 1 per minute |
serial mean |
126.0 |
mmHg |
0.58 |
1.0 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
|
|
100186 |
2439 |
| PCK-Pkhd1pck/CrljCrl |
both kidneys wet weight as percentage of body weight |
control condition |
Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. |
kidney mass |
male |
60.0 days
| 3 |
|
|
0.98 |
% |
0.03 |
0.06 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
100191 |
2439 |
| PCK-Pkhd1pck/CrljCrl |
both kidneys wet weight as percentage of body weight |
control condition |
Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. |
kidney mass |
male |
180.0 days
| 4 |
|
|
0.92 |
% |
0.03 |
0.05 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
100195 |
2439 |
| SD |
both kidneys wet weight as percentage of body weight |
control condition |
Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. |
kidney mass |
male |
120.0 days
| 3 |
|
|
0.55 |
% |
0.03 |
0.06 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
100194 |
2439 |
| SD |
plasma urea nitrogen level |
control condition |
Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. |
blood urea nitrogen amount |
male |
120.0 days
| 3 |
|
|
6.78 |
mmol/l |
0.41 |
0.71 |
plasma urea nitrogen analysis |
|
0.0 |
|
|
|
|
|
|
|
100200 |
2439 |
| SD |
serum creatinine level |
control condition |
Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. |
blood creatinine amount |
male |
180.0 days
| 5 |
|
|
0.55 |
mg/dl |
0.06 |
0.1 |
serum creatinine analysis |
|
0.0 |
|
|
|
|
|
|
|
100208 |
2439 |
| PCK-Pkhd1pck/CrljCrl |
ratio of the area occupied by cysts to the total area of the kidney |
control condition |
Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. |
kidney integrity trait |
male |
180.0 days
| 4 |
|
|
43.0 |
% |
4.04 |
7.0 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
100217 |
2439 |
| SD |
plasma angiotensin II level |
control condition |
Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. |
blood angiotensin II amount |
male |
60.0 days
| 3 |
|
|
170.0 |
pg/ml |
92.38 |
160.0 |
enzyme immunoassay |
|
0.0 |
|
|
|
|
|
|
|
100225 |
2439 |
| SD |
systolic blood pressure |
control condition |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
arterial blood pressure trait |
male |
days
| 8 |
undefined |
|
126.0 |
mmHg |
1.06 |
3.0 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
|
|
99925 |
2358 |
| SD |
blood glucose level |
control condition |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
blood glucose amount |
male |
days
| 8 |
|
|
98.0 |
mg/dl |
3.18 |
9.0 |
blood glucose analysis |
|
0.0 |
|
|
|
|
|
|
|
99922 |
2358 |
| SD |
systolic blood pressure |
control condition |
Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. |
arterial blood pressure trait |
male |
210.0 days
| 5 |
mean of 3 samples - 1 per minute |
serial mean |
136.0 |
mmHg |
1.79 |
4.0 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
|
|
100176 |
2439 |
| Crl:WI |
plasma troponin T level |
control condition |
Korkmaz-Ic�z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. |
blood protein amount |
male |
112.0 days
| 10 |
|
|
755.0 |
pg/ml |
135.0 |
426.91 |
electrochemiluminescence immunoassay |
|
0.0 |
|
|
|
|
|
|
|
102934 |
2783 |
| GK/MolTac |
plasma troponin T level |
control condition |
Korkmaz-Ic�z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. |
blood protein amount |
male |
112.0 days
| 8 |
|
|
3044.0 |
pg/ml |
750.0 |
2121.32 |
electrochemiluminescence immunoassay |
|
0.0 |
|
|
|
|
|
|
|
102935 |
2783 |
| GK/MolTac |
serum insulin level |
control condition |
Korkmaz-Ic�z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. |
blood insulin amount |
male |
112.0 days
| 8 |
|
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
|
|
|
102943 |
2783 |
| GK/MolTac |
serum aldosterone level |
control condition |
Korkmaz-Ic�z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. |
blood aldosterone amount |
male |
112.0 days
| 8 |
|
|
3.63 |
nmol/l |
0.91 |
2.59 |
radioimmunoassay |
|
0.0 |
|
|
|
|
|
|
|
102945 |
2783 |
| SS.BN-(D13Hmgc64-4582)/Mcwi |
body weight |
control condition |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
body mass |
male |
49.0 days-63.0 days |
13 |
|
|
262.3 |
g |
9.8 |
35.33 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
99001 |
2198 |
| SS/JrHsdMcwi |
body weight |
control condition |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
body mass |
male |
49.0 days-63.0 days |
4 |
|
|
259.4 |
g |
5.9 |
11.8 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
99013 |
2198 |
| SS/JrHsdMcwi |
body weight |
control condition |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
body mass |
male |
49.0 days-63.0 days |
3 |
|
|
278.8 |
g |
3.0 |
5.2 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
99015 |
2198 |
| LETO |
systolic blood pressure |
control condition (for 84 days) |
Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. |
arterial blood pressure trait |
male |
364.0 days
| 11 |
undefined |
|
128.5 |
mmHg |
4.7 |
15.59 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
|
|
99425 |
2298 |
| LETO |
diastolic blood pressure |
control condition (for 84 days) |
Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. |
arterial blood pressure trait |
male |
364.0 days
| 11 |
undefined |
|
98.2 |
mmHg |
3.4 |
11.28 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
|
|
99430 |
2298 |
| OLETF |
blood triglyceride level |
control condition (for 84 days) |
Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. |
blood triglyceride amount |
male |
364.0 days
| 12 |
|
|
232.74 |
mg/dl |
32.74 |
113.43 |
blood triglyceride analysis |
|
0.0 |
|
|
|
|
|
|
|
99436 |
2298 |
| Crl:SD |
number of podocytes per kidney glomerulus |
control condition |
Benigni A, et al., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10. |
podocyte morphology trait |
male |
427.0 days
| 6 |
|
|
212.59 |
null |
18.05 |
44.21 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
100793 |
2522 |
| MW |
efferent arteriolar plasma protein concentration |
nephrectomy (for 28 days) then control condition |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
blood total protein amount |
male |
days
| 8 |
|
|
8.0 |
g/dl |
0.2 |
0.57 |
micropuncture fluid collection |
|
0.0 |
5/6 nephrectomy |
28 |
days |
|
|
|
|
101022 |
2561 |
| SS.BN-(D13Rat25-RN34_13048990782)/Mcwi |
tibialis anterior muscle weight to body weight ratio |
control condition (for 7 days) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56.0 days-70.0 days |
14 |
TA/BW |
|
1.83 |
mg/g |
0.03 |
0.11 |
ex vivo method |
|
0.0 |
|
|
|
|
TA or EDL muscle weight body weight ratio |
|
|
99031 |
2198 |
| SS/JrHsdMcwi |
tibialis anterior muscle weight to body weight ratio |
control condition (for 7 days) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56.0 days-70.0 days |
10 |
TA/BW |
|
1.8 |
mg/g |
0.06 |
0.19 |
ex vivo method |
|
0.0 |
|
|
|
|
TA or EDL muscle weight body weight ratio |
|
|
99047 |
2198 |
| Crl:WI |
systolic blood pressure |
control condition (for 547 days) |
Ruiz-Torres MP, et al., J Am Soc Nephrol. 1998 May;9(5):782-91. |
arterial blood pressure trait |
male |
547.0 days
| 10 |
|
|
146.0 |
mmHg |
7.0 |
22.14 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
|
|
101283 |
2584 |
| Crl:WI |
plasma creatinine level |
control condition (for 547 days) |
Ruiz-Torres MP, et al., J Am Soc Nephrol. 1998 May;9(5):782-91. |
blood creatinine amount |
male |
547.0 days
| 10 |
|
|
0.63 |
mg/dl |
0.07 |
0.22 |
plasma creatinine analysis |
|
0.0 |
|
|
|
|
|
|
|
101287 |
2584 |
| SS.ZUC-Leprfa-/-/Slc |
ejection fraction |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
cardiac output trait |
male |
91.0 days
| 7 |
|
|
82.46 |
% |
1.65 |
4.37 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
101811 |
2641 |
| SS.ZUC-Leprfa-/-/Slc |
time constant of left ventricular pressure decay |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
heart left ventricular blood pressure trait |
male |
91.0 days
| 7 |
|
|
36.72 |
ms |
1.45 |
3.84 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
101827 |
2641 |
| SS.ZUC-Leprfa+/+/Slc |
heart left ventricular end-diastolic blood pressure to heart left ventricular end-diastolic diameter ratio |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
heart left ventricular blood pressure trait |
male |
91.0 days
| 4 |
|
|
0.56 |
mmHg/mm |
0.04 |
0.08 |
echocardiography |
|
0.0 |
|
|
|
|
lvedp/lvdd |
|
|
101829 |
2641 |
| SS.ZUC-Leprfa-/-/Slc |
blood high density lipoprotein cholesterol level |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
blood HDL cholesterol amount |
male |
91.0 days
| 7 |
|
|
73.0 |
mg/dl |
15.83 |
41.88 |
blood cholesterol analysis |
|
0.0 |
|
|
|
|
|
|
|
101843 |
2641 |
| SS.ZUC-Leprfa+/+/Slc |
blood aspartate aminotransferase activity level |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
blood aspartate transaminase amount |
male |
91.0 days
| 8 |
|
|
48.5 |
U/l |
0.5 |
1.41 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
101857 |
2641 |
| SS.ZUC-Leprfa-/-/Slc |
blood aspartate aminotransferase activity level |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
blood aspartate transaminase amount |
male |
91.0 days
| 7 |
|
|
45.0 |
U/l |
3.53 |
9.34 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
101859 |
2641 |
| SS.ZUC-Leprfa+/+/Slc |
serum creatinine level |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
blood creatinine amount |
male |
91.0 days
| 8 |
|
|
0.35 |
mg/dl |
0.01 |
0.03 |
serum creatinine analysis |
|
0.0 |
|
|
|
|
|
|
|
101873 |
2641 |
| SS.ZUC-Leprfa+/+/Slc |
tibia straight segment length |
control condition |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
tibia length |
male |
126.0 days
| 6 |
|
|
40.27 |
mm |
0.24 |
0.59 |
body measuring method |
|
0.0 |
|
|
|
|
|
|
|
101887 |
2642 |
| SS.ZUC-Leprfa+/+/Slc |
systolic blood pressure |
control condition |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
arterial blood pressure trait |
male |
126.0 days
| 6 |
|
|
137.7 |
mmHg |
3.04 |
7.45 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
|
|
101889 |
2642 |
| SS.ZUC-Leprfa+/+/Slc |
heart rate |
control condition |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
heart pumping trait |
male |
126.0 days
| 6 |
|
|
417.32 |
beats/min |
13.71 |
33.58 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
|
|
101891 |
2642 |
| SS.ZUC-Leprfa-/-/Slc |
heart rate |
control condition |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
heart pumping trait |
male |
126.0 days
| 7 |
|
|
400.73 |
beats/min |
15.4 |
40.74 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
|
|
101892 |
2642 |
| SS.ZUC-Leprfa+/+/Slc |
heart weight to tibia length ratio |
control condition |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
heart mass |
male |
126.0 days
| 6 |
|
|
0.33 |
g/cm |
0.01 |
0.04 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
101893 |
2642 |
| SS.ZUC-Leprfa-/-/Slc |
heart weight to tibia length ratio |
control condition |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
heart mass |
male |
126.0 days
| 7 |
|
|
0.42 |
g/cm |
0.0 |
0.01 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
101894 |
2642 |
| SS.ZUC-Leprfa-/-/Slc |
both kidneys wet weight to tibia length ratio |
control condition |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
kidney mass |
male |
126.0 days
| 7 |
|
|
1.29 |
g/cm |
0.04 |
0.1 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
101902 |
2642 |
| SS.ZUC-Leprfa-/-/Slc |
liver weight to tibia length ratio |
control condition |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
liver mass |
male |
126.0 days
| 7 |
|
|
600.11 |
mg/mm |
42.14 |
111.49 |
post excision weight measurement |
|
0.0 |
|
|
|
|
liv/tl |
|
|
101904 |
2642 |
| SS.ZUC-Leprfa-/-/Slc |
retroperitoneal fat pad weight to tibia length ratio |
control condition |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
retroperitoneal fat pad mass |
male |
126.0 days
| 7 |
|
|
839.28 |
mg/mm |
33.0 |
87.31 |
post excision weight measurement |
|
0.0 |
|
|
|
|
rf/tl |
|
|
101906 |
2642 |
| LH/Mav |
urine sodium level to body weight ratio |
control condition |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
urine sodium amount |
male |
133.0 days
| 10 |
|
|
0.49 |
mmol/l/100g |
0.04 |
0.13 |
flame photometry |
|
0.0 |
|
|
|
|
|
|
|
102053 |
2645 |
| BN/NHsdMcwi |
urine sodium level to body weight ratio |
control condition |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
urine sodium amount |
male |
133.0 days
| 10 |
|
|
0.49 |
mmol/l/100g |
0.04 |
0.13 |
flame photometry |
|
0.0 |
|
|
|
|
. |
|
|
102052 |
2645 |
| SD-Fhem1+/+ |
blood hemoglobin level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood hemoglobin amount |
female |
days
| 3 |
|
|
1320.0 |
g/dl |
75.63 |
131.0 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104854 |
2989 |
| SD-Fhem1+/- |
blood hemoglobin level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood hemoglobin amount |
male |
days
| 3 |
|
|
1450.0 |
g/dl |
40.41 |
70.0 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104855 |
2989 |
| SD-Fhem1+/+ |
mean platelet volume |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
platelet size trait |
female |
days
| 3 |
|
|
8.5 |
fl |
0.12 |
0.2 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104866 |
2989 |
| SD-Fhem1+/- |
mean corpuscular hemoglobin |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood hemoglobin amount |
female |
days
| 3 |
|
|
17.7 |
pg |
0.23 |
0.4 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104880 |
2989 |
| SD-Fhem1+/- |
blood lymphocyte count |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
lymphocyte quantity |
female |
days
| 3 |
|
|
1.8 |
x 1000 cells/ul |
0.29 |
0.5 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104900 |
2989 |
| SD-Fhem1+/+ |
blood monocyte count |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
leukocyte quantity |
male |
days
| 3 |
|
|
0.3 |
x 1000 cells/ul |
0.12 |
0.2 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104901 |
2989 |
| SD-Fhem1+/- |
blood monocyte count |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
leukocyte quantity |
female |
days
| 3 |
|
|
0.1 |
x 1000 cells/ul |
0.0 |
0.0 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104904 |
2989 |
| SD-Fhem1+/+ |
red blood cell distribution width-coefficient of variation |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
erythrocyte size trait |
male |
days
| 3 |
|
|
17.3 |
% |
0.4 |
0.7 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104913 |
2989 |
| SD-Fhem1+/- |
red blood cell distribution width-coefficient of variation |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
erythrocyte size trait |
female |
days
| 3 |
|
|
16.0 |
% |
0.69 |
1.2 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104916 |
2989 |
| Crl:LE |
blood monocyte count to total leukocyte count ratio |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
monocyte quantity |
male |
91.0 days
| 5 |
|
|
1.6 |
% |
0.58 |
1.3 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104371 |
2947 |
| SD-Cd59em1Ask+/+ |
blood hemoglobin level |
control condition (between 56 and 70 days) |
Yao X and Verkman AS, Acta Neuropathol Commun. 2017 Feb 17;5(1):15. doi: 10.1186/s40478-017-0417-9. |
blood hemoglobin amount |
both |
56.0 days-70.0 days |
6 |
|
|
14.8 |
g/dl |
0.2 |
0.5 |
automated hematology analysis |
|
0.0 |
|
|
|
|
|
|
|
104619 |
2971 |
| SD-Cd59em1Ask+/+ |
red blood cell count |
control condition (between 56 and 70 days) |
Yao X and Verkman AS, Acta Neuropathol Commun. 2017 Feb 17;5(1):15. doi: 10.1186/s40478-017-0417-9. |
erythrocyte quantity |
both |
56.0 days-70.0 days |
6 |
|
|
8.7 |
x 10E6 cells/ul |
0.16 |
0.4 |
automated blood cell counting method |
|
0.0 |
|
|
|
|
|
|
|
104621 |
2971 |
| SD-Cd59em1Ask-/- |
red blood cell count |
control condition (between 56 and 70 days) |
Yao X and Verkman AS, Acta Neuropathol Commun. 2017 Feb 17;5(1):15. doi: 10.1186/s40478-017-0417-9. |
erythrocyte quantity |
both |
56.0 days-70.0 days |
6 |
|
|
7.8 |
x 10E6 cells/ul |
0.08 |
0.2 |
automated blood cell counting method |
|
0.0 |
|
|
|
|
|
|
|
104622 |
2971 |
| MNS |
artery tunica media width to artery inner diameter ratio |
control condition |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
kidney blood vessel morphology trait |
male |
252.0 days
| |
|
|
0.75 |
null |
|
0.26 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
104134 |
2907 |
| MHS |
artery lumen to artery total diameter ratio |
control condition |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
kidney blood vessel morphology trait |
male |
252.0 days
| |
|
|
36.9 |
% |
|
8.0 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
104152 |
2907 |
| LE-Lrrk2em1Sage-/- |
gastrointestinal tract weight |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
gastrointestinal system mass |
male |
91.0 days
| 5 |
|
|
20.2 |
g |
0.89 |
2.0 |
post excision weight measurement |
|
0.0 |
|
|
|
|
gi weight |
|
|
104258 |
2947 |
| Crl:LE |
blood insulin level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood insulin amount |
male |
91.0 days
| 5 |
|
|
29.1 |
mU/l |
4.7 |
10.5 |
blood insulin analysis |
|
0.0 |
|
|
|
|
|
|
|
104305 |
2947 |
| LE-Lrrk2em1Sage-/- |
blood adrenocorticotropic hormone level (ACTH) |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood adrenocorticotropin amount |
male |
91.0 days
| 5 |
|
|
629.0 |
pg/ml |
127.9 |
286.0 |
blood hormone analysis |
|
0.0 |
|
|
|
|
|
|
|
104292 |
2947 |
| Crl:LE |
blood urea nitrogen level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood urea nitrogen amount |
male |
91.0 days
| 5 |
|
|
17.8 |
mg/dl |
0.58 |
1.3 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104327 |
2947 |
| SD-Fhem1+/+ |
blood lymphocyte count |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
lymphocyte quantity |
female |
days
| 3 |
|
|
3.3 |
x 1000 cells/ul |
0.75 |
1.3 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104898 |
2989 |
| SD-Fhem1+/- |
platelet-large cell ratio |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
platelet size trait |
male |
days
| 3 |
|
|
16.5 |
% |
1.44 |
2.5 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104921 |
2989 |
| SD-Fhem1+/+ |
blood aspartate aminotransferase activity level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood aspartate transaminase amount |
male |
days
| 3 |
|
|
130.3 |
U/l |
5.83 |
10.1 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104929 |
2989 |
| SD-Fhem1+/- |
blood alkaline phosphatase activity level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood alkaline phosphatase amount |
male |
days
| 3 |
|
|
69.3 |
U/l |
2.6 |
4.5 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104939 |
2989 |
| SD-Fhem1+/- |
plasma indirect bilirubin level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood bilirubin amount |
female |
days
| 3 |
|
|
-0.2 |
umol/l |
0.17 |
0.3 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104952 |
2989 |
| SD-Fhem1+/+ |
plasma indirect bilirubin level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood bilirubin amount |
female |
days
| 3 |
|
|
0.1 |
umol/l |
0.12 |
0.2 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104950 |
2989 |
| SD-Fhem1+/- |
plasma indirect bilirubin level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood bilirubin amount |
male |
days
| 3 |
|
|
-0.6 |
umol/l |
0.12 |
0.2 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104951 |
2989 |
| FHH.BN-(D1Hmgc14-D1Hmgc15)/Mcwi-Rab38em1Mcwi-/- |
mean arterial blood pressure |
control condition (for 91 days) |
Rangel-Filho A, et al., J Am Soc Nephrol. 2013 Feb;24(2):283-92. doi: 10.1681/ASN.2012090927. Epub 2013 Jan 4. |
arterial blood pressure trait |
male |
91.0 days
| 8 |
3hr/day x 3days |
serial mean |
111.0 |
mmHg |
1.0 |
2.83 |
intra-aortic abdominal radiotelemetry via femoral cannulation |
|
0.0 |
|
|
|
|
|
|
|
104244 |
2946 |
| FHH.BN-(D1Hmgc14-D1Hmgc15)/Mcwi |
urine total protein excretion rate |
control condition (for 84 days) |
Rangel-Filho A, et al., J Am Soc Nephrol. 2013 Feb;24(2):283-92. doi: 10.1681/ASN.2012090927. Epub 2013 Jan 4. |
total urine protein amount |
male |
84.0 days
| 5 |
|
|
91.0 |
mg/d |
4.0 |
8.94 |
urine protein analysis |
|
0.0 |
|
|
|
|
|
|
|
104245 |
2946 |
| FHH.BN-(D1Hmgc14-D1Hmgc15)/Mcwi-Rab38em1Mcwi-/- |
urine albumin excretion rate |
control condition (for 84 days) |
Rangel-Filho A, et al., J Am Soc Nephrol. 2013 Feb;24(2):283-92. doi: 10.1681/ASN.2012090927. Epub 2013 Jan 4. |
urine albumin amount |
male |
84.0 days
| 8 |
|
|
58.0 |
mg/d |
10.0 |
28.28 |
urine albumin analysis |
|
0.0 |
|
|
|
|
|
|
|
104252 |
2946 |
| Crl:LE |
kidney wet weight |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
kidney mass |
male |
91.0 days
| 5 |
|
|
2.9 |
g |
0.22 |
0.5 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
104259 |
2947 |
| Crl:LE |
blood galanin level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood hormone amount |
male |
91.0 days
| 5 |
|
|
0.3 |
ng/ml |
0.09 |
0.2 |
automated plasma protein analysis |
|
0.0 |
|
|
|
|
plasma |
|
|
104301 |
2947 |
| LE-Lrrk2em1Sage-/- |
blood galanin level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood hormone amount |
male |
91.0 days
| 5 |
|
|
1.0 |
ng/ml |
0.22 |
0.5 |
automated plasma protein analysis |
|
0.0 |
|
|
|
|
plasma |
|
|
104302 |
2947 |
| LE-Lrrk2em1Sage-/- |
plasma plasminogen activator inhibitor 1 level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood plasminogen activator inhibitor 1 amount |
male |
91.0 days
| 5 |
|
|
1.2 |
ng/ml |
0.13 |
0.3 |
automated plasma protein analysis |
|
0.0 |
|
|
|
|
plasma plasminogen activator inhibitor 1 level (CMO:0003695) |
|
|
104314 |
2947 |
| LE-Lrrk2em1Sage-/- |
blood progesterone level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood progesterone amount |
male |
91.0 days
| 5 |
|
|
47.3 |
ng/ml |
4.29 |
9.6 |
blood hormone analysis |
|
0.0 |
|
|
|
|
|
|
|
104316 |
2947 |
| LE-Lrrk2em1Sage-/- |
blood alkaline phosphatase activity level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood alkaline phosphatase amount |
male |
91.0 days
| 5 |
|
|
204.0 |
U/l |
10.51 |
23.5 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104322 |
2947 |
| SS-Kcnj1em1Kasu+/- |
blood pH |
control condition (for 13 days) |
Zhou X, et al., Hypertension. 2013 Aug;62(2):288-94. doi: 10.1161/HYPERTENSIONAHA.111.01051. Epub 2013 Jun 10. |
blood acidity-alkalinity balance trait |
male |
13.0 days
| 6 |
|
|
7.3 |
null |
0.02 |
0.05 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104437 |
2948 |
| SS-Kcnj1em1Kasu+/+ |
blood urea nitrogen level |
control condition (for 13 days) |
Zhou X, et al., Hypertension. 2013 Aug;62(2):288-94. doi: 10.1161/HYPERTENSIONAHA.111.01051. Epub 2013 Jun 10. |
blood urea nitrogen amount |
male |
13.0 days
| 6 |
|
|
35.07 |
mg/dl |
4.57 |
11.19 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104439 |
2948 |
| SD-Lepem1Sage-/- |
liver triglyceride level |
control condition (for 126 days) |
D'souza AM, et al., Endocrinology. 2014 Apr;155(4):1268-79. doi: 10.1210/en.2013-1523. Epub 2014 Jan 27. |
liver triglyceride amount |
male |
126.0 days
| 6 |
|
|
10.65 |
mg/g |
1.35 |
3.32 |
enzymatic triglyceride assay |
|
0.0 |
|
|
|
|
|
|
|
104443 |
2949 |
| SD-Lepem1Sage-/- |
liver cholesterol level |
control condition (for 126 days) |
D'souza AM, et al., Endocrinology. 2014 Apr;155(4):1268-79. doi: 10.1210/en.2013-1523. Epub 2014 Jan 27. |
liver cholesterol amount |
male |
126.0 days
| 6 |
|
|
2.16 |
mg/g |
0.12 |
0.3 |
enzymatic cholesterol assay |
|
0.0 |
|
|
|
|
|
|
|
104447 |
2949 |
| SD-Lepem1Sage+/+ |
skeletal muscle triglyceride level |
control condition (for 126 days) |
D'souza AM, et al., Endocrinology. 2014 Apr;155(4):1268-79. doi: 10.1210/en.2013-1523. Epub 2014 Jan 27. |
muscle triglyceride amount |
female |
126.0 days
| 6 |
|
|
0.11 |
nmol/mg |
0.02 |
0.05 |
enzymatic triglyceride assay |
|
0.0 |
|
|
|
|
|
|
|
104452 |
2949 |
| SD-Lepem1Sage-/- |
liver cholesterol level |
control condition (for 126 days) |
D'souza AM, et al., Endocrinology. 2014 Apr;155(4):1268-79. doi: 10.1210/en.2013-1523. Epub 2014 Jan 27. |
liver cholesterol amount |
female |
126.0 days
| 6 |
|
|
2.54 |
mg/g |
0.28 |
0.69 |
enzymatic cholesterol assay |
|
0.0 |
|
|
|
|
|
|
|
104449 |
2949 |
| LE-Lrrk2em1Sage-/- |
blood monocyte count to total leukocyte count ratio |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
monocyte quantity |
male |
91.0 days
| 5 |
|
|
1.4 |
% |
0.22 |
0.5 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104372 |
2947 |
| LE-Lrrk2em1Sage-/- |
single kidney wet weight to body weight ratio |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
kidney mass |
male |
91.0 days
| 5 |
|
|
7.6 |
g/kg |
0.45 |
1.0 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
104278 |
2947 |
| Crl:LE |
liver weight as percentage of body weight |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
liver mass |
male |
91.0 days
| 5 |
|
|
3.9 |
% |
0.13 |
0.3 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
104279 |
2947 |
| LE-Lrrk2em1Sage-/- |
liver weight as percentage of body weight |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
liver mass |
male |
91.0 days
| 5 |
|
|
4.3 |
% |
0.13 |
0.3 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
104280 |
2947 |
| LE-Lrrk2em1Sage-/- |
both testes wet weight to body weight ratio |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
testis mass |
male |
91.0 days
| 5 |
|
|
0.74 |
% |
0.04 |
0.08 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
104284 |
2947 |
| Crl:LE |
thymus weight to body weight ratio |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
thymus mass |
male |
91.0 days
| 5 |
|
|
1.5 |
mg/g |
0.4 |
0.9 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
104285 |
2947 |
| Crl:LE |
blood angiotensin I converting enzyme activity level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
angiotensin I-converting enzyme activity |
male |
91.0 days
| 5 |
|
|
51.9 |
ng/ml |
3.8 |
8.5 |
blood enzyme activity assay |
|
0.0 |
|
|
|
|
|
|
|
104293 |
2947 |
| Crl:LE |
plasma triglyceride level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood triglyceride amount |
male |
91.0 days
| 5 |
|
|
2.46 |
mmol/l |
0.26 |
0.57 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104333 |
2947 |
| Crl:LE |
plasma total cholesterol level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood cholesterol amount |
male |
91.0 days
| 5 |
|
|
94.8 |
mg/dl |
3.71 |
8.3 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104331 |
2947 |
| Crl:LE |
plasma total bilirubin level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood bilirubin amount |
male |
91.0 days
| 5 |
|
|
0.6 |
mg/dl |
0.04 |
0.1 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104339 |
2947 |
| Crl:LE |
plasma potassium level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood potassium amount |
male |
91.0 days
| 5 |
|
|
7.4 |
mmol/l |
0.31 |
0.7 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104345 |
2947 |
| Crl:LE |
red blood cell count |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
erythrocyte quantity |
male |
91.0 days
| 5 |
|
|
8.6 |
x 10E6 cells/ul |
0.04 |
0.1 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104355 |
2947 |
| SD-Fhem1+/- |
blood globulin level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood globulin amount |
male |
days
| 3 |
|
|
301.0 |
g/dl |
6.35 |
11.0 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104963 |
2989 |
| SD-Fhem1+/+ |
blood glucose level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood glucose amount |
male |
days
| 3 |
|
|
147.6 |
mg/dl |
3.12 |
5.4 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104965 |
2989 |
| SD-Fhem1+/+ |
blood urea nitrogen level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood urea nitrogen amount |
female |
days
| 3 |
|
|
670.0 |
mg/dl |
17.32 |
30.0 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104970 |
2989 |
| SD-Fhem1+/- |
blood uric acid level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood uric acid amount |
female |
days
| 3 |
|
|
2.83 |
mg/dl |
0.13 |
0.22 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104976 |
2989 |
| SD-Fhem1+/- |
blood creatine kinase activity level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood creatine kinase amount |
male |
days
| 3 |
|
|
41.0 |
IU/l |
0.58 |
1.0 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104983 |
2989 |
| MNS |
body weight |
control condition |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
body mass |
male |
252.0 days
| 14 |
|
|
552.0 |
g |
6.41 |
24.0 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
104068 |
2907 |
| MHS |
body weight |
control condition |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
body mass |
male |
252.0 days
| 14 |
|
|
558.0 |
g |
7.48 |
28.0 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
104070 |
2907 |
| MNS |
blood glucose level |
control condition |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
blood glucose amount |
male |
168.0 days
| 8 |
|
|
115.2 |
mg/dl |
3.82 |
10.8 |
colorimetry |
tail vein |
0.0 |
|
|
|
|
|
|
|
104077 |
2907 |
| MHS |
blood glucose level |
control condition |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
blood glucose amount |
male |
168.0 days
| 8 |
|
|
115.2 |
mg/dl |
3.18 |
9.0 |
colorimetry |
tail vein |
0.0 |
|
|
|
|
|
|
|
104079 |
2907 |
| MHS |
blood glucose level |
control condition |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
blood glucose amount |
male |
252.0 days
| 14 |
|
|
113.4 |
mg/dl |
2.89 |
10.8 |
colorimetry |
tail vein |
0.0 |
|
|
|
|
|
|
|
104083 |
2907 |
| Crl:WI |
blood hemoglobin A1c level |
control condition |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
blood hemoglobin amount |
male |
252.0 days
| 10 |
|
|
5.5 |
% |
0.13 |
0.4 |
affinity chromatography |
tail vein |
0.0 |
|
|
|
affinity chromatography (MMO:0000845) |
|
|
|
104098 |
2907 |
| MNS |
renal filtration fraction |
control condition |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
glomerular filtration trait |
male |
126.0 days
| 6 |
((A-V)/A)*100 |
|
0.25 |
null |
0.02 |
0.05 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
|
|
|
|
filtration fraction |
|
|
104118 |
2907 |
| MHS |
renal vascular resistance |
control condition |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
renal blood flow trait |
male |
126.0 days
| 6 |
|
|
6.59 |
mmHg/ml/min |
0.7 |
1.72 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
|
|
|
|
|
|
|
104128 |
2907 |
| LE-Lrrk2em1Sage-/- |
blood segmented neutrophil count |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
neutrophil quantity |
male |
91.0 days
| 5 |
|
|
1032.0 |
cells/ul |
74.68 |
167.0 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104378 |
2947 |
| Crl:LE |
blood lymphocyte count |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
lymphocyte quantity |
male |
91.0 days
| 5 |
|
|
7.99 |
x 1000 cells/ul |
0.35 |
0.79 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104379 |
2947 |
| LE-Lrrk2em1Sage-/- |
urine albumin level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
urine albumin amount |
male |
91.0 days
| 5 |
|
|
4.1 |
ng/ml |
2.73 |
6.1 |
urine albumin analysis |
|
0.0 |
|
|
|
|
|
|
|
104386 |
2947 |
| LE-Lrrk2em1Sage-/- |
urine osteopontin level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
urine protein amount |
male |
91.0 days
| 5 |
|
|
0.0 |
ng/ml |
|
|
urine protein analysis |
|
0.0 |
|
|
|
|
|
|
|
104390 |
2947 |
| SD-Apoeem1Sage |
plasma corticosterone level |
control condition |
Ekuni D, et al., Lipids Health Dis. 2014 Sep 5;13:144. doi: 10.1186/1476-511X-13-144. |
blood corticosterone amount |
male |
56.0 days
| 7 |
|
|
14.2 |
ng/ml |
1.85 |
4.9 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
|
|
|
104493 |
2968 |
| SD-Lepem1Sage-/- |
total volumetric bone mineral density |
control condition |
Vaira S, et al., Endocrinology. 2012 Nov;153(11):5622-8. doi: 10.1210/en.2012-1462. Epub 2012 Sep 4. |
femur mineral mass |
not specified |
56.0 days
| 10 |
|
|
441.1 |
mg/cm3 |
19.1 |
60.4 |
micro-computed tomography |
|
0.0 |
|
|
|
|
|
|
|
104562 |
2969 |
| SD-Fhem1+/- |
blood protein measurement |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood total protein amount |
female |
days
| 3 |
|
|
677.0 |
g/dl |
16.74 |
29.0 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104956 |
2989 |
| SD-Fhem1+/- |
blood albumin level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood albumin amount |
female |
days
| 3 |
|
|
373.0 |
g/dl |
12.7 |
22.0 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104960 |
2989 |
| MHS |
body weight |
control condition |
Capasso G, et al., Am J Physiol Renal Physiol. 2005 Jun;288(6):F1173-82. doi: 10.1152/ajprenal.00228.2004. Epub 2005 Feb 1. |
body mass |
not specified |
23.0 days-25.0 days |
11 |
|
|
72.0 |
g |
2.1 |
6.96 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
104155 |
2926 |
| MHS |
plasma osmolality |
control condition |
Capasso G, et al., Am J Physiol Renal Physiol. 2005 Jun;288(6):F1173-82. doi: 10.1152/ajprenal.00228.2004. Epub 2005 Feb 1. |
blood molecular composition trait |
not specified |
23.0 days-25.0 days |
11 |
|
|
293.7 |
umol/g |
1.5 |
4.97 |
osmometry |
|
0.0 |
|
|
|
|
|
|
|
104163 |
2926 |
| MHS |
mean arterial blood pressure |
control condition |
Capasso G, et al., Am J Physiol Renal Physiol. 2005 Jun;288(6):F1173-82. doi: 10.1152/ajprenal.00228.2004. Epub 2005 Feb 1. |
arterial blood pressure trait |
not specified |
23.0 days-25.0 days |
11 |
|
|
97.4 |
mmHg |
1.4 |
4.64 |
vascular fluid filled catheter |
|
0.0 |
|
|
|
|
|
|
|
104161 |
2926 |
| LE-Lrrk2em1Sage-/- |
serum lipocalin 2 level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood protein amount |
male |
91.0 days
| 5 |
|
|
11.5 |
ng/ml |
3.44 |
7.7 |
automated serum protein analysis |
|
0.0 |
|
|
|
|
|
|
|
104394 |
2947 |
| Crl:LE |
serum lipocalin 2 level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood protein amount |
male |
91.0 days
| 5 |
|
|
38.6 |
ng/ml |
1.92 |
4.3 |
automated serum protein analysis |
|
0.0 |
|
|
|
|
|
|
|
104393 |
2947 |
| Crl:LE |
serum osteopontin level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood protein amount |
male |
91.0 days
| 5 |
|
|
11.5 |
ng/ml |
0.49 |
1.1 |
automated serum protein analysis |
|
0.0 |
|
|
|
|
|
|
|
104395 |
2947 |
| Crl:LE |
serum cystatin C level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood cystatin C amount |
male |
91.0 days
| 5 |
|
|
1104.0 |
ng/ml |
84.52 |
189.0 |
automated serum protein analysis |
|
0.0 |
|
|
|
|
|
|
|
104405 |
2947 |
| LE-Lrrk2em1Sage-/- |
serum glutathione S-transferase-u level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood protein amount |
male |
91.0 days
| 5 |
|
|
3.9 |
ug/ml |
1.07 |
2.4 |
automated serum protein analysis |
|
0.0 |
|
|
|
|
|
|
|
104410 |
2947 |
| Crl:LE |
serum tissue inhibitor of metalloproteinase 1 level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood protein amount |
male |
91.0 days
| 5 |
|
|
8.3 |
ng/ml |
0.27 |
0.6 |
automated serum protein analysis |
|
0.0 |
|
|
|
|
|
|
|
104411 |
2947 |
| SS-Kcnj1em1Kasu+/- |
blood sodium level |
control condition (for 13 days) |
Zhou X, et al., Hypertension. 2013 Aug;62(2):288-94. doi: 10.1161/HYPERTENSIONAHA.111.01051. Epub 2013 Jun 10. |
blood sodium amount |
male |
13.0 days
| 6 |
|
|
127.7 |
mmol/l |
0.6 |
1.47 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104425 |
2948 |
| SS-Kcnj1em1Kasu+/+ |
blood sodium level |
control condition (for 13 days) |
Zhou X, et al., Hypertension. 2013 Aug;62(2):288-94. doi: 10.1161/HYPERTENSIONAHA.111.01051. Epub 2013 Jun 10. |
blood sodium amount |
male |
13.0 days
| 6 |
|
|
129.3 |
mmol/l |
0.6 |
1.47 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104424 |
2948 |
| SS-Kcnj1em1Kasu+/+ |
blood chloride level |
control condition (for 13 days) |
Zhou X, et al., Hypertension. 2013 Aug;62(2):288-94. doi: 10.1161/HYPERTENSIONAHA.111.01051. Epub 2013 Jun 10. |
blood chloride amount |
male |
13.0 days
| 6 |
|
|
99.3 |
mmol/l |
0.8 |
1.96 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104430 |
2948 |
| SD-Fhem1+/+ |
white blood cell count |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
leukocyte quantity |
male |
days
| 3 |
|
|
6.5 |
x 1000 cells/ul |
0.81 |
1.4 |
automated blood cell counting method |
|
0.0 |
|
|
|
|
|
|
|
104833 |
2989 |
| SD-Fhem1+/+ |
red blood cell count |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
erythrocyte quantity |
male |
days
| 3 |
|
|
8.6 |
x 10E6 cells/ul |
0.12 |
0.2 |
automated blood cell counting method |
|
0.0 |
|
|
|
|
|
|
|
104837 |
2989 |
| Crl:CD(SD) |
plasma very low density lipoprotein cholesterol level |
control condition (for 140 days) |
Wang HY, et al., Biol Open. 2016 Jul 15;5(7):979-86. doi: 10.1242/bio.019802. |
blood VLDL cholesterol amount |
not specified |
140.0 days
| 5 |
|
|
5.41 |
mg/dl |
2.59 |
5.78 |
plasma very low-density lipoprotein-cholesterol measurement test |
|
0.0 |
|
|
|
|
|
|
|
105039 |
3009 |
| SD-Ldlrem1 |
plasma very low density lipoprotein cholesterol level |
control condition (for 140 days) |
Wang HY, et al., Biol Open. 2016 Jul 15;5(7):979-86. doi: 10.1242/bio.019802. |
blood VLDL cholesterol amount |
not specified |
140.0 days
| 4 |
|
|
22.55 |
mg/dl |
3.05 |
6.1 |
plasma very low-density lipoprotein-cholesterol measurement test |
|
0.0 |
|
|
|
|
|
|
|
105040 |
3009 |
| SD-Abcb11em1Sage |
liver weight to body weight ratio |
control condition (for 63 days) |
Cheng Y, et al., Biopharm Drug Dispos. 2016 Jul;37(5):276-86. doi: 10.1002/bdd.2011. |
liver mass |
male |
63.0 days
| 5 |
|
|
0.44 |
g/kg |
0.02 |
0.04 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
105046 |
3010 |
| SD-Ldlrem1 |
plasma high density lipoprotein cholesterol level |
control condition (for 140 days) |
Wang HY, et al., Biol Open. 2016 Jul 15;5(7):979-86. doi: 10.1242/bio.019802. |
blood HDL cholesterol amount |
not specified |
140.0 days
| 4 |
|
|
40.42 |
mg/dl |
6.1 |
12.2 |
plasma high-density lipoprotein-cholesterol measurement test |
|
0.0 |
|
|
|
|
|
|
|
105044 |
3009 |
| WI-Mc4rm1Hubr |
brain weight |
control condition |
Stepp DW, et al., Physiol Rep. 2013 Nov;1(6):e00146. doi: 10.1002/phy2.146. Epub 2013 Nov 13. |
brain mass |
male |
70.0 days-140.0 days |
8 |
|
|
2.14 |
g |
0.1 |
0.28 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
105513 |
3017 |
| WI-Mc4rm1Hubr |
plasma free fatty acids level |
control condition |
Stepp DW, et al., Physiol Rep. 2013 Nov;1(6):e00146. doi: 10.1002/phy2.146. Epub 2013 Nov 13. |
blood free fatty acid amount |
male |
70.0 days-140.0 days |
8 |
|
|
0.01 |
mmol/l |
0.0 |
0.0 |
plasma free fatty acid analysis |
|
0.0 |
|
|
|
|
**suspected wrong units in paper(mg/dl) |
|
|
105527 |
3017 |
| WI-Mc4rm1Hubr |
plasma glucose level |
control condition |
Stepp DW, et al., Physiol Rep. 2013 Nov;1(6):e00146. doi: 10.1002/phy2.146. Epub 2013 Nov 13. |
blood glucose amount |
male |
70.0 days-140.0 days |
8 |
|
|
121.0 |
mg/dl |
7.0 |
19.8 |
plasma glucose analysis |
|
0.0 |
|
|
|
|
|
|
|
105529 |
3017 |
| WI-Mc4rm1Hubr |
mean arterial blood pressure |
control condition |
Stepp DW, et al., Physiol Rep. 2013 Nov;1(6):e00146. doi: 10.1002/phy2.146. Epub 2013 Nov 13. |
arterial blood pressure trait |
male |
70.0 days-126.0 days |
8 |
every 10 min for 24hr |
|
111.0 |
mmHg |
1.0 |
2.83 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
|
|
|
|
|
|
105537 |
3017 |
| Crl:WI |
plasma leptin level |
control condition |
Stepp DW, et al., Physiol Rep. 2013 Nov;1(6):e00146. doi: 10.1002/phy2.146. Epub 2013 Nov 13. |
blood leptin amount |
male |
70.0 days-140.0 days |
8 |
|
|
1.43 |
ng/ml |
0.1 |
285.67 |
plasma leptin analysis |
|
0.0 |
|
|
|
plasma leptin analysis |
pg/ml |
|
|
105534 |
3017 |
| Crl:WI |
mean arterial blood pressure |
control condition |
Stepp DW, et al., Physiol Rep. 2013 Nov;1(6):e00146. doi: 10.1002/phy2.146. Epub 2013 Nov 13. |
arterial blood pressure trait |
male |
70.0 days-126.0 days |
8 |
every 10 min for 24hr |
|
108.0 |
mmHg |
1.0 |
2.83 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
|
|
|
|
|
|
105536 |
3017 |
| WI-Mc4rm1Hubr |
plasma leptin level |
control condition |
Stepp DW, et al., Physiol Rep. 2013 Nov;1(6):e00146. doi: 10.1002/phy2.146. Epub 2013 Nov 13. |
blood leptin amount |
male |
70.0 days-140.0 days |
8 |
|
|
7.03 |
ng/ml |
0.55 |
1564.12 |
plasma leptin analysis |
|
0.0 |
|
|
|
plasma leptin analysis |
pg/ml |
|
|
105535 |
3017 |
| SD |
serum immunoglobulin E level |
control condition |
Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. |
blood immunoglobulin E amount |
not specified |
days
| 8 |
|
|
0.1 |
ug/l |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
error not defined |
|
|
105406 |
3015 |
| F344 |
heart rate |
control condition |
Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. |
heart pumping trait |
male |
days
| 3 |
|
|
449.89 |
beats/min |
16.8 |
29.1 |
electrocardiography |
|
0.0 |
|
|
|
|
|
|
|
105574 |
3018 |
| F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi-/- |
heart rate |
control condition |
Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. |
heart pumping trait |
male |
days
| 3 |
|
|
471.78 |
beats/min |
6.62 |
11.47 |
electrocardiography |
|
0.0 |
|
|
|
|
|
|
|
105575 |
3018 |
| F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi-/- |
QRS duration |
control condition |
Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. |
heart electrical impulse conduction trait |
male |
days
| 3 |
|
|
17.49 |
ms |
0.83 |
1.44 |
electrocardiography |
|
0.0 |
|
|
|
|
|
|
|
105587 |
3018 |
| F344 |
QT interval |
control condition |
Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. |
heart electrical impulse conduction trait |
male |
days
| 3 |
|
|
68.11 |
ms |
4.56 |
7.9 |
electrocardiography |
|
0.0 |
|
|
|
|
|
|
|
105594 |
3018 |
| Crl:WI |
body length, nose to rump |
control condition |
Stepp DW, et al., Physiol Rep. 2013 Nov;1(6):e00146. doi: 10.1002/phy2.146. Epub 2013 Nov 13. |
body length |
male |
70.0 days-140.0 days |
8 |
|
|
10.7 |
cm |
1.0 |
2.83 |
body length measuring method |
|
0.0 |
|
|
|
|
|
|
|
105514 |
3017 |
| Crl:WI |
food intake rate |
control condition |
Stepp DW, et al., Physiol Rep. 2013 Nov;1(6):e00146. doi: 10.1002/phy2.146. Epub 2013 Nov 13. |
eating behavior trait |
male |
70.0 days-140.0 days |
8 |
|
|
21.0 |
g/d |
1.0 |
2.83 |
food intake measuring method |
|
0.0 |
|
|
|
|
|
|
|
105516 |
3017 |
| WI-Mc4rm1Hubr |
mean arterial blood pressure |
control condition |
Stepp DW, et al., Physiol Rep. 2013 Nov;1(6):e00146. doi: 10.1002/phy2.146. Epub 2013 Nov 13. |
arterial blood pressure trait |
male |
70.0 days-126.0 days |
8 |
night every 10 min |
|
114.0 |
mmHg |
1.0 |
2.83 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
|
|
|
|
|
|
105545 |
3017 |
| WI-Mc4rm1Hubr |
heart rate |
control condition |
Stepp DW, et al., Physiol Rep. 2013 Nov;1(6):e00146. doi: 10.1002/phy2.146. Epub 2013 Nov 13. |
heart pumping trait |
male |
70.0 days-126.0 days |
8 |
|
|
340.0 |
beats/min |
6.0 |
16.97 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
|
|
|
|
|
|
105547 |
3017 |
| Crl:LE |
mean corpuscular hemoglobin concentration |
control condition (for 30 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
erythrocyte hemoglobin amount |
male |
30.0 days
| 4 |
|
|
32.0 |
g/dl |
0.02 |
0.04 |
automated hematology analysis |
|
|
|
|
|
|
|
|
|
106206 |
3026 |
| LE-Lrrk2em1Sage-/- |
mean corpuscular hemoglobin concentration |
control condition (for 30 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
erythrocyte hemoglobin amount |
male |
30.0 days
| 4 |
|
|
32.5 |
g/dl |
0.28 |
0.56 |
automated hematology analysis |
|
|
|
|
|
|
|
|
|
106207 |
3026 |
| LE-Lrrk2em1Sage-/- |
red blood cell distribution width-coefficient of variation |
control condition (for 30 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
erythrocyte size trait |
male |
30.0 days
| 4 |
|
|
13.3 |
% |
0.17 |
0.34 |
automated hematology analysis |
|
|
|
|
|
|
|
|
|
106213 |
3026 |
| Crl:LE |
serum phosphate level |
control condition (for 30 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
blood phosphate amount |
male |
30.0 days
| 4 |
|
|
10.6 |
mg/dl |
0.65 |
1.3 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106222 |
3026 |
| LE-Lrrk2em1Sage-/- |
serum chloride level |
control condition (for 30 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
blood chloride amount |
male |
30.0 days
| 4 |
|
|
99.0 |
mmol/l |
0.6 |
1.2 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106225 |
3026 |
| LE-Lrrk2em1Sage-/- |
serum sorbital dehydrogenase activity |
control condition (for 30 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
blood sorbital dehydrogenase amount |
male |
30.0 days
| 4 |
|
|
11.0 |
U/l |
0.8 |
1.6 |
automated serum analysis |
|
|
|
|
|
|
serum sorbital dehydrogenase level |
|
|
106229 |
3026 |
| LE-Lrrk2em1Sage-/- |
urine specific gravity |
control condition (for 30 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
urine solute amount |
male |
30.0 days
| 4 |
|
|
1.06 |
null |
0.01 |
0.02 |
urine analysis |
|
|
|
|
|
|
|
|
|
106231 |
3026 |
| LE-Lrrk2em1Sage-/- |
creatinine clearance |
control condition (for 30 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
glomerular filtration trait |
male |
30.0 days
| 4 |
|
|
1.64 |
ml/min |
0.08 |
0.16 |
automated urine analysis |
|
|
|
|
|
|
|
|
|
106237 |
3026 |
| Crl:LE |
urine potassium level to urine creatinine level ratio |
control condition (for 30 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
urine potassium amount |
male |
30.0 days
| 4 |
|
|
0.55 |
mEq/mg |
0.01 |
0.01 |
automated urine analysis |
|
|
|
|
|
|
|
|
|
106244 |
3026 |
| LE-Lrrk2em1Sage-/- |
urine potassium level |
control condition (for 30 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
urine potassium amount |
male |
30.0 days
| 4 |
|
|
381.5 |
mmol/l |
36.4 |
72.8 |
automated urine analysis |
|
|
|
|
|
|
|
|
|
106243 |
3026 |
| Crl:LE |
urine chloride level to urine creatinine level ratio |
control condition (for 30 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
urine chloride amount |
male |
30.0 days
| 4 |
|
|
0.44 |
mEq/mg |
0.02 |
0.04 |
automated urine analysis |
|
|
|
|
|
|
|
|
|
106248 |
3026 |
| Crl:LE |
red blood cell count |
control condition (for 60 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
erythrocyte quantity |
male |
60.0 days
| 4 |
|
|
8.85 |
x 10E6 cells/ul |
0.13 |
0.27 |
automated hematology analysis |
|
|
|
|
|
|
|
|
|
106250 |
3026 |
| LE-Lrrk2em1Sage-/- |
mean corpuscular volume |
control condition (for 60 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
erythrocyte size trait |
male |
60.0 days
| 4 |
|
|
61.0 |
fl |
0.15 |
0.3 |
automated hematology analysis |
|
|
|
|
|
|
|
|
|
106257 |
3026 |
| Crl:LE |
mean corpuscular hemoglobin concentration |
control condition (for 60 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
erythrocyte hemoglobin amount |
male |
60.0 days
| 4 |
|
|
32.4 |
g/dl |
0.15 |
0.3 |
automated hematology analysis |
|
|
|
|
|
|
|
|
|
106260 |
3026 |
| Crl:LE |
mean corpuscular hemoglobin |
control condition (for 60 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
erythrocyte hemoglobin amount |
male |
60.0 days
| 4 |
|
|
18.7 |
pg |
0.23 |
0.46 |
automated hematology analysis |
|
|
|
|
|
|
|
|
|
106258 |
3026 |
| LE-Lrrk2em1Sage-/- |
mean corpuscular hemoglobin concentration |
control condition (for 60 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
erythrocyte hemoglobin amount |
male |
60.0 days
| 4 |
|
|
33.7 |
g/dl |
0.17 |
0.34 |
automated hematology analysis |
|
|
|
|
|
|
|
|
|
106261 |
3026 |
| LE-Lrrk2em1Sage-/- |
reticulocyte count to total red blood cell count ratio |
control condition (for 60 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
reticulocyte quantity |
male |
60.0 days
| 4 |
|
|
2.1 |
% |
0.28 |
0.56 |
automated hematology analysis |
|
|
|
|
|
|
|
|
|
106265 |
3026 |
| Crl:LE |
serum sorbital dehydrogenase activity |
control condition (for 60 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
blood sorbital dehydrogenase amount |
male |
60.0 days
| 4 |
|
|
5.0 |
U/l |
0.6 |
1.2 |
automated serum analysis |
|
|
|
|
|
|
serum sorbital dehydrogenase level |
|
|
106282 |
3026 |
| LE-Lrrk2em1Sage-/- |
serum sorbital dehydrogenase activity |
control condition (for 60 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
blood sorbital dehydrogenase amount |
male |
60.0 days
| 4 |
|
|
12.0 |
U/l |
1.6 |
3.2 |
automated serum analysis |
|
|
|
|
|
|
serum sorbital dehydrogenase level |
|
|
106283 |
3026 |
| LE-Lrrk2em1Sage-/- |
timed urine volume |
control condition (for 60 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
urine output |
male |
60.0 days
| 4 |
|
|
13.3 |
ml/d |
1.03 |
2.06 |
metabolic cage urine volume measurement method |
|
|
|
|
|
|
|
|
|
106287 |
3026 |
| Crl:LE |
timed urine volume |
control condition (for 60 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
urine output |
male |
60.0 days
| 4 |
|
|
3.5 |
ml/d |
0.65 |
1.3 |
metabolic cage urine volume measurement method |
|
|
|
|
|
|
|
|
|
106286 |
3026 |
| LE-Lrrk2em1Sage-/- |
urine potassium level to urine creatinine level ratio |
control condition (for 60 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
urine potassium amount |
male |
60.0 days
| 4 |
|
|
0.28 |
mEq/mg |
0.02 |
0.04 |
automated urine analysis |
|
|
|
|
|
|
|
|
|
106299 |
3026 |
| LE-Lrrk2em1Sage-/- |
urine potassium level |
control condition (for 60 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
urine potassium amount |
male |
60.0 days
| 4 |
|
|
105.2 |
mmol/l |
1.87 |
3.74 |
automated urine analysis |
|
|
|
|
|
|
|
|
|
106297 |
3026 |
| Crl:LE |
mean corpuscular volume |
control condition (for 480 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
erythrocyte size trait |
male |
480.0 days
| 4 |
|
|
52.3 |
fl |
0.52 |
1.04 |
automated hematology analysis |
|
|
|
|
|
|
|
|
|
106310 |
3026 |
| Crl:LE |
mean corpuscular hemoglobin |
control condition (for 480 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
erythrocyte hemoglobin amount |
male |
480.0 days
| 4 |
|
|
16.9 |
pg |
0.23 |
0.46 |
automated hematology analysis |
|
|
|
|
|
|
|
|
|
106312 |
3026 |
| LE-Lrrk2em1Sage-/- |
hematocrit |
control condition (for 480 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
erythrocyte quantity |
male |
480.0 days
| 4 |
|
|
48.6 |
% |
0.3 |
0.6 |
automated hematology analysis |
|
|
|
|
|
|
|
|
|
106309 |
3026 |
| Crl:LE |
red blood cell distribution width-coefficient of variation |
control condition (for 480 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
erythrocyte size trait |
male |
480.0 days
| 4 |
|
|
13.2 |
% |
0.14 |
0.28 |
automated hematology analysis |
|
|
|
|
|
|
|
|
|
106320 |
3026 |
| Crl:LE |
serum sorbital dehydrogenase activity |
control condition (for 480 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
blood sorbital dehydrogenase amount |
male |
480.0 days
| 4 |
|
|
4.0 |
U/l |
0.6 |
1.2 |
automated serum analysis |
|
|
|
|
|
|
serum sorbital dehydrogenase level |
|
|
106336 |
3026 |
| LE-Lrrk2em1Sage-/- |
serum sorbital dehydrogenase activity |
control condition (for 480 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
blood sorbital dehydrogenase amount |
male |
480.0 days
| 4 |
|
|
25.0 |
U/l |
1.3 |
2.6 |
automated serum analysis |
|
0.0 |
|
|
|
|
serum sorbital dehydrogenase level |
|
|
106337 |
3026 |
| LE-Lrrk2em1Sage-/- |
urine specific gravity |
control condition (for 480 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
urine solute amount |
male |
480.0 days
| 4 |
|
|
1.03 |
null |
0.0 |
0.0 |
urine analysis |
|
|
|
|
|
|
|
|
|
106339 |
3026 |
| DA-Tph2em3Mcwi+/+ |
forebrain serotonin level |
control condition (for 63 days) |
Kaplan K, et al., J Appl Physiol (1985). 2016 May 1;120(9):1070-81. doi: 10.1152/japplphysiol.01015.2015. Epub 2016 Feb 11. |
forebrain serotonin amount |
not specified |
60.0 days-64.0 days |
2 |
|
|
439.1 |
ng/g |
4.9 |
6.93 |
high-performance liquid chromatography |
|
0.0 |
|
|
|
|
serotonin |
|
|
105601 |
3019 |
| DA-Tph2em3Mcwi+/- |
forebrain serotonin level |
control condition (for 63 days) |
Kaplan K, et al., J Appl Physiol (1985). 2016 May 1;120(9):1070-81. doi: 10.1152/japplphysiol.01015.2015. Epub 2016 Feb 11. |
forebrain serotonin amount |
not specified |
58.0 days-62.0 days |
4 |
|
|
442.5 |
ng/g |
20.7 |
41.4 |
high-performance liquid chromatography |
|
0.0 |
|
|
|
|
serotonin |
|
|
105602 |
3019 |
| DA-Tph2em2Mcwi-/- |
forebrain norepinephrine level |
control condition (for 63 days) |
Kaplan K, et al., J Appl Physiol (1985). 2016 May 1;120(9):1070-81. doi: 10.1152/japplphysiol.01015.2015. Epub 2016 Feb 11. |
forebrain norepinephrine amount |
not specified |
62.0 days-64.0 days |
3 |
|
|
358.7 |
ng/g |
22.1 |
38.28 |
high-performance liquid chromatography |
|
0.0 |
|
|
|
|
norepinephrine |
|
|
105606 |
3019 |
| DA-Tph2em3Mcwi+/+ |
forebrain dopamine level |
control condition (for 63 days) |
Kaplan K, et al., J Appl Physiol (1985). 2016 May 1;120(9):1070-81. doi: 10.1152/japplphysiol.01015.2015. Epub 2016 Feb 11. |
forebrain dopamine amount |
not specified |
60.0 days-64.0 days |
2 |
|
|
2098.3 |
ng/g |
63.0 |
89.1 |
high-performance liquid chromatography |
|
0.0 |
|
|
|
|
dopamine |
|
|
105613 |
3019 |
| DA-Tph2em3Mcwi+/- |
forebrain dopamine level |
control condition (for 63 days) |
Kaplan K, et al., J Appl Physiol (1985). 2016 May 1;120(9):1070-81. doi: 10.1152/japplphysiol.01015.2015. Epub 2016 Feb 11. |
forebrain dopamine amount |
not specified |
58.0 days-62.0 days |
4 |
|
|
2414.5 |
ng/g |
168.7 |
337.4 |
high-performance liquid chromatography |
|
0.0 |
|
|
|
|
dopamine |
|
|
105614 |
3019 |
| SD-Cftrem1Sage+/+ |
nasal septum epithelium intracellular mucus area to basement membrane width ratio |
control condition (for 42 days) |
Tuggle KL, et al., PLoS One. 2014 Mar 7;9(3):e91253. doi: 10.1371/journal.pone.0091253. eCollection 2014. |
nasal septum morphology trait |
male |
21.0 days-42.0 days |
4 |
|
|
3.5 |
um2/um |
0.9 |
1.8 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
105866 |
3024 |
| SD-Cftrem1Sage-/- |
trachea cartilage area to trachea lumen circumference ratio |
control condition (for 42 days) |
Tuggle KL, et al., PLoS One. 2014 Mar 7;9(3):e91253. doi: 10.1371/journal.pone.0091253. eCollection 2014. |
trachea morphology trait |
male |
21.0 days-42.0 days |
3 |
|
|
0.08 |
mm2/mm |
0.01 |
0.02 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
105873 |
3024 |
| SD-Cftrem1Sage+/+ |
trachea cartilage area to trachea lumen circumference ratio |
control condition (for 42 days) |
Tuggle KL, et al., PLoS One. 2014 Mar 7;9(3):e91253. doi: 10.1371/journal.pone.0091253. eCollection 2014. |
trachea morphology trait |
male |
21.0 days-42.0 days |
3 |
|
|
0.11 |
mm2/mm |
0.01 |
0.02 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
105872 |
3024 |
| SD-Cftrem1Sage+/+ |
trachea epithelial layer thickness |
control condition (for 42 days) |
Tuggle KL, et al., PLoS One. 2014 Mar 7;9(3):e91253. doi: 10.1371/journal.pone.0091253. eCollection 2014. |
trachea morphology trait |
male |
21.0 days-42.0 days |
3 |
|
|
11.5 |
um |
0.7 |
1.21 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
105876 |
3024 |
| SD-Ahrem2Sage |
serum alanine aminotransferase activity level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood alanine transaminase amount |
male |
84.0 days
| 5 |
|
|
59.4 |
U/l |
14.6 |
32.65 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106363 |
3025 |
| SD-Ahrem2Sage |
serum aspartate aminotransferase activity level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood aspartate transaminase amount |
male |
84.0 days
| 5 |
|
|
154.4 |
U/l |
8.4 |
18.78 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106367 |
3025 |
| SD-Ahrem2Sage |
serum alkaline phosphatase activity level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood alkaline phosphatase amount |
male |
84.0 days
| 5 |
|
|
77.8 |
U/l |
14.8 |
33.09 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106371 |
3025 |
| SD-Ahrem2Sage |
serum total bilirubin level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood bilirubin amount |
male |
84.0 days
| 5 |
|
|
0.06 |
mg/dl |
0.02 |
0.04 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106375 |
3025 |
| Hsd:SD |
serum albumin level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood albumin amount |
male |
84.0 days
| 5 |
|
|
4.5 |
g/dl |
0.3 |
0.67 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106386 |
3025 |
| SD-Ahrem2Sage |
serum globulin level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood globulin amount |
female |
84.0 days
| 4 |
|
|
2.2 |
g/dl |
0.1 |
0.2 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106393 |
3025 |
| SD-Ahrem2Sage |
blood albumin level to blood globulin level ratio |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood albumin amount |
male |
84.0 days
| 5 |
|
|
1.8 |
null |
0.2 |
0.45 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106395 |
3025 |
| SD-Ahrem2Sage |
blood albumin level to blood globulin level ratio |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood albumin amount |
female |
84.0 days
| 4 |
|
|
2.0 |
null |
0.1 |
0.2 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106397 |
3025 |
| Hsd:SD |
serum triglyceride level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood triglyceride amount |
female |
84.0 days
| 5 |
|
|
130.4 |
mg/dl |
35.4 |
79.16 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106404 |
3025 |
| SD-Ahrem2Sage |
serum creatinine level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood creatinine amount |
female |
84.0 days
| 4 |
|
|
0.38 |
mg/dl |
0.05 |
0.1 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106413 |
3025 |
| SD-Ahrem2Sage |
serum sodium level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood sodium amount |
female |
84.0 days
| 4 |
|
|
146.8 |
mmol/l |
2.1 |
4.2 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106421 |
3025 |
| Hsd:SD |
serum chloride level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood chloride amount |
female |
84.0 days
| 5 |
|
|
100.4 |
mmol/l |
4.8 |
10.73 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106428 |
3025 |
| SD-Ahrem2Sage |
serum chloride level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood chloride amount |
female |
84.0 days
| 4 |
|
|
99.0 |
mmol/l |
2.3 |
4.6 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106429 |
3025 |
| Hsd:SD |
body weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
body mass |
male |
84.0 days
| 5 |
|
|
386.2 |
g |
20.4 |
45.62 |
body weighing method |
|
|
|
|
|
|
|
|
|
106438 |
3025 |
| SD-Ahrem2Sage |
body weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
body mass |
female |
84.0 days
| 5 |
|
|
252.7 |
g |
18.8 |
42.04 |
body weighing method |
|
|
|
|
|
|
|
|
|
106441 |
3025 |
| SD-Ahrem2Sage |
kidney weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
kidney mass |
female |
84.0 days
| 5 |
|
|
0.99 |
g |
0.09 |
0.2 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
106449 |
3025 |
| SD-Ahrem2Sage |
heart weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
heart mass |
male |
84.0 days
| 5 |
|
|
0.38 |
g |
0.02 |
0.04 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
106451 |
3025 |
| Hsd:SD |
pancreas weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
pancreas mass |
male |
84.0 days
| 5 |
|
|
280.0 |
mg |
40.0 |
89.44 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
106454 |
3025 |
| SD-Ahrem2Sage |
pancreas weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
pancreas mass |
female |
84.0 days
| 5 |
|
|
330.0 |
mg |
110.0 |
245.97 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
106457 |
3025 |
| SD-Ahrem2Sage |
spleen weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
spleen mass |
male |
84.0 days
| 5 |
|
|
0.24 |
g |
0.02 |
0.04 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
106459 |
3025 |
| Hsd:SD |
lung weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
lung mass |
male |
84.0 days
| 5 |
|
|
0.59 |
g |
0.11 |
0.25 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
106470 |
3025 |
| SD-Ahrem2Sage |
pituitary gland weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
pituitary gland mass |
male |
84.0 days
| 5 |
|
|
0.0 |
g |
0.0 |
0.0 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
106483 |
3025 |
| Hsd:SD |
both ovaries weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
ovary mass |
female |
84.0 days
| 12 |
|
|
0.05 |
g |
0.0 |
0.01 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
106486 |
3025 |
| SD-Ahrem2Sage |
both ovaries weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
ovary mass |
female |
84.0 days
| 12 |
|
|
0.04 |
g |
0.0 |
0.01 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
106487 |
3025 |
| Hsd:SD |
epididymides weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
epididymis mass |
male |
84.0 days
| 12 |
|
|
0.56 |
g |
0.06 |
0.21 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
106490 |
3025 |
| LOU/M |
serum creatinine level |
control condition |
van Hoesel QG, etal., J Natl Cancer Inst. 1986 Feb;76(2):299-307. |
blood creatinine amount |
female |
84.0 days
| 43 |
|
|
0.43 |
mg/dl |
0.01 |
0.03 |
serum creatinine analysis |
|
0.0 |
|
|
|
|
|
|
|
109291 |
3144 |
| MWF/Ztm |
kidney glomerulus diameter |
control condition |
Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882. |
kidney glomerulus size trait |
male |
20.0 days
| 5 |
|
|
62.5 |
um |
0.98 |
2.2 |
ex vivo light microscopy with histochemistry |
|
0.0 |
|
|
|
|
|
|
|
109356 |
3137 |
| SHR/Bbb |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
control condition |
Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. |
vasodilation trait |
male |
84.0 days
| 10 |
|
|
68.1 |
% |
4.3 |
13.6 |
wire myography |
|
0.0 |
|
|
|
|
|
|
|
109368 |
3141 |
| SHR/FubRkb |
norepinephrine-induced blood vessel contractile force expressed as percent of force of contraction to KCL |
control condition |
Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. |
vasoconstriction trait |
male |
84.0 days
| 10 |
|
|
147.4 |
% |
18.0 |
56.92 |
wire myography |
|
0.0 |
|
|
|
|
norepinephrine-induced blood vessel contractile force expressed as percent of force at baseline (CMO:0003676) |
|
|
109378 |
3141 |
| MWF-Chr 8SHR/Rkb |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
control condition |
Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. |
vasodilation trait |
male |
84.0 days
| 10 |
|
|
83.4 |
% |
7.0 |
22.14 |
wire myography |
|
0.0 |
|
|
|
|
|
|
|
109370 |
3141 |
| WKY/NCrl |
negative logarithm of the molar concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value |
control condition |
Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. |
vasoconstriction trait |
male |
84.0 days
| 10 |
|
|
7.8 |
null |
0.2 |
0.63 |
wire myography |
|
0.0 |
|
|
|
|
logarithm of the concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value (CMO:0003677) |
|
|
109382 |
3141 |
| SHR/FubRkb |
fetal body weight |
control condition |
Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a. |
body mass |
not specified |
-5.0 days
| 10 |
|
|
0.24 |
g |
0.01 |
0.02 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
109507 |
3145 |
| MWF/FubRkb |
kidney weight |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
kidney mass |
male |
58.0 days
| 5 |
|
|
1.06 |
g |
0.04 |
0.08 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
109699 |
3152 |
| MWF/FubRkb |
kidney weight |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
kidney mass |
female |
58.0 days
| 5 |
|
|
0.73 |
g |
0.03 |
0.07 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
109700 |
3152 |
| MWF/Hsd |
body weight |
control condition |
Ulu N, etal., Am J Nephrol. 2009;30(3):209-17. doi: 10.1159/000218062. Epub 2009 May 5. |
body mass |
male |
182.0 days
| 12 |
|
|
375.0 |
g |
7.0 |
24.25 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
109756 |
3153 |
| LEW/SsNHsd |
plasma symmetric dimethylarginine level |
control condition |
Ulu N, etal., Am J Nephrol. 2009;30(3):209-17. doi: 10.1159/000218062. Epub 2009 May 5. |
blood arginine amount |
male |
182.0 days
| 12 |
|
|
0.18 |
umol/l |
0.01 |
0.03 |
high-performance liquid chromatography |
|
0.0 |
|
|
|
|
|
|
|
109819 |
3153 |
| MWF/Hsd |
plasma asymmetric dimethylarginine level |
control condition |
Ulu N, etal., Am J Nephrol. 2009;30(3):209-17. doi: 10.1159/000218062. Epub 2009 May 5. |
blood arginine amount |
male |
182.0 days
| 12 |
|
|
0.43 |
umol/l |
0.01 |
0.03 |
high-performance liquid chromatography |
|
0.0 |
|
|
|
|
|
|
|
109818 |
3153 |
| FHH/EurMcwiCrl |
plasma symmetric dimethylarginine level |
control condition |
Ulu N, etal., Am J Nephrol. 2009;30(3):209-17. doi: 10.1159/000218062. Epub 2009 May 5. |
blood arginine amount |
male |
182.0 days
| 12 |
|
|
0.22 |
umol/l |
0.01 |
0.03 |
high-performance liquid chromatography |
|
0.0 |
|
|
|
|
|
|
|
109821 |
3153 |
| GK/Par |
heart weight to body weight ratio |
control condition |
Fourny N, et al., Nutrients. 2019 Jan 6;11(1). pii: nu11010105. doi: 10.3390/nu11010105. |
heart mass |
female |
270.0 days-300.0 days |
14 |
|
|
3.69 |
g/kg |
0.06 |
0.22 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
109882 |
3159 |
| GK/MolTac |
food intake rate |
control condition |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
eating behavior trait |
female |
60.0 days
| 6 |
|
|
16.1 |
g/d |
0.4 |
0.98 |
food intake measuring method |
|
0.0 |
|
|
|
|
|
|
food consumption |
106899 |
3071 |
| WKY/NMolTac |
blood glucose level |
control condition |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
blood glucose amount |
female |
60.0 days
| 6 |
|
|
106.2 |
mg/dl |
7.2 |
17.64 |
blood glucose test strip read by optical glucometer |
|
0.0 |
|
|
|
|
|
|
fasting blood glucose, non fasting blood glucose |
106908 |
3071 |
| WKY/NMolTac |
blood glucose level |
control condition |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
blood glucose amount |
female |
420.0 days
| 9 |
|
|
93.6 |
mg/dl |
5.4 |
16.2 |
blood glucose test strip read by optical glucometer |
|
0.0 |
|
|
|
|
|
|
fasting blood glucose, non fasting blood glucose |
106910 |
3071 |
| SHRSP/A3NCrl |
end-diastolic volume |
control condition |
Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. |
cardiac output trait |
male |
134.0 days-141.0 days |
8 |
|
|
0.04 |
ml |
0.02 |
0.05 |
transthoracic echocardiography |
|
0.0 |
|
|
|
3-5 cardiac cycles |
|
|
|
106965 |
3073 |
| SHRSP/A3NCrl |
cardiac output |
control condition |
Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. |
cardiac output trait |
male |
134.0 days-141.0 days |
8 |
|
|
89.0 |
ml/min |
4.0 |
11.31 |
transthoracic echocardiography |
|
0.0 |
|
|
|
3-5 cardiac cycles |
|
|
|
106996 |
3073 |
| SHRSP/A3NCrl |
ejection fraction |
control condition |
Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. |
cardiac output trait |
male |
134.0 days-141.0 days |
8 |
|
|
65.0 |
% |
1.0 |
2.83 |
transthoracic echocardiography |
|
0.0 |
|
|
|
3-5 cardiac cycles |
|
|
|
107022 |
3073 |
| SHRSP/A3NCrl |
stroke volume |
control condition |
Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. |
cardiac output trait |
male |
134.0 days-141.0 days |
8 |
|
|
255000.0 |
ml |
9000.0 |
25455.84 |
transthoracic echocardiography |
|
0.0 |
|
|
|
3-5 cardiac cycles |
|
|
|
107028 |
3073 |
| SHRSP/A3NCrl |
mean arterial blood pressure |
control condition |
Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. |
arterial blood pressure trait |
male |
99.0 days-141.0 days |
9 |
|
serial mean |
153.0 |
mmHg |
2.0 |
6.0 |
vascular indwelling catheter method |
femoral artery |
432000.0 |
|
|
|
10 seconds every 5 minutes for 24hr |
8 weeks |
|
baseline and after treatment |
107047 |
3073 |
| SHRSP/A3NCrl |
concentration of carbachol at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
control condition |
Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. |
vasodilation trait |
male |
141.0 days-148.0 days |
14 |
|
|
119.0 |
nmol/l |
15.0 |
56.12 |
tissue force analysis utilizing a force transducer |
|
0.0 |
|
|
|
|
percent reversal of contractile response to 0.3uM phenylephrine |
|
|
107299 |
3073 |
| SS/HsdMcwiCrl |
body weight |
control condition |
Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53. |
body mass |
male |
88.0 days-94.0 days |
8 |
|
|
341.0 |
g |
16.0 |
45.25 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
107348 |
3077 |
| DA/OlaHsd |
body weight |
control condition |
Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53. |
body mass |
male |
88.0 days-94.0 days |
9 |
|
|
258.0 |
g |
6.0 |
18.0 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
107354 |
3077 |
| SHRSP/A3NCrl |
systolic blood pressure |
control condition (for 91 days) |
Lenhard SC, etal., J Pharmacol Exp Ther. 2003 Dec;307(3):939-46. doi: 10.1124/jpet.103.057398. Epub 2003 Oct 15. |
arterial blood pressure trait |
male |
161.0 days-175.0 days |
7 |
|
|
160.0 |
mmHg |
5.0 |
13.23 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
|
|
107386 |
3083 |
| LEC/Hok |
liver copper weight to liver dry weight ratio |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
hepatic copper amount |
female |
224.0 days
| 3 |
|
|
631.1 |
ug/g |
113.1 |
195.9 |
flame atomic absorption spectrometry |
|
0.0 |
|
|
|
|
|
|
|
107417 |
3086 |
| LEC/Hok |
serum copper level |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
blood copper amount |
male |
168.0 days
| 3 |
|
|
5.0 |
umol/l |
0.92 |
1.6 |
graphite furnace atomic absorption spectrometry |
|
0.0 |
|
|
|
|
|
|
|
107505 |
3086 |
| LEA/Hok |
urine copper level to urine creatinine level ratio |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
urine copper amount |
male |
168.0 days
| 3 |
|
|
1.07 |
umol/umol Cr |
0.29 |
0.5 |
graphite furnace atomic absorption spectrometry |
|
0.0 |
|
|
|
|
urine copper level to urine creatinine level ratio (CMO:0003493) |
|
|
107507 |
3086 |
| LEA/Hok |
urine copper level to urine creatinine level ratio |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
urine copper amount |
female |
168.0 days
| 3 |
|
|
3.76 |
umol/umol Cr |
0.82 |
1.42 |
graphite furnace atomic absorption spectrometry |
|
0.0 |
|
|
|
|
urine copper level to urine creatinine level ratio (CMO:0003493) |
|
|
107509 |
3086 |
| WKY/N |
kidney weight |
control condition (between 42 and 77 days) |
Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21. |
kidney mass |
male |
126.0 days-182.0 days |
|
|
|
2.18 |
g |
0.08 |
|
post excision weight measurement |
kidney |
0.0 |
|
|
|
|
|
|
|
107529 |
3090 |
| WKY/N |
kidney total tubule cast count |
control condition |
Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21. |
kidney integrity trait |
male |
126.0 days-182.0 days |
|
|
|
1.0 |
/section |
1.0 |
|
ex vivo light microscopy with histochemistry |
|
0.0 |
|
|
|
|
|
|
|
107553 |
3090 |
| SHRSP/A3N |
body weight |
control condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
body mass |
male |
120.0 days-140.0 days |
24 |
|
|
316.0 |
g |
9.0 |
44.09 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
107572 |
3093 |
| SHRSP/A3N |
thymus weight |
control condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
thymus mass |
female |
120.0 days-140.0 days |
24 |
|
|
0.17 |
g |
0.01 |
0.02 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
107586 |
3093 |
| SHRSP/A3N |
kidney weight |
control condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
kidney mass |
female |
120.0 days-140.0 days |
24 |
|
|
0.81 |
g |
0.01 |
0.05 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
107594 |
3093 |
| SHRSP/A3N |
serum alanine aminotransferase activity level |
control condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood alanine transaminase amount |
male |
120.0 days-140.0 days |
24 |
|
|
70.0 |
U/l |
6.0 |
29.39 |
automated serum analysis |
|
0.0 |
|
|
|
|
|
|
|
107608 |
3093 |
| NISAG |
plasma corticosterone level |
control condition |
Cherkasova OP, Bull Exp Biol Med. 2006 Jan;141(1):30-2. doi: 10.1007/s10517-006-0085-4. |
blood corticosterone amount |
male |
150.0 days-180.0 days |
6 |
|
|
46.0 |
ng/ml |
5.31 |
13.0 |
plasma corticosterone analysis |
|
0.0 |
|
|
|
plasma corticosterone analysis (MMO:0000745) |
NISAG rat strain |
|
|
107653 |
3087 |
| WAG/Nov |
plasma 11-dehydrocorticosterone level |
control condition |
Cherkasova OP, Bull Exp Biol Med. 2006 Jan;141(1):30-2. doi: 10.1007/s10517-006-0085-4. |
blood corticosterone amount |
male |
150.0 days-180.0 days |
6 |
|
|
20.0 |
ng/ml |
3.27 |
8.0 |
plasma 11-dehydrocorticosterone analysis |
|
0.0 |
|
|
|
plasma 11-dehydrocorticosterone analysis (MMO:0000748) |
|
|
|
107656 |
3087 |
| WAG/Nov |
spleen cell count |
control condition |
Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. |
spleen morphology trait |
male |
150.0 days-180.0 days |
10 |
|
|
582.17 |
x10E6/organ |
139.01 |
439.59 |
isolated cell counting method |
|
0.0 |
|
|
|
|
|
|
|
107699 |
3096 |
| ISIAH |
CD45RA+ splenocyte count to total splenocyte count ratio |
control condition |
Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. |
splenocyte morphology trait |
male |
150.0 days-180.0 days |
10 |
|
|
35.23 |
% |
0.8 |
2.53 |
flow cytometry method |
|
0.0 |
|
|
|
|
cd45 RA+ spleen |
|
|
107744 |
3096 |
| ISIAH |
CD3+ splenocyte count |
control condition |
Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. |
splenocyte morphology trait |
male |
150.0 days-180.0 days |
10 |
|
|
252.6 |
x10E6/organ |
32.4 |
102.46 |
flow cytometry method |
|
0.0 |
|
|
|
|
cd3+ spleen |
|
|
107756 |
3096 |
| SHRSP/A3NCrl |
percentage of study population developing cerebral small perivascular bleeds and no beta-amyloid deposits during a period of time |
control condition |
Pirici D, etal., Brain Pathol. 2017 Mar;27(2):169-180. doi: 10.1111/bpa.12384. Epub 2016 May 30. |
cerebral cortex integrity trait |
male |
84.0 days-308.0 days |
62 |
|
|
26.0 |
% |
|
|
ex vivo light microscopy with histochemistry |
|
0.0 |
|
|
|
|
|
|
|
107922 |
3099 |
| W/Jpe |
plasma free fatty acids level |
control condition |
Sena CM, etal., Br J Pharmacol. 2008 Mar;153(5):894-906. doi: 10.1038/sj.bjp.0707474. Epub 2007 Oct 1. |
blood free fatty acid amount |
male |
540.0 days
| 20 |
|
|
0.54 |
mmol/l |
0.15 |
0.67 |
enzymatic lipid assay |
|
0.0 |
|
|
|
|
|
|
|
108014 |
3108 |
| GK/Jpe |
plasma free fatty acids level |
control condition |
Sena CM, etal., Br J Pharmacol. 2008 Mar;153(5):894-906. doi: 10.1038/sj.bjp.0707474. Epub 2007 Oct 1. |
blood free fatty acid amount |
male |
540.0 days
| 20 |
|
|
0.74 |
mmol/l |
0.1 |
0.45 |
enzymatic lipid assay |
|
0.0 |
|
|
|
|
|
|
|
108015 |
3108 |
| GK/Jpe |
urine albumin excretion rate |
control condition |
Sena CM, etal., Br J Pharmacol. 2008 Mar;153(5):894-906. doi: 10.1038/sj.bjp.0707474. Epub 2007 Oct 1. |
urine albumin amount |
male |
540.0 days
| 20 |
|
|
29.2 |
mg/d |
4.7 |
21.02 |
urine albumin analysis |
|
0.0 |
|
|
|
|
|
|
|
108020 |
3108 |
| W/Jpe |
urine albumin excretion rate |
control condition |
Sena CM, etal., Br J Pharmacol. 2008 Mar;153(5):894-906. doi: 10.1038/sj.bjp.0707474. Epub 2007 Oct 1. |
urine albumin amount |
male |
540.0 days
| 20 |
|
|
2.2 |
mg/d |
0.4 |
1.79 |
urine albumin analysis |
|
0.0 |
|
|
|
|
|
|
|
108019 |
3108 |
| LOU/M |
percentage of study population developing intestine tumors during a period of time |
control condition |
Bazin H, etal., Cancer Lett. 1980 Feb;8(4):353-7. doi: 10.1016/0304-3835(80)90152-4. |
intestine integrity trait |
both |
240.0 days-720.0 days |
163 |
|
|
0.6 |
% |
|
|
manual palpation method |
|
0.0 |
|
|
|
|
|
|
|
108047 |
3114 |
| Hsd:WI |
fetal body weight |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
body mass |
not specified |
-6.0 days
| |
|
|
0.31 |
g |
0.0 |
|
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
108070 |
3115 |
| Hsd:WI |
neonatal body weight |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
body mass |
not specified |
12.0 days
| |
|
|
22.8 |
g |
0.4 |
|
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
108080 |
3115 |
| W/Kyo |
soleus muscle weight to body weight ratio |
control condition |
Kondo H, etal., Muscle Nerve. 2015 Mar;51(3):391-9. doi: 10.1002/mus.24316. Epub 2015 Jan 6. |
soleus muscle mass |
male |
63.0 days
| 6 |
|
|
0.36 |
mg/g |
0.01 |
0.02 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
108115 |
3110 |
| SHR |
systolic blood pressure |
control condition |
Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9. |
arterial blood pressure trait |
male |
90.0 days-120.0 days |
7 |
|
|
163.57 |
mmHg |
8.15 |
21.55 |
tail cuff plethysmography |
|
|
|
|
|
|
|
|
|
108284 |
3101 |
| SHR |
measurement of minimal mechanical stimulus needed to elicit evasive reaction |
control condition |
Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9. |
tactile sensory behavior trait |
male |
90.0 days-120.0 days |
7 |
|
|
9.8 |
gx10 |
0.37 |
0.97 |
Randall-Selitto test |
|
|
|
|
|
|
|
|
|
108344 |
3101 |
| WKY |
measurement of minimal mechanical stimulus needed to elicit evasive reaction |
control condition |
Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9. |
tactile sensory behavior trait |
male |
90.0 days-120.0 days |
7 |
|
|
11.3 |
gx10 |
0.41 |
1.08 |
Randall-Selitto test |
|
|
|
|
|
|
|
|
|
108345 |
3101 |
| SHR |
measurement of minimal mechanical stimulus needed to elicit evasive reaction |
control condition |
Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9. |
tactile sensory behavior trait |
male |
90.0 days-120.0 days |
7 |
|
|
9.85 |
gx10 |
0.58 |
1.53 |
Randall-Selitto test |
|
|
|
|
|
|
|
|
|
108352 |
3101 |
| WKY |
systolic blood pressure |
control condition |
Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9. |
arterial blood pressure trait |
male |
90.0 days-120.0 days |
7 |
|
|
123.4 |
mmHg |
0.76 |
2.0 |
tail cuff plethysmography |
|
|
|
|
|
|
|
|
|
108365 |
3101 |
| RCS/N |
scotopic B wave amplitude of ERG waveform |
control condition then controlled exposure to darkness (for 12 hours) then visible light stimulus (2.5 cd x s/m2) |
Deng WT, et al., Invest Ophthalmol Vis Sci. 2012 Apr 6;53(4):1895-904. doi: 10.1167/iovs.11-8831. |
rod electrophysiology trait |
not specified |
62.0 days
| 6 |
|
|
61.0 |
uV |
19.6 |
48.0 |
electroretinography |
cornea |
0.0 |
AAV8 injection |
60 |
days |
contralateral control eye |
scotopic b-wave amplitude ERG |
|
|
108683 |
3129 |
| RCS-p+/LavRrrc |
retinal inner nuclear layer thickness |
control condition |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
retinal inner nuclear layer morphology trait |
both |
75.0 days
| 3 |
|
|
25.1 |
um |
1.3 |
2.25 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
55 |
days |
control for age matched plasmid injection |
|
|
|
108698 |
3131 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
control condition then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
rod electrophysiology trait |
both |
53.0 days
| 5 |
|
|
186.0 |
uV |
23.8 |
53.22 |
electroretinography |
cornea |
0.0 |
|
37 |
days |
control for age matched plasmid injection |
scotopic b-wave ERG |
|
|
108702 |
3131 |
| HsdCpb:WU |
lung wet weight to body weight ratio |
control condition |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
lung mass |
male |
84.0 days
| 5 |
|
|
0.33 |
% |
0.0 |
0.0 |
post excision weight measurement |
lung |
0.0 |
|
|
|
|
|
|
|
108762 |
3130 |
| HsdCpb:WU |
urine total protein excretion rate |
control condition |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
total urine protein amount |
male |
84.0 days
| 5 |
|
|
28.0 |
mg/d |
5.0 |
11.18 |
urine total protein analysis |
|
0.0 |
|
|
|
|
|
|
|
108766 |
3130 |
| SD-Cftrem1Apb |
hematocrit |
control condition |
McCarron A, et al., Am J Pathol. 2020 May;190(5):977-993. doi: 10.1016/j.ajpath.2020.01.009. Epub 2020 Feb 18. |
erythrocyte quantity |
not specified |
days
| |
|
|
51.0 |
% |
4.0 |
|
hematocrit analysis |
|
0.0 |
|
|
|
|
|
|
|
111448 |
3184 |
| SD-Htr7em1Msu |
plasma osmolality |
control condition |
Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. |
blood homeostasis trait |
male |
91.0 days-154.0 days |
|
|
|
287.3 |
umol/g |
2.75 |
|
osmometry |
|
0.0 |
|
|
|
|
|
|
calculated plasma osmolality - mmol/kg body weight |
111472 |
3067 |
| MWF |
urine total protein excretion rate |
control condition |
Fassi A, etal., Am J Kidney Dis. 1999 Feb;33(2):267-75. doi: 10.1016/s0272-6386(99)70299-4. |
total urine protein amount |
male |
126.0 days-140.0 days |
6 |
|
|
133.0 |
mg/d |
16.33 |
40.0 |
Bradford protein assay |
|
0.0 |
|
|
|
|
|
|
|
110013 |
3163 |
| SD-Cftrem1Apb |
litter size |
control condition |
McCarron A, et al., Am J Pathol. 2020 May;190(5):977-993. doi: 10.1016/j.ajpath.2020.01.009. Epub 2020 Feb 18. |
fertility trait |
female |
days
| 3 |
|
|
9.8 |
null |
|
|
in vivo visual assessment |
|
0.0 |
|
|
|
|
3 het p508 x 3 homo p508 16 litters |
|
|
110764 |
3184 |
| MWF/FubRkb |
kidney wet weight to body weight ratio |
control condition |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
kidney mass |
male |
84.0 days
| |
|
|
5.96 |
mg/g |
0.18 |
|
post excision weight measurement |
kidney |
0.0 |
|
|
|
|
|
|
|
109051 |
3116 |
| MWF/FubRkb |
heart weight |
control condition |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
heart mass |
male |
84.0 days
| |
|
|
0.75 |
g |
0.02 |
|
post excision weight measurement |
heart |
0.0 |
|
|
|
|
|
|
|
109057 |
3116 |
| MWF/Ztm |
volume of glomerular capillary tuft occupied by sclerosis |
control condition |
Remuzzi A, etal., Kidney Int. 2006 Apr;69(7):1124-30. doi: 10.1038/sj.ki.5000060. |
kidney glomerulus integrity trait |
male |
350.0 days
| 9 |
|
|
0.43 |
um3 x 10E-6 |
0.03 |
0.1 |
ex vivo light microscopy with histochemistry and digital image analysis |
glomerular tuft |
0.0 |
|
|
|
|
|
|
|
109929 |
3158 |
| MWF/Ztm |
volume of glomerular capillary tuft not affected by sclerosis |
control condition |
Remuzzi A, etal., Kidney Int. 2006 Apr;69(7):1124-30. doi: 10.1038/sj.ki.5000060. |
kidney glomerulus integrity trait |
male |
350.0 days
| 9 |
|
|
0.53 |
um3 x 10E-6 |
0.01 |
0.03 |
ex vivo light microscopy with histochemistry and digital image analysis |
glomerular tuft |
0.0 |
|
|
|
|
|
|
|
109955 |
3158 |
| WAG/Nov |
plasma corticosterone level |
control condition |
Cherkasova OP, Bull Exp Biol Med. 2006 Jan;141(1):30-2. doi: 10.1007/s10517-006-0085-4. |
blood corticosterone amount |
male |
150.0 days-180.0 days |
6 |
|
|
66.0 |
ng/ml |
6.12 |
15.0 |
plasma corticosterone analysis |
|
0.0 |
|
|
|
plasma corticosterone analysis (MMO:0000745) |
|
|
|
107652 |
3087 |
| NISAG |
plasma 11-dehydrocorticosterone level |
control condition |
Cherkasova OP, Bull Exp Biol Med. 2006 Jan;141(1):30-2. doi: 10.1007/s10517-006-0085-4. |
blood corticosterone amount |
male |
150.0 days-180.0 days |
6 |
|
|
17.0 |
ng/ml |
1.63 |
4.0 |
plasma 11-dehydrocorticosterone analysis |
|
0.0 |
|
|
|
plasma 11-dehydrocorticosterone analysis (MMO:0000748) |
|
|
|
107657 |
3087 |
| MHS |
body weight |
control condition |
Capasso G, etal., Am J Physiol Renal Physiol. 2008 Aug;295(2):F556-67. doi: 10.1152/ajprenal.00340.2007. Epub 2008 May 14. |
body mass |
not specified |
85.0 days-87.0 days |
11 |
|
|
364.0 |
g |
5.0 |
16.58 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
110139 |
3164 |
| SD-Myh7bem1Blar+/+ |
heart left ventricle end-diastolic internal diameter |
control condition |
Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17. |
heart left ventricle end-diastolic diameter |
not specified |
84.0 days
| |
|
|
4.98 |
mm |
0.43 |
|
echocardiography |
|
0.0 |
|
|
|
|
SD-Myh7bem1Blar+/+ (RS:0005005) |
|
|
110948 |
3192 |
| SD-Myh7bem1Blar+/- |
heart left ventricle end-diastolic internal diameter |
control condition |
Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17. |
heart left ventricle end-diastolic diameter |
not specified |
84.0 days
| |
|
|
3.34 |
mm |
0.88 |
|
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
110949 |
3192 |
| SD-Myh7bem1Blar-/- |
heart interventricular end-diastolic septal wall thickness |
control condition |
Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17. |
heart ventricle septum thickness |
not specified |
84.0 days
| |
|
|
2.58 |
mm |
0.4 |
|
echocardiography |
|
0.0 |
|
|
|
|
heart left ventricle end-systolic internal diameter (CMO:0003851) |
|
|
110956 |
3192 |
| SD-Myh7bem1Blar-/- |
heart left ventricle end-diastolic posterior wall thickness |
control condition |
Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17. |
heart left ventricle posterior wall thickness |
not specified |
84.0 days
| |
|
|
3.2 |
mm |
0.5 |
|
echocardiography |
|
0.0 |
|
|
|
|
heart left ventricle end-systolic internal diameter (CMO:0003851) |
|
|
110962 |
3192 |
| WKY/N |
urine total protein excretion rate |
control condition |
Wong VY, etal., Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329. |
urine protein amount |
male |
210.0 days-224.0 days |
|
|
|
18.0 |
mg/d |
2.0 |
|
urine protein analysis |
|
86400.0 |
|
|
|
metabolic cage; sulfosalicylic acid method |
|
|
|
107471 |
3088 |
| WAG/Nov |
systolic blood pressure |
control condition |
Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. |
arterial blood pressure trait |
male |
150.0 days-180.0 days |
10 |
|
|
125.0 |
mmHg |
10.2 |
32.26 |
unspecified method |
|
0.0 |
|
|
|
|
|
|
|
107670 |
3096 |
| MHS/Gib |
red blood cell sodium level |
control condition |
Ferrari P, etal., Biochim Biophys Acta. 1992 Oct 19;1111(1):111-9. doi: 10.1016/0005-2736(92)90280-y. |
erythrocyte sodium amount |
male |
49.0 days-56.0 days |
15 |
|
|
3.12 |
mmol/l |
0.13 |
0.5 |
atomic absorption spectrometry |
|
0.0 |
|
|
|
|
|
|
sodium content |
110543 |
3172 |
| MHS/Gib |
red blood cell potassium level |
control condition |
Ferrari P, etal., Biochim Biophys Acta. 1992 Oct 19;1111(1):111-9. doi: 10.1016/0005-2736(92)90280-y. |
erythrocyte potassium amount |
male |
49.0 days-56.0 days |
15 |
|
|
110.6 |
mmol/l |
5.5 |
21.3 |
atomic absorption spectrometry |
|
0.0 |
|
|
|
|
|
|
potassium content trait |
110548 |
3172 |
| MHS/Gib |
rate constant of red blood cell Na-K-Cl cotransport activity |
control condition |
Ferrari P, etal., Biochim Biophys Acta. 1992 Oct 19;1111(1):111-9. doi: 10.1016/0005-2736(92)90280-y. |
erythrocyte physiology trait |
male |
49.0 days-56.0 days |
4 |
|
|
0.04 |
/h |
0.06 |
0.12 |
Na-K-Cl cotransport activity assay in sulfate medium |
|
0.0 |
|
|
|
Na-K-Cl cotransport activity assay in sulfate medium (MMO:0000782) |
|
|
|
110559 |
3172 |
| Sah:SD |
plasma aspartate aminotransferase activity level |
control condition |
McCarron A, et al., Am J Pathol. 2020 May;190(5):977-993. doi: 10.1016/j.ajpath.2020.01.009. Epub 2020 Feb 18. |
blood aspartate transaminase amount |
not specified |
days
| 3 |
|
|
144.33 |
U/l |
27.38 |
47.42 |
automated plasma aspartate aminotransferase activity assay |
|
0.0 |
|
|
|
automated plasma aspartate aminotransferase activity assay (MMO:0000812) |
Sah:SD (RS:0005133) |
|
|
111396 |
3184 |
| GK/MolTac |
serum insulin level |
control condition |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
blood insulin amount |
female |
420.0 days
| 11 |
|
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
|
|
fasting insulin, non fasting insulin |
106919 |
3071 |
| WKY/NMolTac |
serum insulin level |
control condition |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
blood insulin amount |
female |
240.0 days
| 9 |
|
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
|
|
fasting insulin, non fasting insulin |
106921 |
3071 |
| WKY/NMolTac |
heart wet weight |
control condition |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
heart mass |
female |
420.0 days
| |
|
|
0.71 |
g |
0.02 |
|
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
106946 |
3071 |
| SD-Myh7bem1Blar+/- |
heart left ventricle end-systolic internal diameter |
control condition |
Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17. |
heart left ventricle end-systolic diameter |
not specified |
84.0 days
| |
|
|
0.36 |
mm |
0.32 |
|
echocardiography |
|
0.0 |
|
|
|
|
heart left ventricle end-systolic internal diameter (CMO:0003851) |
|
|
110952 |
3192 |
| SD-Myh7bem1Blar+/+ |
maximum rate of positive change in left ventricular blood pressure |
control condition |
Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17. |
heart left ventricular blood pressure trait |
not specified |
84.0 days
| |
|
|
12352.4 |
mmHg/s |
1965.9 |
|
pulsed wave doppler ultrasound |
|
0.0 |
|
|
|
|
|
|
|
110975 |
3192 |
| Sah:SD |
plasma total protein level |
control condition |
McCarron A, et al., Am J Pathol. 2020 May;190(5):977-993. doi: 10.1016/j.ajpath.2020.01.009. Epub 2020 Feb 18. |
blood total protein amount |
not specified |
days
| 3 |
|
|
70.33 |
mg/ml |
1.2 |
2.08 |
automated plasma total protein analysis |
|
0.0 |
|
|
|
|
Sah:SD (RS:0005133) |
|
|
111411 |
3184 |
| SD-Htr7em1Msu |
plasma globulin level |
control condition |
Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. |
blood globulin amount |
male |
91.0 days-154.0 days |
|
|
|
32.66 |
g/l |
0.5 |
|
automated plasma globulin analysis |
|
|
|
|
|
automated plasma globulin analysis (MMO:0000806) |
|
|
plasma globulin |
106837 |
3067 |
| Crl:SD |
plasma triglyceride level |
control condition |
Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. |
blood triglyceride amount |
male |
91.0 days-154.0 days |
|
|
|
0.83 |
mmol/l |
0.22 |
|
automated plasma triglyceride analysis |
|
|
|
|
|
|
|
|
plasma triglyceride |
106843 |
3067 |
| SD-Htr7em1Msu |
plasma triglyceride level |
control condition |
Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. |
blood triglyceride amount |
male |
91.0 days-154.0 days |
|
|
|
0.48 |
mmol/l |
0.08 |
|
automated plasma triglyceride analysis |
|
|
|
|
|
|
|
|
plasma triglyceride |
106845 |
3067 |
| Crl:SD |
plasma total cholesterol level |
control condition |
Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. |
blood cholesterol amount |
male |
91.0 days-154.0 days |
|
|
|
66.8 |
mg/dl |
8.49 |
|
automated plasma total cholesterol analysis |
|
|
|
|
|
|
|
|
plasma total cholesterol |
106847 |
3067 |
| SD-Htr7em1Msu |
plasma glucose level |
control condition |
Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. |
blood glucose amount |
female |
91.0 days-154.0 days |
|
|
|
170.1 |
mg/dl |
3.42 |
|
automated plasma glucose analysis |
|
|
|
|
|
|
|
|
plasma glucose |
106862 |
3067 |
| Crl:SD |
plasma chloride level |
control condition |
Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. |
blood chloride amount |
male |
91.0 days-154.0 days |
|
|
|
101.83 |
mmol/l |
0.31 |
|
automated plasma chloride test |
|
|
|
|
|
|
|
|
plasma chloride |
106871 |
3067 |
| SD-Htr7em1Msu |
plasma chloride level |
control condition |
Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. |
blood chloride amount |
male |
91.0 days-154.0 days |
|
|
|
103.0 |
mmol/l |
0.97 |
|
automated plasma chloride test |
|
|
|
|
|
|
|
|
plasma chloride |
106873 |
3067 |
| Crl:SD |
plasma alkaline phosphatase activity level |
control condition |
Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. |
blood alkaline phosphatase amount |
male |
91.0 days-154.0 days |
|
|
|
279.8 |
IU/l |
45.35 |
|
automated plasma alkaline phosphatase activity assay |
|
|
|
|
|
|
|
|
plasma AP |
106875 |
3067 |
| Crl:SD |
plasma alanine aminotransferase activity level |
control condition |
Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. |
blood alanine transaminase amount |
female |
91.0 days-154.0 days |
|
|
|
41.0 |
U/l |
4.32 |
|
automated plasma alanine aminotransferase activity assay |
|
|
|
|
|
automated plasma alanine aminotransferase activity assay (MMO:0000808) |
|
|
plasma ALT |
106880 |
3067 |
| SD-Htr7em1Msu |
plasma alanine aminotransferase activity level |
control condition |
Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. |
blood alanine transaminase amount |
male |
91.0 days-154.0 days |
|
|
|
50.83 |
U/l |
3.7 |
|
automated plasma alanine aminotransferase activity assay |
|
|
|
|
|
automated plasma alanine aminotransferase activity assay (MMO:0000808) |
|
|
plasma ALT |
106881 |
3067 |
| GK/MolTac |
kidney fractional mesangial volume |
control condition |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
kidney glomerulus morphology trait |
female |
420.0 days
| |
|
|
35.0 |
% |
1.7 |
|
ex vivo electron microscopy with digital image analysis |
|
0.0 |
|
|
|
|
kidney fractional mesangial volume |
|
|
106949 |
3071 |
| MWF/Hsd |
renal blood flow rate to kidney weight ratio |
control condition |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
arterial blood pressure trait |
male |
84.0 days
| 5 |
|
|
2.6 |
ml/min/g |
0.6 |
1.34 |
flowmetry |
renal artery |
0.0 |
|
|
|
|
|
|
|
108783 |
3130 |
| MWF/Ztm |
body weight |
control condition |
Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882. |
body mass |
male |
20.0 days
| 5 |
|
|
34.7 |
g |
0.91 |
2.03 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
109295 |
3137 |
| MWF/Ztm |
body weight |
control condition |
Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882. |
body mass |
male |
45.0 days
| 5 |
|
|
170.0 |
g |
2.58 |
5.76 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
109296 |
3137 |
| MWF/Ztm |
body weight |
control condition |
Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882. |
body mass |
male |
60.0 days
| 5 |
|
|
229.9 |
g |
4.4 |
9.83 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
109297 |
3137 |
| MWF/Ztm |
kidney wet weight |
control condition |
Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882. |
kidney mass |
male |
10.0 days
| 5 |
|
|
0.21 |
g |
0.0 |
0.01 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
109306 |
3137 |
| MWF/Ztm |
kidney wet weight |
control condition |
Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882. |
kidney mass |
male |
150.0 days
| 5 |
|
|
3.67 |
g |
0.13 |
0.28 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
109311 |
3137 |
| LEW/Ztm |
kidney wet weight |
control condition |
Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882. |
kidney mass |
male |
100.0 days
| 5 |
|
|
3.38 |
g |
0.17 |
0.37 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
109316 |
3137 |
| LEW/Ztm |
kidney wet weight |
control condition |
Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882. |
kidney mass |
male |
150.0 days
| 5 |
|
|
3.22 |
g |
0.26 |
0.58 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
109317 |
3137 |
| MWF/Ztm |
kidney wet weight to body weight ratio |
control condition |
Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882. |
kidney mass |
male |
150.0 days
| 5 |
|
|
8.7 |
mg/g |
0.27 |
0.6 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
109323 |
3137 |
| MWF/Ztm |
kidney wet weight to body weight ratio |
control condition |
Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882. |
kidney mass |
male |
60.0 days
| 5 |
|
|
11.0 |
mg/g |
0.36 |
0.8 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
109320 |
3137 |
| LEW/Ztm |
kidney wet weight to body weight ratio |
control condition |
Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882. |
kidney mass |
male |
20.0 days
| 5 |
|
|
13.7 |
mg/g |
0.22 |
0.5 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
109325 |
3137 |
| LEW/Ztm |
kidney wet weight to body weight ratio |
control condition |
Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882. |
kidney mass |
male |
100.0 days
| 5 |
|
|
9.9 |
mg/g |
0.45 |
1.0 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
109328 |
3137 |
| MWF/Ztm |
renal cortex thickness |
control condition |
Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882. |
kidney cortex morphology trait |
male |
20.0 days
| 5 |
|
|
0.97 |
mm |
0.04 |
0.1 |
ex vivo light microscopy with histochemistry |
|
0.0 |
|
|
|
|
|
|
|
109331 |
3137 |
| MWF/Ztm |
renal cortex thickness |
control condition |
Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882. |
kidney cortex morphology trait |
male |
150.0 days
| 5 |
|
|
2.89 |
mm |
1.29 |
2.89 |
ex vivo light microscopy with histochemistry |
|
0.0 |
|
|
|
|
|
|
|
109336 |
3137 |
| Crl:WI |
kidney weight |
control condition |
Kreutz R, etal., J Hypertens. 2007 Nov;25(11):2308-16. doi: 10.1097/HJH.0b013e3282ef8611. |
kidney mass |
male |
115.0 days
| 8 |
|
|
1.27 |
g |
0.05 |
0.14 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
109848 |
3156 |
| MNS/Gib |
rate constant of red blood cell sodium/potassium passive permeability |
control condition |
Ferrari P, etal., Biochim Biophys Acta. 1992 Oct 19;1111(1):111-9. doi: 10.1016/0005-2736(92)90280-y. |
erythrocyte physiology trait |
male |
49.0 days-56.0 days |
15 |
|
|
0.11 |
/h |
0.01 |
0.04 |
Na+ passive permeability assay |
|
0.0 |
|
|
|
|
rate constant of red blood cell sodium/potassium passive permeability (CMO:0003863) |
|
|
110983 |
3172 |
| Jcl:WI |
serum triglyceride level |
control condition |
Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5. |
blood triglyceride amount |
male |
154.0 days
| 7 |
|
|
312.39 |
mg/dl |
22.12 |
58.53 |
solid phase colorimetry |
|
0.0 |
|
|
|
|
|
|
|
110225 |
3167 |
| Jcl:WI |
serum total cholesterol level |
control condition |
Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5. |
blood cholesterol amount |
male |
154.0 days
| 7 |
|
|
30.89 |
mg/dl |
1.93 |
5.11 |
solid phase colorimetry |
|
0.0 |
|
|
|
|
|
|
|
110229 |
3167 |
| Hsd:WI |
both kidneys wet weight to body weight ratio |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
kidney mass |
male |
100.0 days
| 16 |
|
|
5.7 |
g/kg |
0.2 |
0.8 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
108101 |
3115 |
| Hsd:WI |
creatinine clearance |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
glomerular filtration trait |
not specified |
100.0 days
| |
|
|
2.76 |
ml/min |
0.17 |
|
urine creatinine analysis |
|
0.0 |
|
|
|
|
|
|
|
108105 |
3115 |
| Crl:WI |
blood hemoglobin A1c level |
control condition |
El-Omar MM, et al., Basic Res Cardiol. 2004 Mar;99(2):133-41. doi: 10.1007/s00395-004-0440-4. Epub 2003 Oct 7. |
blood hemoglobin amount |
male |
150.0 days-240.0 days |
6 |
|
|
4.0 |
% |
0.03 |
0.07 |
blood hemoglobin analysis |
|
0.0 |
|
|
|
|
at least 6 animals |
|
|
110437 |
3174 |
| Crl:WI |
heart weight to body weight ratio |
control condition |
El-Omar MM, et al., Basic Res Cardiol. 2004 Mar;99(2):133-41. doi: 10.1007/s00395-004-0440-4. Epub 2003 Oct 7. |
heart mass |
male |
150.0 days-240.0 days |
6 |
|
|
3.0 |
g/kg |
0.08 |
0.2 |
post excision weight measurement |
|
0.0 |
|
|
|
|
at least 6 animals |
|
|
110443 |
3174 |
| GK/Wnsm |
heart weight |
control condition |
El-Omar MM, et al., Basic Res Cardiol. 2004 Mar;99(2):133-41. doi: 10.1007/s00395-004-0440-4. Epub 2003 Oct 7. |
heart mass |
male |
150.0 days-240.0 days |
6 |
|
|
1.46 |
g |
0.05 |
0.12 |
post excision weight measurement |
|
0.0 |
|
|
|
|
at least 6 animals |
|
|
110442 |
3174 |
| GK/MolTac |
mean arterial blood pressure |
control condition |
Kold-Petersen H, etal., J Vasc Res. 2012;49(3):267-78. doi: 10.1159/000335487. Epub 2012 Apr 11. |
arterial blood pressure trait |
male |
112.0 days
| |
|
|
118.0 |
mmHg |
1.0 |
|
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
|
|
108031 |
3109 |
| GK/MolTac |
blood glucose level |
control condition |
Kold-Petersen H, etal., J Vasc Res. 2012;49(3):267-78. doi: 10.1159/000335487. Epub 2012 Apr 11. |
blood glucose amount |
male |
154.0 days
| |
|
|
165.6 |
mg/dl |
34.2 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
|
|
|
|
|
|
108037 |
3109 |
| HanTac:WH |
blood glucose level |
control condition |
Kold-Petersen H, etal., J Vasc Res. 2012;49(3):267-78. doi: 10.1159/000335487. Epub 2012 Apr 11. |
blood glucose amount |
male |
112.0 days
| |
|
|
95.4 |
mg/dl |
1.8 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
|
|
|
|
|
|
108034 |
3109 |
| MNS |
total kidney protein to kidney weight ratio |
control condition |
Gmaj P, etal., Biochim Biophys Acta. 1988 Jun 22;941(2):187-97. doi: 10.1016/0005-2736(88)90179-4. |
kidney molecular composition trait |
male |
20.0 days-21.0 days |
15 |
|
|
257.0 |
mg/g |
30.0 |
116.19 |
Bradford protein assay |
|
0.0 |
|
|
|
|
total kidney protein to kidney weight ratio (CMO:0003850) |
|
|
110943 |
3175 |
| WAG/Nov |
plasma corticosterone level to 11-dehydrocorticosterone level ratio |
control condition |
Cherkasova OP, Bull Exp Biol Med. 2006 Jan;141(1):30-2. doi: 10.1007/s10517-006-0085-4. |
blood corticosterone amount |
male |
150.0 days-180.0 days |
6 |
|
|
5.05 |
null |
0.43 |
1.05 |
plasma corticosterone analysis |
|
0.0 |
|
|
|
plasma corticosterone analysis (MMO:0000745) |
|
|
|
107660 |
3087 |
| MWF/FubRkb |
timed urine volume |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
urine output |
not specified |
100.0 days
| |
|
|
11.3 |
ml/d |
1.1 |
|
metabolic cage urine volume measurement method |
|
0.0 |
|
|
|
|
|
|
|
108104 |
3115 |
| RCS-p+/LavRrrc |
retinal outer nuclear layer photoreceptor nucleus count to layer length ratio |
control condition |
Kang S, et al., Transl Vis Sci Technol. 2019 Aug 7;8(4):19. doi: 10.1167/tvst.8.4.19. eCollection 2019 Jul. |
retinal photoreceptor quantity |
not specified |
180.0 days
| 8 |
|
|
3.3 |
/ 100 um |
2.8 |
7.92 |
ex vivo light microscopy with histochemistry |
|
0.0 |
|
|
|
|
|
|
|
109122 |
3082 |
| MWF/FubRkb |
kidney wet weight to body weight ratio |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
kidney mass |
male |
58.0 days
| 5 |
|
|
4.4 |
mg/g |
0.13 |
0.3 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
109713 |
3152 |
| MWF/FubRkb |
kidney wet weight to body weight ratio |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
kidney mass |
female |
58.0 days
| 5 |
|
|
4.4 |
mg/g |
0.09 |
0.2 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
109714 |
3152 |
| MWF/FubRkb |
urine albumin excretion rate |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
urine albumin amount |
male |
44.0 days
| 5 |
|
|
18.4 |
mg/d |
4.65 |
10.4 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
|
|
|
109717 |
3152 |
| MWF/FubRkb |
urine albumin excretion rate |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
urine albumin amount |
male |
58.0 days
| 5 |
|
|
20.07 |
mg/d |
3.0 |
6.7 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
|
|
|
109719 |
3152 |
| MWF/FubRkb |
number of podocytes per kidney glomerulus |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
podocyte morphology trait |
female |
31.0 days
| 5 |
|
|
248.1 |
null |
13.73 |
30.7 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
109722 |
3152 |
| MWF/FubRkb |
number of podocytes per kidney glomerulus |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
podocyte morphology trait |
male |
59.0 days
| 5 |
|
|
241.0 |
null |
11.4 |
25.5 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
109725 |
3152 |
| MNS/Gib |
ouabain-sensitive red blood cell Na+ export rate |
control condition |
Ferrari P, etal., J Hypertens. 1987 Apr;5(2):199-206. doi: 10.1097/00004872-198704000-00011. |
erythrocyte ion transport trait |
male |
50.0 days-70.0 days |
10 |
|
|
880.0 |
umol/l/h |
53.0 |
167.6 |
Na+/K+ ATPase activity assay in choline medium |
|
0.0 |
|
|
|
Na+/K+ ATPase activity assay in choline medium (MMO:0000768) |
|
|
|
110304 |
3169 |
| ACI/SegHsd |
percentage of study population developing unilateral renal agenesis during a period of time |
control condition |
Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. |
kidney integrity trait |
male |
900.0 days
| 12 |
|
|
24.0 |
% |
|
|
necropsy |
|
0.0 |
|
|
|
|
|
|
|
106885 |
341 |
| Hsd:WI |
body weight |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
body mass |
not specified |
100.0 days
| |
|
|
376.0 |
g |
8.0 |
|
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
108082 |
3115 |
| MHS/Gib |
ouabain-sensitive red blood cell Na+ export rate |
control condition |
Ferrari P, etal., J Hypertens. 1987 Apr;5(2):199-206. doi: 10.1097/00004872-198704000-00011. |
erythrocyte ion transport trait |
male |
50.0 days-70.0 days |
9 |
|
|
1069.0 |
umol/l/h |
92.0 |
276.0 |
Na+/K+ ATPase activity assay in Mg++ medium |
|
0.0 |
|
|
|
Na+/K+ ATPase activity assay in Mg++ medium (MMO:0000767) |
|
|
|
110301 |
3169 |
| MNS/Gib |
ouabain-sensitive red blood cell Na+ export rate |
control condition |
Ferrari P, etal., J Hypertens. 1987 Apr;5(2):199-206. doi: 10.1097/00004872-198704000-00011. |
erythrocyte ion transport trait |
male |
50.0 days-70.0 days |
10 |
|
|
1110.0 |
umol/l/h |
11.0 |
34.79 |
Na+/K+ ATPase activity assay in Mg++ medium |
|
0.0 |
|
|
|
Na+/K+ ATPase activity assay in Mg++ medium (MMO:0000767) |
|
|
|
110302 |
3169 |
| MNS/Gib |
bumetanide-sensitive red blood cell Na+ export rate |
control condition |
Ferrari P, etal., J Hypertens. 1987 Apr;5(2):199-206. doi: 10.1097/00004872-198704000-00011. |
erythrocyte ion transport trait |
male |
50.0 days-70.0 days |
10 |
|
|
466.0 |
umol/l/h |
20.0 |
63.25 |
Na-K-Cl cotransport activity assay in choline medium |
|
0.0 |
|
|
|
|
|
|
|
110308 |
3169 |
| MNS/Gib |
ouabain- and bumetanide-resistant red blood cell Na+ import rate |
control condition |
Ferrari P, etal., J Hypertens. 1987 Apr;5(2):199-206. doi: 10.1097/00004872-198704000-00011. |
erythrocyte ion transport trait |
male |
50.0 days-70.0 days |
10 |
|
|
173.3 |
umol/l/h |
19.0 |
60.08 |
Na+ passive permeability assay in Mg++ medium |
|
0.0 |
|
|
|
|
|
|
|
110310 |
3169 |
| MWF/Hsd |
mean arterial blood pressure |
control condition |
Ulu N, etal., Am J Nephrol. 2009;30(3):209-17. doi: 10.1159/000218062. Epub 2009 May 5. |
arterial blood pressure trait |
male |
182.0 days
| 12 |
|
|
110.0 |
mmHg |
4.0 |
13.86 |
vascular transducer tipped catheter |
dorsal aorta |
0.0 |
|
|
|
|
|
|
|
109791 |
3153 |
| MWF/Hsd |
calculated plasma triglyceride level |
control condition |
Ulu N, etal., Am J Nephrol. 2009;30(3):209-17. doi: 10.1159/000218062. Epub 2009 May 5. |
blood triglyceride amount |
male |
182.0 days
| 12 |
|
|
273.7 |
mg/dl |
19.3 |
66.86 |
automated plasma triglyceride analysis |
|
0.0 |
|
|
|
|
|
|
|
109806 |
3153 |
| FHH/EurMcwiCrl |
calculated plasma triglyceride level |
control condition |
Ulu N, etal., Am J Nephrol. 2009;30(3):209-17. doi: 10.1159/000218062. Epub 2009 May 5. |
blood triglyceride amount |
male |
182.0 days
| 14 |
|
|
162.2 |
mg/dl |
13.1 |
49.02 |
automated plasma triglyceride analysis |
|
0.0 |
|
|
|
|
|
|
|
109805 |
3153 |
| FHH/EurMcwiCrl |
plasma total cholesterol level |
control condition |
Ulu N, etal., Am J Nephrol. 2009;30(3):209-17. doi: 10.1159/000218062. Epub 2009 May 5. |
blood cholesterol amount |
male |
182.0 days
| 14 |
|
|
115.6 |
mg/dl |
4.6 |
17.21 |
automated plasma total cholesterol analysis |
|
0.0 |
|
|
|
|
|
|
|
109808 |
3153 |
| FHH/EurMcwiCrl |
plasma arginine level |
control condition |
Ulu N, etal., Am J Nephrol. 2009;30(3):209-17. doi: 10.1159/000218062. Epub 2009 May 5. |
blood arginine amount |
male |
182.0 days
| 14 |
|
|
113.0 |
umol/l |
10.0 |
37.42 |
high-performance liquid chromatography |
|
0.0 |
|
|
|
|
|
|
|
109811 |
3153 |
| LEW/SsNHsd |
plasma asymmetric dimethylarginine level |
control condition |
Ulu N, etal., Am J Nephrol. 2009;30(3):209-17. doi: 10.1159/000218062. Epub 2009 May 5. |
blood arginine amount |
male |
182.0 days
| 12 |
|
|
0.45 |
umol/l |
0.02 |
0.07 |
high-performance liquid chromatography |
|
0.0 |
|
|
|
|
|
|
|
109816 |
3153 |
| LOU/MWsl |
serum albumin level |
control condition |
van Hoesel QG, etal., J Natl Cancer Inst. 1984 May;72(5):1141-50. |
blood albumin amount |
male |
102.0 days
| 5 |
|
|
408.0 |
g/dl |
21.91 |
49.0 |
gel electrophoresis |
|
0.0 |
|
|
|
|
|
|
|
109822 |
3155 |
| GK/MolTac |
body weight |
control condition |
Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22. |
body mass |
male |
112.0 days
| 8 |
|
|
337.1 |
g |
9.3 |
26.3 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
110732 |
3183 |
| Sah:SD |
plasma bicarbonate level |
control condition |
McCarron A, et al., Am J Pathol. 2020 May;190(5):977-993. doi: 10.1016/j.ajpath.2020.01.009. Epub 2020 Feb 18. |
blood bicarbonate amount |
not specified |
days
| 3 |
|
|
19.33 |
mmol/l |
4.63 |
8.02 |
automated plasma bicarbonate test |
|
0.0 |
|
|
|
automated plasma bicarbonate test (MMO:0000819) |
|
|
|
111426 |
3184 |
| Sah:SD |
plasma sodium level |
control condition |
McCarron A, et al., Am J Pathol. 2020 May;190(5):977-993. doi: 10.1016/j.ajpath.2020.01.009. Epub 2020 Feb 18. |
blood sodium amount |
not specified |
days
| 3 |
|
|
148.67 |
mmol/l |
1.86 |
3.22 |
automated plasma sodium test |
|
0.0 |
|
|
|
automated plasma sodium test (MMO:0000823) |
|
|
|
111435 |
3184 |
| Sah:SD |
hematocrit |
control condition |
McCarron A, et al., Am J Pathol. 2020 May;190(5):977-993. doi: 10.1016/j.ajpath.2020.01.009. Epub 2020 Feb 18. |
erythrocyte quantity |
not specified |
days
| |
|
|
49.0 |
% |
2.0 |
|
hematocrit analysis |
|
0.0 |
|
|
|
|
|
|
|
111447 |
3184 |
| MHS |
mean arterial blood pressure |
control condition |
Capasso G, etal., Am J Physiol Renal Physiol. 2008 Aug;295(2):F556-67. doi: 10.1152/ajprenal.00340.2007. Epub 2008 May 14. |
arterial blood pressure trait |
not specified |
85.0 days-87.0 days |
11 |
|
|
167.0 |
mmHg |
1.7 |
5.64 |
vascular indwelling catheter method |
right internal carotid artery |
0.0 |
|
|
|
|
|
|
|
110141 |
3164 |
| MNS |
mean arterial blood pressure |
control condition |
Capasso G, etal., Am J Physiol Renal Physiol. 2008 Aug;295(2):F556-67. doi: 10.1152/ajprenal.00340.2007. Epub 2008 May 14. |
arterial blood pressure trait |
not specified |
85.0 days-87.0 days |
11 |
|
|
139.0 |
mmHg |
1.5 |
4.97 |
vascular indwelling catheter method |
right internal carotid artery |
0.0 |
|
|
|
|
|
|
|
110140 |
3164 |
| MNS/Gib |
mean corpuscular volume |
control condition |
Ferrari P, etal., Biochim Biophys Acta. 1992 Oct 19;1111(1):111-9. doi: 10.1016/0005-2736(92)90280-y. |
erythrocyte size trait |
male |
49.0 days-56.0 days |
15 |
|
|
42.9 |
fl |
0.41 |
1.59 |
Coulter counter cell/particle size/count analysis method |
|
0.0 |
|
|
|
|
|
|
|
110540 |
3172 |
| ISIAH |
amount of time spent making head dipping movements during experiment in an elevated plus maze |
control condition |
Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. |
anxiety-related behavior trait |
male |
84.0 days-98.0 days |
13 |
|
|
22.45 |
s |
2.78 |
10.02 |
computerized assessment of in vivo video recording |
|
300.0 |
|
|
|
within elevated plus maze |
amount of time spent making head dipping movements during experiment in an elevated plus maze (CMO:0003788) |
|
|
110715 |
3182 |
| WAG/Nov |
amount of time spent making head dipping movements during experiment in an elevated plus maze |
control condition |
Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. |
anxiety-related behavior trait |
male |
84.0 days-98.0 days |
6 |
|
|
2.62 |
s |
1.76 |
4.31 |
computerized assessment of in vivo video recording |
|
300.0 |
|
|
|
within elevated plus maze |
amount of time spent making head dipping movements during experiment in an elevated plus maze (CMO:0003788) |
|
|
110716 |
3182 |
| ISIAH |
number of stretched attend postures in elevated zero maze |
control condition |
Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. |
anxiety-related behavior trait |
male |
84.0 days-98.0 days |
13 |
|
|
6.77 |
null |
1.4 |
5.05 |
computerized assessment of in vivo video recording |
|
300.0 |
|
|
|
|
|
|
|
110719 |
3182 |
| WAG/Nov |
amount of time spent making stretched attend posture movements in an elevated plus maze |
control condition |
Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. |
anxiety-related behavior trait |
male |
84.0 days-98.0 days |
6 |
|
|
28.72 |
s |
10.01 |
24.52 |
computerized assessment of in vivo video recording |
|
300.0 |
|
|
|
|
amount of time spent making stretched attend posture movements in an elevated plus maze (CMO:0004087) |
|
|
110722 |
3182 |
| ISIAH |
time to first stretched attend posture movement in an elevated plus maze |
control condition |
Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. |
anxiety-related behavior trait |
male |
84.0 days-98.0 days |
13 |
|
|
64.78 |
s |
21.32 |
76.87 |
computerized assessment of in vivo video recording |
|
300.0 |
|
|
|
|
time to first stretched attend posture movement in an elevated plus maze (CMO:0004088) |
|
|
110723 |
3182 |
| BDIX/CrCrl |
frequency of contractions above 10 mmHg of anorectal pressure |
control condition |
Trebol J, etal., World J Stem Cells. 2018 Jan 26;10(1):1-14. doi: 10.4252/wjsc.v10.i1.1. |
gastrointestinal system physiology trait |
female |
112.0 days-168.0 days |
36 |
|
|
1.7 |
/min |
0.1 |
0.58 |
anorectal manometry |
anus |
720.0 |
|
|
|
|
|
|
|
111007 |
3194 |
| BDIX/CrCrl |
time to peak anorectal sphincter contraction |
control condition |
Trebol J, etal., World J Stem Cells. 2018 Jan 26;10(1):1-14. doi: 10.4252/wjsc.v10.i1.1. |
gastrointestinal system physiology trait |
female |
112.0 days-168.0 days |
36 |
|
|
8.88 |
s |
0.49 |
2.93 |
anorectal manometry |
anus |
1800.0 |
|
|
|
|
|
|
|
111009 |
3194 |
| BDIX/CrCrl |
duration of contractions above 10 mmHg of anorectal pressure |
control condition |
Trebol J, etal., World J Stem Cells. 2018 Jan 26;10(1):1-14. doi: 10.4252/wjsc.v10.i1.1. |
gastrointestinal system physiology trait |
female |
112.0 days-168.0 days |
36 |
|
|
26.67 |
s |
1.11 |
6.67 |
anorectal manometry |
anus |
1800.0 |
|
|
|
|
|
|
|
111008 |
3194 |
| BDIX/Orl |
body weight |
control condition |
Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7. |
body mass |
female |
84.0 days
| 2 |
|
|
207.0 |
g |
0.0 |
15.6 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
body weight |
106977 |
3074 |
| BDIX/Orl |
body weight |
control condition |
Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7. |
body mass |
female |
119.0 days- days |
2 |
|
|
241.0 |
g |
7.99 |
11.3 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
body weight |
106978 |
3074 |
| SHRSP/A3N |
heart wet weight |
control condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
heart mass |
male |
120.0 days-140.0 days |
24 |
|
|
1.41 |
g |
0.02 |
0.11 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
107588 |
3093 |
| WKY/NCrl |
body weight |
control condition |
Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. |
body mass |
male |
84.0 days
| 10 |
|
|
282.4 |
g |
4.9 |
15.5 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
109272 |
3141 |
| WKY/NCrl |
heart weight to body weight ratio |
control condition |
Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. |
heart mass |
male |
84.0 days
| 10 |
|
|
2.65 |
g/kg |
0.08 |
0.25 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
109278 |
3141 |
| SHR/FubRkb |
heart weight to body weight ratio |
control condition |
Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. |
heart mass |
male |
84.0 days
| 10 |
|
|
2.86 |
g/kg |
0.02 |
0.06 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
109279 |
3141 |
| SHR/FubRkb |
urine albumin excretion rate |
control condition |
Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. |
urine albumin amount |
male |
84.0 days
| 10 |
|
|
1.1 |
mg/d |
0.2 |
0.63 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
|
|
|
109285 |
3141 |
| MHS |
plasma sodium level |
control condition |
Capasso G, etal., Am J Physiol Renal Physiol. 2008 Aug;295(2):F556-67. doi: 10.1152/ajprenal.00340.2007. Epub 2008 May 14. |
blood sodium amount |
not specified |
85.0 days-87.0 days |
11 |
|
|
146.7 |
mmol/l |
1.3 |
4.31 |
automated blood electrolyte analysis |
|
0.0 |
|
|
|
|
|
|
|
110153 |
3164 |
| MHS |
urine chloride excretion rate |
control condition |
Capasso G, etal., Am J Physiol Renal Physiol. 2008 Aug;295(2):F556-67. doi: 10.1152/ajprenal.00340.2007. Epub 2008 May 14. |
urine chloride amount |
not specified |
85.0 days-87.0 days |
5 |
|
|
1.79 |
umol/min |
0.41 |
0.92 |
urine electrolyte analysis |
|
0.0 |
|
|
|
|
|
|
|
110164 |
3164 |
| GK/Jcl |
body weight |
control condition |
Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5. |
body mass |
male |
154.0 days
| 7 |
|
|
339.0 |
g |
7.12 |
18.84 |
body measuring method |
|
0.0 |
|
|
|
|
|
|
|
110207 |
3167 |
| ISIAH |
body weight |
control condition |
Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. |
body mass |
male |
14.0 days
| 13 |
|
|
21.0 |
g |
1.8 |
6.49 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
110673 |
3182 |
| WAG/Nov |
body weight |
control condition |
Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. |
body mass |
male |
14.0 days
| 15 |
|
|
21.2 |
g |
1.6 |
6.2 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
110674 |
3182 |
| WAG/Nov |
systolic blood pressure |
control condition |
Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. |
arterial blood pressure trait |
male |
84.0 days-98.0 days |
6 |
|
|
134.58 |
mmHg |
6.28 |
15.38 |
tail cuff volume pressure recording |
|
0.0 |
|
|
|
|
|
|
|
110682 |
3182 |
| MWF/Ztm |
urine total protein excretion rate |
control condition |
Macconi D, etal., J Am Soc Nephrol. 2000 Mar;11(3):477-89. |
total urine protein amount |
male |
140.0 days
| 15 |
|
|
233.0 |
mg/d |
16.27 |
63.0 |
Bradford protein assay |
|
0.0 |
|
|
|
|
|
|
|
110071 |
3161 |
| MWF-Chr 6SHR/Rkb |
number of glomeruli per kidney to number of ureteric bud tips per kidney ratio |
control condition |
Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a. |
kidney glomerulus quantity |
not specified |
-6.0 days
| 12 |
|
|
0.59 |
null |
0.03 |
0.12 |
immunofluorescence confocal microscopy |
|
0.0 |
|
|
|
immunofluorescence confocal microscopy with digital image analysis (MMO:0000751) |
number of glomeruli per kidney to number of ureteric bud tips per kidney ratio (CMO:0003849) |
|
|
109521 |
3145 |
| GK/MolTac |
blood glucose level |
control condition |
Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027. |
blood glucose amount |
female |
56.0 days
| 9 |
|
|
120.6 |
mg/dl |
1.8 |
5.4 |
blood glucose analysis |
|
0.0 |
|
|
|
|
|
|
|
110263 |
3168 |
| SHRSP/A3NCrl |
urine albumin excretion rate |
control condition |
Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. |
urine albumin amount |
male |
99.0 days-148.0 days |
9 |
|
|
5.3 |
mg/d |
0.8 |
2.4 |
urine microalbumin analysis |
|
86400.0 |
|
|
|
8 week |
8 week control diet group |
|
|
107059 |
3073 |
| SHRSP/A3NCrl |
urine sodium excretion rate |
control condition |
Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. |
urine sodium amount |
male |
84.0 days-91.0 days |
9 |
|
|
2.3 |
mEq/d |
0.2 |
0.6 |
urine sodium analysis |
|
86400.0 |
|
|
|
baseline |
baseline control group |
|
|
107062 |
3073 |
| SHRSP/A3NCrl |
urine sodium excretion rate |
control condition |
Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. |
urine sodium amount |
male |
99.0 days-148.0 days |
9 |
|
|
2.8 |
mEq/d |
0.1 |
0.3 |
urine sodium analysis |
|
86400.0 |
|
|
|
8 week |
8 week control diet group |
|
|
107064 |
3073 |
| SHRSP/A3N |
pituitary gland weight |
control condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
pituitary gland mass |
male |
120.0 days-140.0 days |
24 |
|
|
0.01 |
g |
0.0 |
0.0 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
107576 |
3093 |
| SHRSP/A3N |
both adrenal glands wet weight |
control condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
adrenal gland mass |
male |
120.0 days-140.0 days |
24 |
|
|
23.0 |
mg |
1.0 |
4.9 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
107580 |
3093 |
| WI |
kidney glomerulus volume |
control condition |
Macconi D, etal., Am J Pathol. 2006 Jan;168(1):42-54. doi: 10.2353/ajpath.2006.050398. |
kidney glomerulus morphology trait |
male |
70.0 days
| |
|
|
0.73 |
x 10E6 um3 |
0.17 |
|
ex vivo light microscopy with histochemistry and digital image analysis |
renal glomerulus |
0.0 |
|
|
|
|
|
|
|
108564 |
3034 |
| GK |
plasma glucose level |
control condition |
Ladriere L, et al., Cell Biochem Funct. 1997 Dec;15(4):287-92. doi: 10.1002/(SICI)1099-0844(199712)15:4<287::AID-CBF753>3.0.CO;2-X. |
blood glucose amount |
male |
73.0 days
| 6 |
|
|
293.4 |
mg/dl |
52.2 |
127.86 |
plasma glucose analysis |
|
0.0 |
|
|
|
|
|
|
|
110611 |
3179 |
| GK |
plasma insulin level |
control condition |
Ladriere L, et al., Cell Biochem Funct. 1997 Dec;15(4):287-92. doi: 10.1002/(SICI)1099-0844(199712)15:4<287::AID-CBF753>3.0.CO;2-X. |
blood insulin amount |
female |
73.0 days
| 6 |
|
|
48.0 |
mU/l |
3.0 |
7.35 |
plasma insulin analysis |
|
0.0 |
|
|
|
|
|
|
|
110617 |
3179 |
| Crl:WI |
plasma glucose level |
control condition |
Fourny N, et al., Nutrients. 2019 Jan 6;11(1). pii: nu11010105. doi: 10.3390/nu11010105. |
blood glucose amount |
female |
270.0 days-300.0 days |
11 |
|
|
164.0 |
mg/dl |
7.0 |
23.22 |
plasma glucose analysis |
|
0.0 |
|
|
|
|
|
|
|
109865 |
3159 |
| GK/Par |
plasma glucose level |
control condition |
Fourny N, et al., Nutrients. 2019 Jan 6;11(1). pii: nu11010105. doi: 10.3390/nu11010105. |
blood glucose amount |
female |
270.0 days-300.0 days |
14 |
|
|
246.0 |
mg/dl |
9.0 |
33.67 |
plasma glucose analysis |
|
0.0 |
|
|
|
|
|
|
|
109866 |
3159 |
| Crl:WI |
heart weight |
control condition |
Fourny N, et al., Nutrients. 2019 Jan 6;11(1). pii: nu11010105. doi: 10.3390/nu11010105. |
heart mass |
female |
270.0 days-300.0 days |
11 |
|
|
0.85 |
g |
0.02 |
0.07 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
109877 |
3159 |
| Crl:WI |
heart weight to body weight ratio |
control condition |
Fourny N, et al., Nutrients. 2019 Jan 6;11(1). pii: nu11010105. doi: 10.3390/nu11010105. |
heart mass |
female |
270.0 days-300.0 days |
11 |
|
|
2.95 |
g/kg |
0.09 |
0.3 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
109881 |
3159 |
| SHRSP/A3N |
serum free fatty acids level |
control condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood free fatty acid amount |
male |
120.0 days-140.0 days |
24 |
|
|
180.0 |
mmol/l |
17.0 |
83.28 |
automated serum analysis |
|
0.0 |
|
|
|
|
|
|
|
107616 |
3093 |
| SHRSP/A3N |
serum free fatty acids level |
control condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood free fatty acid amount |
female |
120.0 days-140.0 days |
24 |
|
|
180.0 |
mmol/l |
16.0 |
78.38 |
automated serum analysis |
|
0.0 |
|
|
|
|
|
|
|
107618 |
3093 |
| SHRSP/A3N |
serum total cholesterol level |
control condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood cholesterol amount |
male |
120.0 days-140.0 days |
24 |
|
|
87.0 |
mg/dl |
2.0 |
9.8 |
serum total cholesterol measurement test |
|
0.0 |
|
|
|
|
|
|
|
107624 |
3093 |
| SHRSP/A3N |
serum glucose level |
control condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood glucose amount |
female |
120.0 days-140.0 days |
24 |
|
|
145.0 |
mg/dl |
3.0 |
14.7 |
automated serum analysis |
|
0.0 |
|
|
|
|
|
|
|
107630 |
3093 |
| GK/Far |
timed urine volume |
control condition |
Nobrega MA, et al., Diabetes 2004 Mar;53(3):735-42. |
urine output |
male |
360.0 days
| 6 |
|
|
11.8 |
ml/d |
0.8 |
1.96 |
metabolic cage urine volume measurement method |
|
86400.0 |
|
|
|
|
n=6-27 |
|
|
110564 |
3177 |
| BN/NHsdMcwi |
timed urine volume |
control condition |
Nobrega MA, et al., Diabetes 2004 Mar;53(3):735-42. |
urine output |
male |
360.0 days
| 6 |
|
|
10.8 |
ml/d |
1.5 |
3.67 |
metabolic cage urine volume measurement method |
|
86400.0 |
|
|
|
|
n=6-27 |
|
|
110563 |
3177 |
| BN/NHsdMcwi |
urine albumin excretion rate |
control condition |
Nobrega MA, et al., Diabetes 2004 Mar;53(3):735-42. |
urine albumin amount |
male |
180.0 days
| |
|
|
0.7 |
mg/d |
0.1 |
|
albumin blue 580-based urine albumin analysis with spectrophotometric readout |
|
86400.0 |
|
|
|
albumin blue 580-based urine albumin analysis with spectrophotometric readout (MMO:0000756) |
n=6-27 |
|
|
110566 |
3177 |
| BN/NHsdMcwi |
kidney glomerulus diameter |
control condition |
Nobrega MA, et al., Diabetes 2004 Mar;53(3):735-42. |
kidney glomerulus size trait |
male |
360.0 days
| 6 |
|
|
140.0 |
um |
2.0 |
4.9 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
|
|
|
n=6-27 |
|
|
110587 |
3177 |
| T2DN/Mcwi |
kidney glomerulus diameter |
control condition |
Nobrega MA, et al., Diabetes 2004 Mar;53(3):735-42. |
kidney glomerulus size trait |
male |
180.0 days
| 6 |
|
|
172.0 |
um |
4.0 |
9.8 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
|
|
|
n=6-27 |
|
|
110586 |
3177 |
| T2DN/Mcwi |
kidney glomerulus diameter |
control condition |
Nobrega MA, et al., Diabetes 2004 Mar;53(3):735-42. |
kidney glomerulus size trait |
male |
360.0 days
| 6 |
|
|
187.0 |
um |
6.0 |
14.7 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
|
|
|
n=6-27 |
|
|
110589 |
3177 |
| BN/NHsdMcwi |
single kidney wet weight |
control condition |
Nobrega MA, et al., Diabetes 2004 Mar;53(3):735-42. |
kidney mass |
male |
180.0 days
| 6 |
|
|
1.0 |
g |
0.03 |
0.07 |
post excision weight measurement |
|
0.0 |
|
|
|
|
n=6-27 |
|
|
110596 |
3177 |
| T2DN/Mcwi |
single kidney wet weight |
control condition |
Nobrega MA, et al., Diabetes 2004 Mar;53(3):735-42. |
kidney mass |
male |
180.0 days
| 6 |
|
|
2.2 |
g |
0.04 |
0.1 |
post excision weight measurement |
|
0.0 |
|
|
|
|
n=6-27 |
|
|
110598 |
3177 |
| GK/Far |
single kidney wet weight to body weight ratio |
control condition |
Nobrega MA, et al., Diabetes 2004 Mar;53(3):735-42. |
kidney mass |
male |
360.0 days
| 6 |
|
|
5.01 |
g/kg |
0.2 |
0.49 |
post excision weight measurement |
|
0.0 |
|
|
|
|
n=6-27 |
|
|
110606 |
3177 |
| W/Jpe |
liver weight |
control condition |
Sena CM, etal., Int J Mol Sci. 2018 Sep 11;19(9). pii: ijms19092706. doi: 10.3390/ijms19092706. |
liver mass |
male |
540.0 days
| 7 |
|
|
6.75 |
g |
0.6 |
1.59 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
110850 |
3193 |
| SHRSP/A3N |
interstitial nephritis foci count |
control condition |
Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21. |
kidney integrity trait |
male |
126.0 days-182.0 days |
|
|
|
4.9 |
/section |
1.0 |
|
ex vivo light microscopy with histochemistry |
|
0.0 |
|
|
|
|
|
|
|
107550 |
3090 |
| MHS/Gib |
ouabain-sensitive red blood cell Na+ export rate |
control condition |
Ferrari P, etal., J Hypertens. 1987 Apr;5(2):199-206. doi: 10.1097/00004872-198704000-00011. |
erythrocyte ion transport trait |
male |
50.0 days-70.0 days |
6 |
|
|
803.4 |
umol/l/h |
99.4 |
243.48 |
Na+/K+ ATPase activity assay in hypotonic choline medium |
|
0.0 |
|
|
|
|
|
|
|
110315 |
3169 |
| MHS/Gib |
bumetanide-sensitive red blood cell Na+ export rate |
control condition |
Ferrari P, etal., J Hypertens. 1987 Apr;5(2):199-206. doi: 10.1097/00004872-198704000-00011. |
erythrocyte ion transport trait |
male |
50.0 days-70.0 days |
6 |
|
|
464.0 |
umol/l/h |
26.5 |
64.91 |
Na-K-Cl cotransport activity assay in isotonic choline medium |
|
0.0 |
|
|
|
|
|
|
|
110317 |
3169 |
| MNS/Gib |
bumetanide-sensitive red blood cell Na+ export rate |
control condition |
Ferrari P, etal., J Hypertens. 1987 Apr;5(2):199-206. doi: 10.1097/00004872-198704000-00011. |
erythrocyte ion transport trait |
male |
50.0 days-70.0 days |
6 |
|
|
336.6 |
umol/l/h |
47.7 |
116.84 |
Na-K-Cl cotransport activity assay in isotonic choline medium |
|
0.0 |
|
|
|
|
|
|
|
110318 |
3169 |
| MHS/Gib |
mean corpuscular volume |
control condition |
Ferrari P, etal., J Hypertens. 1987 Apr;5(2):199-206. doi: 10.1097/00004872-198704000-00011. |
erythrocyte size trait |
not specified |
50.0 days-70.0 days |
|
|
|
40.4 |
fl |
6.0 |
|
Coulter counter cell/particle size/count analysis method |
|
0.0 |
|
|
|
|
|
|
|
110326 |
3169 |
| ACI/SegHsd |
area of ventral prostate occupied by tumorous lesions with solid structure to total ventral prostate area ratio |
control condition |
Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. |
prostate integrity trait |
male |
900.0 days
| 12 |
|
|
1.09 |
% |
0.38 |
1.31 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
109891 |
341 |
| SD-Cftrem1Apb |
percentage of study population developing meconium ileus during a period of time |
control condition |
McCarron A, et al., Am J Pathol. 2020 May;190(5):977-993. doi: 10.1016/j.ajpath.2020.01.009. Epub 2020 Feb 18. |
intestine integrity trait |
not specified |
7.0 days
| |
|
|
16.0 |
% |
0.0 |
|
necropsy |
|
0.0 |
|
|
|
|
percentage of study population developing meconium ileus during a period of time (CMO:0003881) |
|
|
111463 |
3184 |
| MWF/FubRkb |
heart left ventricle weight to body weight ratio |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
heart left ventricle mass |
male |
100.0 days
| 10 |
|
|
1.91 |
mg/g |
0.02 |
0.06 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
108100 |
3115 |
| MWF/Hsd |
urine total protein excretion rate |
control condition |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
total urine protein amount |
male |
84.0 days
| 5 |
|
|
76.0 |
mg/d |
19.0 |
42.49 |
urine total protein analysis |
|
0.0 |
|
|
|
|
|
|
|
108767 |
3130 |
| MWF-Chr 8SHR/Rkb |
body weight |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
body mass |
male |
168.0 days
| 20 |
|
|
351.1 |
g |
6.8 |
30.41 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
108918 |
3133 |
| SHR/FubRkb |
body weight |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
body mass |
female |
168.0 days
| 10 |
|
|
208.0 |
g |
5.5 |
17.39 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
108917 |
3133 |
| MWF/FubRkb |
body weight |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
body mass |
female |
168.0 days
| 18 |
|
|
207.2 |
g |
1.2 |
5.09 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
108921 |
3133 |
| MWF-Chr 8SHR/Rkb |
single kidney wet weight |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
kidney mass |
female |
168.0 days
| 10 |
|
|
1.17 |
g |
0.02 |
0.06 |
post excision weight measurement |
kidney |
0.0 |
|
|
|
|
|
|
|
108925 |
3133 |
| MNS |
kidney weight |
control condition |
Gmaj P, etal., Biochim Biophys Acta. 1988 Jun 22;941(2):187-97. doi: 10.1016/0005-2736(88)90179-4. |
kidney mass |
male |
20.0 days-21.0 days |
15 |
|
|
0.66 |
g |
0.08 |
0.32 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
110512 |
3175 |
| SD-Myh7bem1Blar+/+ |
body weight |
control condition |
Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17. |
body mass |
not specified |
84.0 days
| |
|
|
307.6 |
g |
16.5 |
|
body weighing method |
|
0.0 |
|
|
|
|
SD-Myh7bem1Blar+/+ (RS:0005005) |
|
|
110827 |
3192 |
| SD-Myh7bem1Blar-/- |
heart left ventricle end-systolic internal diameter |
control condition |
Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17. |
heart left ventricle end-systolic diameter |
not specified |
84.0 days
| |
|
|
0.69 |
mm |
0.44 |
|
echocardiography |
|
0.0 |
|
|
|
|
heart left ventricle end-systolic internal diameter (CMO:0003851) |
|
|
110953 |
3192 |
| SD-Myh7bem1Blar+/- |
heart left ventricle fractional shortening |
control condition |
Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17. |
heart left ventricle end-diastolic diameter |
not specified |
84.0 days
| |
|
|
84.34 |
% |
11.12 |
|
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
110947 |
3192 |
| SD-Myh7bem1Blar+/+ |
heart left ventricle end-systolic internal diameter |
control condition |
Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17. |
heart left ventricle end-systolic diameter |
not specified |
84.0 days
| |
|
|
1.43 |
mm |
0.93 |
|
echocardiography |
|
0.0 |
|
|
|
|
heart left ventricle end-systolic internal diameter (CMO:0003851) |
|
|
110951 |
3192 |
| SD-Myh7bem1Blar-/- |
heart interventricular end-systolic septal wall thickness |
control condition |
Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17. |
heart ventricle septum thickness |
not specified |
84.0 days
| |
|
|
3.89 |
mm |
0.73 |
|
echocardiography |
|
0.0 |
|
|
|
|
heart left ventricle end-systolic internal diameter (CMO:0003851) |
|
|
110959 |
3192 |
| SHRSP/A3N |
kidney total tubule cast count |
control condition |
Wong VY, etal., Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329. |
kidney integrity trait |
male |
210.0 days-224.0 days |
|
|
|
72.0 |
/section |
18.0 |
|
ex vivo light microscopy with histochemistry |
|
0.0 |
|
|
|
|
total tubular casts |
|
|
107492 |
3088 |
| SD-Cftrem1Sage-/- |
trachea submucosal gland intracellular mucus area to total trachea submucosal gland area ratio |
control condition (for 42 days) |
Tuggle KL, et al., PLoS One. 2014 Mar 7;9(3):e91253. doi: 10.1371/journal.pone.0091253. eCollection 2014. |
trachea morphology trait |
male |
21.0 days-42.0 days |
|
|
|
8.4 |
% |
2.0 |
|
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
110844 |
3024 |
| MWF/Ztm |
urine total protein excretion rate |
control condition |
Macconi D, etal., Am J Pathol. 2006 Jan;168(1):42-54. doi: 10.2353/ajpath.2006.050398. |
total urine protein amount |
male |
140.0 days
| 13 |
|
|
356.0 |
mg/d |
113.0 |
407.43 |
Bradford protein assay |
|
0.0 |
|
|
|
|
|
|
|
108560 |
3034 |
| BDIX/OrlCrl |
body weight |
control condition |
Maggiori L, etal., Int J Exp Pathol. 2012 Dec;93(6):414-20. doi: 10.1111/j.1365-2613.2012.00841.x. |
body mass |
male |
days
| 5 |
|
|
204.0 |
g |
7.6 |
17.0 |
body weighing method |
|
0.0 |
|
|
|
|
baseline group 2 |
|
|
111025 |
3195 |
| BDIX/OrlCrl |
body weight |
control condition |
Maggiori L, etal., Int J Exp Pathol. 2012 Dec;93(6):414-20. doi: 10.1111/j.1365-2613.2012.00841.x. |
body mass |
male |
days
| 5 |
|
|
195.0 |
g |
5.81 |
13.0 |
body weighing method |
|
0.0 |
|
|
|
|
baseline group 3 |
|
|
111026 |
3195 |
| Sah:SD |
plasma albumin level |
control condition |
McCarron A, et al., Am J Pathol. 2020 May;190(5):977-993. doi: 10.1016/j.ajpath.2020.01.009. Epub 2020 Feb 18. |
blood albumin amount |
not specified |
days
| 3 |
|
|
39.33 |
g/l |
2.73 |
4.73 |
automated plasma albumin analysis |
|
0.0 |
|
|
|
automated serum albumin analysis |
Sah:SD (RS:0005133) |
|
|
111408 |
3184 |
| SD-Cftrem1Apb |
plasma total protein level |
control condition |
McCarron A, et al., Am J Pathol. 2020 May;190(5):977-993. doi: 10.1016/j.ajpath.2020.01.009. Epub 2020 Feb 18. |
blood total protein amount |
not specified |
days
| 3 |
|
|
67.33 |
mg/ml |
3.48 |
6.03 |
automated plasma total protein analysis |
|
0.0 |
|
|
|
|
3 het p508 x 3 homo p508 16 litters |
|
|
111412 |
3184 |
| MWF/FubRkb |
heart left ventricle weight |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
heart left ventricle mass |
male |
168.0 days
| 10 |
|
|
0.68 |
g |
0.02 |
0.06 |
post excision weight measurement |
heart left ventricle |
0.0 |
|
|
|
|
|
|
|
108938 |
3133 |
| MWF/FubRkb |
heart left ventricle weight to body weight ratio |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
heart left ventricle mass |
male |
168.0 days
| 10 |
|
|
1.86 |
mg/g |
0.02 |
0.06 |
post excision weight measurement |
heart left ventricle |
0.0 |
|
|
|
|
|
|
|
108944 |
3133 |
| MWF/FubRkb |
heart left ventricle weight to body weight ratio |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
heart left ventricle mass |
female |
168.0 days
| 10 |
|
|
2.42 |
mg/g |
0.04 |
0.13 |
post excision weight measurement |
heart left ventricle |
0.0 |
|
|
|
|
|
|
|
108945 |
3133 |
| MWF-Chr 8SHR/Rkb |
heart left ventricle weight to body weight ratio |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
heart left ventricle mass |
female |
168.0 days
| 10 |
|
|
2.49 |
mg/g |
0.05 |
0.16 |
post excision weight measurement |
heart left ventricle |
0.0 |
|
|
|
|
|
|
|
108943 |
3133 |
| SHR/FubRkb |
serum urea nitrogen level |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
blood urea nitrogen amount |
female |
168.0 days
| 10 |
|
|
19.13 |
mg/dl |
0.67 |
2.13 |
serum urea analysis |
|
0.0 |
|
|
|
|
|
|
|
108959 |
3133 |
| MWF/FubRkb |
urine albumin excretion rate |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
urine albumin amount |
male |
56.0 days
| 18 |
|
|
18.1 |
mg/d |
2.0 |
8.49 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
|
|
|
108965 |
3133 |
| MWF/FubRkb |
urine albumin excretion rate |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
urine albumin amount |
female |
56.0 days
| 18 |
|
|
5.2 |
mg/d |
0.9 |
3.82 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
|
|
|
108969 |
3133 |
| SHR/FubRkb |
kidney weight |
control condition |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
kidney mass |
male |
84.0 days
| |
|
|
1.74 |
g |
0.09 |
|
post excision weight measurement |
kidney |
0.0 |
|
|
|
|
|
|
|
109041 |
3116 |
| MWF/FubRkb |
body weight |
control condition |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
body mass |
male |
84.0 days
| |
|
|
279.3 |
g |
5.5 |
|
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
109039 |
3116 |
| F344/Jcl |
number of ventral prostate tumorous lesions with round, irregular size nuclei |
control condition |
Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. |
prostate integrity trait |
male |
900.0 days
| 8 |
|
|
1.3 |
null |
0.64 |
1.8 |
ex vivo light microscopy |
|
0.0 |
|
|
|
|
|
|
|
109960 |
341 |
| ACI/SegHsd |
area of individual ventral prostate tumorous lesion with round, irregular size nuclei |
control condition |
Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. |
prostate integrity trait |
male |
900.0 days
| 12 |
|
|
1.73 |
mm2 |
0.36 |
1.24 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
109961 |
341 |
| Sah:SD |
blood hemoglobin level |
control condition |
McCarron A, et al., Am J Pathol. 2020 May;190(5):977-993. doi: 10.1016/j.ajpath.2020.01.009. Epub 2020 Feb 18. |
blood hemoglobin amount |
not specified |
days
| |
|
|
1525.0 |
g/dl |
45.0 |
|
blood hemoglobin analysis |
|
0.0 |
|
|
|
|
|
|
|
111450 |
3184 |
| MWF/Ztm |
urine total protein excretion rate |
control condition |
Macconi D, etal., J Am Soc Nephrol. 2012 Sep;23(9):1496-505. doi: 10.1681/ASN.2011121144. Epub 2012 Jul 19. |
total urine protein amount |
male |
280.0 days
| 7 |
|
|
504.0 |
mg/d |
21.17 |
56.0 |
urine total protein analysis |
|
0.0 |
|
|
|
|
|
|
|
109531 |
3147 |
| MWF/Ztm |
serum creatinine level |
control condition |
Macconi D, etal., J Am Soc Nephrol. 2012 Sep;23(9):1496-505. doi: 10.1681/ASN.2011121144. Epub 2012 Jul 19. |
blood creatinine amount |
male |
350.0 days
| 7 |
|
|
0.77 |
mg/dl |
0.11 |
0.3 |
serum creatinine analysis |
|
0.0 |
|
|
|
|
|
|
|
109541 |
3147 |
| SD-Myh7bem1Blar+/+ |
systolic blood pressure |
control condition |
Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17. |
arterial blood pressure trait |
not specified |
84.0 days
| |
|
|
123.8 |
mmHg |
8.2 |
|
plethysmography |
|
0.0 |
|
|
|
|
|
|
|
110836 |
3192 |
| Hsd:SD |
blood high density lipoprotein particle diameter |
control condition |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood HDL particle size |
male |
448.0 days
| 9 |
|
|
11.6 |
nm |
0.3 |
0.9 |
nuclear magnetic resonance spectroscopy |
|
0.0 |
|
|
|
|
|
|
|
138338 |
3201 |
| BUF/NHsd |
nose to tail body mass index |
control condition |
Keele GR, etal., Obesity (Silver Spring). 2018 Jan;26(1):213-222. doi: 10.1002/oby.22075. Epub 2017 Nov 28. |
body mass |
male |
119.0 days
| 8 |
|
|
3.15 |
(g/cm2) x 10 |
0.33 |
0.93 |
body weighing method |
|
|
|
|
|
|
|
|
|
138395 |
3200 |
| BUF/NHsd |
nose to rump body mass index |
control condition |
Keele GR, etal., Obesity (Silver Spring). 2018 Jan;26(1):213-222. doi: 10.1002/oby.22075. Epub 2017 Nov 28. |
body mass |
male |
119.0 days
| 8 |
|
|
9.05 |
(g/cm2) x 10 |
0.55 |
1.56 |
body weighing method |
|
|
|
|
|
|
|
|
|
138394 |
3200 |
| F344/NHsd |
epididymal fat pad weight |
control condition |
Keele GR, etal., Obesity (Silver Spring). 2018 Jan;26(1):213-222. doi: 10.1002/oby.22075. Epub 2017 Nov 28. |
epididymal fat pad mass |
male |
119.0 days
| 17 |
|
|
7.99 |
g |
0.72 |
2.98 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
138402 |
3200 |
| WKY/NHsd |
nose to tail body mass index |
control condition |
Keele GR, etal., Obesity (Silver Spring). 2018 Jan;26(1):213-222. doi: 10.1002/oby.22075. Epub 2017 Nov 28. |
body mass |
male |
119.0 days
| 16 |
|
|
2.27 |
(g/cm2) x 10 |
0.04 |
0.15 |
body weighing method |
|
|
|
|
|
|
|
|
|
138415 |
3200 |
| NMcwi:HS |
retroperitoneal fat pad weight |
control condition |
Keele GR, etal., Obesity (Silver Spring). 2018 Jan;26(1):213-222. doi: 10.1002/oby.22075. Epub 2017 Nov 28. |
retroperitoneal fat pad mass |
male |
119.0 days
| 741 |
|
|
5.2 |
g |
0.07 |
1.94 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
138411 |
3200 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
2.54 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129186 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
16.76 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129197 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
4.18 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129200 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
54.05 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129204 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
253.73 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129205 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
15.39 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129217 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
10.85 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129219 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
8.12 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129222 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
2.03 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129231 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
1.42 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129232 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
6.46 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129241 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
7.69 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129242 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
17.45 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129246 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
5.22 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129252 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
6.69 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129271 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
3.16 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129278 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
5.2 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129281 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
2.63 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129285 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
3.59 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129300 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
11.0 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129301 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
7.41 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129306 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
2.16 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129307 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
6.38 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129310 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
9.21 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129329 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
6.8 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129335 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
9.28 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129341 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
12.03 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129343 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
11.05 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129344 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
13.3 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129348 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
4.79 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129357 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
5.64 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129364 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
3.74 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129362 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
11.51 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129372 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
6.79 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129370 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
6.81 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129374 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
66.71 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129381 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
2.98 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129398 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
10.69 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129399 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
7.25 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129409 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
37.78 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129413 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
8.62 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129429 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
3.93 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129427 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
22.19 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129439 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
5.68 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129447 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
7.32 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129457 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
5.15 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129466 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
7.2 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129468 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
6.87 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129470 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
7.16 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129473 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
19.15 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129474 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
43.34 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129477 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
7.44 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129490 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
11.57 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129494 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
4.79 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129499 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
8.32 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129495 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
17.49 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129501 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
9.76 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129507 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
5.01 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129084 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
3.58 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129108 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
4.69 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129115 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
3.48 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129116 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
7.89 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129121 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
3.27 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129124 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
3.1 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129123 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
11.5 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129126 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
3.7 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129127 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
7.96 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129147 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
total urine protein amount |
male |
168.0 days
| 1 |
|
|
6.63 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129152 |
3188 |
| Iusm:HAD2 |
tibia length |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
tibia length |
male |
120.0 days
| 16 |
|
geometric mean |
4.21 |
cm |
0.02 |
0.08 |
post excision length measurement |
|
0.0 |
|
|
|
|
|
|
|
138530 |
3202 |
| Iusm:HAD2 |
ulna length |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
ulna length |
male |
90.0 days
| 16 |
|
geometric mean |
32.05 |
mm |
0.17 |
0.68 |
post excision length measurement |
|
0.0 |
|
|
|
|
|
|
|
138512 |
3202 |
| Iusm:HAD1 |
humerus length |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
humerus length |
male |
120.0 days
| 16 |
|
geometric mean |
29.3 |
mm |
0.28 |
1.12 |
post excision length measurement |
|
0.0 |
|
|
|
|
|
|
|
138534 |
3202 |
| Iusm:LAD1 |
total volumetric bone mineral density |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
tibia mineral mass |
male |
120.0 days
| 16 |
|
geometric mean |
667.28 |
mg/cm3 |
7.6 |
30.4 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
1 mm from proximal epiphysis |
|
|
138563 |
3202 |
| Iusm:NP |
compact volumetric bone mineral density |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
femur mineral mass |
male |
120.0 days
| 16 |
|
geometric mean |
1116.6 |
mg/cm3 |
27.92 |
111.68 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
1 mm from distal epiphysis |
|
|
138573 |
3202 |
| Iusm:LAD1 |
compact volumetric bone mineral density |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
tibia mineral mass |
male |
120.0 days
| 16 |
|
geometric mean |
1123.65 |
mg/cm3 |
10.03 |
40.12 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
1 mm from proximal epiphysis |
|
|
138581 |
3202 |
| Iusm:HAD1 |
total volumetric bone mineral density |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
femur mineral mass |
male |
120.0 days
| 16 |
|
geometric mean |
700.62 |
mg/cm3 |
14.87 |
59.48 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
1 mm from distal epiphysis |
|
|
138558 |
3202 |
| Iusm:LAD1 |
trabecular volumetric bone mineral density |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
tibia mineral mass |
male |
120.0 days
| 16 |
|
geometric mean |
387.83 |
mg/cm3 |
13.86 |
55.44 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
1 mm from proximal epiphysis |
|
|
138599 |
3202 |
| Iusm:HAD1 |
femur length |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
femur length |
male |
90.0 days
| 16 |
|
geometric mean |
3.54 |
cm |
0.05 |
0.19 |
post excision length measurement |
|
0.0 |
|
|
|
|
|
|
|
138492 |
3202 |
| Iusm:HAD2 |
femur length |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
femur length |
male |
90.0 days
| 16 |
|
geometric mean |
3.64 |
cm |
0.02 |
0.06 |
post excision length measurement |
|
0.0 |
|
|
|
|
|
|
|
138494 |
3202 |
| Iusm:LAD2 |
total volumetric bone mineral density |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
femur mineral mass |
male |
120.0 days
| 16 |
|
geometric mean |
960.38 |
mg/cm3 |
5.64 |
22.56 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
midshaft |
|
|
138547 |
3202 |
| Iusm:HAD1 |
total volumetric bone mineral density |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
femur mineral mass |
male |
120.0 days
| 16 |
|
geometric mean |
1014.62 |
mg/cm3 |
10.38 |
41.52 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
midshaft |
|
|
138546 |
3202 |
| Iusm:NP |
humerus length |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
humerus length |
male |
90.0 days
| 16 |
|
geometric mean |
29.8 |
mm |
0.16 |
0.64 |
post excision length measurement |
|
0.0 |
|
|
|
|
|
|
|
138501 |
3202 |
| Iusm:NP |
compact volumetric bone mineral density |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
tibia mineral mass |
male |
120.0 days
| 16 |
|
geometric mean |
1217.18 |
mg/cm3 |
18.27 |
73.08 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
1 mm from proximal epiphysis |
|
|
138579 |
3202 |
| Iusm:LAD2 |
trabecular volumetric bone mineral density |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
femur mineral mass |
male |
120.0 days
| 16 |
|
geometric mean |
225.5 |
mg/cm3 |
12.45 |
49.8 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
1 mm from distal epiphysis |
|
|
138595 |
3202 |
| Iusm:HAD2 |
trabecular volumetric bone mineral density |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
lumbar vertebra mineral mass |
male |
120.0 days
| 16 |
|
geometric mean |
416.48 |
mg/cm3 |
18.95 |
75.8 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
caudo-cranial center of the vertebral body |
|
|
138608 |
3202 |
| Iusm:HAD2 |
total volumetric bone mineral density |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
femur mineral mass |
male |
120.0 days
| 16 |
|
geometric mean |
1044.3 |
mg/cm3 |
7.22 |
28.88 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
midshaft |
|
|
138548 |
3202 |
| Iusm:HAD2 |
body weight |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
body mass |
male |
90.0 days
| 16 |
|
geometric mean |
318.36 |
g |
6.74 |
26.96 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
138488 |
3202 |
| Iusm:HAD1 |
humerus length |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
humerus length |
male |
90.0 days
| 16 |
|
geometric mean |
27.33 |
mm |
0.38 |
1.52 |
post excision length measurement |
|
0.0 |
|
|
|
|
|
|
|
138504 |
3202 |
| Iusm:NP |
tibia length |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
tibia length |
male |
90.0 days
| 16 |
|
geometric mean |
4.16 |
cm |
0.01 |
0.05 |
post excision length measurement |
|
0.0 |
|
|
|
|
|
|
|
138495 |
3202 |
| Iusm:P |
humerus length |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
humerus length |
male |
120.0 days
| 16 |
|
geometric mean |
31.15 |
mm |
0.32 |
1.28 |
post excision length measurement |
|
0.0 |
|
|
|
|
|
|
|
138532 |
3202 |
| Iusm:LAD1 |
total volumetric bone mineral density |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
lumbar vertebra mineral mass |
male |
120.0 days
| 16 |
|
geometric mean |
713.54 |
mg/cm3 |
11.68 |
46.72 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
caudo-cranial center of the vertebral body |
|
|
138569 |
3202 |
| Iusm:HAD2 |
compact volumetric bone mineral density |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
tibia mineral mass |
male |
120.0 days
| 16 |
|
geometric mean |
1263.0 |
mg/cm3 |
10.55 |
42.2 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
1 mm from proximal epiphysis |
|
|
138584 |
3202 |
| BN/NHsdMcwi |
body weight |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body mass |
female |
21.0 days
| 10 |
|
|
42.9 |
g |
1.75 |
5.55 |
body weighing method |
|
|
|
|
|
weight scale |
Body weight |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
138873 |
3292 |
| BN/NHsdMcwi |
total body fat mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body fat mass |
female |
21.0 days
| 10 |
|
|
4.91 |
g |
0.43 |
1.35 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
138884 |
3292 |
| BN/NHsdMcwi |
total body fat-free mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body lean mass |
female |
21.0 days
| 10 |
|
|
37.99 |
g |
1.36 |
4.3 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat-free mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
138887 |
3292 |
| BN/NHsdMcwi |
total body lean mass to total body mass ratio |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body lean mass |
female |
21.0 days
| 10 |
|
|
69.21 |
% |
0.41 |
1.3 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body lean mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
138889 |
3292 |
| BN/NHsdMcwi |
total body fat mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body fat mass |
female |
21.0 days
| 10 |
|
|
4.66 |
g |
0.31 |
0.99 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
138941 |
3292 |
| BN/NHsdMcwi |
total body lean mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body lean mass |
female |
21.0 days
| 10 |
|
|
29.27 |
g |
1.0 |
3.17 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body lean mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
138942 |
3292 |
| BN/NHsdMcwi |
total body water mass to total body mass ratio |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body water amount |
female |
21.0 days
| 10 |
|
|
7.73 |
% |
0.35 |
1.09 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fluid mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
138947 |
3292 |
| BN/NHsdMcwi |
total body fat mass to total body mass ratio |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body fat mass |
female |
21.0 days
| 10 |
|
|
10.95 |
% |
0.42 |
1.34 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
138945 |
3292 |
| BN/NHsdMcwi |
total body lean mass to total body mass ratio |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body lean mass |
female |
21.0 days
| 10 |
|
|
69.38 |
% |
0.44 |
1.4 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body lean mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
138946 |
3292 |
| BN/NHsdMcwi |
total body water mass to total body mass ratio |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body water amount |
male |
21.0 days
| 10 |
|
|
7.75 |
% |
0.24 |
0.76 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fluid mass |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
139001 |
3292 |
| BN/NHsdMcwi |
total body water mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body water amount |
male |
21.0 days
| 11 |
|
|
3.59 |
g |
0.09 |
0.3 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fluid mass |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
139059 |
3292 |
| BN/NHsdMcwi |
total body lean mass to total body mass ratio |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body lean mass |
male |
21.0 days
| 11 |
|
|
70.14 |
% |
0.29 |
0.96 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body lean mass |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
139062 |
3292 |
| BUF/MnaMcwi |
total body water mass to total body mass ratio |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body water amount |
female |
21.0 days
| 10 |
|
|
10.0 |
% |
0.19 |
0.59 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fluid mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139192 |
3292 |
| BUF/MnaMcwi |
body weight |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body mass |
male |
7.0 days
| 10 |
|
|
11.81 |
g |
0.6 |
1.89 |
body weighing method |
|
|
|
|
|
weight scale |
Body weight |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
139236 |
3292 |
| BUF/MnaMcwi |
total body fat-free mass to total body mass ratio |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body lean mass |
male |
21.0 days
| 11 |
|
|
87.4 |
% |
0.19 |
0.62 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat-free mass |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
139322 |
3292 |
| F344/StmMcwi |
body weight |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body mass |
female |
21.0 days
| 9 |
|
|
36.89 |
g |
0.99 |
2.98 |
body weighing method |
|
|
|
|
|
weight scale |
Body weight |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139367 |
3292 |
| F344/StmMcwi |
body weight |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body mass |
female |
14.0 days
| 9 |
|
|
19.87 |
g |
0.62 |
1.85 |
body weighing method |
|
|
|
|
|
weight scale |
Body weight |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139366 |
3292 |
| F344/StmMcwi |
body weight |
control condition (0 null) |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body mass |
female |
21.0 days
| 9 |
|
|
36.44 |
g |
0.93 |
2.79 |
body weighing method |
|
|
|
|
|
weight scale |
Body weight |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139433 |
3292 |
| F344/StmMcwi |
total body fat mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body fat mass |
female |
21.0 days
| 9 |
|
|
5.1 |
g |
0.28 |
0.83 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139444 |
3292 |
| F344/StmMcwi |
body weight |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body mass |
male |
14.0 days
| 12 |
|
|
21.92 |
g |
0.48 |
1.65 |
body weighing method |
|
|
|
|
|
weight scale |
Body weight |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
139495 |
3292 |
| F344/StmMcwi |
body weight |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body mass |
male |
21.0 days
| 12 |
|
|
37.92 |
g |
1.08 |
3.73 |
body weighing method |
|
|
|
|
|
weight scale |
Body weight |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
139496 |
3292 |
| F344/StmMcwi |
total body fat-free mass to total body mass ratio |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body lean mass |
male |
21.0 days
| 12 |
|
|
87.29 |
% |
0.47 |
1.64 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat-free mass |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
139514 |
3292 |
| F344/StmMcwi |
body weight |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body mass |
male |
14.0 days
| 12 |
|
|
21.91 |
g |
0.52 |
1.79 |
body weighing method |
|
|
|
|
|
weight scale |
Body weight |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
139561 |
3292 |
| M520/NRrrcMcwi |
body weight |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body mass |
female |
21.0 days
| 11 |
|
|
43.55 |
g |
1.85 |
6.14 |
body weighing method |
|
|
|
|
|
weight scale |
Body weight |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139625 |
3292 |
| M520/NRrrcMcwi |
total body fat-free mass to total body mass ratio |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body lean mass |
female |
21.0 days
| 11 |
|
|
87.1 |
% |
0.5 |
1.65 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat-free mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139643 |
3292 |
| M520/NRrrcMcwi |
body weight |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body mass |
female |
14.0 days
| 9 |
|
|
24.58 |
g |
0.71 |
2.12 |
body weighing method |
|
|
|
|
|
weight scale |
Body weight |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139690 |
3292 |
| M520/NRrrcMcwi |
total body fat mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body fat mass |
female |
21.0 days
| 9 |
|
|
5.55 |
g |
0.4 |
1.21 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139702 |
3292 |
| M520/NRrrcMcwi |
total body fat-free mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body lean mass |
female |
21.0 days
| 9 |
|
|
36.89 |
g |
1.15 |
3.44 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat-free mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139705 |
3292 |
| M520/NRrrcMcwi |
total body fat mass to total body mass ratio |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body fat mass |
female |
21.0 days
| 9 |
|
|
12.96 |
% |
0.54 |
1.61 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139706 |
3292 |
| M520/NRrrcMcwi |
body weight |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body mass |
male |
7.0 days
| 12 |
|
|
12.48 |
g |
0.53 |
1.82 |
body weighing method |
|
|
|
|
|
weight scale |
Body weight |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
139752 |
3292 |
| M520/NRrrcMcwi |
total body fat mass to total body mass ratio |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body fat mass |
male |
21.0 days
| 12 |
|
|
12.28 |
% |
0.61 |
2.1 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat mass |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
139769 |
3292 |
| M520/NRrrcMcwi |
total body lean mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body lean mass |
male |
21.0 days
| 12 |
|
|
31.16 |
g |
1.29 |
4.46 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body lean mass |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
139832 |
3292 |
| M520/NRrrcMcwi |
total body fat mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body fat mass |
male |
21.0 days
| 12 |
|
|
5.51 |
g |
0.43 |
1.49 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat mass |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
139831 |
3292 |
| M520/NRrrcMcwi |
total body water mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body water amount |
male |
21.0 days
| 12 |
|
|
3.91 |
g |
0.14 |
0.47 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fluid mass |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
139833 |
3292 |
| WKY/NCrl |
body weight |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body mass |
female |
7.0 days
| 10 |
|
|
10.07 |
g |
0.56 |
1.77 |
body weighing method |
|
|
|
|
|
weight scale |
Body weight |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139881 |
3292 |
| WKY/NCrl |
total body fat-free mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body lean mass |
female |
21.0 days
| 10 |
|
|
34.71 |
g |
1.21 |
3.83 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat-free mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139897 |
3292 |
| WKY/NCrl |
total body water mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body water amount |
female |
21.0 days
| 10 |
|
|
4.03 |
g |
0.11 |
0.35 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fluid mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139896 |
3292 |
| WKY/NCrl |
total body fat mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body fat mass |
male |
21.0 days
| 15 |
|
|
4.87 |
g |
0.38 |
1.49 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat mass |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
140023 |
3292 |
| WKY/NCrl |
total body fat-free mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body lean mass |
male |
21.0 days
| 15 |
|
|
34.73 |
g |
1.14 |
4.42 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat-free mass |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
140026 |
3292 |
| WKY/NCrl |
body weight |
control condition (0 null) |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body mass |
male |
7.0 days
| 15 |
|
|
10.62 |
g |
0.32 |
1.22 |
body weighing method |
|
|
|
|
|
weight scale |
Body weight |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
140076 |
3292 |
| WKY/NCrl |
total body fat mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body fat mass |
male |
21.0 days
| 15 |
|
|
4.87 |
g |
0.36 |
1.4 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat mass |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
140089 |
3292 |
| ACI/EurMcwi |
total body water mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body water amount |
female |
21.0 days
| 15 |
|
|
2.57 |
g |
0.05 |
0.21 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fluid mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
138628 |
3292 |
| ACI/EurMcwi |
total body fat-free mass to total body mass ratio |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body lean mass |
female |
21.0 days
| 11 |
|
|
90.37 |
% |
0.3 |
0.99 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat-free mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
138699 |
3292 |
| ACI/EurMcwi |
body weight |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body mass |
male |
7.0 days
| 12 |
|
|
11.16 |
g |
0.29 |
1.01 |
body weighing method |
|
|
|
|
|
weight scale |
Body weight |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
138742 |
3292 |
| ACI/EurMcwi |
total body fat mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body fat mass |
male |
21.0 days
| 12 |
|
|
2.96 |
g |
0.12 |
0.43 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat mass |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
138755 |
3292 |
| ACI/EurMcwi |
total body water mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body water amount |
male |
21.0 days
| 12 |
|
|
2.72 |
g |
0.05 |
0.17 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fluid mass |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
138757 |
3292 |
| SS-Chr 7BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
9 |
|
|
90.46 |
breaths/min |
4.32 |
12.95 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14981 |
381 |
| GH/OmrMcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
7 |
|
|
102.08 |
breaths/min |
4.63 |
12.26 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14985 |
381 |
| SS-Chr 17BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
8 |
|
|
100.76 |
breaths/min |
6.05 |
17.11 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14983 |
381 |
| FHH-Chr 19BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
11 |
|
|
110.57 |
breaths/min |
12.4 |
41.13 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14989 |
381 |
| SS-Chr 3BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
11 |
|
|
96.43 |
breaths/min |
4.49 |
14.89 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14992 |
381 |
| SS-Chr 11BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
9 |
|
|
98.3 |
breaths/min |
1.95 |
5.84 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14998 |
381 |
| SS-Chr 1BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
10 |
|
|
131.26 |
breaths/min |
4.0 |
12.66 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15004 |
381 |
| FHH-Chr 3BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
10 |
|
|
111.79 |
breaths/min |
4.22 |
13.34 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15000 |
381 |
| SS/JrHsdMcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
67 |
|
|
98.21 |
breaths/min |
2.42 |
19.85 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15003 |
381 |
| SS-Chr 11BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
10 |
|
|
104.02 |
breaths/min |
6.47 |
20.46 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15001 |
381 |
| SS-Chr 1BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
10 |
|
|
143.2 |
breaths/min |
10.5 |
33.2 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15006 |
381 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
11 |
|
|
123.06 |
mmHg |
2.43 |
8.05 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15066 |
381 |
| FHH-Chr 6BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
1 |
|
|
121.15 |
mmHg |
|
|
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15072 |
381 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
8 |
|
|
130.43 |
mmHg |
3.29 |
9.31 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15071 |
381 |
| SS-Chr 9BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
11 |
|
|
121.13 |
mmHg |
3.18 |
10.54 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15074 |
381 |
| SS-Chr 17BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
8 |
|
|
125.49 |
mmHg |
5.13 |
14.52 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15078 |
381 |
| SS-Chr 5BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
4 |
|
|
130.67 |
mmHg |
13.02 |
26.04 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15085 |
381 |
| SS-Chr 7BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
9 |
|
|
120.67 |
mmHg |
2.9 |
8.69 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15088 |
381 |
| SS-Chr 16BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
12 |
|
|
118.09 |
mmHg |
3.36 |
11.64 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15096 |
381 |
| SS-Chr 3BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
5 |
|
|
140.86 |
mmHg |
7.28 |
16.27 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15104 |
381 |
| FHH-Chr 8BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
5 |
|
|
122.62 |
mmHg |
4.76 |
10.63 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15103 |
381 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
62 |
|
|
125.01 |
mmHg |
1.69 |
13.31 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15118 |
381 |
| FHH-Chr 4BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
2 |
|
|
143.58 |
mmHg |
30.04 |
42.48 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15124 |
381 |
| FHH-Chr 11BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
3 |
|
|
136.44 |
mmHg |
15.4 |
26.68 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15125 |
381 |
| SS-Chr 19BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
4 |
|
|
123.99 |
mmHg |
7.48 |
14.97 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15127 |
381 |
| SS-Chr 12BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
5 |
|
|
114.49 |
mmHg |
11.8 |
26.38 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15128 |
381 |
| FHH-Chr 11BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
7 |
|
|
132.9 |
mmHg |
8.84 |
23.39 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15129 |
381 |
| BN/NHsdMcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
14 |
|
|
117.38 |
mmHg |
4.81 |
18.0 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15137 |
381 |
| FHH-Chr 7BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
3 |
|
|
143.07 |
mmHg |
11.89 |
20.59 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15139 |
381 |
| FHH-Chr 1BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
8 |
|
|
113.99 |
mmHg |
3.85 |
10.9 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15141 |
381 |
| SS-Chr 16BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
5 |
|
|
28.85 |
ml/min |
1.91 |
4.28 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
15175 |
381 |
| SS/JrHsdMcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
7 |
|
|
28.96 |
ml/min |
0.9 |
2.38 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
15177 |
381 |
| GH/OmrMcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
3 |
|
|
473.85 |
beats/min |
11.68 |
20.23 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
15194 |
381 |
| FHH/EurMcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
5 |
|
|
474.88 |
beats/min |
17.79 |
39.79 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
15192 |
381 |
| SS-Chr 16BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
2 |
|
|
425.88 |
beats/min |
7.92 |
11.2 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
15195 |
381 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
10 |
|
|
126.99 |
mmHg |
3.33 |
10.55 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
15199 |
381 |
| FHH-Chr 9BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
9 |
|
|
0.23 |
ml |
0.02 |
0.07 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15479 |
381 |
| LEW/Crl |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
17 |
|
|
30.24 |
ml/min |
3.54 |
14.58 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
15489 |
381 |
| SS-Chr 18BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
6 |
|
|
133.44 |
mmHg |
3.43 |
8.4 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
15546 |
381 |
| FHH/EurMcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
9 |
|
|
128.32 |
mmHg |
7.56 |
22.67 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
15548 |
381 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
11 |
|
|
131.2 |
mmHg |
2.53 |
8.39 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
15547 |
381 |
| SHR/NCrl |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
7 |
|
|
131.36 |
mmHg |
1.4 |
3.71 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
15550 |
381 |
| SS-Chr 16BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
7 |
|
|
129.33 |
mmHg |
4.8 |
12.71 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
15552 |
381 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
9 |
|
|
131.39 |
mmHg |
4.31 |
12.92 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
15556 |
381 |
| BN/NHsdMcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
9 |
|
|
30.71 |
ml/min |
2.29 |
6.88 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
15619 |
381 |
| WKY/NCrl |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
14 |
|
|
121.44 |
mmHg |
5.03 |
18.81 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
15792 |
381 |
| F344/DuCrl |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
13 |
|
|
112.28 |
mmHg |
2.36 |
8.5 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
15796 |
381 |
| SS-Chr 10BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
9 |
|
|
417.15 |
beats/min |
14.1 |
42.31 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15903 |
381 |
| SS-Chr 9BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
10 |
|
|
457.61 |
beats/min |
11.08 |
35.02 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15910 |
381 |
| SS-Chr 6BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
10 |
|
|
417.55 |
beats/min |
10.2 |
32.26 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15911 |
381 |
| FHH-Chr 17BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
6 |
|
|
388.44 |
beats/min |
20.8 |
50.96 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15918 |
381 |
| SS-Chr 17BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
1 |
|
|
514.91 |
beats/min |
|
|
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15919 |
381 |
| SHR/NCrl |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
8 |
|
|
391.25 |
beats/min |
7.75 |
21.92 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15920 |
381 |
| SHR/NCrl |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
12 |
|
|
413.63 |
beats/min |
10.58 |
36.64 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15925 |
381 |
| SS-Chr 7BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
8 |
|
|
453.22 |
beats/min |
9.74 |
27.56 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15924 |
381 |
| FHH-Chr 8BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
7 |
|
|
395.68 |
beats/min |
10.88 |
28.78 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15927 |
381 |
| FHH-Chr 19BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
6 |
|
|
427.24 |
beats/min |
21.18 |
51.87 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15929 |
381 |
| FHH/EurMcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
8 |
|
|
438.2 |
beats/min |
10.21 |
28.87 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15930 |
381 |
| SS-Chr 16BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
8 |
|
|
406.22 |
beats/min |
7.22 |
20.41 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15936 |
381 |
| FHH-Chr 13BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
4 |
|
|
423.87 |
beats/min |
14.54 |
29.08 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15938 |
381 |
| SS-Chr 16BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
6 |
|
|
0.23 |
ml |
0.01 |
0.03 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
15327 |
381 |
| SS-Chr 16BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
6 |
|
|
0.28 |
ml |
0.01 |
0.03 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
15329 |
381 |
| WKY/NCrl |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
male |
82.0 days-99.0 days |
11 |
|
|
32.46 |
mmHg |
0.78 |
2.59 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
15359 |
381 |
| F344/DuCrl |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
male |
82.0 days-99.0 days |
10 |
|
|
31.95 |
mmHg |
0.82 |
2.58 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
15363 |
381 |
| LEW/Crl |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
female |
82.0 days-99.0 days |
14 |
|
|
31.65 |
mmHg |
0.79 |
2.94 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
15361 |
381 |
| LE/BluGill |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
female |
82.0 days-99.0 days |
8 |
|
|
32.62 |
mmHg |
0.77 |
2.17 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
15365 |
381 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
21 |
|
|
0.34 |
ml |
0.01 |
0.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15383 |
381 |
| FHH-Chr 2BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
10 |
|
|
0.29 |
ml |
0.02 |
0.07 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15389 |
381 |
| FHH-Chr 6BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
9 |
|
|
0.27 |
ml |
0.03 |
0.1 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15385 |
381 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
16 |
|
|
0.28 |
ml |
0.01 |
0.05 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15387 |
381 |
| SS-Chr 5BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
9 |
|
|
0.27 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15392 |
381 |
| SS-Chr 5BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
9 |
|
|
0.3 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15395 |
381 |
| FHH-Chr XBN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
0.26 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15397 |
381 |
| SS-Chr 15BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
15 |
|
|
0.23 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15400 |
381 |
| FHH-Chr 4BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
0.24 |
ml |
0.02 |
0.05 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15415 |
381 |
| SS-Chr 19BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
8 |
|
|
0.3 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15417 |
381 |
| FHH-Chr 15BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
10 |
|
|
0.26 |
ml |
0.02 |
0.05 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15425 |
381 |
| FHH-Chr 5BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
0.27 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15427 |
381 |
| SS-Chr 6BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
11 |
|
|
0.39 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15436 |
381 |
| SS-Chr 7BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
9 |
|
|
0.25 |
ml |
0.01 |
0.02 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15443 |
381 |
| SS-Chr 16BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
12 |
|
|
0.26 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15453 |
381 |
| FHH-Chr 3BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
0.18 |
ml |
0.01 |
0.03 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15452 |
381 |
| FHH/EurMcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
43 |
|
|
0.27 |
ml |
0.01 |
0.07 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15461 |
381 |
| FHH-Chr 11BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
4 |
|
|
0.31 |
ml |
0.03 |
0.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15472 |
381 |
| FHH-Chr 7BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
0.26 |
ml |
0.02 |
0.07 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15475 |
381 |
| F344/DuCrl |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
11 |
|
|
0.28 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
14432 |
381 |
| Crl:CD(SD) |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
11 |
|
|
0.29 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
14433 |
381 |
| FHH/EurMcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
9 |
|
|
86.5 |
breaths/min |
3.07 |
9.21 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
14441 |
381 |
| SS-Chr 16BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
7 |
|
|
102.53 |
breaths/min |
9.73 |
25.74 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
14442 |
381 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
6 |
|
|
122.15 |
mmHg |
2.63 |
6.45 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
14652 |
381 |
| SS-Chr 16BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
2 |
|
|
114.91 |
mmHg |
1.57 |
2.21 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
14656 |
381 |
| SS-Chr 13BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
7 |
|
|
456.56 |
beats/min |
10.43 |
27.59 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15942 |
381 |
| SHR.BN-(D2Rat114-D2Rat123)/Jk |
diastolic blood pressure |
control condition |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
arterial blood pressure trait |
male |
99.0 days
| 22 |
|
continuous mean |
127.0 |
mmHg |
2.0 |
9.38 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
|
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
|
65352 |
306 |
| FHH-Chr 18BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
6 |
|
|
409.46 |
beats/min |
15.5 |
37.97 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15946 |
381 |
| SS-Chr 11BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
6 |
|
|
446.88 |
beats/min |
8.86 |
21.7 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15947 |
381 |
| SS-Chr YBN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
16 |
|
|
432.09 |
beats/min |
17.32 |
69.29 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15950 |
381 |
| SS-Chr 13BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
8 |
|
|
429.15 |
beats/min |
16.44 |
46.5 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15949 |
381 |
| FHH/EurMcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
13 |
|
|
460.69 |
beats/min |
54.79 |
197.55 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15948 |
381 |
| SS-Chr 18BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
12 |
|
|
437.33 |
beats/min |
12.59 |
43.61 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15952 |
381 |
| SS/JrHsdMcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
50 |
|
|
419.34 |
beats/min |
5.77 |
40.82 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15953 |
381 |
| FHH-Chr 11BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
5 |
|
|
742.73 |
beats/min |
162.02 |
362.28 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15959 |
381 |
| SS-Chr 4BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
7 |
|
|
439.68 |
beats/min |
18.06 |
47.8 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15964 |
381 |
| SS-Chr 12BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
4 |
|
|
464.94 |
beats/min |
13.07 |
26.14 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15968 |
381 |
| SS-Chr 2BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
8 |
|
|
424.03 |
beats/min |
15.3 |
43.29 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15973 |
381 |
| SHR.WKY-(D1Got158-D1Got161)/Njs |
systolic blood pressure |
control condition |
Clemitson JR, et al., Circ Res. 2007 Apr 13;100(7):992-9. Epub 2007 Mar 1. |
arterial blood pressure trait |
male |
112.0 days-114.0 days |
17 |
|
|
166.1 |
mmHg |
0.61 |
2.5 |
tail cuff plethysmography |
|
|
|
|
|
|
|
|
|
65252 |
564 |
| SHR/NCruk |
systolic blood pressure |
control condition |
Clemitson JR, et al., Circ Res. 2007 Apr 13;100(7):992-9. Epub 2007 Mar 1. |
arterial blood pressure trait |
male |
112.0 days-114.0 days |
20 |
|
|
174.0 |
mmHg |
0.31 |
1.4 |
tail cuff plethysmography |
|
|
|
|
|
|
|
|
|
65250 |
564 |
| LEW/NIcoCrlf |
number of 20 x 20 cm floor squares crossed in the center of an open field apparatus |
control condition |
Ramos A, et al., Behav Brain Res. 1998 Nov;96(1-2):195-205 |
emotion/affect behavior trait |
male |
70.0 days-77.0 days |
5 |
|
|
1.0 |
null |
0.0 |
0.0 |
visual assessment of in vivo video recording |
|
300 |
|
|
|
|
number of 20 x 20 cm floor squares crossed in the center of an open field apparatus (CMO:0004017) |
|
|
65842 |
108 |
| SHR/NIcoCrlf |
number of 20 x 20 cm floor squares crossed on the periphery of an open field apparatus |
control condition |
Ramos A, et al., Behav Brain Res. 1998 Nov;96(1-2):195-205 |
emotion/affect behavior trait |
male |
70.0 days-77.0 days |
12 |
|
|
58.2 |
null |
4.7 |
16.28 |
visual assessment of in vivo video recording |
|
300 |
|
|
|
|
number of 20 x 20 cm floor squares crossed on the periphery of an open field apparatus (CMO:0004016) |
|
|
65847 |
108 |
| LEW/NIcoCrlf |
total number of entries into the arms of an elevated plus maze |
control condition |
Ramos A, et al., Behav Brain Res. 1998 Nov;96(1-2):195-205 |
anxiety-related behavior trait |
male |
56.0 days-63.0 days |
5 |
|
|
4.8 |
null |
1.1 |
2.46 |
visual assessment of in vivo video recording |
|
300 |
|
|
|
|
total number of entries into the arms of an elevated plus maze (CMO:0004008) |
|
|
65850 |
108 |
| LEW/NIcoCrlf |
number of 20 x 20 cm floor squares crossed on the periphery of an open field apparatus |
control condition |
Ramos A, et al., Behav Brain Res. 1998 Nov;96(1-2):195-205 |
emotion/affect behavior trait |
female |
70.0 days-77.0 days |
5 |
|
|
74.3 |
null |
12.3 |
27.5 |
visual assessment of in vivo video recording |
|
300 |
|
|
|
|
number of 20 x 20 cm floor squares crossed on the periphery of an open field apparatus (CMO:0004016) |
|
|
65848 |
108 |
| LEW/NIcoCrlf |
total amount of experiment time spent in an enclosed arm of an elevated plus maze |
control condition |
Ramos A, et al., Behav Brain Res. 1998 Nov;96(1-2):195-205 |
anxiety-related behavior trait |
male |
56.0 days-63.0 days |
5 |
|
|
236.0 |
s |
10.0 |
22.36 |
visual assessment of in vivo video recording |
|
300 |
|
|
|
|
total amount of experiment time spent in an enclosed arm of an elevated plus maze (CMO:0004012) |
|
|
65862 |
108 |
| SHR/NIcoCrlf |
total amount of experiment time spent in the open arms of an elevated plus maze |
control condition |
Ramos A, et al., Behav Brain Res. 1998 Nov;96(1-2):195-205 |
anxiety-related behavior trait |
male |
56.0 days-63.0 days |
12 |
|
|
30.3 |
s |
7.8 |
27.02 |
visual assessment of in vivo video recording |
|
300 |
|
|
|
|
total amount of experiment time spent in an open arm of an elevated plus maze (CMO:0004014) |
|
|
65867 |
108 |
| BN/SsN |
white blood cell count |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
leukocyte quantity |
both |
132.0 days-139.0 days |
207 |
|
|
9.6 |
x 1000 cells/ul |
0.16 |
2.34 |
automated total white blood cell count test |
|
0 |
|
|
|
|
|
|
|
65870 |
114 |
| ACI/N |
white blood cell count |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
leukocyte quantity |
both |
132.0 days-139.0 days |
207 |
|
|
8.6 |
x 1000 cells/ul |
0.2 |
2.9 |
automated total white blood cell count test |
|
0 |
|
|
|
|
|
|
|
65871 |
114 |
| F344/NRrrc |
blood CD4 cell count |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
CD4-positive T cell quantity |
both |
132.0 days-139.0 days |
203 |
|
|
1.39 |
x 1000 cells/ul |
0.01 |
0.2 |
automated differential white blood cell count test |
|
0 |
|
|
|
|
|
|
|
65883 |
114 |
| BN/SsN |
blood CD8 cell count |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
CD8-positive T cell quantity |
both |
132.0 days-139.0 days |
200 |
|
|
0.12 |
x 10E6 cells/ml |
0.0 |
0.02 |
automated differential white blood cell count test |
|
0 |
|
|
|
|
|
|
|
65885 |
114 |
| ACI/N |
blood CD8 cell count |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
CD8-positive T cell quantity |
both |
132.0 days-139.0 days |
200 |
|
|
0.31 |
x 10E6 cells/ml |
0.0 |
0.06 |
automated differential white blood cell count test |
|
0 |
|
|
|
|
|
|
|
65886 |
114 |
| WKY.SHRSP-(D1Wox29-D1Arb21)/Izm |
cell membrane potential |
control condition |
Iigaya K, et al., Hypertension. 2008 Dec 1. |
action potential trait |
not specified |
days-4.0 days |
7 |
|
|
-46.4 |
mV |
0.87 |
2.3 |
whole-cell patch clamp technique |
|
600 |
|
|
|
|
regularly firing neurons |
|
|
65894 |
634 |
| WKY.SHRSP-(D1Wox29-D1Arb21)/Izm |
cell membrane potential |
control condition |
Iigaya K, et al., Hypertension. 2008 Dec 1. |
action potential trait |
not specified |
days-4.0 days |
8 |
|
|
-49.3 |
mV |
1.06 |
3.0 |
whole-cell patch clamp technique |
|
600 |
|
|
|
|
irregularly firing neurons |
|
|
65898 |
634 |
| ACI/N |
blood CD25 cell count to CD4 cell count ratio |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
regulatory T cell quantity |
both |
132.0 days-139.0 days |
215 |
|
|
43.3 |
% |
1.13 |
16.6 |
automated differential white blood cell count test |
|
0 |
|
|
|
|
|
|
|
65903 |
114 |
| ACI/N |
blood CD25 cell count to CD8 cell count ratio |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
regulatory T cell quantity |
both |
132.0 days-139.0 days |
215 |
|
|
71.6 |
% |
0.86 |
12.6 |
automated cell/particle size/count analysis method |
|
0 |
|
|
|
|
|
|
|
65906 |
114 |
| F344/NRrrc |
blood CD25 cell count to CD8 cell count ratio |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
regulatory T cell quantity |
both |
132.0 days-139.0 days |
215 |
|
|
71.5 |
% |
1.9 |
27.9 |
automated cell/particle size/count analysis method |
|
0 |
|
|
|
|
|
|
|
65907 |
114 |
| BN/SsN |
hematocrit |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
erythrocyte quantity |
both |
132.0 days-139.0 days |
208 |
|
|
52.4 |
% |
0.11 |
1.6 |
automated blood cell counting method |
|
0 |
|
|
|
|
|
|
|
65909 |
114 |
| BUF/N |
hematocrit |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
erythrocyte quantity |
both |
132.0 days-139.0 days |
208 |
|
|
44.2 |
% |
0.19 |
2.7 |
automated blood cell counting method |
|
0 |
|
|
|
|
|
|
|
65912 |
114 |
| ACI/N |
blood hemoglobin level |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
blood hemoglobin amount |
both |
132.0 days-139.0 days |
208 |
|
|
15.8 |
g/dl |
0.04 |
0.6 |
automated blood cell counting method |
|
0 |
|
|
|
|
|
|
|
65916 |
114 |
| BUF/N |
blood hemoglobin level |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
blood hemoglobin amount |
both |
132.0 days-139.0 days |
208 |
|
|
14.6 |
g/dl |
0.03 |
0.5 |
automated blood cell counting method |
|
0 |
|
|
|
|
|
|
|
65918 |
114 |
| N:HS |
mean corpuscular volume |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
erythrocyte size trait |
both |
132.0 days-139.0 days |
208 |
|
|
52.44 |
fl |
0.16 |
2.35 |
automated blood cell counting method |
|
0 |
|
|
|
|
|
|
|
65920 |
114 |
| F344/NRrrc |
platelet count |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
platelet quantity |
both |
132.0 days-139.0 days |
208 |
|
|
812.0 |
x 1000 /ul |
1.66 |
24.0 |
automated blood cell counting method |
|
0 |
|
|
|
|
|
|
|
65931 |
114 |
| F344/NRrrc |
white blood cell count |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
leukocyte quantity |
both |
132.0 days-139.0 days |
208 |
|
|
6.1 |
x 1000 cells/ul |
0.07 |
1.0 |
automated total white blood cell count test |
|
0 |
|
|
|
|
|
|
|
65943 |
114 |
| WKY.SHR-(D1Wox19-D1Mit2)/Njs |
mean arterial blood pressure |
control condition |
Frantz SA, et al., Hypertension 1998 Oct;32(4):639-46 |
arterial blood pressure trait |
male |
112.0 days
| 29 |
|
continuous mean |
127.3 |
mmHg |
1.6 |
8.6 |
tail cuff plethysmography |
|
0 |
|
|
|
animals were prewarmed to 34 degrees C for 20 min before BP |
|
|
|
65081 |
206 |
| SHR.WKY-(D1Wox19-D1Wox34)/Njs |
mean arterial blood pressure |
control condition |
Frantz SA, et al., Hypertension 1998 Oct;32(4):639-46 |
arterial blood pressure trait |
male |
112.0 days
| 31 |
|
continuous mean |
186.5 |
mmHg |
2.57 |
14.3 |
tail cuff plethysmography |
|
0 |
|
|
|
animals were prewarmed to 34 degrees C for 20 min before BP |
|
|
|
65083 |
206 |
| SHR |
mean arterial blood pressure |
control condition |
Frantz SA, et al., Hypertension 1998 Oct;32(4):639-46 |
arterial blood pressure trait |
male |
140.0 days
| 28 |
|
continuous mean |
206.8 |
mmHg |
2.36 |
12.5 |
tail cuff plethysmography |
|
|
|
|
|
animals were prewarmed to 34 degrees C for 20 min before BP |
|
|
|
65086 |
206 |
| SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm |
mammary gland terminal end bud count |
control condition |
Lella V, et al., Int J Cancer. 2007 Oct 15;121(8):1738-43. |
mammary gland development trait |
female |
55.0 days
| 5 |
|
|
60.3 |
null |
4.9 |
10.96 |
ex vivo light microscopy |
|
0 |
|
|
|
|
|
|
|
66137 |
709 |
| FHH/EurMcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
9 |
|
|
0.37 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
14880 |
381 |
| FHH/EurMcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
8 |
|
|
0.34 |
ml |
0.03 |
0.08 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
14885 |
381 |
| SS/JrHsdMcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
0.33 |
ml |
0.02 |
0.05 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
14888 |
381 |
| FHH-Chr 12BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
17 |
|
|
91.43 |
breaths/min |
2.24 |
9.22 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14920 |
381 |
| FHH-Chr 10BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
10 |
|
|
110.73 |
breaths/min |
5.51 |
17.41 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14928 |
381 |
| SS-Chr 5BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
9 |
|
|
109.45 |
breaths/min |
9.07 |
27.2 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14933 |
381 |
| SS-Chr 20BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
16 |
|
|
101.16 |
breaths/min |
4.9 |
19.61 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14937 |
381 |
| FHH-Chr 18BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
7 |
|
|
108.08 |
breaths/min |
7.72 |
20.44 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14943 |
381 |
| FHH-Chr YBN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
21 |
|
|
102.23 |
breaths/min |
3.62 |
16.59 |
stop flow air displacement plethysmography |
|
|
|
|
|